DPD_Class,DPD_DIN,DPD_brand_name,Virtual_name_from_DPDIngred,Company_name,BC_hazard_group,AB_hazard_categories,NIOSH_table,DPD_status,DPD_status_date,ATC_code_from_DPD,ATC_description_from_DPD
Human,00813966,Cytotec 100 Mcg,misoprostol 100 mcg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2004-07-26,A02BB01,Misoprostol
Human,02244022,Misoprostol,misoprostol 100 mcg oral tablet,Aa Pharma Inc,2.0,R,2.0,Marketed,2011-12-14,A02BB01,Misoprostol
Human,02240754,Novo-Misoprostol Tablets,misoprostol 100 mcg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled post market,2018-05-18,A02BB01,Misoprostol
Human,02244124,Pms-Misoprostol (0.1Mg),misoprostol 100 mcg oral tablet,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2017-09-30,A02BB01,Misoprostol
Human,00632600,Cytotec 200 Mcg,misoprostol 200 mcg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2005-08-05,A02BB01,Misoprostol
Human,02545284,Jamp Misoprostol,misoprostol 200 mcg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Approved,2024-02-13,A02BB01,Misoprostol
Human,02244023,Misoprostol,misoprostol 200 mcg oral tablet,Aa Pharma Inc,2.0,R,2.0,Marketed,2011-08-06,A02BB01,Misoprostol
Human,02248846,Misoprostol-200,misoprostol 200 mcg oral tablet,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2009-07-23,A02BB01,Misoprostol
Human,02240755,Novo-Misoprostol Tablets,misoprostol 200 mcg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled post market,2018-05-18,A02BB01,Misoprostol
Human,02244125,Pms-Misoprostol (0.2Mg),misoprostol 200 mcg oral tablet,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2017-09-30,A02BB01,Misoprostol
Human,02537745,Imcivree,setmelanotide (setmelanotide acetate) 10 mg / mL solution for injection,"Rhythm Pharmaceuticals, Inc.",,R,,Marketed,2023-07-12,A08AA12,Setmelanotide
Human,02478293,Soliqua,insulin glargine 100 units / mL + lixisenatide 33 mcg / mL solution for injection,Sanofi-Aventis Canada Inc,,R,,Marketed,2018-09-12,A10AE54,Insulin glargine and lixisenatide
Human,02361817,Byetta,exenatide 10 mcg / actuation solution for injection,Astrazeneca Canada Inc,,P,2.0,Cancelled post market,2022-02-01,A10BJ01,Exenatide
Human,02448610,Bydureon,exenatide 2 mg / dose kit (sustained-release powder for suspension) for injection,Astrazeneca Canada Inc,,P,2.0,Cancelled post market,2022-04-01,A10BJ01,Exenatide
Human,02483203,Bydureon Bcise,exenatide 2 mg / dose prolonged-release suspension for injection,Astrazeneca Canada Inc,,P,2.0,Cancelled pre market,2022-05-30,A10BJ01,Exenatide
Human,02361809,Byetta,exenatide 5 mcg / actuation solution for injection,Astrazeneca Canada Inc,,P,2.0,Cancelled post market,2022-01-06,A10BJ01,Exenatide
Human,02464349,Adlyxine,lixisenatide 0.05 mg / mL with lixisenatide 0.1 mg / mL kit (solution) for injection,Sanofi-Aventis Canada Inc,,R,,Cancelled post market,2018-10-08,A10BJ03,Lixisenatide
Human,02464276,Adlyxine,lixisenatide 10 mcg / actuation solution for injection,Sanofi-Aventis Canada Inc,,R,,Cancelled post market,2023-05-04,A10BJ03,Lixisenatide
Human,02464284,Adlyxine,lixisenatide 20 mcg / actuation solution for injection,Sanofi-Aventis Canada Inc,,R,,Cancelled post market,2023-09-15,A10BJ03,Lixisenatide
Human,02564106,Poviztra,semaglutide 0.25 mg / 0.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02522551,Wegovy,semaglutide 0.25 mg / 0.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2021-11-23,A10BJ06,Semaglutide
Human,02564114,Poviztra,semaglutide 0.5 mg / 0.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02522578,Wegovy,semaglutide 0.5 mg / 0.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2021-11-23,A10BJ06,Semaglutide
Human,02540258,Ozempic,semaglutide 0.68 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Marketed,2023-12-22,A10BJ06,Semaglutide
Human,02564041,Plosbrio,semaglutide 0.68 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02564122,Poviztra,semaglutide 1 mg / 0.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02522586,Wegovy,semaglutide 1 mg / 0.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2021-11-23,A10BJ06,Semaglutide
Human,02564157,Poviztra,semaglutide 1 mg / 1.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02528509,Wegovy,semaglutide 1 mg / 1.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Marketed,2024-03-28,A10BJ06,Semaglutide
Human,02471469,Ozempic,semaglutide 1.34 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Marketed,2018-02-22,A10BJ06,Semaglutide
Human,02471477,Ozempic,semaglutide 1.34 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Marketed,2018-02-22,A10BJ06,Semaglutide
Human,02562618,Ozempic,semaglutide 1.34 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-11-04,A10BJ06,Semaglutide
Human,02564068,Plosbrio,semaglutide 1.34 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02564076,Plosbrio,semaglutide 1.34 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02551012,Rybelsus,semaglutide 1.5 mg oral tablet,Novo Nordisk Canada Inc,1.0,P,,Approved,2024-10-09,A10BJ06,Semaglutide
Human,02564130,Poviztra,semaglutide 1.7 mg / 0.75 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02522594,Wegovy,semaglutide 1.7 mg / 0.75 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2021-11-23,A10BJ06,Semaglutide
Human,02497611,Rybelsus,semaglutide 14 mg oral tablet,Novo Nordisk Canada Inc,1.0,P,,Marketed,2020-04-19,A10BJ06,Semaglutide
Human,02564173,Poviztra,semaglutide 2 mg / 1.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02528517,Wegovy,semaglutide 2 mg / 1.5 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Marketed,2024-04-02,A10BJ06,Semaglutide
Human,02564165,Poviztra,semaglutide 2 mg / 3 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02552698,Wegovy,semaglutide 2 mg / 3 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2024-10-25,A10BJ06,Semaglutide
Human,02564149,Poviztra,semaglutide 2.4 mg / 0.75 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02522608,Wegovy,semaglutide 2.4 mg / 0.75 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2021-11-23,A10BJ06,Semaglutide
Human,02523930,Ozempic,semaglutide 2.68 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2022-01-04,A10BJ06,Semaglutide
Human,02562626,Ozempic,semaglutide 2.68 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-11-04,A10BJ06,Semaglutide
Human,02564084,Plosbrio,semaglutide 2.68 mg / mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02497581,Rybelsus,semaglutide 3 mg oral tablet,Novo Nordisk Canada Inc,1.0,P,,Marketed,2020-04-19,A10BJ06,Semaglutide
Human,02564181,Poviztra,semaglutide 4 mg / 3 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02528525,Wegovy,semaglutide 4 mg / 3 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Marketed,2024-03-28,A10BJ06,Semaglutide
Human,02551020,Rybelsus,semaglutide 4 mg oral tablet,Novo Nordisk Canada Inc,1.0,P,,Approved,2024-10-08,A10BJ06,Semaglutide
Human,02564203,Poviztra,semaglutide 6.8 mg / 3 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02528533,Wegovy,semaglutide 6.8 mg / 3 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Marketed,2024-04-02,A10BJ06,Semaglutide
Human,02497603,Rybelsus,semaglutide 7 mg oral tablet,Novo Nordisk Canada Inc,1.0,P,,Marketed,2020-04-19,A10BJ06,Semaglutide
Human,02551039,Rybelsus,semaglutide 9 mg oral tablet,Novo Nordisk Canada Inc,1.0,P,,Approved,2024-10-09,A10BJ06,Semaglutide
Human,02564211,Poviztra,semaglutide 9.6 mg / 3 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Approved,2025-12-22,A10BJ06,Semaglutide
Human,02528541,Wegovy,semaglutide 9.6 mg / 3 mL solution for injection,Novo Nordisk Canada Inc,1.0,P,,Marketed,2024-04-22,A10BJ06,Semaglutide
Human,02532921,Mounjaro,tirzepatide 10 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Approved,2022-11-24,A10BX16,Tirzepatide
Human,02541084,Mounjaro,tirzepatide 10 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2023-10-23,A10BX16,Tirzepatide
Human,02551985,Mounjaro Kwikpen,tirzepatide 10 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2024-12-10,A10BX16,Tirzepatide
Human,02557533,Zepbound Kwikpen,tirzepatide 10 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2025-07-09,A10BX16,Tirzepatide
Human,02532948,Mounjaro,tirzepatide 12.5 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Approved,2022-11-24,A10BX16,Tirzepatide
Human,02541092,Mounjaro,tirzepatide 12.5 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2023-10-23,A10BX16,Tirzepatide
Human,02551993,Mounjaro Kwikpen,tirzepatide 12.5 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2024-12-10,A10BX16,Tirzepatide
Human,02557541,Zepbound Kwikpen,tirzepatide 12.5 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2025-07-09,A10BX16,Tirzepatide
Human,02532956,Mounjaro,tirzepatide 15 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Approved,2022-11-24,A10BX16,Tirzepatide
Human,02541106,Mounjaro,tirzepatide 15 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2023-10-23,A10BX16,Tirzepatide
Human,02552000,Mounjaro Kwikpen,tirzepatide 15 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2024-12-10,A10BX16,Tirzepatide
Human,02557568,Zepbound Kwikpen,tirzepatide 15 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2025-07-09,A10BX16,Tirzepatide
Human,02532891,Mounjaro,tirzepatide 2.5 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Approved,2022-11-24,A10BX16,Tirzepatide
Human,02541041,Mounjaro,tirzepatide 2.5 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2023-10-23,A10BX16,Tirzepatide
Human,02551950,Mounjaro Kwikpen,tirzepatide 2.5 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2024-12-10,A10BX16,Tirzepatide
Human,02557509,Zepbound Kwikpen,tirzepatide 2.5 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2025-07-09,A10BX16,Tirzepatide
Human,02532905,Mounjaro,tirzepatide 5 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Approved,2022-11-24,A10BX16,Tirzepatide
Human,02541068,Mounjaro,tirzepatide 5 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2023-10-23,A10BX16,Tirzepatide
Human,02551969,Mounjaro Kwikpen,tirzepatide 5 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2024-12-10,A10BX16,Tirzepatide
Human,02557517,Zepbound Kwikpen,tirzepatide 5 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2025-07-09,A10BX16,Tirzepatide
Human,02532913,Mounjaro,tirzepatide 7.5 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Approved,2022-11-24,A10BX16,Tirzepatide
Human,02541076,Mounjaro,tirzepatide 7.5 mg / 0.5 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2023-10-23,A10BX16,Tirzepatide
Human,02551977,Mounjaro Kwikpen,tirzepatide 7.5 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2024-12-10,A10BX16,Tirzepatide
Human,02557525,Zepbound Kwikpen,tirzepatide 7.5 mg / 0.6 mL solution for injection,Eli Lilly Canada Inc,1.0,K,,Marketed,2025-07-09,A10BX16,Tirzepatide
Human,02526255,Palynziq,pegvaliase 10 mg / 0.5 mL solution for injection,Biomarin International Limited,2.0,P,,Marketed,2022-08-26,A16AB19,Pegvaliase
Human,02526247,Palynziq,pegvaliase 2.5 mg / 0.5 mL solution for injection,Biomarin International Limited,2.0,P,,Marketed,2022-08-26,A16AB19,Pegvaliase
Human,02526263,Palynziq,pegvaliase 20 mg / mL solution for injection,Biomarin International Limited,2.0,P,,Marketed,2022-08-26,A16AB19,Pegvaliase
Human,02563576,Elfabrio,pegunigalsidase alfa 20 mg / 10 mL solution for injection,Chiesi Farmaceutici S.P.A.,2.0,,,Approved,2025-12-09,A16AB20,Pegunigalsidase alfa
Human,02563568,Elfabrio,pegunigalsidase alfa 5 mg / 2.5 mL solution for injection,Chiesi Farmaceutici S.P.A.,2.0,,,Approved,2025-12-09,A16AB20,Pegunigalsidase alfa
Human,02436663,Pheburane,sodium phenylbutyrate 483 mg / g oral granules,Medunik Canada,,R,,Marketed,2015-01-27,A16AX03,Sodium phenylbutyrate
Human,02468042,Galafold,migalastat (migalastat hydrochloride) 123 mg oral capsule,Amicus Therapeutics Canada Inc.,2.0,,,Marketed,2023-08-03,A16AX14,Migalastat
Human,02506343,Givlaari,givosiran (givosiran sodium) 189 mg / mL solution for injection,Alnylam Netherlands B.V.,2.0,,,Marketed,2020-12-01,A16AX16,Givosiran
Human,02242924,Apo-Warfarin,warfarin sodium 1 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2000-10-16,B01AA03,Warfarin
Human,01918311,Coumadin Tab 1Mg,warfarin sodium 1 mg oral tablet,Bristol-Myers Squibb Canada,2.0,R,2.0,Cancelled post market,2020-06-30,B01AA03,Warfarin
Human,02244462,Mylan-Warfarin,warfarin sodium 1 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,B01AA03,Warfarin
Human,02265273,Novo-Warfarin,warfarin sodium 1 mg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled post market,2015-10-26,B01AA03,Warfarin
Human,02335611,Nu-Warfarin,warfarin sodium 1 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,B01AA03,Warfarin
Human,02242680,Taro-Warfarin,warfarin sodium 1 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2000-08-09,B01AA03,Warfarin
Human,02344025,Warfarin,warfarin sodium 1 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Cancelled post market,2014-08-01,B01AA03,Warfarin
Human,02242929,Apo-Warfarin,warfarin sodium 10 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2000-10-16,B01AA03,Warfarin
Human,01918362,Coumadin Tab 10Mg,warfarin sodium 10 mg oral tablet,Bristol-Myers Squibb Canada,2.0,R,2.0,Cancelled post market,2020-06-22,B01AA03,Warfarin
Human,02244467,Mylan-Warfarin,warfarin sodium 10 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,B01AA03,Warfarin
Human,02265370,Novo-Warfarin,warfarin sodium 10 mg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled pre market,2015-10-16,B01AA03,Warfarin
Human,02335689,Nu-Warfarin,warfarin sodium 10 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,B01AA03,Warfarin
Human,02242687,Taro-Warfarin,warfarin sodium 10 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2000-08-09,B01AA03,Warfarin
Human,02344114,Warfarin,warfarin sodium 10 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Cancelled post market,2014-08-01,B01AA03,Warfarin
Human,02242925,Apo-Warfarin,warfarin sodium 2 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2000-10-16,B01AA03,Warfarin
Human,01918338,Coumadin Tab 2Mg,warfarin sodium 2 mg oral tablet,Bristol-Myers Squibb Canada,2.0,R,2.0,Cancelled post market,2020-06-21,B01AA03,Warfarin
Human,02244463,Mylan-Warfarin,warfarin sodium 2 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,B01AA03,Warfarin
Human,02265281,Novo-Warfarin,warfarin sodium 2 mg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled post market,2015-10-26,B01AA03,Warfarin
Human,02335638,Nu-Warfarin,warfarin sodium 2 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,B01AA03,Warfarin
Human,02242681,Taro-Warfarin,warfarin sodium 2 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2000-08-09,B01AA03,Warfarin
Human,02344033,Warfarin,warfarin sodium 2 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Cancelled post market,2014-08-01,B01AA03,Warfarin
Human,02242926,Apo-Warfarin,warfarin sodium 2.5 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2000-10-16,B01AA03,Warfarin
Human,01918346,Coumadin Tab 2.5Mg,warfarin sodium 2.5 mg oral tablet,Bristol-Myers Squibb Canada,2.0,R,2.0,Cancelled post market,2020-08-24,B01AA03,Warfarin
Human,02244464,Mylan-Warfarin,warfarin sodium 2.5 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,B01AA03,Warfarin
Human,02265303,Novo-Warfarin,warfarin sodium 2.5 mg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled post market,2015-10-26,B01AA03,Warfarin
Human,02335646,Nu-Warfarin,warfarin sodium 2.5 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,B01AA03,Warfarin
Human,02242682,Taro-Warfarin,warfarin sodium 2.5 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2000-08-09,B01AA03,Warfarin
Human,02344041,Warfarin,warfarin sodium 2.5 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Cancelled post market,2014-08-01,B01AA03,Warfarin
Human,02245618,Apo-Warfarin,warfarin sodium 3 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2002-04-23,B01AA03,Warfarin
Human,02240205,Coumadin Tab 3Mg,warfarin sodium 3 mg oral tablet,Bristol-Myers Squibb Canada,2.0,R,2.0,Cancelled post market,2020-08-24,B01AA03,Warfarin
Human,02287498,Mylan-Warfarin,warfarin sodium 3 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,B01AA03,Warfarin
Human,02265311,Novo-Warfarin,warfarin sodium 3 mg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled post market,2015-10-26,B01AA03,Warfarin
Human,02335654,Nu-Warfarin,warfarin sodium 3 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,B01AA03,Warfarin
Human,02242683,Taro-Warfarin,warfarin sodium 3 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2000-08-09,B01AA03,Warfarin
Human,02344068,Warfarin,warfarin sodium 3 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Cancelled post market,2014-08-01,B01AA03,Warfarin
Human,02242927,Apo-Warfarin,warfarin sodium 4 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2000-10-16,B01AA03,Warfarin
Human,02007959,Coumadin Tab 4Mg,warfarin sodium 4 mg oral tablet,Bristol-Myers Squibb Canada,2.0,R,2.0,Cancelled post market,2020-06-25,B01AA03,Warfarin
Human,02244465,Mylan-Warfarin,warfarin sodium 4 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,B01AA03,Warfarin
Human,02265338,Novo-Warfarin,warfarin sodium 4 mg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled post market,2015-10-26,B01AA03,Warfarin
Human,02335662,Nu-Warfarin,warfarin sodium 4 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,B01AA03,Warfarin
Human,02242684,Taro-Warfarin,warfarin sodium 4 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2000-08-09,B01AA03,Warfarin
Human,02344076,Warfarin,warfarin sodium 4 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Cancelled post market,2014-08-01,B01AA03,Warfarin
Human,00010308,Warfilone Tab 5Mg,warfarin sodium 5 mg / tablet oral tablet,"Merck Frosst Canada & Cie, Merck Frosst Canada & Co.",2.0,R,2.0,Cancelled post market,2000-08-03,B01AA03,Warfarin
Human,02229741,Coumadin,warfarin sodium 5 mg / vial powder for solution for injection,Bristol-Myers Squibb Canada,2.0,R,2.0,Cancelled post market,2006-05-29,B01AA03,Warfarin
Human,02242928,Apo-Warfarin,warfarin sodium 5 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2000-10-16,B01AA03,Warfarin
Human,01918354,Coumadin Tab 5Mg,warfarin sodium 5 mg oral tablet,Bristol-Myers Squibb Canada,2.0,R,2.0,Cancelled post market,2020-08-20,B01AA03,Warfarin
Human,02244466,Mylan-Warfarin,warfarin sodium 5 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,B01AA03,Warfarin
Human,02265346,Novo-Warfarin,warfarin sodium 5 mg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled post market,2015-10-26,B01AA03,Warfarin
Human,02335670,Nu-Warfarin,warfarin sodium 5 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,B01AA03,Warfarin
Human,02242685,Taro-Warfarin,warfarin sodium 5 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2000-08-09,B01AA03,Warfarin
Human,02344084,Warfarin,warfarin sodium 5 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Cancelled post market,2014-08-01,B01AA03,Warfarin
Human,02240206,Coumadin Tab 6 Mg,warfarin sodium 6 mg oral tablet,Bristol-Myers Squibb Canada,2.0,R,2.0,Cancelled post market,2020-06-25,B01AA03,Warfarin
Human,02287501,Mylan-Warfarin,warfarin sodium 6 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,B01AA03,Warfarin
Human,02265354,Novo-Warfarin,warfarin sodium 6 mg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled pre market,2015-10-16,B01AA03,Warfarin
Human,02242686,Taro-Warfarin,warfarin sodium 6 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2000-08-09,B01AA03,Warfarin
Human,02344092,Warfarin,warfarin sodium 6 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Cancelled post market,2014-08-01,B01AA03,Warfarin
Human,02287528,Mylan-Warfarin,warfarin sodium 7.5 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,B01AA03,Warfarin
Human,02265362,Novo-Warfarin,warfarin sodium 7.5 mg oral tablet,Novopharm Limited,2.0,R,2.0,Cancelled pre market,2015-10-16,B01AA03,Warfarin
Human,02242697,Taro-Warfarin,warfarin sodium 7.5 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2000-08-09,B01AA03,Warfarin
Human,02344106,Warfarin,warfarin sodium 7.5 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Cancelled post market,2014-08-01,B01AA03,Warfarin
Human,02461382,Revolade,eltrombopag (eltrombopag olamine) 12.5 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,,,Cancelled pre market,2020-03-11,B02BX05,Eltrombopag
Human,02506742,Apo-Eltrombopag,eltrombopag (eltrombopag olamine) 25 mg oral tablet,Apotex Inc,2.0,,,Marketed,2023-05-23,B02BX05,Eltrombopag
Human,02361825,Revolade,eltrombopag (eltrombopag olamine) 25 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,,,Marketed,2016-03-24,B02BX05,Eltrombopag
Human,02551721,Teva-Eltrombopag,eltrombopag (eltrombopag olamine) 25 mg oral tablet,Teva Canada Limited,2.0,,,Approved,2024-09-18,B02BX05,Eltrombopag
Human,02506769,Apo-Eltrombopag,eltrombopag (eltrombopag olamine) 50 mg oral tablet,Apotex Inc,2.0,,,Marketed,2023-05-23,B02BX05,Eltrombopag
Human,02361833,Revolade,eltrombopag (eltrombopag olamine) 50 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,,,Marketed,2016-02-16,B02BX05,Eltrombopag
Human,02551748,Teva-Eltrombopag,eltrombopag (eltrombopag olamine) 50 mg oral tablet,Teva Canada Limited,2.0,,,Approved,2024-09-18,B02BX05,Eltrombopag
Human,02423049,Revolade,eltrombopag (eltrombopag olamine) 75 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,,,Cancelled pre market,2020-03-11,B02BX05,Eltrombopag
Human,02542706,Doptelet,avatrombopag (avatrombopag maleate) 20 mg oral tablet,Swedish Orphan Biovitrum Ab (Publ),2.0,,,Marketed,2024-01-22,B02BX08,Avatrombopag
Human,02508052,Tavalisse,fostamatinib (fostamatinib disodium) 100 mg oral tablet,Medison Pharma Canada Inc.,2.0,R,,Marketed,2022-08-15,B02BX09,Fostamatinib
Human,02508060,Tavalisse,fostamatinib (fostamatinib disodium) 150 mg oral tablet,Medison Pharma Canada Inc.,2.0,R,,Marketed,2022-07-04,B02BX09,Fostamatinib
Human,02425696,Firazyr,icatibant (icatibant acetate) 10 mg / mL solution for injection,Takeda Canada Inc,2.0,R,2.0,Marketed,2021-07-21,B06AC02,Icatibant
Human,02523337,Icatibant Injection,icatibant (icatibant acetate) 10 mg / mL solution for injection,Juno Pharmaceuticals Corp.,2.0,R,2.0,Approved,2022-12-05,B06AC02,Icatibant
Human,02547562,Icatibant Injection,icatibant (icatibant acetate) 10 mg / mL solution for injection,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2024-10-04,B06AC02,Icatibant
Human,02524619,Mint-Icatibant,icatibant (icatibant acetate) 10 mg / mL solution for injection,Mint Pharmaceuticals Inc,2.0,R,2.0,Approved,2022-12-05,B06AC02,Icatibant
Human,02513773,Teva-Icatibant,icatibant (icatibant acetate) 10 mg / mL solution for injection,Teva Canada Limited,2.0,R,2.0,Cancelled pre market,2025-07-30,B06AC02,Icatibant
Human,02516608,Icatibant Injection,icatibant (icatibant acetate) 30 mg / 3 mL solution for injection,Accord Healthcare Inc,2.0,R,2.0,Cancelled pre market,2025-06-09,B06AC02,Icatibant
Human,02514397,Asn-Dronedarone,dronedarone (dronedarone hydrochloride) 400 mg oral tablet,Ascend Laboratories Ltd,2.0,R,2.0,Approved,2021-03-29,C01BD07,Dronedarone
Human,02330989,Multaq,dronedarone (dronedarone hydrochloride) 400 mg oral tablet,Sanofi-Aventis Canada Inc,2.0,R,2.0,Marketed,2009-09-28,C01BD07,Dronedarone
Human,02537060,Verquvo,vericiguat 10 mg oral tablet,Bayer Inc,2.0,,,Marketed,2023-09-19,C01DX22,Vericiguat
Human,02537044,Verquvo,vericiguat 2.5 mg oral tablet,Bayer Inc,2.0,,,Marketed,2023-09-19,C01DX22,Vericiguat
Human,02537052,Verquvo,vericiguat 5 mg oral tablet,Bayer Inc,2.0,,,Marketed,2023-09-19,C01DX22,Vericiguat
Human,02459973,Lancora,ivabradine (ivabradine hydrochloride) 5 mg oral tablet,Servier Canada Inc,2.0,R,2.0,Marketed,2017-03-17,C01EB17,Ivabradine
Human,02459981,Lancora,ivabradine (ivabradine hydrochloride) 7.5 mg oral tablet,Servier Canada Inc,2.0,R,2.0,Marketed,2017-03-17,C01EB17,Ivabradine
Human,02532565,Camzyos,mavacamten 10 mg oral capsule,Bristol-Myers Squibb Canada,,P,,Marketed,2023-06-13,C01EB24,Mavacamten
Human,02532573,Camzyos,mavacamten 15 mg oral capsule,Bristol-Myers Squibb Canada,,P,,Marketed,2023-08-08,C01EB24,Mavacamten
Human,02532549,Camzyos,mavacamten 2.5 mg oral capsule,Bristol-Myers Squibb Canada,,P,,Marketed,2023-01-09,C01EB24,Mavacamten
Human,02532557,Camzyos,mavacamten 5 mg oral capsule,Bristol-Myers Squibb Canada,,P,,Marketed,2023-01-09,C01EB24,Mavacamten
Human,02435403,Accel-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Accel Pharma Inc,2.0,R,2.0,Cancelled pre market,2017-05-19,C02KX01,Bosentan
Human,02386208,Act Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Actavis Pharma Company,2.0,R,2.0,Cancelled post market,2018-04-25,C02KX01,Bosentan
Human,02423065,Alembic-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Alembic Pharmaceuticals Limited,2.0,R,2.0,Approved,2021-12-16,C02KX01,Bosentan
Human,02399210,Apo-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Apotex Inc,2.0,R,2.0,Dormant,2019-11-03,C02KX01,Bosentan
Human,02526409,Auro-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Approved,2022-04-07,C02KX01,Bosentan
Human,02466546,Bio-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Biomed Pharma,2.0,R,2.0,Cancelled post market,2022-07-19,C02KX01,Bosentan
Human,02463563,Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Actelion Pharmaceuticals Ltd,2.0,R,2.0,Cancelled pre market,2018-09-28,C02KX01,Bosentan
Human,02468530,Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Panda Pharmaceuticals Inc.,2.0,R,2.0,Approved,2017-09-22,C02KX01,Bosentan
Human,02426463,Bosentan Tablets,bosentan (bosentan monohydrate) 125 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Cancelled post market,2015-06-02,C02KX01,Bosentan
Human,02424045,Mar-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Cancelled pre market,2023-06-23,C02KX01,Bosentan
Human,02383500,Mylan-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2018-07-12,C02KX01,Bosentan
Human,02467992,Nat-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Natco Pharma (Canada) Inc,2.0,R,2.0,Marketed,2020-04-30,C02KX01,Bosentan
Human,02383020,Pms-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2012-06-12,C02KX01,Bosentan
Human,02386283,Sandoz Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2021-01-30,C02KX01,Bosentan
Human,02483149,Taro-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2020-05-07,C02KX01,Bosentan
Human,02398419,Teva-Bosentan,bosentan (bosentan monohydrate) 125 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2017-08-21,C02KX01,Bosentan
Human,02244982,Tracleer,bosentan (bosentan monohydrate) 125 mg oral tablet,Janssen Inc,2.0,R,2.0,Marketed,2019-10-18,C02KX01,Bosentan
Human,02386194,Act Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Actavis Pharma Company,2.0,R,2.0,Cancelled post market,2018-04-25,C02KX01,Bosentan
Human,02423057,Alembic-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Alembic Pharmaceuticals Limited,2.0,R,2.0,Approved,2021-12-16,C02KX01,Bosentan
Human,02399202,Apo-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Apotex Inc,2.0,R,2.0,Dormant,2019-10-04,C02KX01,Bosentan
Human,02526395,Auro-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Approved,2022-04-07,C02KX01,Bosentan
Human,02466538,Bio-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Biomed Pharma,2.0,R,2.0,Cancelled post market,2022-07-19,C02KX01,Bosentan
Human,02463555,Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Actelion Pharmaceuticals Ltd,2.0,R,2.0,Cancelled pre market,2018-09-28,C02KX01,Bosentan
Human,02468522,Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Panda Pharmaceuticals Inc.,2.0,R,2.0,Approved,2017-09-22,C02KX01,Bosentan
Human,02424037,Mar-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Cancelled pre market,2023-06-23,C02KX01,Bosentan
Human,02383497,Mylan-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2018-07-12,C02KX01,Bosentan
Human,02467984,Nat-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Natco Pharma (Canada) Inc,2.0,R,2.0,Marketed,2020-04-30,C02KX01,Bosentan
Human,02383012,Pms-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2012-06-12,C02KX01,Bosentan
Human,02386275,Sandoz Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2020-04-30,C02KX01,Bosentan
Human,02483130,Taro-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2020-05-07,C02KX01,Bosentan
Human,02398400,Teva-Bosentan,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2021-08-12,C02KX01,Bosentan
Human,02244981,Tracleer,bosentan (bosentan monohydrate) 62.5 mg oral tablet,Janssen Inc,2.0,R,2.0,Marketed,2020-02-20,C02KX01,Bosentan
Human,02475383,Apo-Ambrisentan,ambrisentan 10 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2018-11-26,C02KX02,Ambrisentan
Human,02527103,Auro-Ambrisentan,ambrisentan 10 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Approved,2022-05-05,C02KX02,Ambrisentan
Human,02521946,Jamp Ambrisentan,ambrisentan 10 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Dormant,2025-07-31,C02KX02,Ambrisentan
Human,02554097,M-Ambrisentan,ambrisentan 10 mg oral tablet,Mantra Pharma Inc,2.0,R,2.0,Approved,2024-12-17,C02KX02,Ambrisentan
Human,02525313,Sandoz Ambrisentan,ambrisentan 10 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled pre market,2023-07-26,C02KX02,Ambrisentan
Human,02526883,Sandoz Ambrisentan Tablets,ambrisentan 10 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2022-10-07,C02KX02,Ambrisentan
Human,02536242,Teva-Ambrisentan,ambrisentan 10 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled pre market,2024-04-30,C02KX02,Ambrisentan
Human,02307073,Volibris,ambrisentan 10 mg oral tablet,Glaxosmithkline Inc,2.0,R,2.0,Marketed,2008-06-24,C02KX02,Ambrisentan
Human,02475375,Apo-Ambrisentan,ambrisentan 5 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2018-11-26,C02KX02,Ambrisentan
Human,02527081,Auro-Ambrisentan,ambrisentan 5 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Approved,2022-05-05,C02KX02,Ambrisentan
Human,02521938,Jamp Ambrisentan,ambrisentan 5 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Dormant,2025-07-31,C02KX02,Ambrisentan
Human,02554089,M-Ambrisentan,ambrisentan 5 mg oral tablet,Mantra Pharma Inc,2.0,R,2.0,Approved,2024-12-17,C02KX02,Ambrisentan
Human,02525305,Sandoz Ambrisentan,ambrisentan 5 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled pre market,2023-07-26,C02KX02,Ambrisentan
Human,02526875,Sandoz Ambrisentan Tablets,ambrisentan 5 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2022-10-07,C02KX02,Ambrisentan
Human,02536234,Teva-Ambrisentan,ambrisentan 5 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled pre market,2024-04-30,C02KX02,Ambrisentan
Human,02307065,Volibris,ambrisentan 5 mg oral tablet,Glaxosmithkline Inc,2.0,R,2.0,Marketed,2008-06-24,C02KX02,Ambrisentan
Human,02415690,Opsumit,macitentan 10 mg oral tablet,Janssen Inc,2.0,R,2.0,Marketed,2019-09-09,C02KX04,Macitentan
Human,02561069,Opsumit,macitentan 2.5 mg oral tablet for suspension,Janssen Inc,2.0,R,2.0,Approved,2025-09-12,C02KX04,Macitentan
Human,02412764,Adempas,riociguat 0.5 mg oral tablet,Bayer Inc,2.0,R,2.0,Marketed,2013-09-25,C02KX05,Riociguat
Human,02533545,Sandoz Riociguat,riociguat 0.5 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2024-04-29,C02KX05,Riociguat
Human,02412772,Adempas,riociguat 1 mg oral tablet,Bayer Inc,2.0,R,2.0,Marketed,2013-09-25,C02KX05,Riociguat
Human,02533561,Sandoz Riociguat,riociguat 1 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2024-04-29,C02KX05,Riociguat
Human,02412799,Adempas,riociguat 1.5 mg oral tablet,Bayer Inc,2.0,R,2.0,Marketed,2013-09-25,C02KX05,Riociguat
Human,02533588,Sandoz Riociguat,riociguat 1.5 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2024-04-29,C02KX05,Riociguat
Human,02412802,Adempas,riociguat 2 mg oral tablet,Bayer Inc,2.0,R,2.0,Marketed,2013-09-25,C02KX05,Riociguat
Human,02533596,Sandoz Riociguat,riociguat 2 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2024-04-29,C02KX05,Riociguat
Human,02412810,Adempas,riociguat 2.5 mg oral tablet,Bayer Inc,2.0,R,2.0,Marketed,2013-09-25,C02KX05,Riociguat
Human,02533618,Sandoz Riociguat,riociguat 2.5 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2024-04-29,C02KX05,Riociguat
Human,02551306,Winrevair,sotatercept 45 mg / vial kit (powder for solution) for injection,Merck Canada Inc,2.0,,,Marketed,2025-02-12,C02KX06,Sotatercept
Human,02551284,Winrevair,sotatercept 45 mg / vial powder for solution for injection,Merck Canada Inc,2.0,,,Approved,2024-08-28,C02KX06,Sotatercept
Human,02551314,Winrevair,sotatercept 60 mg / vial kit (powder for solution) for injection,Merck Canada Inc,2.0,,,Marketed,2025-02-12,C02KX06,Sotatercept
Human,02551292,Winrevair,sotatercept 60 mg / vial powder for solution for injection,Merck Canada Inc,2.0,,,Approved,2024-08-28,C02KX06,Sotatercept
Human,02521083,Opsynvi,macitentan 10 mg + tadalafil 40 mg oral tablet,Janssen Inc,2.0,R,2.0,Marketed,2021-11-25,C02KX54,Macitentan and tadalafil
Human,00285455,Aldactone 100 Mg,spironolactone 100 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2009-02-03,C03DA01,Spironolactone
Human,02518848,Jamp Spironolactone,spironolactone 100 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2022-07-14,C03DA01,Spironolactone
Human,02488159,Mint-Spironolactone,spironolactone 100 mg oral tablet,Mint Pharmaceuticals Inc,2.0,P,2.0,Marketed,2020-02-06,C03DA01,Spironolactone
Human,02347628,Ntp-Spironolactone,spironolactone 100 mg oral tablet,Nt Pharma Canada Ltd,2.0,P,2.0,Cancelled pre market,2017-03-16,C03DA01,Spironolactone
Human,00613223,Teva-Spironolactone,spironolactone 100 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2011-06-29,C03DA01,Spironolactone
Human,00028606,Aldactone 25 Mg,spironolactone 25 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2006-02-13,C03DA01,Spironolactone
Human,02518821,Jamp Spironolactone,spironolactone 25 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2022-07-14,C03DA01,Spironolactone
Human,02488140,Mint-Spironolactone,spironolactone 25 mg oral tablet,Mint Pharmaceuticals Inc,2.0,P,2.0,Marketed,2020-02-06,C03DA01,Spironolactone
Human,02347601,Ntp-Spironolactone,spironolactone 25 mg oral tablet,Nt Pharma Canada Ltd,2.0,P,2.0,Cancelled pre market,2017-03-16,C03DA01,Spironolactone
Human,00613215,Teva-Spironolactone,spironolactone 25 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2011-06-29,C03DA01,Spironolactone
Human,02531917,Kerendia,finerenone 10 mg oral tablet,Bayer Inc,2.0,,,Marketed,2022-11-22,C03DA05,Finerenone
Human,02531925,Kerendia,finerenone 20 mg oral tablet,Bayer Inc,2.0,,,Marketed,2022-11-22,C03DA05,Finerenone
Human,02564726,Kerendia,finerenone 40 mg oral tablet,Bayer Inc,2.0,,,Approved,2026-01-19,C03DA05,Finerenone
Human,00613231,Teva-Spironolactone/Hctz,hydrochlorothiazide 25 mg + spironolactone 25 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2011-06-29,C03EA01,Hydrochlorothiazide and potassium-sparing agents
Human,00180408,Aldactazide 25,hydrochlorothiazide 25 mg + spironolactone 25 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Cancelled post market,2020-04-01,C03EA01,Hydrochlorothiazide and potassium-sparing agents
Human,00520802,Apo-Spirozide Tab,hydrochlorothiazide 25 mg + spironolactone 25 mg oral tablet,Apotex Inc,2.0,P,2.0,Cancelled post market,2011-08-05,C03EA01,Hydrochlorothiazide and potassium-sparing agents
Human,00657182,Teva-Spironolactone/Hctz,hydrochlorothiazide 50 mg + spironolactone 50 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2011-06-29,C03EA01,Hydrochlorothiazide and potassium-sparing agents
Human,00594377,Aldactazide 50,hydrochlorothiazide 50 mg + spironolactone 50 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Cancelled post market,2020-04-01,C03EA01,Hydrochlorothiazide and potassium-sparing agents
Human,02366223,Cleviprex,clevidipine 0.5 mg / mL emulsion for injection,Chiesi Farmaceutici S.P.A.,,R,,Marketed,2023-08-04,C08CA16,Clevidipine
Human,02420376,Juxtapid,lomitapide (lomitapide mesylate) 10 mg oral capsule,Chiesi Farmaceutici S.P.A.,2.0,R,2.0,Marketed,2024-02-23,C10AX12,Lomitapide
Human,02420384,Juxtapid,lomitapide (lomitapide mesylate) 20 mg oral capsule,Chiesi Farmaceutici S.P.A.,2.0,R,2.0,Marketed,2024-02-23,C10AX12,Lomitapide
Human,02420341,Juxtapid,lomitapide (lomitapide mesylate) 5 mg oral capsule,Chiesi Farmaceutici S.P.A.,2.0,R,2.0,Marketed,2024-03-18,C10AX12,Lomitapide
Human,02541769,Evkeeza,evinacumab 150 mg / mL solution for injection,Ultragenyx Pharmaceutical Inc,2.0,R,,Marketed,2023-11-21,C10AX17,Evinacumab
Human,00156124,Elase Chloromycetin Ont,chloramphenicol 10 mg / g + deoxyribonuclease pancreatic 666 units / g + fibrinolysin 1 units / g cutaneous ointment,"Parke-Davis Division, Warner-Lambert Canada Inc.",1.0,K,1.0,Cancelled post market,1998-09-14,D03BA,Proteolytic enzymes
Human,00698059,Ultra Mop Lotion 1%,methoxsalen 1 % / % topical liquid,Canderm G.P.,,,,Cancelled post market,2008-08-06,D05AD02,"Methoxalen, topical"
Human,01907476,Oxsoralen Lot 10Mg/Ml,methoxsalen 10 mg / mL cutaneous lotion,Valeant Canada Lp / Valeant Canada S.E.C.,,,,Cancelled post market,2015-08-05,D05AD02,"Methoxalen, topical"
Human,01946374,Oxsoralen Cap 10Mg,methoxsalen 10 mg oral capsule,Valeant Canada Lp / Valeant Canada S.E.C.,,,,Cancelled post market,2015-08-05,D05BA02,"Methoxalen, systemic"
Human,00252654,Oxsoralen-Ultra Cap 10Mg,methoxsalen 10 mg oral capsule,Valeant Canada Lp / Valeant Canada S.E.C.,,,,Cancelled post market,2015-08-05,D05BA02,"Methoxalen, systemic"
Human,00646237,Ultramop Cap 10Mg,methoxsalen 10 mg oral capsule,Canderm G.P.,,,,Cancelled post market,2011-07-28,D05BA02,"Methoxalen, systemic"
Human,02406233,Uvadex,methoxsalen 20 mcg / mL extracorporeal solution,Therakos Llc,,,,Marketed,2013-12-09,D05BA02,"Methoxalen, systemic"
Human,02468840,Mint-Acitretin,acitretin 10 mg oral capsule,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2018-01-24,D05BB02,Acitretin
Human,02070847,Soriatane,acitretin 10 mg oral capsule,Allergan Inc,2.0,R,2.0,Marketed,2019-12-07,D05BB02,Acitretin
Human,02466074,Taro-Acitretin,acitretin 10 mg oral capsule,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2018-02-06,D05BB02,Acitretin
Human,02540703,Jamp Acitretin,acitretin 25 mg oral capsule,Jamp Pharma Corporation,2.0,R,2.0,Approved,2023-08-24,D05BB02,Acitretin
Human,02468859,Mint-Acitretin,acitretin 25 mg oral capsule,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2018-01-24,D05BB02,Acitretin
Human,02070863,Soriatane,acitretin 25 mg oral capsule,Allergan Inc,2.0,R,2.0,Marketed,2020-03-20,D05BB02,Acitretin
Human,02466082,Taro-Acitretin,acitretin 25 mg oral capsule,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2018-03-26,D05BB02,Acitretin
Human,00206342,Verban Ont,colchicine 100 mg / 100 g + podophyllin 2 g / 100 g cutaneous ointment,"Welcker-Lyster Ltd., Division Of Technilab Inc.",2.0,R,2.0,Cancelled post market,1999-09-17,D06BB54,"Podophyllin, combinations"
Human,02038242,Actinac Pws,allantoin 24 mg / g + chloramphenicol 40 mg / g + hydrocortisone acetate 40 mg / g + nicoboxil 24 mg / g + sulfur 320 mg / g topical powder for solution,Hoechst Roussel Canada Inc.,1.0,K,1.0,Cancelled post market,2001-07-20,D10AA,"Corticosteroids,combinations for treatment of acne"
Human,00897329,Retin-A,tretinoin 0.01 % / w/w cutaneous cream,"Bausch Health, Canada Inc.",2.0,R,2.0,Dormant,2019-12-13,D10AD01,Tretinoin
Human,00657204,Stieva-A,tretinoin 0.01 % / w/w cutaneous cream,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2024-03-25,D10AD01,Tretinoin
Human,00870013,Retin-A,tretinoin 0.01 % / w/w topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Dormant,2019-12-13,D10AD01,Tretinoin
Human,01926497,Vitamin A Acid 0.01% Cream,tretinoin 0.01 % cutaneous cream,Sanofi-Aventis Canada Inc,2.0,R,2.0,Cancelled post market,2008-08-04,D10AD01,Tretinoin
Human,00587958,Stievaa Gel 0.01%,tretinoin 0.01 % topical gel,Stiefel Canada Ulc,2.0,R,2.0,Cancelled post market,2007-08-31,D10AD01,Tretinoin
Human,01926462,Vitamin A Acid,tretinoin 0.01 % topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2020-09-30,D10AD01,Tretinoin
Human,00897310,Retin-A,tretinoin 0.025 % / w/w cutaneous cream,"Bausch Health, Canada Inc.",2.0,R,2.0,Dormant,2019-12-18,D10AD01,Tretinoin
Human,00578576,Stieva-A,tretinoin 0.025 % / w/w cutaneous cream,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2023-11-29,D10AD01,Tretinoin
Human,00443816,Retin-A,tretinoin 0.025 % / w/w topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2019-12-13,D10AD01,Tretinoin
Human,02192640,Rejuva-A,tretinoin 0.025 % cutaneous cream,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2014-05-01,D10AD01,Tretinoin
Human,01926500,Vitamin A Acid 0.025% Cream,tretinoin 0.025 % cutaneous cream,Sanofi-Aventis Canada Inc,2.0,R,2.0,Cancelled post market,2008-08-04,D10AD01,Tretinoin
Human,02125293,Vitinoin - Crm 0.025%,tretinoin 0.025 % cutaneous cream,Penederm Inc.,2.0,R,2.0,Cancelled post market,2001-08-17,D10AD01,Tretinoin
Human,00587966,Stieva-A Gel,tretinoin 0.025 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2012-07-03,D10AD01,Tretinoin
Human,01926470,Vitamin A Acid,tretinoin 0.025 % topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2020-09-30,D10AD01,Tretinoin
Human,02069598,Vitinoin Gel - 0.025%,tretinoin 0.025 % topical gel,Penederm Inc.,2.0,R,2.0,Cancelled post market,2001-08-17,D10AD01,Tretinoin
Human,00578568,Stieva-A Solution,tretinoin 0.025 % topical solution,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2011-12-22,D10AD01,Tretinoin
Human,02264633,Retin-A Micro,tretinoin 0.04 % / w/w topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2020-09-30,D10AD01,Tretinoin
Human,00443794,Retin-A,tretinoin 0.05 % / w/w cutaneous cream,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2019-12-13,D10AD01,Tretinoin
Human,00518182,Stieva-A,tretinoin 0.05 % / w/w cutaneous cream,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2023-11-29,D10AD01,Tretinoin
Human,02510243,Altreno,tretinoin 0.05 % / w/w cutaneous lotion,"Bausch Health, Canada Inc.",2.0,R,2.0,Approved,2021-10-08,D10AD01,Tretinoin
Human,02052407,Renova,tretinoin 0.05 % cutaneous cream,Valeant Canada Lp / Valeant Canada S.E.C.,2.0,R,2.0,Cancelled post market,2014-07-30,D10AD01,Tretinoin
Human,01926519,Vitamin A Acid 0.05% Cream,tretinoin 0.05 % cutaneous cream,Sanofi-Aventis Canada Inc,2.0,R,2.0,Cancelled post market,2008-08-04,D10AD01,Tretinoin
Human,02125307,Vitinoin - Crm 0.05%,tretinoin 0.05 % cutaneous cream,Penederm Inc.,2.0,R,2.0,Cancelled post market,2001-08-17,D10AD01,Tretinoin
Human,00641863,Stieva-A Gel,tretinoin 0.05 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2012-02-21,D10AD01,Tretinoin
Human,01926489,Vitamin A Acid,tretinoin 0.05 % topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2020-09-30,D10AD01,Tretinoin
Human,00518174,Stie Vaa Sol 0.05%,tretinoin 0.05 % topical liquid,Stiefel Canada Ulc,2.0,R,2.0,Cancelled post market,2005-04-20,D10AD01,Tretinoin
Human,00870021,Retin-A,tretinoin 0.1 % / w/w cutaneous cream,"Bausch Health, Canada Inc.",2.0,R,2.0,Dormant,2019-12-13,D10AD01,Tretinoin
Human,02243914,Retin-A Micro,tretinoin 0.1 % / w/w topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2020-09-30,D10AD01,Tretinoin
Human,00662348,Stieva-A Cream,tretinoin 0.1 % cutaneous cream,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2017-02-12,D10AD01,Tretinoin
Human,01926527,Vitamin A Acid 0.1% Cream,tretinoin 0.1 % cutaneous cream,Sanofi-Aventis Canada Inc,2.0,R,2.0,Cancelled post market,2008-08-04,D10AD01,Tretinoin
Human,02125315,Vitinoin - Crm 0.1%,tretinoin 0.1 % cutaneous cream,Penederm Inc.,2.0,R,2.0,Cancelled post market,2001-08-17,D10AD01,Tretinoin
Human,00784338,Isotrex Gel 0.05%,isotretinoin 0.05 % topical gel,Stiefel Canada Ulc,2.0,R,2.0,Cancelled post market,2005-05-03,D10AD04,Isotretinoin
Human,02008688,Retisol-A,avobenzone 2 % + octinoxate 7.5 % + tretinoin 0.01 % cutaneous cream,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-07-03,D10AD51,"Tretinoin, combinations"
Human,02008696,Retisol-A,avobenzone 2 % + octinoxate 7.5 % + tretinoin 0.025 % cutaneous cream,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-07-03,D10AD51,"Tretinoin, combinations"
Human,02008718,Retisol-A,avobenzone 2 % + octinoxate 7.5 % + tretinoin 0.05 % cutaneous cream,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-07-03,D10AD51,"Tretinoin, combinations"
Human,02008726,Retisol-A,avobenzone 2 % + octinoxate 7.5 % + tretinoin 0.1 % cutaneous cream,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-07-03,D10AD51,"Tretinoin, combinations"
Human,02563487,Twyneo,benzoyl peroxide 3 % / w/w + tretinoin 0.1 % / w/w cutaneous cream,Searchlight Pharma Inc,2.0,R,2.0,Approved,2025-12-04,D10AD51,"Tretinoin, combinations"
Human,02359685,Biacna Topical Gel,clindamycin phosphate 1.2 % / w/w + tretinoin 0.025 % / w/w topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2019-10-18,D10AF51,"Clindamycin, combinations"
Human,02359685,Biacna Topical Gel,clindamycin phosphate 1.2 % / w/w + tretinoin 0.025 % / w/w topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2019-10-18,D10AF51,"Clindamycin, combinations"
Human,02359685,Biacna Topical Gel,clindamycin phosphate 1.2 % / w/w + tretinoin 0.025 % / w/w topical gel,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2019-10-18,D10AF51,"Clindamycin, combinations"
Human,02015994,Stievamycin Mild,erythromycin 4 % + tretinoin 0.01 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-08-24,D10AF52,"Erythromycin, combinations"
Human,02015994,Stievamycin Mild,erythromycin 4 % + tretinoin 0.01 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-08-24,D10AF52,"Erythromycin, combinations"
Human,02015994,Stievamycin Mild,erythromycin 4 % + tretinoin 0.01 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-08-24,D10AF52,"Erythromycin, combinations"
Human,01905112,Stievamycin Regular,erythromycin 4 % + tretinoin 0.025 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2016-01-06,D10AF52,"Erythromycin, combinations"
Human,01905112,Stievamycin Regular,erythromycin 4 % + tretinoin 0.025 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2016-01-06,D10AF52,"Erythromycin, combinations"
Human,01905112,Stievamycin Regular,erythromycin 4 % + tretinoin 0.025 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2016-01-06,D10AF52,"Erythromycin, combinations"
Human,01945262,Stievamycin Forte,erythromycin 4 % + tretinoin 0.05 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-08-24,D10AF52,"Erythromycin, combinations"
Human,01945262,Stievamycin Forte,erythromycin 4 % + tretinoin 0.05 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-08-24,D10AF52,"Erythromycin, combinations"
Human,01945262,Stievamycin Forte,erythromycin 4 % + tretinoin 0.05 % topical gel,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2015-08-24,D10AF52,"Erythromycin, combinations"
Human,00429090,Actinac Pwr,allantoin 24 mg / g + chloramphenicol 40 mg / g + hydrocortisone acetate 40 mg / g + nicoboxil 24 mg / g + sulfur 320 mg / g topical powder,Roussel Canada Inc.,1.0,K,1.0,Cancelled post market,1996-09-09,D10AF53,"Chloramphenicol, combinations"
Human,00582344,Accutane,isotretinoin 10 mg oral capsule,Cheplapharm Schweiz Gmbh,2.0,R,2.0,Marketed,2025-09-10,D10BA01,Isotretinoin
Human,02257955,Clarus,isotretinoin 10 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2010-03-01,D10BA01,Isotretinoin
Human,02396971,Epuris,isotretinoin 10 mg oral capsule,Cipher Pharmaceuticals Inc,2.0,R,2.0,Marketed,2013-05-07,D10BA01,Isotretinoin
Human,02309173,Ran-Isotretinoin,isotretinoin 10 mg oral capsule,Ranbaxy Pharmaceuticals Canada Inc.,2.0,R,2.0,Cancelled pre market,2025-06-16,D10BA01,Isotretinoin
Human,02539055,Absorica Ld,isotretinoin 16 mg oral capsule,Sun Pharmaceutical Industries Limited,2.0,R,2.0,Marketed,2023-09-26,D10BA01,Isotretinoin
Human,02396998,Epuris,isotretinoin 20 mg oral capsule,Cipher Pharmaceuticals Inc,2.0,R,2.0,Marketed,2013-05-07,D10BA01,Isotretinoin
Human,02539063,Absorica Ld,isotretinoin 24 mg oral capsule,Sun Pharmaceutical Industries Limited,2.0,R,2.0,Marketed,2023-09-26,D10BA01,Isotretinoin
Human,02397005,Epuris,isotretinoin 30 mg oral capsule,Cipher Pharmaceuticals Inc,2.0,R,2.0,Marketed,2013-05-07,D10BA01,Isotretinoin
Human,02539071,Absorica Ld,isotretinoin 32 mg oral capsule,Sun Pharmaceutical Industries Limited,2.0,R,2.0,Marketed,2023-09-26,D10BA01,Isotretinoin
Human,00582352,Accutane,isotretinoin 40 mg oral capsule,Cheplapharm Schweiz Gmbh,2.0,R,2.0,Marketed,2025-09-05,D10BA01,Isotretinoin
Human,02257963,Clarus,isotretinoin 40 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2010-03-01,D10BA01,Isotretinoin
Human,02397013,Epuris,isotretinoin 40 mg oral capsule,Cipher Pharmaceuticals Inc,2.0,R,2.0,Marketed,2013-05-07,D10BA01,Isotretinoin
Human,02539047,Absorica Ld,isotretinoin 8 mg oral capsule,Sun Pharmaceutical Industries Limited,2.0,R,2.0,Marketed,2023-09-26,D10BA01,Isotretinoin
Human,02531399,Leo Pharma - Tacrolimus,tacrolimus 0.03 % / w/w cutaneous ointment,"Leo Pharma Gen, A Division Of Leo Pharma Inc.",2.0,P,2.0,Approved,2022-09-29,D11AH01,Tacrolimus
Human,02244149,Protopic,tacrolimus 0.03 % / w/w cutaneous ointment,Leo Pharma Inc,2.0,P,2.0,Marketed,2017-05-25,D11AH01,Tacrolimus
Human,02531380,Leo Pharma - Tacrolimus,tacrolimus 0.1 % / w/w cutaneous ointment,"Leo Pharma Gen, A Division Of Leo Pharma Inc.",2.0,P,2.0,Approved,2022-09-29,D11AH01,Tacrolimus
Human,02244148,Protopic,tacrolimus 0.1 % / w/w cutaneous ointment,Leo Pharma Inc,2.0,P,2.0,Marketed,2017-05-25,D11AH01,Tacrolimus
Human,02240328,Panretin,alitretinoin 0.1 % topical gel,Ligand Pharmaceuticals Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-04-05,D11AH04,Alitretinoin
Human,02477432,Hanzema,alitretinoin 10 mg oral capsule,Dr. Reddy'S Laboratories Inc,2.0,R,2.0,Marketed,2021-06-09,D11AH04,Alitretinoin
Human,02337630,Toctino,alitretinoin 10 mg oral capsule,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2023-07-14,D11AH04,Alitretinoin
Human,02477440,Hanzema,alitretinoin 30 mg oral capsule,Dr. Reddy'S Laboratories Inc,2.0,R,2.0,Marketed,2021-06-09,D11AH04,Alitretinoin
Human,02337649,Toctino,alitretinoin 30 mg oral capsule,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2023-07-14,D11AH04,Alitretinoin
Human,02428148,Auro-Finasteride 1Mg,finasteride 1 mg oral tablet,Auro Pharma Inc,2.0,R,,Marketed,2014-11-12,D11AX10,Finasteride
Human,02445085,Finasteride,finasteride 1 mg oral tablet,Sanis Health Inc,2.0,R,,Marketed,2015-10-14,D11AX10,Finasteride
Human,02447568,Finasteride,finasteride 1 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,,Marketed,2015-11-25,D11AX10,Finasteride
Human,02554461,Jamp Finasteride Tablets,finasteride 1 mg oral tablet,Jamp Pharma Corporation,2.0,R,,Approved,2025-02-13,D11AX10,Finasteride
Human,02537427,Mint-Finasteride,finasteride 1 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,,Marketed,2024-05-15,D11AX10,Finasteride
Human,02392631,Mylan-Finasteride Hg,finasteride 1 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,,Cancelled post market,2017-01-09,D11AX10,Finasteride
Human,02320169,Pms-Finasteride,finasteride 1 mg oral tablet,Pharmascience Inc,2.0,R,,Marketed,2010-05-13,D11AX10,Finasteride
Human,02238213,Propecia,finasteride 1 mg oral tablet,Organon Canada Inc.,2.0,R,,Marketed,2022-05-11,D11AX10,Finasteride
Human,02549204,Riva-Finasteride,finasteride 1 mg oral tablet,Laboratoire Riva Inc.,2.0,R,,Approved,2024-06-28,D11AX10,Finasteride
Human,02339471,Sandoz Finasteride A,finasteride 1 mg oral tablet,Sandoz Canada Incorporated,2.0,R,,Marketed,2010-05-12,D11AX10,Finasteride
Human,02348888,Finasteride,finasteride 5 mg oral tablet,Meliapharm Inc,2.0,R,,Cancelled post market,2014-06-25,D11AX10,Finasteride
Human,02243837,Vaniqa,eflornithine hydrochloride 13.9 % / w/w cutaneous cream,Cipher Pharmaceuticals Inc,2.0,R,,Marketed,2015-12-04,D11AX16,Eflornithine
Human,02243257,Solagé,mequinol 2 % / w/v + tretinoin 0.01 % / w/v topical solution,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2014-03-04,D11AX56,"Mequinol, combinations"
Human,02243257,Solagé,mequinol 2 % / w/v + tretinoin 0.01 % / w/v topical solution,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2014-03-04,D11AX56,"Mequinol, combinations"
Human,02243257,Solagé,mequinol 2 % / w/v + tretinoin 0.01 % / w/v topical solution,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2014-03-04,D11AX56,"Mequinol, combinations"
Human,02517760,Extra Strength Clotrimazole Extra Fort -Fluconazole Combi,clotrimazole 2 % + fluconazole 150 mg cutaneous cream or capsule,Taro Pharmaceuticals Inc,2.0,R,,Marketed,2022-05-03,G01AF02,Clotrimazole
Human,00015709,Ergotrate Maleate Tablet 1572 0.2Mg,ergonovine maleate 0.2 mg / tablet oral tablet,Eli Lilly Canada Inc,2.0,R,2.0,Cancelled post market,1998-08-04,G02AB03,Ergometrine
Human,01996096,Ergonovine Maleate Injection,ergonovine maleate 0.25 mg / mL solution for injection,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2022-01-20,G02AB03,Ergometrine
Human,00497312,Ergonovine Maleate Injection Usp,ergonovine maleate 0.25 mg / mL solution for injection,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2020-01-23,G02AB03,Ergometrine
Human,02441241,Ergonovine Maleate Injection Usp,ergonovine maleate 0.25 mg / mL solution for injection,Hikma Canada Limited,2.0,R,2.0,Marketed,2023-06-29,G02AB03,Ergometrine
Human,02296144,"Ergonovine Maleate Injection Usp, 0.25Mg/Ml",ergonovine maleate 0.25 mg / mL solution for injection,Alveda Pharmaceuticals Inc,2.0,R,2.0,Cancelled (unreturned annual),2024-01-08,G02AB03,Ergometrine
Human,00860786,Prepidil Gel,dinoprostone 0.5 mg / 2.5 mL intracervical gel,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2006-06-19,G02AD02,Dinoprostone
Human,00400688,Prostin E2 Tablets,dinoprostone 0.5 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2006-07-04,G02AD02,Dinoprostone
Human,01919679,Prostin E2 Vaginal Gel,dinoprostone 1 mg / 3 g vaginal gel,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2006-06-12,G02AD02,Dinoprostone
Human,02231047,Cervidil,dinoprostone 10 mg / insert vaginal insert,Ferring Inc,2.0,R,2.0,Marketed,1997-06-17,G02AD02,Dinoprostone
Human,01919687,Prostin E2 Vaginal Gel,dinoprostone 2 mg / 3 g vaginal gel,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2006-05-15,G02AD02,Dinoprostone
Human,02546779,Carboprost Tromethamine Injection,carboprost (carboprost tromethamine) 250 mcg / mL solution for injection,Jamp Pharma Corporation,,R,,Marketed,2025-02-13,G02AD04,Carboprost
Human,02538377,Carboprost Tromethamine Injection Usp,carboprost (carboprost tromethamine) 250 mcg / mL solution for injection,Juno Pharmaceuticals Corp.,,R,,Marketed,2024-01-18,G02AD04,Carboprost
Human,02530430,"Carboprost Tromethamine Injection, Usp",carboprost (carboprost tromethamine) 250 mcg / mL solution for injection,Dr Reddy'S Laboratories Ltd,,R,,Marketed,2023-05-16,G02AD04,Carboprost
Human,02553856,"Carboprost Tromethamine Injection, Usp",carboprost (carboprost tromethamine) 250 mcg / mL solution for injection,Dr Reddy'S Laboratories Ltd,,R,,Approved,2024-12-11,G02AD04,Carboprost
Human,02230417,Hemabate,carboprost (carboprost tromethamine) 250 mcg / mL solution for injection,Pfizer Canada Ulc,,R,,Marketed,2009-02-03,G02AD04,Carboprost
Human,02408295,Jaydess,levonorgestrel 13.5 mg intrauterine prolonged-release insert,Bayer Inc,2.0,P,2.0,Cancelled post market,2018-12-20,G02BA03,Plastic iud with progestogens
Human,02459523,Kyleena,levonorgestrel 19.5 mg intrauterine prolonged-release insert,Bayer Inc,2.0,P,2.0,Marketed,2017-01-10,G02BA03,Plastic iud with progestogens
Human,02243005,Mirena,levonorgestrel 52 mg intrauterine prolonged-release insert,Bayer Inc,2.0,P,2.0,Marketed,2007-11-22,G02BA03,Plastic iud with progestogens
Human,02554070,Ringza,ethinyl estradiol 17.4 mg + segesterone acetate 103 mg vaginal slow-release ring,Duchesnay Inc,1.0,K,1.0,Approved,2024-12-18,G02BB01,Vaginal ring with progestogen and estrogen
Human,02253186,Nuvaring,ethinyl estradiol 2.6 mg + etonogestrel 11.4 mg vaginal slow-release ring,Organon Canada Inc.,1.0,K,1.0,Marketed,2022-02-01,G02BB01,Vaginal ring with progestogen and estrogen
Human,02520028,Haloette,ethinyl estradiol 2.7 mg + etonogestrel 11.7 mg vaginal slow-release ring,Searchlight Pharma Inc,1.0,K,1.0,Marketed,2021-09-29,G02BB01,Vaginal ring with progestogen and estrogen
Human,02560887,Vloop,ethinyl estradiol 3.474 mg + etonogestrel 11 mg vaginal slow-release ring,Jamp Pharma Corporation,1.0,K,1.0,Approved,2025-09-05,G02BB01,Vaginal ring with progestogen and estrogen
Human,02301407,Act Cabergoline,cabergoline 0.5 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Dormant,2019-11-22,G02CB03,Cabergoline
Human,02455897,Apo-Cabergoline,cabergoline 0.5 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2021-03-01,G02CB03,Cabergoline
Human,02344890,Cabergoline,cabergoline 0.5 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled pre market,2018-12-11,G02CB03,Cabergoline
Human,02242471,Dostinex,cabergoline 0.5 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2006-01-05,G02CB03,Cabergoline
Human,02549611,Jamp Cabergoline,cabergoline 0.5 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2025-02-04,G02CB03,Cabergoline
Human,00469327,Demulen 30 (21 Day Pack),ethinyl estradiol 30 mcg + ethynodiol diacetate 2 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2019-07-04,G03AA01,Etynodiol and estrogen
Human,00471526,Demulen 30 (28 Day Pack),ethinyl estradiol 30 mcg + ethynodiol diacetate 2 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2019-07-04,G03AA01,Etynodiol and estrogen
Human,00028630,Demulen 50 (21 Day Pack),ethinyl estradiol 50 mcg + ethynodiol diacetate 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2005-04-01,G03AA01,Etynodiol and estrogen
Human,00343536,Demulen 50 (28 Day Pack),ethinyl estradiol 50 mcg + ethynodiol diacetate 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2005-04-01,G03AA01,Etynodiol and estrogen
Human,02435659,Generess,ethinyl estradiol 0.025 mg + norethindrone 0.8 mg chewable tablet,Allergan Inc,1.0,K,1.0,Cancelled pre market,2021-07-15,G03AA05,Norethisterone and estrogen
Human,02187086,Brevicon 0.5/35 Tablets (21-Day Pack),ethinyl estradiol 0.035 mg + norethindrone 0.5 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2009-02-03,G03AA05,Norethisterone and estrogen
Human,02187094,Brevicon 0.5/35 Tablets (28-Day Pack),ethinyl estradiol 0.035 mg + norethindrone 0.5 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2006-04-18,G03AA05,Norethisterone and estrogen
Human,00317047,Ortho 0.5/35 Tablets (21 Day),ethinyl estradiol 0.035 mg + norethindrone 0.5 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2017-09-28,G03AA05,Norethisterone and estrogen
Human,00340731,Ortho 0.5/35 Tablets (28 Day),ethinyl estradiol 0.035 mg + norethindrone 0.5 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2017-09-01,G03AA05,Norethisterone and estrogen
Human,02189054,Brevicon 1/35 Tablets (21-Day Pack),ethinyl estradiol 0.035 mg + norethindrone 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2009-02-03,G03AA05,Norethisterone and estrogen
Human,02189062,Brevicon 1/35 Tablets (28-Day Pack),ethinyl estradiol 0.035 mg + norethindrone 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2009-02-03,G03AA05,Norethisterone and estrogen
Human,00372846,Ortho 1/35 Tablets (21 Day),ethinyl estradiol 0.035 mg + norethindrone 1 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2017-09-29,G03AA05,Norethisterone and estrogen
Human,00372838,Ortho 1/35 Tablets (28 Day),ethinyl estradiol 0.035 mg + norethindrone 1 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2017-09-01,G03AA05,Norethisterone and estrogen
Human,02197502,Select 1/35 (21-Day),ethinyl estradiol 0.035 mg + norethindrone 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2006-02-22,G03AA05,Norethisterone and estrogen
Human,02199297,Select 1/35 (28-Day),ethinyl estradiol 0.035 mg + norethindrone 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2005-01-13,G03AA05,Norethisterone and estrogen
Human,00373265,Brevicon 0.5/35 21 Tab,ethinyl estradiol 0.035 mg / tablet + norethindrone 0.5 mg / tablet oral tablet,Syntex Inc.,1.0,K,1.0,Cancelled post market,1996-09-30,G03AA05,Norethisterone and estrogen
Human,00373273,Brevicon 0.5/35 28 Tab,ethinyl estradiol 0.035 mg / tablet + norethindrone 0.5 mg / tablet oral tablet,Syntex Inc.,1.0,K,1.0,Cancelled post market,1996-09-30,G03AA05,Norethisterone and estrogen
Human,00531006,Brevicon 1/35 21 Tab,ethinyl estradiol 0.035 mg / tablet + norethindrone 1 mg / tablet oral tablet,Syntex Inc.,1.0,K,1.0,Cancelled post market,1996-09-30,G03AA05,Norethisterone and estrogen
Human,00531014,Brevicon 1/35 28 Tab,ethinyl estradiol 0.035 mg / tablet + norethindrone 1 mg / tablet oral tablet,Syntex Inc.,1.0,K,1.0,Cancelled post market,1996-09-30,G03AA05,Norethisterone and estrogen
Human,00315966,Minestrin 1/20,ethinyl estradiol 20 mcg + norethindrone acetate 1 mg oral tablet,Allergan Inc,1.0,K,1.0,Cancelled post market,2022-04-26,G03AA05,Norethisterone and estrogen
Human,00343838,Minestrin 1/20,ethinyl estradiol 20 mcg + norethindrone acetate 1 mg oral tablet,Allergan Inc,1.0,K,1.0,Cancelled post market,2022-04-26,G03AA05,Norethisterone and estrogen
Human,00297143,Loestrin 1.5/30,ethinyl estradiol 30 mcg + norethindrone acetate 1.5 mg oral tablet,Allergan Inc,1.0,K,1.0,Cancelled post market,2022-04-22,G03AA05,Norethisterone and estrogen
Human,00353027,Loestrin 1.5/30,ethinyl estradiol 30 mcg + norethindrone acetate 1.5 mg oral tablet,Allergan Inc,1.0,K,1.0,Cancelled post market,2022-01-20,G03AA05,Norethisterone and estrogen
Human,02188724,Norinyl 1/50  -(21-Day Regimen),mestranol 0.05 mg + norethindrone 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2006-08-02,G03AA05,Norethisterone and estrogen
Human,02188732,Norinyl 1/50  -(28-Day Regimen),mestranol 0.05 mg + norethindrone 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2006-08-02,G03AA05,Norethisterone and estrogen
Human,00022608,Ortho-Novum 1/50 Tablets (21 Day),mestranol 0.05 mg + norethindrone 1 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2004-10-12,G03AA05,Norethisterone and estrogen
Human,00030333,Norinyl 1/50 21 Tab,mestranol 0.05 mg / tablet + norethindrone 1 mg / tablet oral tablet,Syntex Inc.,1.0,K,1.0,Cancelled post market,1996-09-30,G03AA05,Norethisterone and estrogen
Human,00340847,Norinyl 1/50 28 Tab,mestranol 0.05 mg / tablet + norethindrone 1 mg / tablet oral tablet,Syntex Inc.,1.0,K,1.0,Cancelled post market,1996-09-30,G03AA05,Norethisterone and estrogen
Human,00340758,Ortho-Novum 1/50 Tablets (28 Day),mestranol 0.05 mg / tablet + norethindrone 1 mg / tablet oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2001-06-18,G03AA05,Norethisterone and estrogen
Human,00034207,Ovral 21 Tab,ethinyl estradiol 0.05 mg + norgestrel (norgestrel) 0.25 mg oral tablet,Wyeth Ltd.,1.0,K,1.0,Cancelled post market,1997-08-14,G03AA06,Norgestrel and estrogen
Human,00340766,Ovral 28Tab,ethinyl estradiol 0.05 mg + norgestrel 0.25 mg oral tablet,Wyeth Ltd.,1.0,K,1.0,Cancelled post market,1996-09-10,G03AA06,Norgestrel and estrogen
Human,02215640,Lo-Femenal 21 Tablets,ethinyl estradiol 30 mcg + norgestrel 300 mcg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2014-04-04,G03AA06,Norgestrel and estrogen
Human,02043033,Ovral 21,ethinyl estradiol 50 mcg + norgestrel (norgestrel) 250 mcg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2010-09-30,G03AA06,Norgestrel and estrogen
Human,02043041,Ovral 28 Tablets,ethinyl estradiol 50 mcg + norgestrel (norgestrel) 250 mcg oral tablet,Wyeth Canada,1.0,K,1.0,Cancelled post market,2006-08-04,G03AA06,Norgestrel and estrogen
Human,02398869,Indayo,ethinyl estradiol 0.03 mg + levonorgestrel 0.15 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,2.0,Marketed,2016-09-01,G03AA07,Levonorgestrel and estrogen
Human,00782432,Min-Ovral 21 Tab,ethinyl estradiol 0.03 mg + levonorgestrel 0.15 mg oral tablet,Wyeth Ltd.,2.0,P,2.0,Cancelled post market,1996-09-10,G03AA07,Levonorgestrel and estrogen
Human,00782440,Min-Ovral 28 Tab,ethinyl estradiol 0.03 mg + levonorgestrel 0.15 mg oral tablet,Wyeth Ltd.,2.0,P,2.0,Cancelled post market,1996-09-10,G03AA07,Levonorgestrel and estrogen
Human,02295946,Portia 21,ethinyl estradiol 0.03 mg + levonorgestrel 0.15 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2015-05-28,G03AA07,Levonorgestrel and estrogen
Human,02295954,Portia 28,ethinyl estradiol 0.03 mg + levonorgestrel 0.15 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2015-05-28,G03AA07,Levonorgestrel and estrogen
Human,02296659,Seasonale,ethinyl estradiol 0.03 mg + levonorgestrel 0.15 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2022-09-26,G03AA07,Levonorgestrel and estrogen
Human,02239806,Preven Emergency Contraceptive,ethinyl estradiol 0.05 mg + levonorgestrel 0.25 mg oral tablet,Gynétics Ltd/Ltée,2.0,P,2.0,Cancelled (unreturned annual),2017-09-01,G03AA07,Levonorgestrel and estrogen
Human,02240544,Preven Tablets,ethinyl estradiol 0.05 mg + levonorgestrel 0.25 mg oral tablet,Shire Pharma Canada Ulc,2.0,P,2.0,Cancelled post market,2001-08-02,G03AA07,Levonorgestrel and estrogen
Human,02236974,Alesse 21,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2012-04-10,G03AA07,Levonorgestrel and estrogen
Human,02236975,Alesse 28,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2012-03-16,G03AA07,Levonorgestrel and estrogen
Human,02387875,Alysena 21,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2012-11-19,G03AA07,Levonorgestrel and estrogen
Human,02387883,Alysena 28,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2012-11-19,G03AA07,Levonorgestrel and estrogen
Human,02532174,Audrina 21,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2023-06-09,G03AA07,Levonorgestrel and estrogen
Human,02532182,Audrina 28,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2023-06-08,G03AA07,Levonorgestrel and estrogen
Human,02298538,Aviane 21,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2015-05-20,G03AA07,Levonorgestrel and estrogen
Human,02298546,Aviane 28,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2015-05-20,G03AA07,Levonorgestrel and estrogen
Human,02388138,Esme 21,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,2.0,Cancelled post market,2018-07-12,G03AA07,Levonorgestrel and estrogen
Human,02388146,Esme 28,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,2.0,Cancelled post market,2018-07-12,G03AA07,Levonorgestrel and estrogen
Human,02424282,Laylaa 21,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Lupin Pharma Canada Limited,2.0,P,2.0,Marketed,2023-11-10,G03AA07,Levonorgestrel and estrogen
Human,02424290,Laylaa 28,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Lupin Pharma Canada Limited,2.0,P,2.0,Marketed,2023-11-10,G03AA07,Levonorgestrel and estrogen
Human,02401185,Lutera 21,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Cobalt Pharmaceuticals Company,2.0,P,2.0,Cancelled post market,2018-06-22,G03AA07,Levonorgestrel and estrogen
Human,02401207,Lutera 28,ethinyl estradiol 20 mcg + levonorgestrel 100 mcg oral tablet,Cobalt Pharmaceuticals Company,2.0,P,2.0,Cancelled post market,2018-06-22,G03AA07,Levonorgestrel and estrogen
Human,02042320,Min-Ovral 21,ethinyl estradiol 30 mcg + levonorgestrel 150 mcg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2011-12-05,G03AA07,Levonorgestrel and estrogen
Human,02042339,Min-Ovral 28,ethinyl estradiol 30 mcg + levonorgestrel 150 mcg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2011-11-25,G03AA07,Levonorgestrel and estrogen
Human,02387085,Ovima 21,ethinyl estradiol 30 mcg + levonorgestrel 150 mcg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2013-08-27,G03AA07,Levonorgestrel and estrogen
Human,02387093,Ovima 28,ethinyl estradiol 30 mcg + levonorgestrel 150 mcg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2013-08-27,G03AA07,Levonorgestrel and estrogen
Human,02317192,Apri 21,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Teva Canada Limited,2.0,,,Marketed,2015-05-28,G03AA09,Desogestrel and estrogen
Human,02317206,Apri 28,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Teva Canada Limited,2.0,,,Marketed,2015-05-28,G03AA09,Desogestrel and estrogen
Human,02396491,Freya 21,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,,,Marketed,2016-09-19,G03AA09,Desogestrel and estrogen
Human,02396610,Freya 28,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,,,Marketed,2016-09-19,G03AA09,Desogestrel and estrogen
Human,02328828,Marfem 21,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Novopharm Limited,2.0,,,Cancelled pre market,2015-10-16,G03AA09,Desogestrel and estrogen
Human,02328836,Marfem 28,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Novopharm Limited,2.0,,,Cancelled pre market,2015-10-16,G03AA09,Desogestrel and estrogen
Human,02042487,Marvelon 21,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Organon Canada Inc.,2.0,,,Marketed,2022-05-19,G03AA09,Desogestrel and estrogen
Human,02042479,Marvelon 28,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Organon Canada Inc.,2.0,,,Marketed,2022-06-17,G03AA09,Desogestrel and estrogen
Human,02556553,Miley 21,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Ambicare Pharmaceuticals Inc.,2.0,,,Marketed,2025-08-18,G03AA09,Desogestrel and estrogen
Human,02556561,Miley 28,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Ambicare Pharmaceuticals Inc.,2.0,,,Marketed,2025-08-18,G03AA09,Desogestrel and estrogen
Human,02042541,Ortho-Cept Tablets (21 Day),desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Janssen Inc,2.0,,,Cancelled post market,2007-08-11,G03AA09,Desogestrel and estrogen
Human,02042533,Ortho-Cept Tablets (28 Day),desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Janssen Inc,2.0,,,Cancelled post market,2015-04-22,G03AA09,Desogestrel and estrogen
Human,02420813,Reclipsen 21,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Actavis Pharma Company,2.0,,,Cancelled post market,2018-04-27,G03AA09,Desogestrel and estrogen
Human,02417464,Reclipsen 28,desogestrel 0.15 mg + ethinyl estradiol 0.03 mg oral tablet,Actavis Pharma Company,2.0,,,Cancelled post market,2018-04-27,G03AA09,Desogestrel and estrogen
Human,02410249,Mirvala 21,desogestrel 0.15 mg / tablet + ethinyl estradiol 0.03 mg / tablet oral tablet,Apotex Inc,2.0,,,Marketed,2014-01-07,G03AA09,Desogestrel and estrogen
Human,02410257,Mirvala 28,desogestrel 0.15 mg / tablet + ethinyl estradiol 0.03 mg / tablet oral tablet,Apotex Inc,2.0,,,Marketed,2014-01-07,G03AA09,Desogestrel and estrogen
Human,01968440,Cyclen Tablets (21 Day),ethinyl estradiol 0.035 mg + norgestimate 0.25 mg oral tablet,Janssen Inc,2.0,,,Cancelled post market,2020-08-27,G03AA11,Norgestimate and estrogen
Human,01992872,Cyclen Tablets (28 Day),ethinyl estradiol 0.035 mg + norgestimate 0.25 mg oral tablet,Janssen Inc,2.0,,,Cancelled post market,2020-06-30,G03AA11,Norgestimate and estrogen
Human,02320061,Previfem  (21Day),ethinyl estradiol 0.035 mg + norgestimate 0.25 mg oral tablet,Novopharm Limited,2.0,,,Cancelled pre market,2018-07-24,G03AA11,Norgestimate and estrogen
Human,02320088,Previfem  (28Day),ethinyl estradiol 0.035 mg + norgestimate 0.25 mg oral tablet,Novopharm Limited,2.0,,,Cancelled pre market,2018-07-24,G03AA11,Norgestimate and estrogen
Human,02411466,Sarensis 21,ethinyl estradiol 0.035 mg + norgestimate 0.25 mg oral tablet,Patriot A Division Of Janssen Inc,2.0,,,Cancelled pre market,2017-08-03,G03AA11,Norgestimate and estrogen
Human,02411474,Sarensis 28,ethinyl estradiol 0.035 mg + norgestimate 0.25 mg oral tablet,Patriot A Division Of Janssen Inc,2.0,,,Cancelled pre market,2017-08-03,G03AA11,Norgestimate and estrogen
Human,02387433,Yaz Plus,drospirenone 3 mg + ethinyl estradiol 0.02 mg + levomefolate calcium 0.451 mg oral tablet,Bayer Inc,2.0,K,,Marketed,2013-03-01,G03AA12,Drospirenone and estrogen
Human,02425726,Drospirenone And Ethinyl Estradiol Tablets,drospirenone 3 mg + ethinyl estradiol 0.02 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,K,,Cancelled pre market,2025-02-13,G03AA12,Drospirenone and estrogen
Human,02462060,Drospirenone And Ethinyl Estradiol Tablets Usp,drospirenone 3 mg + ethinyl estradiol 0.02 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,K,,Marketed,2021-09-07,G03AA12,Drospirenone and estrogen
Human,02415380,Mya,drospirenone 3 mg + ethinyl estradiol 0.02 mg oral tablet,Apotex Inc,2.0,K,,Marketed,2020-09-01,G03AA12,Drospirenone and estrogen
Human,02416492,Nikki,drospirenone 3 mg + ethinyl estradiol 0.02 mg oral tablet,Lupin Limited,2.0,K,,Approved,2014-06-21,G03AA12,Drospirenone and estrogen
Human,02404575,Vestura,drospirenone 3 mg + ethinyl estradiol 0.02 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,K,,Cancelled pre market,2020-01-22,G03AA12,Drospirenone and estrogen
Human,02321157,Yaz,drospirenone 3 mg + ethinyl estradiol 0.02 mg oral tablet,Bayer Inc,2.0,K,,Marketed,2009-01-06,G03AA12,Drospirenone and estrogen
Human,02442744,Yasmin Plus,drospirenone 3 mg + ethinyl estradiol 0.03 mg + levomefolate calcium 0.451 mg oral tablet,Bayer Inc,2.0,K,,Cancelled pre market,2024-11-28,G03AA12,Drospirenone and estrogen
Human,02424452,Drospirenone And Ethinyl Estradiol Tablets 21,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,K,,Cancelled pre market,2025-02-13,G03AA12,Drospirenone and estrogen
Human,02424460,Drospirenone And Ethinyl Estradiol Tablets 28,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,K,,Cancelled pre market,2025-02-13,G03AA12,Drospirenone and estrogen
Human,02421437,Drospirenone And Ethinyl Estradiol Tablets Usp 21,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,K,,Marketed,2021-10-22,G03AA12,Drospirenone and estrogen
Human,02421445,Drospirenone And Ethinyl Estradiol Tablets Usp 28,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,K,,Marketed,2021-10-22,G03AA12,Drospirenone and estrogen
Human,02416506,Qismette 21,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Lupin Limited,2.0,K,,Approved,2013-11-21,G03AA12,Drospirenone and estrogen
Human,02416514,Qismette 28,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Lupin Limited,2.0,K,,Approved,2013-11-15,G03AA12,Drospirenone and estrogen
Human,02261723,Yasmin 21,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Bayer Inc,2.0,K,,Marketed,2007-12-13,G03AA12,Drospirenone and estrogen
Human,02261731,Yasmin 28,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Bayer Inc,2.0,K,,Marketed,2007-11-28,G03AA12,Drospirenone and estrogen
Human,02410788,Zamine 21,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Apotex Inc,2.0,K,,Marketed,2020-09-01,G03AA12,Drospirenone and estrogen
Human,02410796,Zamine 28,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Apotex Inc,2.0,K,,Marketed,2020-09-01,G03AA12,Drospirenone and estrogen
Human,02385058,Zarah 21,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,K,,Cancelled post market,2018-11-12,G03AA12,Drospirenone and estrogen
Human,02385066,Zarah 28,drospirenone 3 mg + ethinyl estradiol 0.03 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,K,,Cancelled post market,2018-11-12,G03AA12,Drospirenone and estrogen
Human,02246340,Evra  -(6/0.75),ethinyl estradiol 0.75 mg + norelgestromin 6 mg transdermal prolonged-release patch,Janssen Inc,2.0,,,Cancelled post market,2006-02-22,G03AA13,Norelgestromin and estrogen
Human,02248297,Evra,ethinyl estradiol 35 mcg / 24 hr + norelgestromin 200 mcg / 24 hr transdermal prolonged-release patch,Searchlight Pharma Inc,2.0,,,Marketed,2022-10-25,G03AA13,Norelgestromin and estrogen
Human,02513218,Nextstellis,drospirenone 3 mg + estetrol monohydrate 15 mg oral tablet,Searchlight Pharma Inc,2.0,K,,Marketed,2021-06-15,G03AA18,Drospirenone and estetrol
Human,02320096,Tri-Previfem  (21 Day),ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Novopharm Limited,1.0,K,1.0,Cancelled pre market,2018-07-24,G03AB,"Progestogens and estrogens, sequential preparations"
Human,02320118,Tri-Previfem  (28 Day),ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Novopharm Limited,1.0,K,1.0,Cancelled pre market,2018-07-24,G03AB,"Progestogens and estrogens, sequential preparations"
Human,02426927,Quaterna,ethinyl estradiol 0.01 mg + ethinyl estradiol 0.03 mg + levonorgestrel 0.15 mg oral tablet,Mylan Pharmaceuticals Ulc,1.0,K,1.0,Approved,2023-07-14,G03AB03,Levonorgestrel and estrogen
Human,02346176,Seasonique,ethinyl estradiol 0.01 mg + ethinyl estradiol 0.03 mg + levonorgestrel 0.15 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2022-06-21,G03AB03,Levonorgestrel and estrogen
Human,00782416,Triphasil 21 Tab,ethinyl estradiol 30 mcg + ethinyl estradiol 30 mcg / tablet + ethinyl estradiol 40 mcg + levonorgestrel 125 mcg + levonorgestrel 50 mcg + levonorgestrel 75 mcg oral tablet,Wyeth Ltd.,1.0,K,1.0,Cancelled post market,1996-09-10,G03AB03,Levonorgestrel and estrogen
Human,02043726,Triphasil 21,ethinyl estradiol 30 mcg + ethinyl estradiol 40 mcg + levonorgestrel 125 mcg + levonorgestrel 50 mcg + levonorgestrel 75 mcg oral tablet,Wyeth Canada,1.0,K,1.0,Cancelled post market,2007-10-23,G03AB03,Levonorgestrel and estrogen
Human,02043734,Triphasil 28,ethinyl estradiol 30 mcg + ethinyl estradiol 40 mcg + levonorgestrel 125 mcg + levonorgestrel 50 mcg + levonorgestrel 75 mcg oral tablet,Wyeth Canada,1.0,K,1.0,Cancelled post market,2007-10-25,G03AB03,Levonorgestrel and estrogen
Human,00707600,Triquilar 21,ethinyl estradiol 30 mcg + ethinyl estradiol 40 mcg + levonorgestrel 125 mcg + levonorgestrel 50 mcg + levonorgestrel 75 mcg oral tablet,Bayer Inc,1.0,K,1.0,Marketed,2008-07-03,G03AB03,Levonorgestrel and estrogen
Human,00707503,Triquilar 28,ethinyl estradiol 30 mcg + ethinyl estradiol 40 mcg + levonorgestrel 125 mcg + levonorgestrel 50 mcg + levonorgestrel 75 mcg oral tablet,Bayer Inc,1.0,K,1.0,Marketed,2008-05-21,G03AB03,Levonorgestrel and estrogen
Human,00782424,Triphasil 28 Tab,ethinyl estradiol 30 mcg / tablet + ethinyl estradiol 40 mcg / tablet + levonorgestrel 125 mcg / tablet + levonorgestrel 50 mcg / tablet + levonorgestrel 75 mcg / tablet oral tablet,Wyeth Ltd.,1.0,K,1.0,Cancelled post market,1996-09-10,G03AB03,Levonorgestrel and estrogen
Human,00602957,Ortho 7/7/7 Tablets (21 Day),ethinyl estradiol 0.035 mg + norethindrone 0.5 mg + norethindrone 0.75 mg + norethindrone 1 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2017-09-29,G03AB04,Norethisterone and estrogen
Human,00602965,Ortho 7/7/7 Tablets (28 Day),ethinyl estradiol 0.035 mg + norethindrone 0.5 mg + norethindrone 0.75 mg + norethindrone 1 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2017-09-01,G03AB04,Norethisterone and estrogen
Human,00538590,Ortho 10/11 Tablets (21 Day),ethinyl estradiol 0.035 mg + norethindrone 0.5 mg + norethindrone 1 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2002-07-31,G03AB04,Norethisterone and estrogen
Human,00538582,Ortho 10/11 Tablets (28 Day),ethinyl estradiol 0.035 mg + norethindrone 0.5 mg + norethindrone 1 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2002-07-31,G03AB04,Norethisterone and estrogen
Human,02187108,Synphasic 21 Tablets,ethinyl estradiol 0.035 mg + norethindrone 0.5 mg + norethindrone 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2009-02-03,G03AB04,Norethisterone and estrogen
Human,02187116,Synphasic 28 Tablets,ethinyl estradiol 0.035 mg + norethindrone 0.5 mg + norethindrone 1 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2006-07-20,G03AB04,Norethisterone and estrogen
Human,00620947,Synphasic 21 Tablets,ethinyl estradiol 0.035 mg / tablet + norethindrone 0.5 mg / tablet + norethindrone 1 mg / tablet oral tablet,Syntex Inc.,1.0,K,1.0,Cancelled post market,1996-09-30,G03AB04,Norethisterone and estrogen
Human,00695734,Synphasic-28 Tablets,ethinyl estradiol 0.035 mg / tablet + norethindrone 0.5 mg / tablet + norethindrone 1 mg / tablet oral tablet,Syntex Inc.,1.0,K,1.0,Cancelled post market,1996-09-30,G03AB04,Norethisterone and estrogen
Human,02417456,Lolo,ethinyl estradiol 10 mcg + norethindrone acetate 1 mg oral tablet,Abbvie Corporation,1.0,K,1.0,Marketed,2024-05-06,G03AB04,Norethisterone and estrogen
Human,02272903,Linessa 21,desogestrel 0.1 mg + desogestrel 0.125 mg + desogestrel 0.15 mg + ethinyl estradiol 0.025 mg oral tablet,Aspen Pharmacare Canada Inc.,1.0,K,1.0,Marketed,2019-02-15,G03AB05,Desogestrel and estrogen
Human,02257238,Linessa 28,desogestrel 0.1 mg + desogestrel 0.125 mg + desogestrel 0.15 mg + ethinyl estradiol 0.025 mg oral tablet,Aspen Pharmacare Canada Inc.,1.0,K,1.0,Marketed,2019-05-13,G03AB05,Desogestrel and estrogen
Human,02379112,Natazia,dienogest 2 mg + dienogest 3 mg + estradiol valerate 1 mg + estradiol valerate 2 mg + estradiol valerate 3 mg oral tablet,Bayer Inc,1.0,K,1.0,Cancelled pre market,2023-07-10,G03AB08,Dienogest and estrogen
Human,02401967,Tri-Cira Lo 21,ethinyl estradiol 0.025 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2021-03-23,G03AB09,Norgestimate and ethinylestradiol
Human,02401975,Tri-Cira Lo 28,ethinyl estradiol 0.025 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2021-03-23,G03AB09,Norgestimate and ethinylestradiol
Human,02508087,Tri-Cira 21,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2021-03-19,G03AB09,Norgestimate and ethinylestradiol
Human,02508095,Tri-Cira 28,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2021-03-08,G03AB09,Norgestimate and ethinylestradiol
Human,02486296,Tri-Jordyna 21,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,1.0,K,1.0,Marketed,2020-07-08,G03AB09,Norgestimate and ethinylestradiol
Human,02486318,Tri-Jordyna 28,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,1.0,K,1.0,Marketed,2020-03-18,G03AB09,Norgestimate and ethinylestradiol
Human,02411431,Centrisa Lo 21,ethinyl estradiol 0.025 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Patriot A Division Of Janssen Inc,1.0,K,1.0,Cancelled pre market,2017-08-03,G03AB11,Norgestimate and estrogen
Human,02411458,Centrisa Lo 28,ethinyl estradiol 0.025 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Patriot A Division Of Janssen Inc,1.0,K,1.0,Cancelled pre market,2017-08-03,G03AB11,Norgestimate and estrogen
Human,02258560,Tri-Cyclen Lo (21 Day),ethinyl estradiol 0.025 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2020-08-28,G03AB11,Norgestimate and estrogen
Human,02258587,Tri-Cyclen Lo (28 Day),ethinyl estradiol 0.025 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2020-09-29,G03AB11,Norgestimate and estrogen
Human,02443457,Tri-Lena Lo 21,ethinyl estradiol 0.025 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Actavis Pharma Company,1.0,K,1.0,Cancelled pre market,2017-09-01,G03AB11,Norgestimate and estrogen
Human,02443465,Tri-Lena Lo 28,ethinyl estradiol 0.025 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Actavis Pharma Company,1.0,K,1.0,Cancelled pre market,2017-09-01,G03AB11,Norgestimate and estrogen
Human,02411199,Centrisa 21,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Patriot A Division Of Janssen Inc,1.0,K,1.0,Cancelled pre market,2017-08-03,G03AB11,Norgestimate and estrogen
Human,02411202,Centrisa 28,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Patriot A Division Of Janssen Inc,1.0,K,1.0,Cancelled pre market,2017-08-03,G03AB11,Norgestimate and estrogen
Human,02028700,Tri-Cyclen Tablets - 21-Day,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2020-06-02,G03AB11,Norgestimate and estrogen
Human,02029421,Tri-Cyclen Tablets - 28-Day,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Janssen Inc,1.0,K,1.0,Cancelled post market,2020-03-05,G03AB11,Norgestimate and estrogen
Human,02443597,Tri-Lena 21,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Actavis Pharma Company,1.0,K,1.0,Cancelled pre market,2017-09-01,G03AB11,Norgestimate and estrogen
Human,02443600,Tri-Lena 28,ethinyl estradiol 0.035 mg + norgestimate 0.18 mg + norgestimate 0.215 mg + norgestimate 0.25 mg oral tablet,Actavis Pharma Company,1.0,K,1.0,Cancelled pre market,2017-09-01,G03AB11,Norgestimate and estrogen
Human,02223090,Ovrette Tablets,norgestrel 0.075 mg oral tablet,Pfizer Canada Ulc,,P,2.0,Cancelled pre market,2019-11-06,G03AC,Progestogens
Human,02441306,Jencycla,norethindrone 0.35 mg oral tablet,Lupin Pharma Canada Limited,2.0,,,Marketed,2018-08-14,G03AC01,Norethisterone
Human,02458683,Maeve,norethindrone 0.35 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,,,Marketed,2022-12-16,G03AC01,Norethisterone
Human,00037605,Micronor Tablets 28-Day,norethindrone 0.35 mg oral tablet,Janssen Inc,2.0,,,Cancelled post market,2020-07-09,G03AC01,Norethisterone
Human,02410303,Movisse,norethindrone 0.35 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,,,Marketed,2016-05-18,G03AC01,Norethisterone
Human,02060590,Norplant System Kit 36Mg/Implant,levonorgestrel 36 mg / implant for injection,Wyeth-Ayerst Canada Inc.,2.0,P,2.0,Cancelled post market,2002-09-24,G03AC03,Levonorgestrel
Human,00585092,Depo-Provera,medroxyprogesterone acetate 150 mg / mL suspension for injection,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2022-08-22,G03AC06,Medroxyprogesterone
Human,02523493,Depo-Provera,medroxyprogesterone acetate 150 mg / mL suspension for injection,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2022-04-25,G03AC06,Medroxyprogesterone
Human,02322250,Medroxyprogesterone Acetate Injectable Suspension Usp,medroxyprogesterone acetate 150 mg / mL suspension for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2021-04-20,G03AC06,Medroxyprogesterone
Human,02519062,Taro-Medroxyprogesterone Injection,medroxyprogesterone acetate 150 mg / mL suspension for injection,Taro Pharmaceuticals Inc,2.0,R,2.0,Approved,2021-08-12,G03AC06,Medroxyprogesterone
Human,00030848,Depo-Provera,medroxyprogesterone acetate 50 mg / mL suspension for injection,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2019-08-16,G03AC06,Medroxyprogesterone
Human,02499509,Nexplanon,etonogestrel 68 mg implant for injection,Organon Canada Inc.,2.0,,,Marketed,2022-09-08,G03AC08,Etonogestrel
Human,02522802,Slynd,drospirenone 4 mg oral tablet,Duchesnay Inc,2.0,K,,Marketed,2022-04-20,G03AC10,Drospirenone
Human,02430177,Backup Plan,levonorgestrel 0.75 mg oral tablet,Apotex Inc,2.0,P,2.0,Cancelled pre market,2019-05-04,G03AD01,Levonorgestrel
Human,02410230,Contingency,levonorgestrel 0.75 mg oral tablet,Jai Pharma Limited,2.0,P,2.0,Cancelled pre market,2017-01-04,G03AD01,Levonorgestrel
Human,02431033,"Levonorgestrel Tablets, 0.75Mg",levonorgestrel 0.75 mg oral tablet,Lupin Limited,2.0,P,2.0,Cancelled pre market,2019-08-14,G03AD01,Levonorgestrel
Human,02364905,Next Choice,levonorgestrel 0.75 mg oral tablet,Actavis Pharma Company,2.0,P,2.0,Cancelled post market,2018-03-05,G03AD01,Levonorgestrel
Human,02285576,Norlevo,levonorgestrel 0.75 mg oral tablet,Laboratoire Hra Pharma,2.0,P,2.0,Cancelled post market,2017-01-31,G03AD01,Levonorgestrel
Human,02371189,Option 2,levonorgestrel 0.75 mg oral tablet,Perrigo International,2.0,P,2.0,Cancelled post market,2021-07-22,G03AD01,Levonorgestrel
Human,02241674,Plan B,levonorgestrel 0.75 mg oral tablet,"Foundation Consumer Healthcare, Llc",2.0,P,2.0,Cancelled post market,2018-05-09,G03AD01,Levonorgestrel
Human,02367874,Teva-Levonorgestrel,levonorgestrel 0.75 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Cancelled pre market,2015-11-25,G03AD01,Levonorgestrel
Human,02433532,Backup Plan Onestep,levonorgestrel 1.5 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2016-06-07,G03AD01,Levonorgestrel
Human,02425009,Contingency One,levonorgestrel 1.5 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,2.0,Marketed,2016-06-29,G03AD01,Levonorgestrel
Human,02548461,Mystep,levonorgestrel 1.5 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2025-06-10,G03AD01,Levonorgestrel
Human,02322919,Norlevo,levonorgestrel 1.5 mg oral tablet,Laboratoire Hra Pharma,2.0,P,2.0,Approved,2015-05-28,G03AD01,Levonorgestrel
Human,02293854,Plan B,levonorgestrel 1.5 mg oral tablet,"Foundation Consumer Healthcare, Llc",2.0,P,2.0,Marketed,2018-10-11,G03AD01,Levonorgestrel
Human,02436329,Ella,ulipristal acetate 30 mg oral tablet,Laboratoire Hra Pharma,2.0,R,2.0,Marketed,2015-09-01,G03AD02,Ulipristal
Human,00030902,Halotestin,fluoxymesterone 5 mg oral tablet,Pfizer Canada Ulc,2.0,P,,Cancelled post market,2006-08-02,G03BA01,Fluoxymesterone
Human,00005622,Metandren 10Mg,methyltestosterone 10 mg / tablet oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Cancelled post market,2001-04-05,G03BA02,Methyltestosterone
Human,00005630,Metandren 25Mg,methyltestosterone 25 mg / tablet oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Cancelled post market,2001-04-05,G03BA02,Methyltestosterone
Human,02245345,Androgel,testosterone 1 % transdermal gel,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2016-04-07,G03BA03,Testosterone
Human,02245346,Androgel,testosterone 1 % transdermal gel,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2016-04-07,G03BA03,Testosterone
Human,02463792,Taro-Testosterone Gel,testosterone 1 % transdermal gel,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2017-10-31,G03BA03,Testosterone
Human,02463806,Taro-Testosterone Gel,testosterone 1 % transdermal gel,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2017-10-31,G03BA03,Testosterone
Human,02280248,Testim 1%,testosterone 1 % transdermal gel,Knight Therapeutics Inc.,2.0,R,2.0,Marketed,2026-01-16,G03BA03,Testosterone
Human,02027046,Malogen Aqueous 100 Sus 100Mg/Ml,testosterone 100 mg / mL suspension for injection,Germiphene Corporation,2.0,R,2.0,Cancelled post market,1998-08-13,G03BA03,Testosterone
Human,02249499,Androgel,testosterone 12.5 mg / actuation transdermal gel,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2016-04-07,G03BA03,Testosterone
Human,02239653,Androderm,testosterone 2.5 mg / 24 hr transdermal patch,Allergan Inc,2.0,R,2.0,Cancelled post market,2022-04-14,G03BA03,Testosterone
Human,02382369,Axiron,testosterone 30 mg / actuation transdermal solution,Eli Lilly Canada Inc,2.0,R,2.0,Cancelled post market,2017-12-04,G03BA03,Testosterone
Human,02450550,Natesto,testosterone 4.5 % / w/w nasal gel,Acerus Biopharma Inc,2.0,R,2.0,Marketed,2022-09-15,G03BA03,Testosterone
Human,02245972,Androderm,testosterone 5 mg / 24 hr transdermal patch,Allergan Inc,2.0,R,2.0,Cancelled post market,2021-12-13,G03BA03,Testosterone
Human,02220318,Scheinpharm Testone-Cyp Inject.- Im 100Mg/Ml,testosterone cypionate 100 mg / mL liquid for injection,Schein Pharmaceutical Canada Inc.,2.0,R,2.0,Cancelled post market,2004-07-26,G03BA03,Testosterone
Human,02246063,Testosterone Cypionate Injection Usp,testosterone cypionate 100 mg / mL liquid for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2021-03-25,G03BA03,Testosterone
Human,01977601,"Testosterone Cypionate Injection, Usp",testosterone cypionate 100 mg / mL liquid for injection,Sterimax Inc,2.0,R,2.0,Cancelled post market,2025-03-11,G03BA03,Testosterone
Human,00030783,Depo-Testosterone Inj 100Mg/Ml,testosterone cypionate 100 mg / mL solution for injection,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2025-07-18,G03BA03,Testosterone
Human,02496003,Taro-Testosterone Cypionate Injection,testosterone cypionate 100 mg / mL solution for injection,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2020-10-20,G03BA03,Testosterone
Human,02027054,Malogex La200 Liq 200Mg/Ml,testosterone enanthate 200 mg / mL liquid for injection,Germiphene Corporation,2.0,R,2.0,Cancelled post market,1998-08-13,G03BA03,Testosterone
Human,00739944,Pms-Testosterone Enanthate Inj 200Mg/Ml Usp,testosterone enanthate 200 mg / mL liquid for injection,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2017-09-30,G03BA03,Testosterone
Human,00716936,Testosterone Enanthate Inj 200Mg/Ml,testosterone enanthate 200 mg / mL liquid for injection,Taro Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2001-08-21,G03BA03,Testosterone
Human,00029246,Delatestryl,testosterone enanthate 200 mg / mL solution for injection,"Bausch Health, Canada Inc.",2.0,R,2.0,Cancelled post market,2025-12-18,G03BA03,Testosterone
Human,02536315,"Testosterone Enanthate Injection, Usp",testosterone enanthate 200 mg / mL solution for injection,Hikma Canada Limited,2.0,R,2.0,Marketed,2024-01-30,G03BA03,Testosterone
Human,02027062,Malogen In Oil Liq 100Mg/Ml,testosterone propionate 100 mg / mL liquid for injection,Germiphene Corporation,2.0,R,2.0,Cancelled post market,1999-04-14,G03BA03,Testosterone
Human,00716944,Testosterone Propionate Inj 100Mg/Ml,testosterone propionate 100 mg / mL liquid for injection,Taro Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2001-08-21,G03BA03,Testosterone
Human,01977571,"Testosterone Propionate Injection, Usp",testosterone propionate 100 mg / mL liquid for injection,Sterimax Inc,2.0,R,2.0,Dormant,2017-08-03,G03BA03,Testosterone
Human,02562723,Kyzatrex,testosterone undecanoate 100 mg oral capsule,"Marius Pharmaceuticals, Inc.",2.0,R,2.0,Approved,2025-11-10,G03BA03,Testosterone
Human,02562731,Kyzatrex,testosterone undecanoate 150 mg oral capsule,"Marius Pharmaceuticals, Inc.",2.0,R,2.0,Approved,2025-11-10,G03BA03,Testosterone
Human,02563770,Jatenzo,testosterone undecanoate 158 mg oral capsule,Tolmar International Ltd.,2.0,R,2.0,Approved,2025-12-12,G03BA03,Testosterone
Human,02563789,Jatenzo,testosterone undecanoate 198 mg oral capsule,Tolmar International Ltd.,2.0,R,2.0,Approved,2025-12-12,G03BA03,Testosterone
Human,02562758,Kyzatrex,testosterone undecanoate 200 mg oral capsule,"Marius Pharmaceuticals, Inc.",2.0,R,2.0,Approved,2025-11-10,G03BA03,Testosterone
Human,02563797,Jatenzo,testosterone undecanoate 237 mg oral capsule,Tolmar International Ltd.,2.0,R,2.0,Approved,2025-12-12,G03BA03,Testosterone
Human,00782327,Andriol,testosterone undecanoate 40 mg oral capsule,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2018-01-29,G03BA03,Testosterone
Human,02322498,Pms-Testosterone,testosterone undecanoate 40 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Dormant,2025-08-01,G03BA03,Testosterone
Human,02421186,Taro-Testosterone,testosterone undecanoate 40 mg oral capsule,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2014-09-02,G03BA03,Testosterone
Human,00028215,Estinyl Tablets 0.02 Mg.,ethinyl estradiol 0.02 mg / tablet oral tablet,Schering-Plough Canada Inc,1.0,K,1.0,Cancelled post market,1998-11-17,G03CA01,Ethinylestradiol
Human,00028223,Estinyl Tab 0.05Mg,ethinyl estradiol 0.05 mg / tablet oral tablet,Schering-Plough Canada Inc,1.0,K,1.0,Cancelled post market,2000-07-11,G03CA01,Ethinylestradiol
Human,00028231,Estinyl Tab 0.5Mg,ethinyl estradiol 0.5 mg / tablet oral tablet,Schering-Plough Canada Inc,1.0,K,1.0,Cancelled post market,2000-07-11,G03CA01,Ethinylestradiol
Human,02238704,Estrogel,estradiol (estradiol hemihydrate) 0.06 % / w/w transdermal gel,Organon Canada Inc.,2.0,P,2.0,Marketed,2022-03-24,G03CA03,Estradiol
Human,02449048,Lupin-Estradiol,estradiol (estradiol hemihydrate) 0.5 mg oral tablet,Lupin Pharma Canada Limited,2.0,P,2.0,Marketed,2016-02-29,G03CA03,Estradiol
Human,02449056,Lupin-Estradiol,estradiol (estradiol hemihydrate) 1 mg oral tablet,Lupin Pharma Canada Limited,2.0,P,2.0,Marketed,2016-02-29,G03CA03,Estradiol
Human,02503697,Imvexxy,estradiol (estradiol hemihydrate) 10 mcg / insert vaginal insert,Knight Therapeutics Inc.,2.0,P,2.0,Marketed,2023-11-14,G03CA03,Estradiol
Human,02542013,Pms-Estradiol 10,estradiol (estradiol hemihydrate) 10 mcg vaginal vaginal tablet,Pharmascience Inc,2.0,P,2.0,Approved,2023-10-05,G03CA03,Estradiol
Human,02325462,Vagifem 10,estradiol (estradiol hemihydrate) 10 mcg vaginal vaginal tablet,Novo Nordisk Canada Inc,2.0,P,2.0,Marketed,2010-09-22,G03CA03,Estradiol
Human,02231510,Climara 100,estradiol (estradiol hemihydrate) 100 mcg / 24 hr transdermal patch,Bayer Inc,2.0,P,2.0,Cancelled post market,2018-07-26,G03CA03,Estradiol
Human,02246969,Sandoz Estradiol Derm 100,estradiol (estradiol hemihydrate) 100 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2006-01-12,G03CA03,Estradiol
Human,02449064,Lupin-Estradiol,estradiol (estradiol hemihydrate) 2 mg oral tablet,Lupin Pharma Canada Limited,2.0,P,2.0,Marketed,2016-02-29,G03CA03,Estradiol
Human,02247499,Climara 25,estradiol (estradiol hemihydrate) 25 mcg / 24 hr transdermal patch,Bayer Inc,2.0,P,2.0,Marketed,2008-07-30,G03CA03,Estradiol
Human,02503689,Imvexxy,estradiol (estradiol hemihydrate) 4 mcg / insert vaginal insert,Knight Therapeutics Inc.,2.0,P,2.0,Marketed,2023-11-14,G03CA03,Estradiol
Human,02231509,Climara 50,estradiol (estradiol hemihydrate) 50 mcg / 24 hr transdermal patch,Bayer Inc,2.0,P,2.0,Marketed,2008-08-15,G03CA03,Estradiol
Human,02246967,Sandoz Estradiol Derm 50,estradiol (estradiol hemihydrate) 50 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2006-01-12,G03CA03,Estradiol
Human,02247500,Climara 75,estradiol (estradiol hemihydrate) 75 mcg / 24 hr transdermal patch,Bayer Inc,2.0,P,2.0,Marketed,2008-06-25,G03CA03,Estradiol
Human,02246968,Sandoz Estradiol Derm 75,estradiol (estradiol hemihydrate) 75 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2006-01-12,G03CA03,Estradiol
Human,02377098,Divigel,estradiol 0.1 % transdermal gel,Teva Canada Limited,2.0,P,2.0,Cancelled post market,2015-04-23,G03CA03,Estradiol
Human,02424835,Divigel,estradiol 0.1 % transdermal gel,Searchlight Pharma Inc,2.0,P,2.0,Marketed,2019-08-26,G03CA03,Estradiol
Human,02424843,Divigel,estradiol 0.1 % transdermal gel,Searchlight Pharma Inc,2.0,P,2.0,Marketed,2019-08-26,G03CA03,Estradiol
Human,02424924,Divigel,estradiol 0.1 % transdermal gel,Searchlight Pharma Inc,2.0,P,2.0,Marketed,2018-11-29,G03CA03,Estradiol
Human,02451239,Estradiol,estradiol 0.5 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Approved,2022-10-26,G03CA03,Estradiol
Human,02225190,Pms-Estradiol,estradiol 0.5 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Dormant,2023-12-15,G03CA03,Estradiol
Human,00464791,Estrace Tab 1Mg,estradiol 1 mg / tablet oral tablet,Bristol Labs Division Of Bristol-Myers Squibb,2.0,P,2.0,Cancelled post market,1999-01-07,G03CA03,Estradiol
Human,02451247,Estradiol,estradiol 1 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Approved,2022-10-26,G03CA03,Estradiol
Human,02148587,Pms-Estradiol,estradiol 1 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Dormant,2023-12-15,G03CA03,Estradiol
Human,02237808,Oesclim,estradiol 10 mg transdermal patch,Fournier Pharma Inc,2.0,P,2.0,Cancelled post market,2002-07-12,G03CA03,Estradiol
Human,02244002,Estradot 100,estradiol 100 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2022-12-06,G03CA03,Estradiol
Human,02243726,Oesclim,estradiol 100 mcg / 24 hr transdermal patch,Searchlight Pharma Inc,2.0,P,2.0,Cancelled post market,2024-07-18,G03CA03,Estradiol
Human,00464805,Estrace Tab 2Mg,estradiol 2 mg / tablet oral tablet,Bristol Labs Division Of Bristol-Myers Squibb,2.0,P,2.0,Cancelled post market,1998-04-07,G03CA03,Estradiol
Human,02451255,Estradiol,estradiol 2 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Approved,2022-10-26,G03CA03,Estradiol
Human,02148595,Pms-Estradiol,estradiol 2 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Dormant,2023-12-15,G03CA03,Estradiol
Human,00756849,Estraderm-25,estradiol 2 mg transdermal prolonged-release patch,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2012-10-25,G03CA03,Estradiol
Human,02168898,Estring,estradiol 2 mg vaginal slow-release ring,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2006-04-13,G03CA03,Estradiol
Human,02245676,Estradot 25,estradiol 25 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2022-12-06,G03CA03,Estradiol
Human,02243722,Oesclim,estradiol 25 mcg / 24 hr transdermal patch,Searchlight Pharma Inc,2.0,P,2.0,Cancelled post market,2023-01-01,G03CA03,Estradiol
Human,02241332,Vagifem,estradiol 25 mcg vaginal vaginal tablet,Novo Nordisk Canada Inc,2.0,P,2.0,Cancelled post market,2014-07-28,G03CA03,Estradiol
Human,02204401,Vivelle 37.5Mcg,estradiol 3.28 mg transdermal patch,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2003-12-03,G03CA03,Estradiol
Human,02243999,Estradot 37.5,estradiol 37.5 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2022-12-06,G03CA03,Estradiol
Human,02243723,Oesclim,estradiol 37.5 mcg / 24 hr transdermal patch,Searchlight Pharma Inc,2.0,P,2.0,Cancelled post market,2024-07-18,G03CA03,Estradiol
Human,00756857,Estraderm-50,estradiol 4 mg / strip transdermal prolonged-release patch,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2010-05-10,G03CA03,Estradiol
Human,02204428,Vivelle 50Mcg,estradiol 4.33 mg transdermal patch,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2008-11-21,G03CA03,Estradiol
Human,02237807,Oesclim,estradiol 5 mg transdermal patch,Fournier Pharma Inc,2.0,P,2.0,Cancelled post market,2002-07-12,G03CA03,Estradiol
Human,02244000,Estradot 50,estradiol 50 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2022-12-07,G03CA03,Estradiol
Human,02243724,Oesclim,estradiol 50 mcg / 24 hr transdermal patch,Searchlight Pharma Inc,2.0,P,2.0,Cancelled post market,2023-01-01,G03CA03,Estradiol
Human,02204436,Vivelle 75Mcg,estradiol 6.56 mg transdermal patch,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2003-12-03,G03CA03,Estradiol
Human,02244001,Estradot 75,estradiol 75 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2022-12-06,G03CA03,Estradiol
Human,02243725,Oesclim,estradiol 75 mcg / 24 hr transdermal patch,Searchlight Pharma Inc,2.0,P,2.0,Cancelled post market,2024-07-18,G03CA03,Estradiol
Human,00756792,Estraderm-100,estradiol 8 mg transdermal prolonged-release patch,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2013-01-08,G03CA03,Estradiol
Human,02204444,Vivelle 100Mcg,estradiol 8.66 mg transdermal patch,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2003-12-03,G03CA03,Estradiol
Human,00029238,Delestrogen Inj 10Mg/Ml,estradiol valerate 10 mg / mL liquid for injection,Theramed Corporation,2.0,P,2.0,Cancelled post market,2008-03-03,G03CA03,Estradiol
Human,00741930,Pms-Estradiol Valerate Inj 10Mg/Ml,estradiol valerate 10 mg / mL liquid for injection,Pharmascience Inc,2.0,P,2.0,Cancelled post market,2016-10-28,G03CA03,Estradiol
Human,00545996,Neo-Diol Inj 20Mg/Ml,estradiol valerate 20 mg / mL liquid for injection,Neolab Inc,2.0,P,2.0,Cancelled post market,2003-07-29,G03CA03,Estradiol
Human,00727369,Estragyn Vaginal Cream,estrone 0.1 % / w/w vaginal cream,Searchlight Pharma Inc,,P,2.0,Marketed,2016-08-18,G03CA07,Estrone
Human,00006211,Oestrilin Cones Vaginaux,estrone 0.25 mg / suppository vaginal suppository,"Desbergers Ltée, Division Of Technilab Inc.",,P,2.0,Cancelled post market,2004-08-09,G03CA07,Estrone
Human,00006149,Oestrilin Creme Vaginale 1Mg,estrone 1 mg / g vaginal cream,"Desbergers Ltée, Division Of Technilab Inc.",,P,2.0,Cancelled post market,2004-08-23,G03CA07,Estrone
Human,02089793,Ogen .625,estropipate 0.75 mg oral tablet,Pfizer Canada Ulc,,P,2.0,Cancelled post market,2012-08-24,G03CA07,Estrone
Human,02089769,Ogen 1.25,estropipate 1.5 mg oral tablet,Pfizer Canada Ulc,,P,2.0,Cancelled post market,2012-08-24,G03CA07,Estrone
Human,02089777,Ogen 2.5,estropipate 3 mg oral tablet,Pfizer Canada Ulc,,P,2.0,Cancelled post market,2012-08-24,G03CA07,Estrone
Human,02414678,Premarin,conjugated estrogens 0.3 mg oral prolonged-release tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2014-10-03,G03CA57,Conjugated estrogens
Human,00798231,Apo-Conest Tab 0.3Mg,conjugated estrogens 0.3 mg oral tablet,Apotex Inc,1.0,K,1.0,Cancelled post market,2009-10-09,G03CA57,Conjugated estrogens
Human,02230891,C.E.S. Tablets,conjugated estrogens 0.3 mg oral tablet,Valeant Canada Lp / Valeant Canada S.E.C.,1.0,K,1.0,Cancelled post market,2014-07-30,G03CA57,Conjugated estrogens
Human,00830240,Congest,conjugated estrogens 0.3 mg oral tablet,Laboratoire Riva Inc.,1.0,K,1.0,Dormant,2018-05-04,G03CA57,Conjugated estrogens
Human,02239654,Pms-Conjugated Estrogens C.S.D.,conjugated estrogens 0.3 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Cancelled post market,2017-09-30,G03CA57,Conjugated estrogens
Human,02043394,Premarin,conjugated estrogens 0.3 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2017-08-02,G03CA57,Conjugated estrogens
Human,00002569,Premarin Tablets 0.3Mg,conjugated estrogens 0.3 mg oral tablet,Ayerst Laboratories,1.0,K,1.0,Cancelled post market,1996-09-10,G03CA57,Conjugated estrogens
Human,00002089,Premarin Crm 0.625Mg/Gm,conjugated estrogens 0.625 mg / g cutaneous cream,Ayerst Laboratories,1.0,K,1.0,Cancelled post market,1996-09-10,G03CA57,Conjugated estrogens
Human,02043440,Premarin Vaginal Cream,conjugated estrogens 0.625 mg / g vaginal cream,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2012-06-19,G03CA57,Conjugated estrogens
Human,02414686,Premarin,conjugated estrogens 0.625 mg oral prolonged-release tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2014-10-03,G03CA57,Conjugated estrogens
Human,00798223,Apo-Conest Tab 0.625Mg,conjugated estrogens 0.625 mg oral tablet,Apotex Inc,1.0,K,1.0,Cancelled post market,2009-10-09,G03CA57,Conjugated estrogens
Human,00265470,C.E.S.,conjugated estrogens 0.625 mg oral tablet,"Bausch Health, Canada Inc.",1.0,K,1.0,Dormant,2020-09-23,G03CA57,Conjugated estrogens
Human,00830232,Congest,conjugated estrogens 0.625 mg oral tablet,Laboratoire Riva Inc.,1.0,K,1.0,Dormant,2018-05-04,G03CA57,Conjugated estrogens
Human,00587281,Pms-Conjugated Estrogens C.S.D.,conjugated estrogens 0.625 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Cancelled post market,2017-09-30,G03CA57,Conjugated estrogens
Human,02043408,Premarin,conjugated estrogens 0.625 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2017-08-02,G03CA57,Conjugated estrogens
Human,00002577,Premarin Tablets 0.625Mg,conjugated estrogens 0.625 mg oral tablet,Ayerst Laboratories,1.0,K,1.0,Cancelled post market,1996-09-10,G03CA57,Conjugated estrogens
Human,00798215,Apo-Conest Tab 0.9Mg,conjugated estrogens 0.9 mg oral tablet,Apotex Inc,1.0,K,1.0,Cancelled post market,2009-10-09,G03CA57,Conjugated estrogens
Human,02230892,C.E.S. Tablets,conjugated estrogens 0.9 mg oral tablet,Valeant Canada Lp / Valeant Canada S.E.C.,1.0,K,1.0,Cancelled post market,2014-07-30,G03CA57,Conjugated estrogens
Human,00830224,Congest,conjugated estrogens 0.9 mg oral tablet,Laboratoire Riva Inc.,1.0,K,1.0,Dormant,2018-05-04,G03CA57,Conjugated estrogens
Human,02239655,Pms-Conjugated Estrogens C.S.D.,conjugated estrogens 0.9 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Cancelled post market,2017-09-30,G03CA57,Conjugated estrogens
Human,02043416,Premarin Tablets 0.9Mg,conjugated estrogens 0.9 mg oral tablet,Wyeth Canada,1.0,K,1.0,Cancelled post market,2007-08-13,G03CA57,Conjugated estrogens
Human,02414694,Premarin,conjugated estrogens 1.25 mg oral prolonged-release tablet,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2014-10-03,G03CA57,Conjugated estrogens
Human,00798207,Apo-Conest Tab 1.25Mg,conjugated estrogens 1.25 mg oral tablet,Apotex Inc,1.0,K,1.0,Cancelled post market,2009-10-09,G03CA57,Conjugated estrogens
Human,00265489,C.E.S. Tablets,conjugated estrogens 1.25 mg oral tablet,Valeant Canada Lp / Valeant Canada S.E.C.,1.0,K,1.0,Cancelled post market,2014-07-30,G03CA57,Conjugated estrogens
Human,00830216,Congest,conjugated estrogens 1.25 mg oral tablet,Laboratoire Riva Inc.,1.0,K,1.0,Dormant,2018-05-04,G03CA57,Conjugated estrogens
Human,00587303,Pms-Conjugated Estrogens C.S.D.,conjugated estrogens 1.25 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Cancelled post market,2017-09-30,G03CA57,Conjugated estrogens
Human,02043424,Premarin,conjugated estrogens 1.25 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2017-08-02,G03CA57,Conjugated estrogens
Human,00002585,Premarin Tablets 1.25Mg,conjugated estrogens 1.25 mg oral tablet,Ayerst Laboratories,1.0,K,1.0,Cancelled post market,1996-09-10,G03CA57,Conjugated estrogens
Human,00798193,Apo-Conest Tab 2.5Mg,conjugated estrogens 2.5 mg oral tablet,Apotex Inc,1.0,K,1.0,Cancelled post market,2009-10-09,G03CA57,Conjugated estrogens
Human,00830208,Congest,conjugated estrogens 2.5 mg oral tablet,Laboratoire Riva Inc.,1.0,K,1.0,Dormant,2018-05-04,G03CA57,Conjugated estrogens
Human,00002593,Premarin Tablets 2.5Mg,conjugated estrogens 2.5 mg oral tablet,Ayerst Laboratories,1.0,K,1.0,Cancelled post market,1997-08-15,G03CA57,Conjugated estrogens
Human,02043432,Premarin Tablets 2.5Mg,conjugated estrogens 2.5 mg oral tablet,Wyeth-Ayerst Canada Inc.,1.0,K,1.0,Cancelled post market,2000-08-02,G03CA57,Conjugated estrogens
Human,00002283,Premarin Inj 25Mg/5Ml,conjugated estrogens 25 mg / 5 mL powder for solution for injection,Ayerst Laboratories,1.0,K,1.0,Cancelled post market,1996-09-10,G03CA57,Conjugated estrogens
Human,02043386,Premarin Intravenous,conjugated estrogens 25 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2014-01-29,G03CA57,Conjugated estrogens
Human,00003336,Stilboestrol Tab 0.1Mg,diethylstilbestrol 0.1 mg / tablet oral tablet,Allen & Hanburys A Glaxo Canada Ltd. Co.,1.0,K,1.0,Cancelled post market,1996-09-10,G03CB02,Diethylstilbestrol
Human,00003352,Stilboestrol Tab 0.5Mg,diethylstilbestrol 0.5 mg / tablet oral tablet,Allen & Hanburys A Glaxo Canada Ltd. Co.,1.0,K,1.0,Cancelled post market,1996-09-20,G03CB02,Diethylstilbestrol
Human,00508578,Stilbestrol Tab 1Mg,diethylstilbestrol 1 mg / tablet oral tablet,Everest Pharmaceuticals Ltd.,1.0,K,1.0,Cancelled post market,1999-07-14,G03CB02,Diethylstilbestrol
Human,02488361,Tibella,tibolone 2.5 mg oral tablet,Biosyent Pharma Inc,1.0,,,Marketed,2020-07-29,G03CX01,Tibolone
Human,02231770,Penta-Medroxyprogesterone Tablets,medroxyprogesterone acetate 10 mg / tablet oral tablet,Pentapharm Ltd.,2.0,R,2.0,Cancelled post market,2004-07-30,G03DA02,Medroxyprogesterone
Human,02239827,Proclim,medroxyprogesterone acetate 10 mg / tablet oral tablet,Fournier Pharma Inc,2.0,R,2.0,Cancelled post market,2000-11-14,G03DA02,Medroxyprogesterone
Human,02277298,Aa-Medroxy,medroxyprogesterone acetate 10 mg oral tablet,Aa Pharma Inc,2.0,R,2.0,Marketed,2024-11-15,G03DA02,Medroxyprogesterone
Human,02247583,Dom-Medroxyprogesterone,medroxyprogesterone acetate 10 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2016-10-25,G03DA02,Medroxyprogesterone
Human,02229840,Gen-Medroxy Tablet 10Mg,medroxyprogesterone acetate 10 mg oral tablet,Genpharm Ulc,2.0,R,2.0,Cancelled post market,2010-08-04,G03DA02,Medroxyprogesterone
Human,02212072,Meprogest,medroxyprogesterone acetate 10 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2019-11-06,G03DA02,Medroxyprogesterone
Human,02246629,Pms-Medroxyprogesterone,medroxyprogesterone acetate 10 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2016-10-28,G03DA02,Medroxyprogesterone
Human,00729973,Provera 10Mg Tablets,medroxyprogesterone acetate 10 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2025-11-14,G03DA02,Medroxyprogesterone
Human,02010933,Provera Pak 10Mg Tablets,medroxyprogesterone acetate 10 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2014-04-04,G03DA02,Medroxyprogesterone
Human,02148579,Ratio-Mpa,medroxyprogesterone acetate 10 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2008-08-01,G03DA02,Medroxyprogesterone
Human,02221306,Teva-Medroxyprogesterone,medroxyprogesterone acetate 10 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2011-01-19,G03DA02,Medroxyprogesterone
Human,02267640,Aa-Medroxy,medroxyprogesterone acetate 100 mg oral tablet,Aa Pharma Inc,2.0,R,2.0,Marketed,2024-12-16,G03DA02,Medroxyprogesterone
Human,00030945,Provera 100Mg Tablets,medroxyprogesterone acetate 100 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2012-02-13,G03DA02,Medroxyprogesterone
Human,02231768,Penta-Medroxyprogesterone Tablets,medroxyprogesterone acetate 2.5 mg / tablet oral tablet,Pentapharm Ltd.,2.0,R,2.0,Cancelled post market,2004-07-30,G03DA02,Medroxyprogesterone
Human,02239825,Proclim,medroxyprogesterone acetate 2.5 mg / tablet oral tablet,Fournier Pharma Inc,2.0,R,2.0,Cancelled post market,2000-11-14,G03DA02,Medroxyprogesterone
Human,02244726,Aa-Medroxy,medroxyprogesterone acetate 2.5 mg oral tablet,Aa Pharma Inc,2.0,R,2.0,Marketed,2024-11-15,G03DA02,Medroxyprogesterone
Human,02247581,Dom-Medroxyprogesterone,medroxyprogesterone acetate 2.5 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2016-10-25,G03DA02,Medroxyprogesterone
Human,02229838,Gen-Medroxy Tablet 2.5Mg,medroxyprogesterone acetate 2.5 mg oral tablet,Genpharm Ulc,2.0,R,2.0,Cancelled post market,2010-08-04,G03DA02,Medroxyprogesterone
Human,02253550,Medroxy-2.5,medroxyprogesterone acetate 2.5 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2020-07-17,G03DA02,Medroxyprogesterone
Human,02212056,Meprogest,medroxyprogesterone acetate 2.5 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2019-11-06,G03DA02,Medroxyprogesterone
Human,02252740,Nu-Medroxy,medroxyprogesterone acetate 2.5 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,G03DA02,Medroxyprogesterone
Human,02246627,Pms-Medroxyprogesterone,medroxyprogesterone acetate 2.5 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2016-10-28,G03DA02,Medroxyprogesterone
Human,00708917,Provera 2.5Mg Tablets,medroxyprogesterone acetate 2.5 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2025-11-14,G03DA02,Medroxyprogesterone
Human,02148552,Ratio-Mpa,medroxyprogesterone acetate 2.5 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2008-08-01,G03DA02,Medroxyprogesterone
Human,02221284,Teva-Medroxyprogesterone,medroxyprogesterone acetate 2.5 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2011-01-19,G03DA02,Medroxyprogesterone
Human,02231769,Penta-Medroxyprogesterone Tablets,medroxyprogesterone acetate 5 mg / tablet oral tablet,Pentapharm Ltd.,2.0,R,2.0,Cancelled post market,2004-07-30,G03DA02,Medroxyprogesterone
Human,02239826,Proclim,medroxyprogesterone acetate 5 mg / tablet oral tablet,Fournier Pharma Inc,2.0,R,2.0,Cancelled post market,2000-11-14,G03DA02,Medroxyprogesterone
Human,02244727,Aa-Medroxy,medroxyprogesterone acetate 5 mg oral tablet,Aa Pharma Inc,2.0,R,2.0,Marketed,2024-12-16,G03DA02,Medroxyprogesterone
Human,02247582,Dom-Medroxyprogesterone,medroxyprogesterone acetate 5 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2016-10-25,G03DA02,Medroxyprogesterone
Human,02229839,Gen-Medroxy Tablet 5Mg,medroxyprogesterone acetate 5 mg oral tablet,Genpharm Ulc,2.0,R,2.0,Cancelled post market,2010-08-04,G03DA02,Medroxyprogesterone
Human,02253577,Medroxy-5,medroxyprogesterone acetate 5 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2020-08-20,G03DA02,Medroxyprogesterone
Human,02212064,Meprogest,medroxyprogesterone acetate 5 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2019-11-06,G03DA02,Medroxyprogesterone
Human,02252759,Nu-Medroxy,medroxyprogesterone acetate 5 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,G03DA02,Medroxyprogesterone
Human,02246628,Pms-Medroxyprogesterone,medroxyprogesterone acetate 5 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2016-10-28,G03DA02,Medroxyprogesterone
Human,00030937,Provera 5Mg Tablets,medroxyprogesterone acetate 5 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2025-11-14,G03DA02,Medroxyprogesterone
Human,02010739,Provera Pak 5Mg Tablets,medroxyprogesterone acetate 5 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2014-03-26,G03DA02,Medroxyprogesterone
Human,02148560,Ratio-Mpa,medroxyprogesterone acetate 5 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2008-08-01,G03DA02,Medroxyprogesterone
Human,02221292,Teva-Medroxyprogesterone,medroxyprogesterone acetate 5 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2011-01-19,G03DA02,Medroxyprogesterone
Human,02493578,Auro-Progesterone,progesterone 100 mg oral capsule,Auro Pharma Inc,2.0,P,2.0,Marketed,2020-03-16,G03DA04,Progesterone
Human,02546493,Eugia-Progesterone,progesterone 100 mg oral capsule,Eugia Pharma Inc.,2.0,P,2.0,Approved,2024-03-19,G03DA04,Progesterone
Human,02476576,Pms-Progesterone,progesterone 100 mg oral capsule,Pharmascience Inc,2.0,P,2.0,Marketed,2018-08-08,G03DA04,Progesterone
Human,02516187,Progesterone,progesterone 100 mg oral capsule,Sanis Health Inc,2.0,P,2.0,Marketed,2022-08-19,G03DA04,Progesterone
Human,02166704,Prometrium,progesterone 100 mg oral capsule,Organon Canada Inc.,2.0,P,2.0,Marketed,2022-02-18,G03DA04,Progesterone
Human,02463113,Reddy-Progesterone,progesterone 100 mg oral capsule,Dr. Reddy'S Laboratories Inc,2.0,P,2.0,Marketed,2018-08-09,G03DA04,Progesterone
Human,02439913,Teva-Progesterone,progesterone 100 mg oral capsule,Teva Canada Limited,2.0,P,2.0,Marketed,2015-04-16,G03DA04,Progesterone
Human,02334992,Endometrin,progesterone 100 mg vaginal effervescent vaginal tablet,Ferring Inc,2.0,P,2.0,Dormant,2025-07-10,G03DA04,Progesterone
Human,02480247,Pms-Progesterone,progesterone 200 mg oral capsule,Pharmascience Inc,2.0,P,2.0,Dormant,2024-07-31,G03DA04,Progesterone
Human,02462818,Utrogestan,progesterone 200 mg vaginal capsule,Besins Healthcare Sa,2.0,P,2.0,Approved,2017-04-05,G03DA04,Progesterone
Human,02515504,Inprosub,progesterone 25 mg / 1.112 mL solution for injection,Ibsa Institut Biochimique Sa,2.0,P,2.0,Cancelled pre market,2024-06-13,G03DA04,Progesterone
Human,02128470,Gesterol In Oil-Liq Im 50Mg/Ml,progesterone 50 mg / mL liquid for injection,Germiphene Corporation,2.0,P,2.0,Cancelled post market,1999-04-14,G03DA04,Progesterone
Human,00739952,Pms-Progesterone Inj 50Mg/Ml Usp,progesterone 50 mg / mL liquid for injection,Pharmascience Inc,2.0,P,2.0,Cancelled post market,2004-01-21,G03DA04,Progesterone
Human,01977652,Progesterone Inj 50Mg/Ml Usp,progesterone 50 mg / mL liquid for injection,Cytex Pharmaceuticals Inc,2.0,P,2.0,Dormant,2017-06-16,G03DA04,Progesterone
Human,02446820,Act Progesterone Injection,progesterone 50 mg / mL solution for injection,Teva Canada Limited,2.0,P,2.0,Marketed,2020-05-12,G03DA04,Progesterone
Human,02562642,Progesterone Injection Usp,progesterone 50 mg / mL solution for injection,Sterimax Inc,2.0,P,2.0,Approved,2025-11-04,G03DA04,Progesterone
Human,02531828,"Progesterone Injection, Usp",progesterone 50 mg / mL solution for injection,Hikma Canada Limited,2.0,P,2.0,Marketed,2023-04-28,G03DA04,Progesterone
Human,02241013,Crinone,progesterone 8 % vaginal gel,"Emd Serono, A Division Of Emd Inc., Canada",2.0,P,2.0,Marketed,2000-06-12,G03DA04,Progesterone
Human,00037117,Colprone Tab 5Mg,medrogestone 5 mg / tablet oral tablet,Ayerst Laboratories,,P,,Cancelled post market,1997-08-15,G03DB03,Medrogestone
Human,02041693,Colprone Tab 5Mg,medrogestone 5 mg / tablet oral tablet,Wyeth-Ayerst Canada Inc.,,P,,Cancelled post market,2001-08-30,G03DB03,Medrogestone
Human,00023760,Norlutate,norethindrone acetate 5 mg oral tablet,Searchlight Pharma Inc,2.0,,,Marketed,2022-10-14,G03DC02,Norethisterone
Human,02061031,Climacteron Injection,estradiol benzoate 1 mg / mL + estradiol dienanthate 7.5 mg / mL + testosterone enanthate benzilic acid hydrazone 150 mg / mL liquid for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2005-10-20,G03EA02,Testosterone and estrogen
Human,00147567,Neo Pause Injection,estradiol valerate 6.5 mg / mL + testosterone enanthate 100 mg / mL solution for injection,Neolab Inc,2.0,R,2.0,Cancelled post market,2006-10-04,G03EA02,Testosterone and estrogen
Human,02309009,Activelle Ld,estradiol 0.5 mg + norethindrone acetate 0.1 mg oral tablet,Novo Nordisk Canada Inc,1.0,K,1.0,Marketed,2008-05-16,G03FA01,Norethisterone and estrogen
Human,02249405,Activelle,estradiol 1 mg + norethindrone acetate 0.5 mg oral tablet,Novo Nordisk Canada Inc,1.0,K,1.0,Marketed,2008-05-16,G03FA01,Norethisterone and estrogen
Human,02241835,Estalis 140/50 Mcg,estradiol 50 mcg / 24 hr + norethindrone acetate 140 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2022-12-06,G03FA01,Norethisterone and estrogen
Human,02241837,Estalis 250/50 Mcg,estradiol 50 mcg / 24 hr + norethindrone acetate 250 mcg / 24 hr transdermal patch,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2022-12-06,G03FA01,Norethisterone and estrogen
Human,02563177,Actifemme,estradiol hemihydrate 1 mg + norethindrone acetate 0.5 mg oral tablet,Novast Laboratories Ltd.,1.0,K,1.0,Approved,2025-12-02,G03FA01,Norethisterone and estrogen
Human,02242531,Femhrt,ethinyl estradiol 5 mcg + norethindrone acetate 1 mg oral tablet,Warner Chilcott Canada Co,1.0,K,1.0,Cancelled post market,2016-08-05,G03FA01,Norethisterone and estrogen
Human,00018953,Neo Mens Tab,ethinyl estradiol 0.05 mg / tablet + ethisterone 50 mg / tablet sublingual tablet,Neolab Inc,1.0,K,1.0,Cancelled post market,1997-08-12,G03FA03,Ethisterone and estrogen
Human,02403404,Estrogel Propak,estradiol (estradiol hemihydrate) 0.06 % + progesterone 100 mg / capsule oral or transdermal metered-dose pump or capsule,Merck Canada Inc,1.0,K,1.0,Cancelled post market,2016-06-08,G03FA04,Progesterone and estrogen
Human,02505215,Bijuva,estradiol (estradiol hemihydrate) 0.5 mg + progesterone 100 mg oral capsule,Knight Therapeutics Inc.,1.0,K,1.0,Approved,2020-09-17,G03FA04,Progesterone and estrogen
Human,02505223,Bijuva,estradiol (estradiol hemihydrate) 1 mg + progesterone 100 mg oral capsule,Knight Therapeutics Inc.,1.0,K,1.0,Marketed,2024-01-31,G03FA04,Progesterone and estrogen
Human,02549158,Ach-Progesterone,progesterone 100 mg oral capsule,Accord Healthcare Inc,1.0,K,1.0,Approved,2024-06-25,G03FA04,Progesterone and estrogen
Human,02551268,M-Progesterone,progesterone 100 mg oral capsule,Mantra Pharma Inc,1.0,K,1.0,Marketed,2025-07-18,G03FA04,Progesterone and estrogen
Human,02250616,Climara Pro,estradiol 45 mcg / 24 hr + levonorgestrel 15 mcg / 24 hr transdermal patch,Bayer Inc,1.0,K,1.0,Cancelled post market,2017-11-30,G03FA11,Levonorgestrel and estrogen
Human,02242880,Premplus Cycle,conjugated estrogens 0.625 mg with medroxyprogesterone acetate 10 mg oral kit (tablet),Pfizer Canada Ulc,1.0,K,1.0,Cancelled pre market,2019-11-06,G03FA12,Medroxyprogesterone and estrogen
Human,02242878,Premplus,conjugated estrogens 0.625 mg with medroxyprogesterone acetate 2.5 mg oral kit (tablet),Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2019-11-06,G03FA12,Medroxyprogesterone and estrogen
Human,02242879,Premplus,conjugated estrogens 0.625 mg with medroxyprogesterone acetate 5 mg oral kit (tablet),Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2019-11-06,G03FA12,Medroxyprogesterone and estrogen
Human,02247906,Prefesta,estradiol 1 mg + norgestimate 90 mcg oral tablet,Searchlight Pharma Inc,1.0,K,1.0,Cancelled pre market,2024-07-29,G03FA13,Norgestimate and estrogen
Human,02268825,Angeliq,drospirenone 1 mg + estradiol 1 mg oral tablet,Bayer Inc,1.0,K,1.0,Marketed,2008-10-20,G03FA17,Drospirenone and estrogen
Human,02243530,Estalis Sequi,estradiol 0.51 mg + estradiol 4.33 mg + norethindrone acetate 4.8 mg transdermal patch,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Cancelled post market,2008-09-04,G03FB05,Norethisterone and estrogen
Human,02243529,Estalis Sequi,estradiol 0.62 mg + estradiol 4.33 mg + norethindrone acetate 2.7 mg transdermal patch,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Cancelled post market,2008-02-07,G03FB05,Norethisterone and estrogen
Human,02108186,Estracomb,estradiol 10 mg + estradiol 4 mg + norethindrone acetate 30 mg transdermal patch,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Cancelled post market,2009-06-08,G03FB05,Norethisterone and estrogen
Human,00002291,Apl Inj 1000 Iu/Ml,chorionic gonadotropin 1000 units / mL liquid for injection,Ayerst Laboratories,2.0,R,2.0,Cancelled post market,2000-08-02,G03GA01,Chorionic gonadotrophin
Human,02168936,A.P.L. - Pws-Liq,chorionic gonadotropin 10000 units / kit with water 10 mL / kit intramuscular (liquid and powder for solution),Wyeth-Ayerst Canada Inc.,2.0,R,2.0,Cancelled post market,2001-06-01,G03GA01,Chorionic gonadotrophin
Human,02182904,Pregnyl,chorionic gonadotropin 10000 units / vial kit (powder for solution) for injection,Organon Canada Inc.,2.0,R,2.0,Marketed,2022-04-06,G03GA01,Chorionic gonadotrophin
Human,02247459,"Chorionic Gonadotropin For Injection, Usp",chorionic gonadotropin 10000 units / vial powder for solution for injection,Fresenius Kabi Canada Ltd,2.0,R,2.0,Marketed,2015-11-13,G03GA01,Chorionic gonadotrophin
Human,00598534,Profasi Hp Inj 10000Unit/Vial Usp,chorionic gonadotropin 10000 units / vial powder for solution for injection,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2009-04-29,G03GA01,Chorionic gonadotrophin
Human,01925679,Profasi Hp 10000,chorionic gonadotropin 10000 units / vial with water 10 mL / vial kit (liquid and powder for solution) for injection,"Emd Serono, A Division Of Emd Inc., Canada",2.0,R,2.0,Cancelled post market,2007-05-07,G03GA01,Chorionic gonadotrophin
Human,00254916,Pergonal 75 I.U.,follicle stimulating hormone (fsh) 75 units / ampoule + luteinizing hormone 75 units / ampoule powder for solution for injection,"Emd Serono, A Division Of Emd Inc., Canada",2.0,R,2.0,Cancelled post market,2007-05-07,G03GA02,Human menopausal gonadotrophin
Human,01958992,Humegon Inj 75 I.U.,follicle stimulating hormone (fsh) 75 units / kit with luteinizing hormone 75 units / kit with sodium chloride 0.9 % / kit intramuscular (liquid and powder for solution),Organon Canada Ltd Ltee,2.0,R,2.0,Cancelled post market,2006-08-17,G03GA02,Human menopausal gonadotrophin
Human,02283093,Menopur,menotropins 75 units / vial powder for solution for injection,Ferring Inc,2.0,R,2.0,Marketed,2006-09-19,G03GA02,Human menopausal gonadotrophin
Human,02247790,Repronex,menotropins 75 units / vial powder for solution for injection,Ferring Inc,2.0,R,2.0,Cancelled post market,2019-04-23,G03GA02,Human menopausal gonadotrophin
Human,02125404,Fertinorm Hp 75 - Pws Diluent Im Sc,sodium chloride 2 mL / kit with urofollitropin 75 units / kit intramuscular or subcutaneous (liquid and powder for solution),"Emd Serono, A Division Of Emd Inc., Canada",,R,2.0,Cancelled post market,2007-05-07,G03GA04,Urofollitropin
Human,02125412,Fertinorm Hp 150 - Pws Diluent Im Sc,sodium chloride 2 mL / vial with urofollitropin 150 units / vial kit (liquid and powder for solution) for injection,"Emd Serono, A Division Of Emd Inc., Canada",,R,2.0,Cancelled post market,2007-05-07,G03GA04,Urofollitropin
Human,00755613,Metrodin 75 I.U.,urofollitropin 75 units / ampoule powder for solution for injection,Industria Farmaceutica Serono Spa,,R,2.0,Cancelled post market,1999-08-11,G03GA04,Urofollitropin
Human,02268140,Bravelle,urofollitropin 75 units / vial powder for solution for injection,Ferring Inc,,R,2.0,Cancelled post market,2019-07-18,G03GA04,Urofollitropin
Human,02262088,Ovidrel,choriogonadotropin alfa 250 mcg / 0.5 mL solution for injection,"Emd Serono, A Division Of Emd Inc., Canada",2.0,R,2.0,Marketed,2004-12-20,G03GA08,Choriogonadotropin alfa
Human,02371588,Ovidrel,choriogonadotropin alfa 250 mcg / 0.5 mL solution for injection,"Emd Serono, A Division Of Emd Inc., Canada",2.0,R,2.0,Marketed,2013-05-28,G03GA08,Choriogonadotropin alfa
Human,00018031,Clomid 50Mg,clomiphene citrate 50 mg / tablet oral tablet,"Merrell Pharms Inc., Division Of Merrell Dow (Can)",2.0,R,,Cancelled post market,1996-09-09,G03GB02,Clomifene
Human,02091879,Clomid,clomiphene citrate 50 mg oral tablet,Sanofi-Aventis Canada Inc,2.0,R,,Cancelled post market,2020-07-15,G03GB02,Clomifene
Human,00640158,Serophene Tab 50Mg,clomiphene citrate 50 mg oral tablet,Pharmascience Inc,2.0,R,,Cancelled post market,2014-09-08,G03GB02,Clomifene
Human,00893722,Serophene Tab 50Mg,clomiphene citrate 50 mg oral tablet,"Emd Serono, A Division Of Emd Inc., Canada",2.0,R,,Cancelled post market,2017-07-07,G03GB02,Clomifene
Human,00704423,Androcur Depot,cyproterone acetate 100 mg / mL solution for injection,Amdipharm Limited,2.0,P,,Dormant,2025-05-08,G03HA01,Cyproterone
Human,02229449,Alti-Cpa,cyproterone acetate 50 mg oral tablet,Altimed Pharma Inc.,2.0,P,,Cancelled post market,2005-05-27,G03HA01,Cyproterone
Human,00704431,Androcur,cyproterone acetate 50 mg oral tablet,Amdipharm Limited,2.0,P,,Marketed,2025-05-08,G03HA01,Cyproterone
Human,02237253,Cyproterone,cyproterone acetate 50 mg oral tablet,Bdh Inc.,2.0,P,,Cancelled post market,2000-08-03,G03HA01,Cyproterone
Human,02245898,Cyproterone,cyproterone acetate 50 mg oral tablet,Aa Pharma Inc,2.0,P,,Marketed,2011-03-22,G03HA01,Cyproterone
Human,02390760,Med-Cyproterone,cyproterone acetate 50 mg oral tablet,Generic Medical Partners Inc,2.0,P,,Marketed,2012-10-02,G03HA01,Cyproterone
Human,02229723,Mylan-Cyproterone,cyproterone acetate 50 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,,Cancelled post market,2011-03-04,G03HA01,Cyproterone
Human,02232872,Novo-Cyproterone,cyproterone acetate 50 mg oral tablet,Novopharm Limited,2.0,P,,Cancelled post market,2015-10-26,G03HA01,Cyproterone
Human,02395797,Riva-Cyproterone,cyproterone acetate 50 mg oral tablet,Laboratoire Riva Inc.,2.0,P,,Marketed,2012-11-28,G03HA01,Cyproterone
Human,02242127,Riva-Cyproterone 50 Mg,cyproterone acetate 50 mg oral tablet,Laboratoire Riva Inc.,2.0,P,,Cancelled post market,2003-07-28,G03HA01,Cyproterone
Human,02564424,Amb-Cyproterone Acetate / Ethinyl Estradiol,cyproterone acetate 2 mg + ethinyl estradiol 0.035 mg oral tablet,Ambicare Pharmaceuticals Inc.,2.0,P,,Approved,2026-01-13,G03HB01,Cyproterone and estrogen
Human,02436736,Cléo -35,cyproterone acetate 2 mg + ethinyl estradiol 0.035 mg oral tablet,Altius Healthcare Inc,2.0,P,,Marketed,2018-05-04,G03HB01,Cyproterone and estrogen
Human,02290308,Cyestra-35,cyproterone acetate 2 mg + ethinyl estradiol 0.035 mg oral tablet,Endo Operations Ltd.,2.0,P,,Marketed,2024-11-20,G03HB01,Cyproterone and estrogen
Human,02491257,Mylan-Cyproterone / Ethinylestradiol,cyproterone acetate 2 mg + ethinyl estradiol 0.035 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,,Cancelled pre market,2022-02-24,G03HB01,Cyproterone and estrogen
Human,02425017,Taro-Cyproterone/Ethinyl Estradiol,cyproterone acetate 2 mg + ethinyl estradiol 0.035 mg oral tablet,Sun Pharma Canada Inc,2.0,P,,Marketed,2020-08-05,G03HB01,Cyproterone and estrogen
Human,02309556,Teva-Cyproterone / Ethinyl Estradiol,cyproterone acetate 2 mg + ethinyl estradiol 0.035 mg oral tablet,Teva Canada Limited,2.0,P,,Marketed,2018-03-08,G03HB01,Cyproterone and estrogen
Human,02233542,Diane-35,cyproterone acetate 2 mg + ethinyl estradiol 35 mcg oral tablet,Bayer Inc,2.0,P,,Marketed,2007-12-17,G03HB01,Cyproterone and estrogen
Human,02018152,Cyclomen,danazol 100 mg oral capsule,Sanofi-Aventis Canada Inc,,R,,Marketed,2008-08-06,G03XA01,Danazol
Human,02018160,Cyclomen,danazol 200 mg oral capsule,Sanofi-Aventis Canada Inc,,R,,Marketed,2009-02-06,G03XA01,Danazol
Human,02018144,Cyclomen,danazol 50 mg oral capsule,Sanofi-Aventis Canada Inc,,R,,Cancelled post market,2025-08-12,G03XA01,Danazol
Human,02408163,Fibristal,ulipristal acetate 5 mg oral tablet,Allergan Inc,2.0,R,2.0,Cancelled post market,2020-09-24,G03XB02,Ulipristal
Human,02560569,Femyso,mifepristone 200 mg with misoprostol 200 mcg buccal or oral kit (tablet),Lupin Pharma Canada Limited,2.0,R,2.0,Approved,2025-08-26,G03XB51,"Mifepristone, combinations"
Human,02444038,Mifegymiso,mifepristone 200 mg with misoprostol 200 mcg buccal or oral kit (tablet),Linepharma International Limited,2.0,R,2.0,Marketed,2017-01-10,G03XB51,"Mifepristone, combinations"
Human,02533553,Mifiso,mifepristone 200 mg with misoprostol 200 mcg buccal or oral kit (tablet),Linepharma International Limited,2.0,R,2.0,Approved,2022-12-16,G03XB51,"Mifepristone, combinations"
Human,02358840,Act Raloxifene,raloxifene hydrochloride 60 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2020-04-16,G03XC01,Raloxifene
Human,02279215,Apo-Raloxifene,raloxifene hydrochloride 60 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2009-03-31,G03XC01,Raloxifene
Human,02239028,Evista,raloxifene hydrochloride 60 mg oral tablet,Eli Lilly Canada Inc,2.0,P,2.0,Marketed,1998-11-20,G03XC01,Raloxifene
Human,02540681,Jamp Raloxifene,raloxifene hydrochloride 60 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2024-06-28,G03XC01,Raloxifene
Human,02358921,Pms-Raloxifene,raloxifene hydrochloride 60 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Cancelled post market,2020-04-22,G03XC01,Raloxifene
Human,02415852,Raloxifene,raloxifene hydrochloride 60 mg oral tablet,Pro Doc Limitee,2.0,P,2.0,Cancelled post market,2018-04-26,G03XC01,Raloxifene
Human,02312298,Teva-Raloxifene,raloxifene hydrochloride 60 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Cancelled post market,2018-05-17,G03XC01,Raloxifene
Human,02518112,Osphena,ospemifene 60 mg oral tablet,Duchesnay Inc,2.0,p,2.0,Marketed,2022-01-13,G03XC05,Ospemifene
Human,02372010,Jalyn,dutasteride 0.5 mg + tamsulosin hydrochloride 0.4 mg oral immediate and extended release capsule,Glaxosmithkline Inc,2.0,R,2.0,Marketed,2011-11-17,G04CA52,Tamsulosin and dutasteride
Human,02401142,Accel-Finasteride Tablets Usp,finasteride 5 mg oral tablet,Accel Pharma Inc,2.0,R,,Cancelled pre market,2017-05-19,G04CB01,Finasteride
Human,02355043,Ach-Finasteride,finasteride 5 mg oral tablet,Accord Healthcare Inc,2.0,R,,Marketed,2014-11-13,G04CB01,Finasteride
Human,02354462,Act Finasteride,finasteride 5 mg oral tablet,Actavis Pharma Company,2.0,R,,Cancelled post market,2019-07-08,G04CB01,Finasteride
Human,02374404,Ag-Finasteride,finasteride 5 mg oral tablet,Angita Pharma Inc.,2.0,R,,Marketed,2021-02-03,G04CB01,Finasteride
Human,02365383,Apo-Finasteride,finasteride 5 mg oral tablet,Apotex Inc,2.0,R,,Dormant,2024-02-24,G04CB01,Finasteride
Human,02405814,Auro-Finasteride,finasteride 5 mg oral tablet,Auro Pharma Inc,2.0,R,,Marketed,2013-05-30,G04CB01,Finasteride
Human,02527847,Bio-Finasteride,finasteride 5 mg oral tablet,Biomed Pharma,2.0,R,,Marketed,2023-04-18,G04CB01,Finasteride
Human,02376709,Dom-Finasteride,finasteride 5 mg oral tablet,Dominion Pharmacal,2.0,R,,Cancelled post market,2025-05-09,G04CB01,Finasteride
Human,02350270,Finasteride,finasteride 5 mg oral tablet,Pro Doc Limitee,2.0,R,,Marketed,2019-08-27,G04CB01,Finasteride
Human,02445077,Finasteride,finasteride 5 mg oral tablet,Sanis Health Inc,2.0,R,,Marketed,2015-10-14,G04CB01,Finasteride
Human,02447541,Finasteride,finasteride 5 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,,Marketed,2015-11-25,G04CB01,Finasteride
Human,02357224,Jamp-Finasteride,finasteride 5 mg oral tablet,Jamp Pharma Corporation,2.0,R,,Marketed,2014-10-11,G04CB01,Finasteride
Human,02522489,M-Finasteride,finasteride 5 mg oral tablet,Mantra Pharma Inc,2.0,R,,Marketed,2022-10-07,G04CB01,Finasteride
Human,02389878,Mint-Finasteride,finasteride 5 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,,Marketed,2012-07-25,G04CB01,Finasteride
Human,02356058,Mylan-Finasteride,finasteride 5 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,,Cancelled post market,2017-01-09,G04CB01,Finasteride
Human,02535637,Nra-Finasteride,finasteride 5 mg oral tablet,Nora Pharma Inc,2.0,R,,Approved,2023-02-21,G04CB01,Finasteride
Human,02376113,Ntp-Finasteride,finasteride 5 mg oral tablet,Teva Canada Limited,2.0,R,,Cancelled pre market,2015-08-06,G04CB01,Finasteride
Human,02310112,Pms-Finasteride,finasteride 5 mg oral tablet,Pharmascience Inc,2.0,R,,Marketed,2010-03-17,G04CB01,Finasteride
Human,02010909,Proscar,finasteride 5 mg oral tablet,Organon Canada Inc.,2.0,R,,Marketed,2022-07-19,G04CB01,Finasteride
Human,02371820,Ran-Finasteride,finasteride 5 mg oral tablet,Ranbaxy Pharmaceuticals Canada Inc.,2.0,R,,Cancelled post market,2022-03-30,G04CB01,Finasteride
Human,02306905,Ratio-Finasteride,finasteride 5 mg oral tablet,Teva Canada Limited,2.0,R,,Cancelled post market,2018-06-22,G04CB01,Finasteride
Human,02455013,Riva-Finasteride,finasteride 5 mg oral tablet,Laboratoire Riva Inc.,2.0,R,,Marketed,2024-06-27,G04CB01,Finasteride
Human,02322579,Sandoz Finasteride,finasteride 5 mg oral tablet,Sandoz Canada Incorporated,2.0,R,,Marketed,2020-10-20,G04CB01,Finasteride
Human,02348500,Teva-Finasteride,finasteride 5 mg oral tablet,Teva Canada Limited,2.0,R,,Marketed,2011-08-12,G04CB01,Finasteride
Human,02428741,Van-Finasteride,finasteride 5 mg oral tablet,Vanc Pharmaceuticals Inc,2.0,R,,Cancelled post market,2019-08-07,G04CB01,Finasteride
Human,02412691,Act Dutasteride,dutasteride 0.5 mg oral capsule,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2019-04-18,G04CB02,Dutasteride
Human,02485672,Ag-Dutasteride,dutasteride 0.5 mg oral capsule,Angita Pharma Inc.,2.0,R,2.0,Marketed,2025-08-19,G04CB02,Dutasteride
Human,02404206,Apo-Dutasteride,dutasteride 0.5 mg oral capsule,Apotex Inc,2.0,R,2.0,Marketed,2014-07-18,G04CB02,Dutasteride
Human,02469308,Auro-Dutasteride,dutasteride 0.5 mg oral capsule,Auro Pharma Inc,2.0,R,2.0,Marketed,2018-06-04,G04CB02,Dutasteride
Human,02247813,Avodart,dutasteride 0.5 mg oral capsule,Glaxosmithkline Inc,2.0,R,2.0,Marketed,2003-11-14,G04CB02,Dutasteride
Human,02421712,Dutasteride,dutasteride 0.5 mg oral capsule,Pro Doc Limitee,2.0,R,2.0,Marketed,2019-04-10,G04CB02,Dutasteride
Human,02429012,Dutasteride,dutasteride 0.5 mg oral capsule,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2025-10-23,G04CB02,Dutasteride
Human,02443058,Dutasteride,dutasteride 0.5 mg oral capsule,Sanis Health Inc,2.0,R,2.0,Marketed,2025-08-13,G04CB02,Dutasteride
Human,02427842,Dutasteride Capsules,dutasteride 0.5 mg oral capsule,Strides Pharma Canada Inc,2.0,R,2.0,Approved,2019-06-06,G04CB02,Dutasteride
Human,02484870,Jamp Dutasteride,dutasteride 0.5 mg oral capsule,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2019-11-07,G04CB02,Dutasteride
Human,02546167,Jamp Dutasteride Capsules,dutasteride 0.5 mg oral capsule,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2025-03-17,G04CB02,Dutasteride
Human,02416298,Med-Dutasteride,dutasteride 0.5 mg oral capsule,Generic Medical Partners Inc,2.0,R,2.0,Marketed,2014-10-10,G04CB02,Dutasteride
Human,02428873,Mint-Dutasteride,dutasteride 0.5 mg oral capsule,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2014-09-19,G04CB02,Dutasteride
Human,02490587,Nra-Dutasteride,dutasteride 0.5 mg oral capsule,Nora Pharma Inc,2.0,R,2.0,Marketed,2024-01-02,G04CB02,Dutasteride
Human,02393220,Pms-Dutasteride,dutasteride 0.5 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Dormant,2020-07-24,G04CB02,Dutasteride
Human,02543990,Pro-Dutasteride,dutasteride 0.5 mg oral capsule,Pro Doc Limitee,2.0,R,2.0,Marketed,2024-07-22,G04CB02,Dutasteride
Human,02427753,Riva-Dutasteride,dutasteride 0.5 mg oral capsule,Laboratoire Riva Inc.,2.0,R,2.0,Marketed,2014-09-18,G04CB02,Dutasteride
Human,02424444,Sandoz Dutasteride,dutasteride 0.5 mg oral capsule,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2024-06-17,G04CB02,Dutasteride
Human,02434369,Sandoz Dutasteride,dutasteride 0.5 mg oral capsule,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled pre market,2019-08-01,G04CB02,Dutasteride
Human,02408287,Teva-Dutasteride,dutasteride 0.5 mg oral capsule,Teva Canada Limited,2.0,R,2.0,Marketed,2014-07-16,G04CB02,Dutasteride
Human,02509733,Increlex,mecasermin 40 mg / 4 mL solution for injection,Ipsen Biopharmaceuticals Canada Inc,,P,,Marketed,2021-03-01,H01AC03,Mecasermin
Human,01944916,Oxytocin Inj 10Unit/Ml Usp,oxytocin 10 units / mL liquid for injection,"Lyphomed, Division Of Fujisawa Canada Inc.",2.0,R,2.0,Cancelled post market,1996-09-10,H01BB02,Oxytocin
Human,00497398,Oxytocin Injection Usp,oxytocin 10 units / mL solution for injection,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2017-10-16,H01BB02,Oxytocin
Human,02139561,"Oxytocin Injection, Usp",oxytocin 10 units / mL solution for injection,Fresenius Kabi Canada Ltd,2.0,R,2.0,Marketed,2021-02-24,H01BB02,Oxytocin
Human,02550199,"Oxytocin Injection, Usp",oxytocin 10 units / mL solution for injection,Hikma Canada Limited,2.0,R,2.0,Marketed,2025-08-26,H01BB02,Oxytocin
Human,02489244,Carbetocin Injection,carbetocin 100 mcg / mL solution for injection,Juno Pharmaceuticals Corp.,2.0,R,,Marketed,2020-09-14,H01BB03,Carbetocin
Human,02231593,Duratocin,carbetocin 100 mcg / mL solution for injection,Ferring Inc,2.0,R,,Cancelled post market,2021-05-18,H01BB03,Carbetocin
Human,02496526,Duratocin,carbetocin 100 mcg / mL solution for injection,Ferring Inc,2.0,R,,Marketed,2020-08-05,H01BB03,Carbetocin
Human,02046210,Lutrepulse Pws 0.8Mg/Vial,gonadorelin acetate 0.8 mg / vial powder for solution for injection,Ferring Inc,2.0,,,Cancelled post market,2024-12-24,H01CA01,Gonadorelin
Human,02046202,Lutrepulse,gonadorelin acetate 3.2 mg / vial powder for solution for injection,Ferring Inc,2.0,,,Dormant,2017-04-21,H01CA01,Gonadorelin
Human,02188783,Synarel,nafarelin (nafarelin acetate) 200 mcg / actuation nasal metered-dose aerosol,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2003-10-09,H01CA02,Nafarelin
Human,01908421,Synarel Nas Sol 2Mg/Ml,nafarelin acetate 2 mg / mL nasal liquid,Syntex Inc.,2.0,R,2.0,Cancelled post market,1996-09-30,H01CA02,Nafarelin
Human,02413299,Signifor,pasireotide (pasireotide diaspartate) 0.3 mg / mL solution for injection,Recordati Rare Diseases Canada Inc,2.0,R,2.0,Marketed,2020-05-21,H01CB05,Pasireotide
Human,02413302,Signifor,pasireotide (pasireotide diaspartate) 0.6 mg / mL solution for injection,Recordati Rare Diseases Canada Inc,2.0,R,2.0,Marketed,2020-05-21,H01CB05,Pasireotide
Human,02413310,Signifor,pasireotide (pasireotide diaspartate) 0.9 mg / mL solution for injection,Recordati Rare Diseases Canada Inc,2.0,R,2.0,Marketed,2020-05-21,H01CB05,Pasireotide
Human,02480425,Signifor Lar,pasireotide (pasireotide pamoate) 10 mg / vial kit (sustained-release powder for suspension) for injection,Recordati Rare Diseases Canada Inc,2.0,R,2.0,Marketed,2020-05-21,H01CB05,Pasireotide
Human,02437252,Signifor Lar,pasireotide (pasireotide pamoate) 20 mg / vial kit (sustained-release powder for suspension) for injection,Recordati Rare Diseases Canada Inc,2.0,R,2.0,Marketed,2020-05-21,H01CB05,Pasireotide
Human,02480433,Signifor Lar,pasireotide (pasireotide pamoate) 30 mg / vial kit (sustained-release powder for suspension) for injection,Recordati Rare Diseases Canada Inc,2.0,R,2.0,Marketed,2020-05-21,H01CB05,Pasireotide
Human,02437260,Signifor Lar,pasireotide (pasireotide pamoate) 40 mg / vial kit (sustained-release powder for suspension) for injection,Recordati Rare Diseases Canada Inc,2.0,R,2.0,Marketed,2020-05-21,H01CB05,Pasireotide
Human,02437279,Signifor Lar,pasireotide (pasireotide pamoate) 60 mg / vial kit (sustained-release powder for suspension) for injection,Recordati Rare Diseases Canada Inc,2.0,R,2.0,Marketed,2020-05-21,H01CB05,Pasireotide
Human,02245641,Orgalutran,ganirelix (ganirelix acetate) 250 mcg / 0.5 mL solution for injection,Organon Canada Inc.,2.0,R,2.0,Marketed,2022-05-17,H01CC01,Ganirelix
Human,02247766,Cetrotide,cetrorelix (cetrorelix acetate) 0.25 mg / vial powder for solution for injection,"Emd Serono, A Division Of Emd Inc., Canada",2.0,R,2.0,Marketed,2004-03-03,H01CC02,Cetrorelix
Human,02247767,Cetrotide,cetrorelix (cetrorelix acetate) 3 mg / vial powder for solution for injection,"Emd Serono, A Division Of Emd Inc., Canada",2.0,R,2.0,Cancelled post market,2014-10-20,H01CC02,Cetrorelix
Human,02481332,Orilissa,elagolix (elagolix sodium) 150 mg oral tablet,Abbvie Corporation,2.0,,,Marketed,2018-10-30,H01CC03,Elagolix
Human,02481340,Orilissa,elagolix (elagolix sodium) 200 mg oral tablet,Abbvie Corporation,2.0,,,Marketed,2019-05-24,H01CC03,Elagolix
Human,02541742,Myfembree,estradiol 1 mg + norethindrone acetate 0.5 mg + relugolix 40 mg oral tablet,Knight Therapeutics Inc.,1.0,K,1.0,Marketed,2025-10-28,H01CC54,"Relugolix, estradiol and norethisterone"
Human,02561506,Agamree,vamorolone 40 mg / mL oral suspension,Kye Pharmaceuticals Inc.,2.0,,,Approved,2025-09-29,H02AB18,Vamorolone
Human,02357941,Apo-Propylthiouracil,propylthiouracil 100 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2010-10-01,H03BA02,Propylthiouracil
Human,02245834,Pms-Propylthiouracil,propylthiouracil 100 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Cancelled pre market,2017-08-14,H03BA02,Propylthiouracil
Human,00010219,Propyl-Thyracil,propylthiouracil 100 mg oral tablet,Paladin Pharma Inc.,2.0,P,2.0,Cancelled post market,2020-04-07,H03BA02,Propylthiouracil
Human,02357933,Apo-Propylthiouracil,propylthiouracil 50 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2010-10-01,H03BA02,Propylthiouracil
Human,02521059,Halycil,propylthiouracil 50 mg oral tablet,Halewood Chemicals Limited,2.0,P,2.0,Marketed,2022-03-23,H03BA02,Propylthiouracil
Human,02245833,Pms-Propylthiouracil,propylthiouracil 50 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Cancelled pre market,2017-08-03,H03BA02,Propylthiouracil
Human,00010200,Propyl-Thyracil,propylthiouracil 50 mg oral tablet,Paladin Pharma Inc.,2.0,P,2.0,Cancelled post market,2020-03-05,H03BA02,Propylthiouracil
Human,02523019,Propylthiouracil Tablets,propylthiouracil 50 mg oral tablet,Phebra Canada Inc,2.0,P,2.0,Marketed,2022-07-21,H03BA02,Propylthiouracil
Human,02490633,Jamp Methimazole,methimazole 10 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2021-08-21,H03BB02,Thiamazole
Human,02480115,Mar-Methimazole,methimazole 10 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,P,2.0,Marketed,2018-10-19,H03BB02,Thiamazole
Human,02489724,Methimazole Tablets Usp,methimazole 10 mg oral tablet,Endo Operations Ltd.,2.0,P,2.0,Cancelled pre market,2023-07-07,H03BB02,Thiamazole
Human,02296039,Tapazole,methimazole 10 mg oral tablet,Knight Therapeutics Inc.,2.0,P,2.0,Marketed,2025-12-19,H03BB02,Thiamazole
Human,02489732,Methimazole Tablets Usp,methimazole 20 mg oral tablet,Endo Operations Ltd.,2.0,P,2.0,Cancelled pre market,2023-07-07,H03BB02,Thiamazole
Human,02296047,Tapazole,methimazole 20 mg oral tablet,Paladin Pharma Inc.,2.0,P,2.0,Cancelled pre market,2021-07-28,H03BB02,Thiamazole
Human,02258935,Apo-Methimazole,methimazole 5 mg oral tablet,Apotex Inc,2.0,P,2.0,Dormant,2017-08-04,H03BB02,Thiamazole
Human,02265869,Dom-Methimazole,methimazole 5 mg oral tablet,Dominion Pharmacal,2.0,P,2.0,Cancelled pre market,2017-08-03,H03BB02,Thiamazole
Human,02490625,Jamp Methimazole,methimazole 5 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2020-08-21,H03BB02,Thiamazole
Human,02480107,Mar-Methimazole,methimazole 5 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,P,2.0,Marketed,2018-10-19,H03BB02,Thiamazole
Human,02489716,Methimazole Tablets Usp,methimazole 5 mg oral tablet,Endo Operations Ltd.,2.0,P,2.0,Cancelled pre market,2023-07-07,H03BB02,Thiamazole
Human,02265850,Phl-Methimazole,methimazole 5 mg oral tablet,Pharmel Inc,2.0,P,2.0,Cancelled pre market,2017-09-12,H03BB02,Thiamazole
Human,02244323,Pms-Methimazole,methimazole 5 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Cancelled post market,2005-05-04,H03BB02,Thiamazole
Human,00015741,Tapazole,methimazole 5 mg oral tablet,Knight Therapeutics Inc.,2.0,P,2.0,Marketed,2025-12-19,H03BB02,Thiamazole
Human,00312363,Chloromycetin Succinate Injection,chloramphenicol (chloramphenicol sodium succinate) 1 g / vial powder for solution for injection,Searchlight Pharma Inc,1.0,K,1.0,Marketed,2022-10-20,J01BA01,Chloramphenicol
Human,00020907,Novo-Chlorocap Cap 250Mg,chloramphenicol 250 mg / capsule oral capsule,Novopharm Limited,1.0,K,1.0,Cancelled post market,2005-08-10,J01BA01,Chloramphenicol
Human,02311739,Canesoral Combi,clotrimazole 1 % + fluconazole 150 mg / capsule cutaneous capsule or cream,Bayer Inc,2.0,R,,Cancelled post market,2020-12-21,J02AC01,Fluconazole
Human,02445131,Clotrimaderm-Fluconazole Combi-Pack,clotrimazole 1 % / w/w with fluconazole 150 mg / capsule cutaneous kit (capsule and cream),Taro Pharmaceuticals Inc,2.0,R,,Cancelled post market,2022-08-29,J02AC01,Fluconazole
Human,02451727,Clotrimazole-Fluconazole Combi,clotrimazole 1 % / w/w with fluconazole 150 mg / capsule cutaneous kit (capsule and cream),Taro Pharmaceuticals Inc,2.0,R,,Marketed,2021-02-11,J02AC01,Fluconazole
Human,02281279,Act Fluconazole,fluconazole 100 mg oral tablet,Teva Canada Limited,2.0,R,,Marketed,2020-04-16,J02AC01,Fluconazole
Human,02237371,Apo-Fluconazole,fluconazole 100 mg oral tablet,Apotex Inc,2.0,R,,Marketed,2024-08-29,J02AC01,Fluconazole
Human,00891819,Diflucan,fluconazole 100 mg oral tablet,Pfizer Canada Ulc,2.0,R,,Cancelled post market,2025-07-02,J02AC01,Fluconazole
Human,02246109,Dom-Fluconazole,fluconazole 100 mg oral tablet,Dominion Pharmacal,2.0,R,,Cancelled post market,2025-05-30,J02AC01,Fluconazole
Human,02301946,Fluconazole,fluconazole 100 mg oral tablet,Sorres Pharma Inc,2.0,R,,Cancelled post market,2014-06-20,J02AC01,Fluconazole
Human,02517418,Fluconazole,fluconazole 100 mg oral tablet,Sanis Health Inc,2.0,R,,Marketed,2022-01-14,J02AC01,Fluconazole
Human,02534894,Fluconazole,fluconazole 100 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,,Marketed,2023-10-24,J02AC01,Fluconazole
Human,02091372,Fluconazole Tablets,fluconazole 100 mg oral tablet,Apotex Inc,2.0,R,,Approved,2024-04-17,J02AC01,Fluconazole
Human,02245293,Mylan-Fluconazole,fluconazole 100 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,,Marketed,2009-12-17,J02AC01,Fluconazole
Human,02294036,Phl-Fluconazole,fluconazole 100 mg oral tablet,Pharmel Inc,2.0,R,,Cancelled pre market,2017-09-12,J02AC01,Fluconazole
Human,02245644,Pms-Fluconazole,fluconazole 100 mg oral tablet,Pharmascience Inc,2.0,R,,Marketed,2002-06-05,J02AC01,Fluconazole
Human,02310686,Pro-Fluconazole,fluconazole 100 mg oral tablet,Pro Doc Limitee,2.0,R,,Marketed,2008-07-08,J02AC01,Fluconazole
Human,02271516,Riva-Fluconazole,fluconazole 100 mg oral tablet,Laboratoire Riva Inc.,2.0,R,,Cancelled post market,2016-05-31,J02AC01,Fluconazole
Human,02249308,Taro-Fluconazole,fluconazole 100 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,,Dormant,2017-08-03,J02AC01,Fluconazole
Human,02236979,Teva-Fluconazole,fluconazole 100 mg oral tablet,Teva Canada Limited,2.0,R,,Cancelled post market,2025-07-30,J02AC01,Fluconazole
Human,02555891,Ag-Fluconazole,fluconazole 150 mg oral capsule,Angita Pharma Inc.,2.0,R,,Approved,2025-03-03,J02AC01,Fluconazole
Human,02241895,Apo-Fluconazole-150,fluconazole 150 mg oral capsule,Apotex Inc,2.0,R,,Marketed,2011-03-02,J02AC01,Fluconazole
Human,02462168,Bio-Fluconazole,fluconazole 150 mg oral capsule,Biomed Pharma,2.0,R,,Marketed,2019-09-20,J02AC01,Fluconazole
Human,02311690,Canesoral,fluconazole 150 mg oral capsule,Bayer Inc,2.0,R,,Marketed,2010-03-10,J02AC01,Fluconazole
Human,02323419,Co Fluconazole-150,fluconazole 150 mg oral capsule,Cobalt Pharmaceuticals Company,2.0,R,,Cancelled post market,2019-03-26,J02AC01,Fluconazole
Human,02141442,Diflucan One,fluconazole 150 mg oral capsule,Pfizer Canada Ulc,2.0,R,,Marketed,2019-07-25,J02AC01,Fluconazole
Human,02309432,Dom-Fluconazole,fluconazole 150 mg oral capsule,Dominion Pharmacal,2.0,R,,Cancelled pre market,2025-05-30,J02AC01,Fluconazole
Human,02246942,Fluconazole,fluconazole 150 mg oral capsule,Pharmel Inc,2.0,R,,Cancelled pre market,2017-09-12,J02AC01,Fluconazole
Human,02301954,Fluconazole,fluconazole 150 mg oral capsule,Sorres Pharma Inc,2.0,R,,Cancelled post market,2014-06-20,J02AC01,Fluconazole
Human,02340038,Fluconazole,fluconazole 150 mg oral capsule,Pendopharm Division Of Pharmascience Inc,2.0,R,,Approved,2010-01-04,J02AC01,Fluconazole
Human,02352133,Fluconazole 150,fluconazole 150 mg oral capsule,Apotex Inc,2.0,R,,Marketed,2011-03-25,J02AC01,Fluconazole
Human,02433095,Fluconazole 150,fluconazole 150 mg oral capsule,Taro Pharmaceuticals Inc,2.0,R,,Approved,2014-11-21,J02AC01,Fluconazole
Human,02340046,Fluconazole-150,fluconazole 150 mg oral capsule,Pharmascience Inc,2.0,R,,Cancelled post market,2019-01-23,J02AC01,Fluconazole
Human,02521229,Fluconazole-150,fluconazole 150 mg oral capsule,Sanis Health Inc,2.0,R,,Marketed,2022-05-12,J02AC01,Fluconazole
Human,02547864,Jamp Fluconazole 150 Mg,fluconazole 150 mg oral capsule,Jamp Pharma Corporation,2.0,R,,Marketed,2025-03-11,J02AC01,Fluconazole
Human,02432471,Jamp-Fluconazole,fluconazole 150 mg oral capsule,Jamp Pharma Corporation,2.0,R,,Marketed,2015-01-08,J02AC01,Fluconazole
Human,02553406,M-Fluconazole-150,fluconazole 150 mg oral capsule,Mantra Pharma Inc,2.0,R,,Marketed,2025-08-22,J02AC01,Fluconazole
Human,02428792,Mar-Fluconazole-150,fluconazole 150 mg oral capsule,Marcan Pharmaceuticals Inc,2.0,R,,Marketed,2016-12-14,J02AC01,Fluconazole
Human,02378302,Monicure,fluconazole 150 mg oral capsule,"Insight Pharmaceuticals, Llc",2.0,R,,Dormant,2018-07-16,J02AC01,Fluconazole
Human,02245697,Mylan-Fluconazole,fluconazole 150 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,R,,Dormant,2017-08-04,J02AC01,Fluconazole
Human,02243645,Novo-Fluconazole-150,fluconazole 150 mg oral capsule,Novopharm Limited,2.0,R,,Cancelled post market,2024-12-18,J02AC01,Fluconazole
Human,02433702,Nra-Fluconazole-150,fluconazole 150 mg oral capsule,Nora Pharma Inc,2.0,R,,Marketed,2025-01-17,J02AC01,Fluconazole
Human,02336162,Nu-Fluconazole-150,fluconazole 150 mg oral capsule,Nu-Pharm Inc,2.0,R,,Cancelled (unreturned annual),2018-03-28,J02AC01,Fluconazole
Human,02294044,Phl-Fluconazole,fluconazole 150 mg oral capsule,Pharmel Inc,2.0,R,,Cancelled post market,2007-08-01,J02AC01,Fluconazole
Human,02282348,Pms-Fluconazole,fluconazole 150 mg oral capsule,Pharmascience Inc,2.0,R,,Cancelled post market,2019-01-23,J02AC01,Fluconazole
Human,02246620,Pms-Fluconazole-150,fluconazole 150 mg oral capsule,Pharmascience Inc,2.0,R,,Dormant,2018-08-02,J02AC01,Fluconazole
Human,02310694,Pro-Fluconazole,fluconazole 150 mg oral capsule,Pro Doc Limitee,2.0,R,,Cancelled post market,2015-08-31,J02AC01,Fluconazole
Human,02255510,Riva-Fluconazole,fluconazole 150 mg oral capsule,Laboratoire Riva Inc.,2.0,R,,Marketed,2014-11-01,J02AC01,Fluconazole
Human,02236980,Novo-Fluconazole,fluconazole 150 mg oral tablet,Teva Canada Limited,2.0,R,,Cancelled pre market,2015-10-16,J02AC01,Fluconazole
Human,02382628,Monicure Combo,fluconazole 150 mg with miconazole nitrate 2 % cutaneous kit (capsule and cream),"Insight Pharmaceuticals, Llc",2.0,R,,Marketed,2012-10-25,J02AC01,Fluconazole
Human,00891835,Diflucan,fluconazole 2 mg / mL solution for injection,Pfizer Canada Ulc,2.0,R,,Marketed,1990-12-31,J02AC01,Fluconazole
Human,02261472,Fluconazole In Sodium Chloride Injection Usp,fluconazole 2 mg / mL solution for injection,Baxter Corporation,2.0,R,,Marketed,2017-02-10,J02AC01,Fluconazole
Human,02247922,Fluconazole Injection,fluconazole 2 mg / mL solution for injection,Teva Canada Limited,2.0,R,,Cancelled post market,2017-09-15,J02AC01,Fluconazole
Human,02248443,Fluconazole Injection,fluconazole 2 mg / mL solution for injection,Sandoz Canada Incorporated,2.0,R,,Cancelled post market,2019-08-01,J02AC01,Fluconazole
Human,02248731,Fluconazole Injection,fluconazole 2 mg / mL solution for injection,Fresenius Kabi Canada Ltd,2.0,R,,Cancelled pre market,2021-06-28,J02AC01,Fluconazole
Human,02388448,Fluconazole Injection Sdz,fluconazole 2 mg / mL solution for injection,Sandoz Canada Incorporated,2.0,R,,Marketed,2012-10-18,J02AC01,Fluconazole
Human,02247749,Fluconazole Omega,fluconazole 2 mg / mL solution for injection,Omega Laboratories Limited,2.0,R,,Dormant,2017-08-04,J02AC01,Fluconazole
Human,02237372,Apo-Fluconazole,fluconazole 200 mg oral tablet,Apotex Inc,2.0,R,,Approved,2024-08-29,J02AC01,Fluconazole
Human,02091380,Fluconazole Tablets,fluconazole 200 mg oral tablet,Apotex Inc,2.0,R,,Approved,2024-04-17,J02AC01,Fluconazole
Human,02249316,Taro-Fluconazole,fluconazole 200 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,,Approved,2004-02-27,J02AC01,Fluconazole
Human,02024152,Diflucan,fluconazole 50 mg / 5 mL oral powder for solution,Pfizer Canada Ulc,2.0,R,,Marketed,1995-12-31,J02AC01,Fluconazole
Human,02281260,Act Fluconazole,fluconazole 50 mg oral tablet,Teva Canada Limited,2.0,R,,Marketed,2020-04-16,J02AC01,Fluconazole
Human,02237370,Apo-Fluconazole,fluconazole 50 mg oral tablet,Apotex Inc,2.0,R,,Marketed,2024-08-29,J02AC01,Fluconazole
Human,00891800,Diflucan,fluconazole 50 mg oral tablet,Pfizer Canada Ulc,2.0,R,,Cancelled post market,2025-07-02,J02AC01,Fluconazole
Human,02246108,Dom-Fluconazole,fluconazole 50 mg oral tablet,Dominion Pharmacal,2.0,R,,Cancelled post market,2025-05-30,J02AC01,Fluconazole
Human,02301938,Fluconazole,fluconazole 50 mg oral tablet,Sorres Pharma Inc,2.0,R,,Cancelled post market,2014-06-20,J02AC01,Fluconazole
Human,02517396,Fluconazole,fluconazole 50 mg oral tablet,Sanis Health Inc,2.0,R,,Marketed,2022-01-14,J02AC01,Fluconazole
Human,02534886,Fluconazole,fluconazole 50 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,,Marketed,2023-10-24,J02AC01,Fluconazole
Human,02091216,Fluconazole Tablets,fluconazole 50 mg oral tablet,Apotex Inc,2.0,R,,Approved,2024-04-17,J02AC01,Fluconazole
Human,02245292,Mylan-Fluconazole,fluconazole 50 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,,Marketed,2010-04-16,J02AC01,Fluconazole
Human,02245643,Pms-Fluconazole,fluconazole 50 mg oral tablet,Pharmascience Inc,2.0,R,,Marketed,2002-06-05,J02AC01,Fluconazole
Human,02249294,Taro-Fluconazole,fluconazole 50 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,,Dormant,2017-08-03,J02AC01,Fluconazole
Human,02236978,Teva-Fluconazole,fluconazole 50 mg oral tablet,Teva Canada Limited,2.0,R,,Cancelled post market,2025-07-30,J02AC01,Fluconazole
Human,02279991,Vfend,voriconazole 200 mg / 5 mL oral powder for suspension,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2008-07-17,J02AC03,Voriconazole
Human,02436353,Pms-Voriconazole,voriconazole 200 mg / vial powder for solution for injection,Pharmascience Inc,2.0,R,2.0,Approved,2017-10-06,J02AC03,Voriconazole
Human,02256487,Vfend,voriconazole 200 mg / vial powder for solution for injection,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2004-11-12,J02AC03,Voriconazole
Human,02381966,Voriconazole For Injection,voriconazole 200 mg / vial powder for solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2014-04-30,J02AC03,Voriconazole
Human,02467852,Voriconazole For Injection,voriconazole 200 mg / vial powder for solution for injection,Pharmaris Canada Inc,2.0,R,2.0,Approved,2022-05-10,J02AC03,Voriconazole
Human,02477696,Voriconazole For Injection,voriconazole 200 mg / vial powder for solution for injection,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2019-07-23,J02AC03,Voriconazole
Human,02486695,Voriconazole For Injection,voriconazole 200 mg / vial powder for solution for injection,Auro Pharma Inc,2.0,R,2.0,Approved,2019-03-18,J02AC03,Voriconazole
Human,02493829,Voriconazole For Injection,voriconazole 200 mg / vial powder for solution for injection,Fresenius Kabi Canada Ltd,2.0,R,2.0,Marketed,2021-09-01,J02AC03,Voriconazole
Human,02542994,Voriconazole For Injection,voriconazole 200 mg / vial powder for solution for injection,Eugia Pharma Inc.,2.0,R,2.0,Approved,2023-11-10,J02AC03,Voriconazole
Human,02544350,Voriconazole For Injection,voriconazole 200 mg / vial powder for solution for injection,Formative Pharma Inc.,2.0,R,2.0,Approved,2024-01-08,J02AC03,Voriconazole
Human,02432005,Ach-Voriconazole,voriconazole 200 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Cancelled pre market,2024-11-01,J02AC03,Voriconazole
Human,02409682,Apo-Voriconazole,voriconazole 200 mg oral tablet,Apotex Inc,2.0,R,2.0,Dormant,2019-06-02,J02AC03,Voriconazole
Human,02451395,Auro-Voriconazole,voriconazole 200 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Approved,2016-01-28,J02AC03,Voriconazole
Human,02525798,Jamp Voriconazole,voriconazole 200 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2022-09-12,J02AC03,Voriconazole
Human,02457709,Med-Voriconazole,voriconazole 200 mg oral tablet,Generic Medical Partners Inc,2.0,R,2.0,Approved,2018-12-12,J02AC03,Voriconazole
Human,02399989,Mylan-Voriconazole,voriconazole 200 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2017-01-11,J02AC03,Voriconazole
Human,02399253,Sandoz Voriconazole,voriconazole 200 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2014-04-02,J02AC03,Voriconazole
Human,02396874,Teva-Voriconazole,voriconazole 200 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2014-03-31,J02AC03,Voriconazole
Human,02256479,Vfend,voriconazole 200 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2004-11-12,J02AC03,Voriconazole
Human,02431998,Ach-Voriconazole,voriconazole 50 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Cancelled pre market,2024-11-01,J02AC03,Voriconazole
Human,02409674,Apo-Voriconazole,voriconazole 50 mg oral tablet,Apotex Inc,2.0,R,2.0,Dormant,2019-06-02,J02AC03,Voriconazole
Human,02451387,Auro-Voriconazole,voriconazole 50 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Approved,2016-01-28,J02AC03,Voriconazole
Human,02525771,Jamp Voriconazole,voriconazole 50 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2022-09-12,J02AC03,Voriconazole
Human,02399962,Mylan-Voriconazole,voriconazole 50 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2017-01-11,J02AC03,Voriconazole
Human,02399245,Sandoz Voriconazole,voriconazole 50 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2014-04-02,J02AC03,Voriconazole
Human,02396866,Teva-Voriconazole,voriconazole 50 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2014-03-31,J02AC03,Voriconazole
Human,02256460,Vfend,voriconazole 50 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2004-11-12,J02AC03,Voriconazole
Human,02511878,Apo-Posaconazole,posaconazole 100 mg oral delayed-release tablet,Apotex Inc,,R,,Approved,2021-01-29,J02AC04,Posaconazole
Human,02542021,Gln-Posaconazole,posaconazole 100 mg oral delayed-release tablet,Glenmark Pharmaceuticals Canada Inc.,,R,,Marketed,2023-10-04,J02AC04,Posaconazole
Human,02544644,Mint-Posaconazole,posaconazole 100 mg oral delayed-release tablet,Mint Pharmaceuticals Inc,,R,,Marketed,2024-07-25,J02AC04,Posaconazole
Human,02424622,Posanol,posaconazole 100 mg oral delayed-release tablet,Merck Canada Inc,,R,,Marketed,2014-05-21,J02AC04,Posaconazole
Human,02496259,Sandoz Posaconazole,posaconazole 100 mg oral delayed-release tablet,Sandoz Canada Incorporated,,R,,Marketed,2020-12-08,J02AC04,Posaconazole
Human,02543311,Taro-Posaconazole,posaconazole 100 mg oral delayed-release tablet,Taro Pharmaceuticals Inc,,R,,Marketed,2024-03-25,J02AC04,Posaconazole
Human,02293404,Posanol,posaconazole 200 mg / 5 mL oral suspension,Merck Canada Inc,,R,,Marketed,2011-03-18,J02AC04,Posaconazole
Human,02432676,Posanol,posaconazole 300 mg / 16.7 mL solution for injection,Merck Canada Inc,,R,,Marketed,2014-11-24,J02AC04,Posaconazole
Human,02530333,Jamp Posaconazole,posaconazole 40 mg / mL oral suspension,Jamp Pharma Corporation,,R,,Marketed,2023-05-24,J02AC04,Posaconazole
Human,02032414,Seromycin Cap 250Mg,cycloserine 250 mg / capsule oral capsule,Eli Lilly Canada Inc,,,,Cancelled post market,1997-08-13,J04AB01,Cycloserine
Human,02162695,Cytovene,ganciclovir (ganciclovir sodium) 500 mg / vial powder for solution for injection,Cheplapharm Arzneimittel Gmbh,1.0,CK,1.0,Marketed,2019-08-09,J05AB06,Ganciclovir
Human,02537168,Ganciclovir For Injection,ganciclovir (ganciclovir sodium) 500 mg / vial powder for solution for injection,Formative Pharma Inc.,1.0,CK,1.0,Marketed,2023-10-04,J05AB06,Ganciclovir
Human,02471930,Ganciclovir For Injection Usp,ganciclovir (ganciclovir sodium) 500 mg / vial powder for solution for injection,Auro Pharma Inc,1.0,CK,1.0,Approved,2018-01-17,J05AB06,Ganciclovir
Human,02475391,Ganciclovir For Injection Usp,ganciclovir (ganciclovir sodium) 500 mg / vial powder for solution for injection,Sterimax Inc,1.0,CK,1.0,Marketed,2021-07-19,J05AB06,Ganciclovir
Human,02538911,Ganciclovir For Injection Usp,ganciclovir (ganciclovir sodium) 500 mg / vial powder for solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2023-06-16,J05AB06,Ganciclovir
Human,02404761,"Ganciclovir For Injection, Usp",ganciclovir (ganciclovir sodium) 500 mg / vial powder for solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Marketed,2025-11-14,J05AB06,Ganciclovir
Human,02186802,Cytovene - Cap 250Mg,ganciclovir 250 mg / capsule oral capsule,Hoffmann-La Roche Limited,1.0,CK,1.0,Cancelled post market,2007-08-02,J05AB06,Ganciclovir
Human,02240362,"Cytovene, 500 Mg",ganciclovir 500 mg / capsule oral capsule,Hoffmann-La Roche Limited,1.0,CK,1.0,Cancelled post market,2007-08-02,J05AB06,Ganciclovir
Human,00865516,Cytovene Inj 500Mg/Vial,ganciclovir sodium 500 mg / vial powder for solution for injection,Syntex Inc.,1.0,CK,1.0,Cancelled post market,1996-09-30,J05AB06,Ganciclovir
Human,02473925,Mar-Cidofovir,cidofovir (cidofovir dihydrate) 375 mg / 5 mL solution for injection,Marcan Pharmaceuticals Inc,1.0,K,1.0,Marketed,2018-07-11,J05AB12,Cidofovir
Human,02393824,Apo-Valganciclovir,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,Apotex Inc,1.0,K,1.0,Dormant,2018-08-03,J05AB14,Valganciclovir
Human,02435179,Auro-Valganciclovir,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,Auro Pharma Inc,1.0,K,1.0,Marketed,2015-04-10,J05AB14,Valganciclovir
Human,02495457,Mint-Valganciclovir,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,Mint Pharmaceuticals Inc,1.0,K,1.0,Marketed,2020-05-27,J05AB14,Valganciclovir
Human,02426579,Mylan-Valganciclovir,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,Mylan Pharmaceuticals Ulc,1.0,K,1.0,Cancelled pre market,2017-01-11,J05AB14,Valganciclovir
Human,02465744,Nat-Valganciclovir,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2021-05-14,J05AB14,Valganciclovir
Human,02413825,Teva-Valganciclovir,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2014-11-27,J05AB14,Valganciclovir
Human,02245777,Valcyte,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,Cheplapharm Arzneimittel Gmbh,1.0,K,1.0,Marketed,2022-07-19,J05AB14,Valganciclovir
Human,02535483,Auro-Valganciclovir,valganciclovir (valganciclovir hydrochloride) 50 mg / mL oral powder for solution,Auro Pharma Inc,1.0,K,1.0,Marketed,2023-09-13,J05AB14,Valganciclovir
Human,02306085,Valcyte,valganciclovir (valganciclovir hydrochloride) 50 mg / mL oral powder for solution,Cheplapharm Arzneimittel Gmbh,1.0,K,1.0,Marketed,2022-07-19,J05AB14,Valganciclovir
Human,02502135,Veklury,remdesivir 100 mg / 20 mL solution for injection,Gilead Sciences Canada Inc,,P,,Cancelled pre market,2021-04-13,J05AB16,Remdesivir
Human,02502143,Veklury,remdesivir 100 mg / vial powder for solution for injection,Gilead Sciences Canada Inc,,P,,Marketed,2020-10-16,J05AB16,Remdesivir
Human,02543850,Tembexa,brincidofovir 10 mg / mL oral suspension,Emergent Biodefense Operations Lansing Llc,,,,Approved,2023-12-11,J05AB17,Brincidofovir
Human,02543842,Tembexa,brincidofovir 100 mg oral tablet,Emergent Biodefense Operations Lansing Llc,,,,Approved,2023-12-11,J05AB17,Brincidofovir
Human,02505924,Vocarvi,foscarnet sodium 24 mg / mL solution for injection,Sterimax Inc,,,,Marketed,2021-03-30,J05AD01,Foscarnet
Human,01902644,Retrovir (Azt),zidovudine 10 mg / mL solution for injection,Viiv Healthcare Ulc,2.0,P,2.0,Marketed,2011-02-11,J05AF01,Zidovudine
Human,01946323,Apo-Zidovudine,zidovudine 100 mg oral capsule,Apotex Inc,2.0,P,2.0,Marketed,1992-12-31,J05AF01,Zidovudine
Human,01953877,Novo-Azt Cap 100Mg,zidovudine 100 mg oral capsule,Novopharm Limited,2.0,P,2.0,Cancelled post market,2015-10-26,J05AF01,Zidovudine
Human,01902660,Retrovir (Azt),zidovudine 100 mg oral capsule,Viiv Healthcare Ulc,2.0,P,2.0,Cancelled post market,2021-06-28,J05AF01,Zidovudine
Human,02238699,Retrovir (Azt)  300Mg,zidovudine 300 mg oral tablet,Glaxo Wellcome Inc.,2.0,P,2.0,Cancelled post market,2000-11-30,J05AF01,Zidovudine
Human,02282186,Zidovudine Oral Solution Usp,zidovudine 50 mg / 5 mL oral solution,Aurobindo Pharma Limited (Unit Iii),2.0,P,2.0,Approved,2016-06-09,J05AF01,Zidovudine
Human,01902652,Retrovir (Azt),zidovudine 50 mg / 5 mL oral syrup,Viiv Healthcare Ulc,2.0,P,2.0,Marketed,2010-05-10,J05AF01,Zidovudine
Human,02240358,Ziagen,abacavir (abacavir sulfate) 20 mg / mL oral solution,Viiv Healthcare Ulc,2.0,P,2.0,Marketed,2010-11-25,J05AF06,Abacavir
Human,02396769,Apo-Abacavir,abacavir (abacavir sulfate) 300 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2016-03-15,J05AF06,Abacavir
Human,02480956,Mint-Abacavir,abacavir (abacavir sulfate) 300 mg oral tablet,Mint Pharmaceuticals Inc,2.0,P,2.0,Marketed,2019-03-25,J05AF06,Abacavir
Human,02240357,Ziagen,abacavir (abacavir sulfate) 300 mg oral tablet,Viiv Healthcare Ulc,2.0,P,2.0,Cancelled post market,2024-01-31,J05AF06,Abacavir
Human,02479907,Accel-Entecavir,entecavir (entecavir monohydrate) 0.5 mg oral tablet,Accel Pharma Inc,2.0,P,2.0,Marketed,2020-03-11,J05AF10,Entecavir
Human,02448777,Auro-Entecavir,entecavir (entecavir monohydrate) 0.5 mg oral tablet,Auro Pharma Inc,2.0,P,2.0,Marketed,2015-12-01,J05AF10,Entecavir
Human,02453797,Entecavir Tablets,entecavir (entecavir monohydrate) 0.5 mg oral tablet,Strides Pharma Canada Inc,2.0,P,2.0,Marketed,2020-12-01,J05AF10,Entecavir
Human,02467232,Jamp Entecavir,entecavir (entecavir monohydrate) 0.5 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2019-02-21,J05AF10,Entecavir
Human,02485907,Mint-Entecavir,entecavir (entecavir monohydrate) 0.5 mg oral tablet,Mint Pharmaceuticals Inc,2.0,P,2.0,Marketed,2020-01-06,J05AF10,Entecavir
Human,02396955,Apo-Entecavir,entecavir 0.5 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2013-01-18,J05AF10,Entecavir
Human,02282224,Baraclude,entecavir 0.5 mg oral tablet,Bristol-Myers Squibb Canada,2.0,P,2.0,Marketed,2006-09-12,J05AF10,Entecavir
Human,02527154,Entecavir,entecavir 0.5 mg oral tablet,Sanis Health Inc,2.0,P,2.0,Marketed,2022-10-20,J05AF10,Entecavir
Human,02430576,Pms-Entecavir,entecavir 0.5 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Marketed,2014-09-09,J05AF10,Entecavir
Human,02418312,Sandoz Entecavir,entecavir 0.5 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Cancelled pre market,2021-04-21,J05AF10,Entecavir
Human,02527162,Entecavir,entecavir 1 mg oral tablet,Sanis Health Inc,2.0,P,2.0,Approved,2022-05-06,J05AF10,Entecavir
Human,02430584,Pms-Entecavir,entecavir 1 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Marketed,2018-09-02,J05AF10,Entecavir
Human,02396653,Apo-Nevirapine,nevirapine 200 mg oral tablet,Apotex Inc,2.0,p,2.0,Approved,2012-11-07,J05AG01,Nevirapine
Human,02318601,Auro-Nevirapine,nevirapine 200 mg oral tablet,Auro Pharma Inc,2.0,p,2.0,Marketed,2020-11-20,J05AG01,Nevirapine
Human,02405776,Jamp Nevirapine,nevirapine 200 mg oral tablet,Jamp Pharma Corporation,2.0,p,2.0,Marketed,2019-10-09,J05AG01,Nevirapine
Human,02387727,Mylan-Nevirapine,nevirapine 200 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,p,2.0,Marketed,2012-06-20,J05AG01,Nevirapine
Human,02352893,Teva-Nevirapine,nevirapine 200 mg oral tablet,Teva Canada Limited,2.0,p,2.0,Cancelled post market,2018-06-19,J05AG01,Nevirapine
Human,02238748,Viramune,nevirapine 200 mg oral tablet,Boehringer Ingelheim (Canada) Ltd Ltee,2.0,p,2.0,Cancelled post market,2019-05-24,J05AG01,Nevirapine
Human,02427931,Apo-Nevirapine Xr,nevirapine 400 mg oral prolonged-release tablet,Apotex Inc,2.0,p,2.0,Cancelled post market,2025-04-17,J05AG01,Nevirapine
Human,02367289,Viramune Xr,nevirapine 400 mg oral prolonged-release tablet,Boehringer Ingelheim (Canada) Ltd Ltee,2.0,p,2.0,Cancelled post market,2019-08-20,J05AG01,Nevirapine
Human,02547465,Apretude,cabotegravir (cabotegravir sodium) 30 mg oral tablet,Viiv Healthcare Ulc,2.0,,,Marketed,2024-06-19,J05AJ04,Cabotegravir
Human,02497204,Vocabria,cabotegravir (cabotegravir sodium) 30 mg oral tablet,Viiv Healthcare Ulc,2.0,,,Marketed,2020-09-21,J05AJ04,Cabotegravir
Human,02547473,Apretude,cabotegravir 200 mg / mL prolonged-release suspension for injection,Viiv Healthcare Ulc,2.0,,,Marketed,2024-06-19,J05AJ04,Cabotegravir
Human,02439212,Ibavyr,ribavirin 200 mg oral tablet,Pendopharm Division Of Pharmascience Inc,2.0,R,2.0,Dormant,2023-07-31,J05AP01,Ribavirin
Human,02436396,Moderiba,ribavirin 200 mg oral tablet,Abbvie Corporation,2.0,R,2.0,Cancelled post market,2018-11-26,J05AP01,Ribavirin
Human,02425890,Ibavyr,ribavirin 400 mg oral tablet,Pendopharm Division Of Pharmascience Inc,2.0,R,2.0,Dormant,2023-07-31,J05AP01,Ribavirin
Human,02436418,Moderiba,ribavirin 400 mg oral tablet,Abbvie Corporation,2.0,R,2.0,Cancelled post market,2018-11-26,J05AP01,Ribavirin
Human,02170140,Virazole,ribavirin 6 g / vial inhalation aerosol or powder for solution,"Bausch Health, Canada Inc.",2.0,R,2.0,Marketed,2020-09-30,J05AP01,Ribavirin
Human,00704008,Virazole Pws 6Gm/Vial,ribavirin 6 g / vial inhalation powder for solution or aerosol,Viratek Inc.,2.0,R,2.0,Cancelled post market,1997-08-08,J05AP01,Ribavirin
Human,02425904,Ibavyr,ribavirin 600 mg oral tablet,Pendopharm Division Of Pharmascience Inc,2.0,R,2.0,Dormant,2020-10-08,J05AP01,Ribavirin
Human,02436426,Moderiba,ribavirin 600 mg oral tablet,Abbvie Corporation,2.0,R,2.0,Cancelled post market,2018-07-30,J05AP01,Ribavirin
Human,02497220,Cabenuva,cabotegravir 200 mg / mL with rilpivirine 300 mg / mL kit (prolonged-release suspension) for injection,Viiv Healthcare Ulc,2.0,,,Marketed,2020-09-21,J05AR,"Antivirals for treatment of hiv infections, combinations"
Human,02497247,Cabenuva,cabotegravir 200 mg / mL with rilpivirine 300 mg / mL kit (prolonged-release suspension) for injection,Viiv Healthcare Ulc,2.0,,,Marketed,2020-09-21,J05AR,"Antivirals for treatment of hiv infections, combinations"
Human,02375540,Apo-Lamivudine-Zidovudine,lamivudine 150 mg + zidovudine 300 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2016-01-22,J05AR01,Zidovudine and lamivudine
Human,02414414,Auro-Lamivudine/Zidovudine,lamivudine 150 mg + zidovudine 300 mg oral tablet,Auro Pharma Inc,2.0,P,2.0,Marketed,2014-03-03,J05AR01,Zidovudine and lamivudine
Human,02239213,Combivir,lamivudine 150 mg + zidovudine 300 mg oral tablet,Viiv Healthcare Ulc,2.0,P,2.0,Cancelled post market,2024-12-31,J05AR01,Zidovudine and lamivudine
Human,02502801,Jamp Lamivudine / Zidovudine,lamivudine 150 mg + zidovudine 300 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2022-03-14,J05AR01,Zidovudine and lamivudine
Human,02387247,Teva-Lamivudine/Zidovudine,lamivudine 150 mg + zidovudine 300 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Cancelled post market,2021-07-30,J05AR01,Zidovudine and lamivudine
Human,02399539,Apo-Abacavir-Lamivudine,abacavir (abacavir sulfate) 600 mg + lamivudine 300 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2020-11-03,J05AR02,Lamivudine and abacavir
Human,02518287,Apo-Abacavir-Lamivudine Tablets,abacavir (abacavir sulfate) 600 mg + lamivudine 300 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2021-07-23,J05AR02,Lamivudine and abacavir
Human,02454513,Auro-Abacavir/Lamivudine,abacavir (abacavir sulfate) 600 mg + lamivudine 300 mg oral tablet,Auro Pharma Inc,2.0,P,2.0,Marketed,2016-08-31,J05AR02,Lamivudine and abacavir
Human,02497654,Jamp Abacavir / Lamivudine,abacavir (abacavir sulfate) 600 mg + lamivudine 300 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2022-02-22,J05AR02,Lamivudine and abacavir
Human,02269341,Kivexa,abacavir (abacavir sulfate) 600 mg + lamivudine 300 mg oral tablet,Viiv Healthcare Ulc,2.0,P,2.0,Cancelled post market,2025-11-11,J05AR02,Lamivudine and abacavir
Human,02497808,Mint-Abacavir/Lamivudine,abacavir (abacavir sulfate) 600 mg + lamivudine 300 mg oral tablet,Mint Pharmaceuticals Inc,2.0,P,2.0,Approved,2020-04-02,J05AR02,Lamivudine and abacavir
Human,02450682,Mylan-Abacavir/Lamivudine,abacavir (abacavir sulfate) 600 mg + lamivudine 300 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,2.0,Marketed,2016-03-29,J05AR02,Lamivudine and abacavir
Human,02458381,Pms-Abacavir-Lamivudine,abacavir (abacavir sulfate) 600 mg + lamivudine 300 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Dormant,2024-10-12,J05AR02,Lamivudine and abacavir
Human,02416662,Teva-Abacavir/Lamivudine,abacavir (abacavir sulfate) 600 mg + lamivudine 300 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2016-03-14,J05AR02,Lamivudine and abacavir
Human,02416255,Apo-Abacavir-Lamivudine-Zidovudine,abacavir (abacavir sulfate) 300 mg + lamivudine 150 mg + zidovudine 300 mg oral tablet,Apotex Inc,2.0,P,2.0,Cancelled post market,2025-04-17,J05AR04,"Zidovudine, lamivudine and abacavir"
Human,02244757,Trizivir,abacavir (abacavir sulfate) 300 mg + lamivudine 150 mg + zidovudine 300 mg oral tablet,Viiv Healthcare Ulc,2.0,P,2.0,Cancelled post market,2019-09-17,J05AR04,"Zidovudine, lamivudine and abacavir"
Human,02281368,Apo-Zidovudine-Lamivudine-Nevirapine,lamivudine 150 mg + nevirapine 200 mg + zidovudine 300 mg oral tablet,Apotex Inc,2.0,p,2.0,Approved,2016-05-30,J05AR05,"Zidovudine, lamivudine and nevirapine"
Human,02430932,Triumeq,abacavir (abacavir sulfate) 600 mg + dolutegravir (dolutegravir sodium) 50 mg + lamivudine 300 mg oral tablet,Viiv Healthcare Ulc,2.0,P,2.0,Marketed,2014-10-22,J05AR13,"Lamivudine, abacavir and dolutegravir"
Human,02530740,Livtencity,maribavir 200 mg oral tablet,Takeda Canada Inc,,R,,Marketed,2022-10-25,J05AX10,Maribavir
Human,02496364,Xofluza,baloxavir marboxil 20 mg oral tablet,Hoffmann-La Roche Limited,2.0,,,Marketed,2025-09-25,J05AX25,Baloxavir marboxil
Human,02496372,Xofluza,baloxavir marboxil 40 mg oral tablet,Hoffmann-La Roche Limited,2.0,,,Approved,2020-02-19,J05AX25,Baloxavir marboxil
Human,02524163,Xofluza,baloxavir marboxil 80 mg oral tablet,Hoffmann-La Roche Limited,2.0,,,Marketed,2025-03-05,J05AX25,Baloxavir marboxil
Human,02520869,Rukobia,fostemsavir (fostemsavir tromethamine) 600 mg oral prolonged-release tablet,Viiv Healthcare Ulc,2.0,,,Marketed,2022-04-26,J05AX29,Fostemsavir
Human,00075124,Bcg Vaccine (Freeze-Dried),bacillus calmette-guerin (bcg) substrain connaught 0.1 mg / 0.1 mL intradermal powder for solution,Sanofi Vaccines Canada Ltd.,1.0,KH,,Cancelled post market,2015-08-18,J07AN01,"Tuberculosis, live attenuated"
Human,01914537,Bcg Vaccine,bacillus calmette-guerin bcg 0.75 mg / mL + water 2 mL / vial intradermal powder for solution or liquid,Id Biomedical Corporation Of Quebec,1.0,KH,,Cancelled post market,2005-08-03,J07AN01,"Tuberculosis, live attenuated"
Human,00013552,Procytox Vial 1000Mg,cyclophosphamide 1 g / vial powder for solution for injection,Carter-Horner Corp.,1.0,CK,1.0,Cancelled post market,2001-05-22,L01AA01,Cyclophosphamide
Human,02531038,Cyclophosphamide For Injection,cyclophosphamide 1000 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Cancelled pre market,2025-06-09,L01AA01,Cyclophosphamide
Human,02546736,Cyclophosphamide For Injection Usp,cyclophosphamide 1000 mg / vial powder for solution for injection,Andone Pharmaceutical Inc,1.0,CK,1.0,Marketed,2025-06-06,L01AA01,Cyclophosphamide
Human,02547686,Cyclophosphamide For Injection Usp,cyclophosphamide 1000 mg / vial powder for solution for injection,Sterimax Inc,1.0,CK,1.0,Marketed,2024-09-27,L01AA01,Cyclophosphamide
Human,02560216,Cyclophosphamide For Injection Usp,cyclophosphamide 1000 mg / vial powder for solution for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Approved,2025-08-18,L01AA01,Cyclophosphamide
Human,00602833,Cytoxan Pws For Inj 1000Mg/Vial,cyclophosphamide 1000 mg / vial powder for solution for injection,Bristol-Myers Squibb Canada,1.0,CK,1.0,Cancelled post market,2008-10-17,L01AA01,Cyclophosphamide
Human,02241799,Procytox,cyclophosphamide 1000 mg / vial powder for solution for injection,Baxter Corporation,1.0,CK,1.0,Marketed,2003-11-18,L01AA01,Cyclophosphamide
Human,02094428,Procytox For Injection 2000Mg Pws Iv,cyclophosphamide 2 g / vial + sodium chloride 900 mg / vial powder for solution for injection,Carter-Horner Corp.,1.0,CK,1.0,Cancelled post market,2001-05-22,L01AA01,Cyclophosphamide
Human,02241797,Procytox,cyclophosphamide 200 mg / vial powder for solution for injection,Baxter Corporation,1.0,CK,1.0,Marketed,2003-08-11,L01AA01,Cyclophosphamide
Human,00013544,Procytox Vial 200Mg,cyclophosphamide 200 mg / vial powder for solution for injection,Carter-Horner Corp.,1.0,CK,1.0,Cancelled post market,2000-11-26,L01AA01,Cyclophosphamide
Human,02531046,Cyclophosphamide For Injection,cyclophosphamide 2000 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Cancelled pre market,2025-06-09,L01AA01,Cyclophosphamide
Human,02546744,Cyclophosphamide For Injection Usp,cyclophosphamide 2000 mg / vial powder for solution for injection,Andone Pharmaceutical Inc,1.0,CK,1.0,Marketed,2025-06-06,L01AA01,Cyclophosphamide
Human,02547694,Cyclophosphamide For Injection Usp,cyclophosphamide 2000 mg / vial powder for solution for injection,Sterimax Inc,1.0,CK,1.0,Marketed,2024-09-27,L01AA01,Cyclophosphamide
Human,02560224,Cyclophosphamide For Injection Usp,cyclophosphamide 2000 mg / vial powder for solution for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Approved,2025-08-18,L01AA01,Cyclophosphamide
Human,00602949,Cytoxan Pws For Inj 2000Mg/Vial,cyclophosphamide 2000 mg / vial powder for solution for injection,Bristol-Myers Squibb Canada,1.0,CK,1.0,Cancelled post market,2008-10-17,L01AA01,Cyclophosphamide
Human,02241800,Procytox,cyclophosphamide 2000 mg / vial powder for solution for injection,Baxter Corporation,1.0,CK,1.0,Marketed,2003-11-03,L01AA01,Cyclophosphamide
Human,00262676,Procytox Tab 25Mg,cyclophosphamide 25 mg / tablet oral tablet,Carter-Horner Corp.,1.0,CK,1.0,Cancelled post market,2001-05-22,L01AA01,Cyclophosphamide
Human,00344877,Cytoxan Tab 25Mg,cyclophosphamide 25 mg oral tablet,Bristol-Myers Squibb Canada,1.0,CK,1.0,Cancelled post market,2008-11-21,L01AA01,Cyclophosphamide
Human,02241795,Procytox Tab 25Mg,cyclophosphamide 25 mg oral tablet,Baxter Corporation,1.0,CK,1.0,Marketed,2003-10-03,L01AA01,Cyclophosphamide
Human,00013749,Procytox Tablets 50Mg,cyclophosphamide 50 mg / tablet oral tablet,Carter-Horner Corp.,1.0,CK,1.0,Cancelled post market,2001-05-22,L01AA01,Cyclophosphamide
Human,00344885,Cytoxan Tab 50Mg,cyclophosphamide 50 mg oral tablet,Bristol-Myers Squibb Canada,1.0,CK,1.0,Cancelled post market,2009-01-22,L01AA01,Cyclophosphamide
Human,02241796,Procytox Tab 50Mg,cyclophosphamide 50 mg oral tablet,Baxter Corporation,1.0,CK,1.0,Marketed,2003-09-09,L01AA01,Cyclophosphamide
Human,02559994,Cyclophosphamide For Injection,cyclophosphamide 500 mg / mL solution for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Approved,2025-08-05,L01AA01,Cyclophosphamide
Human,02531011,Cyclophosphamide For Injection,cyclophosphamide 500 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Cancelled pre market,2025-06-09,L01AA01,Cyclophosphamide
Human,02547678,Cyclophosphamide For Injection Usp,cyclophosphamide 500 mg / vial powder for solution for injection,Sterimax Inc,1.0,CK,1.0,Approved,2024-05-14,L01AA01,Cyclophosphamide
Human,02560208,Cyclophosphamide For Injection Usp,cyclophosphamide 500 mg / vial powder for solution for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Approved,2025-08-18,L01AA01,Cyclophosphamide
Human,02241798,Procytox,cyclophosphamide 500 mg / vial powder for solution for injection,Baxter Corporation,1.0,CK,1.0,Marketed,2003-07-28,L01AA01,Cyclophosphamide
Human,00373753,Procytox Pws 500Mg,cyclophosphamide 500 mg / vial unspecified parenteral powder for solution,Carter-Horner Corp.,1.0,CK,1.0,Cancelled post market,2000-11-17,L01AA01,Cyclophosphamide
Human,00004626,Leukeran,chlorambucil 2 mg oral tablet,Aspen Pharmacare Canada Inc.,1.0,CK,1.0,Marketed,2017-11-01,L01AA02,Chlorambucil
Human,02087286,Alkeran,buffer solution 10 mL / vial with melphalan (melphalan hydrochloride) 50 mg / vial kit (powder for solution and solution) for injection,Aspen Pharmacare Canada Inc.,1.0,CK,1.0,Marketed,2017-06-19,L01AA03,Melphalan
Human,02468921,Melphalan For Injection,buffer solution 10 mL / vial with melphalan (melphalan hydrochloride) 50 mg / vial kit (powder for solution and solution) for injection,Apotex Inc,1.0,CK,1.0,Dormant,2023-04-13,L01AA03,Melphalan
Human,02473348,Melphalan For Injection,buffer solution 10 mL / vial with melphalan (melphalan hydrochloride) 50 mg / vial kit (powder for solution and solution) for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2018-06-18,L01AA03,Melphalan
Human,02480026,Taro-Melphalan,buffer solution 10 mL / vial with melphalan (melphalan hydrochloride) 50 mg / vial kit (powder for solution) for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2021-01-25,L01AA03,Melphalan
Human,02508214,Melphalan For Injection,melphalan (melphalan hydrochloride) 50 mg / vial kit (powder for solution) for injection,Auro Pharma Inc,1.0,CK,1.0,Approved,2025-12-23,L01AA03,Melphalan
Human,02526077,Melphalan For Injection,melphalan (melphalan hydrochloride) 50 mg / vial kit (powder for solution) for injection,Juno Pharmaceuticals Corp.,1.0,CK,1.0,Approved,2022-03-23,L01AA03,Melphalan
Human,02537389,Melphalan For Injection,melphalan (melphalan hydrochloride) 50 mg / vial kit (powder for solution) for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2023-04-21,L01AA03,Melphalan
Human,00004715,Alkeran,melphalan 2 mg oral tablet,Aspen Pharmacare Canada Inc.,1.0,CK,1.0,Marketed,2018-04-26,L01AA03,Melphalan
Human,02516764,Ledaga,chlormethine (chlormethine hydrochloride) 160 mcg / g topical gel,Recordati Rare Diseases Canada Inc,1.0,K,1.0,Marketed,2022-09-14,L01AA05,Chlormethine
Human,00016063,Mustargen,mechlorethamine hydrochloride 10 mg / vial powder for solution for injection,Lundbeck Pharmaceuticals Llc,1.0,K,1.0,Cancelled post market,2011-11-11,L01AA05,Chlormethine
Human,02241357,Ifex,ifosfamide 1 g / vial powder for solution for injection,Baxter Corporation,1.0,CK,1.0,Marketed,2003-09-09,L01AA06,Ifosfamide
Human,00797227,Ifex Pws 1Gm/Vial,ifosfamide 1 g / vial powder for solution for injection,Bristol Labs Division Of Bristol-Myers Squibb,1.0,CK,1.0,Cancelled post market,2001-04-09,L01AA06,Ifosfamide
Human,02246565,Ifosfamide For Injection,ifosfamide 1 g / vial powder for solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Cancelled post market,2024-08-29,L01AA06,Ifosfamide
Human,00797235,Ifex Pws 2G/Vial,ifosfamide 2 g / vial powder for solution for injection,Bristol Labs Division Of Bristol-Myers Squibb,1.0,CK,1.0,Cancelled post market,1997-08-14,L01AA06,Ifosfamide
Human,02241356,Ifex,ifosfamide 3 g / vial powder for solution for injection,Baxter Corporation,1.0,CK,1.0,Marketed,2003-09-09,L01AA06,Ifosfamide
Human,00808601,Ifex Pws 3Gm/Vial,ifosfamide 3 g / vial powder for solution for injection,Bristol Labs Division Of Bristol-Myers Squibb,1.0,CK,1.0,Cancelled post market,2002-07-11,L01AA06,Ifosfamide
Human,02246566,Ifosfamide For Injection,ifosfamide 3 g / vial powder for solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Cancelled pre market,2023-08-16,L01AA06,Ifosfamide
Human,02496860,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 100 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2021-03-02,L01AA09,Bendamustine
Human,02498111,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 100 mg / vial powder for solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled post market,2025-09-25,L01AA09,Bendamustine
Human,02509172,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 100 mg / vial powder for solution for injection,Jamp Pharma Corporation,1.0,CK,1.0,Dormant,2023-07-31,L01AA09,Bendamustine
Human,02509261,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 100 mg / vial powder for solution for injection,Auro Pharma Inc,1.0,CK,1.0,Marketed,2021-03-02,L01AA09,Bendamustine
Human,02526980,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 100 mg / vial powder for solution for injection,Hikma Canada Limited,1.0,CK,1.0,Approved,2022-05-02,L01AA09,Bendamustine
Human,02542005,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 100 mg / vial powder for solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Marketed,2024-10-08,L01AA09,Bendamustine
Human,02496895,Nat-Bendamustine,bendamustine hydrochloride 100 mg / vial powder for solution for injection,Natco Pharma (Canada) Inc,1.0,CK,1.0,Marketed,2021-02-25,L01AA09,Bendamustine
Human,02392569,Treanda,bendamustine hydrochloride 100 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2018-04-09,L01AA09,Bendamustine
Human,02524309,Benvyon,bendamustine hydrochloride 25 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2023-01-30,L01AA09,Bendamustine
Human,02496852,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 25 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2021-03-02,L01AA09,Bendamustine
Human,02498103,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 25 mg / vial powder for solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled post market,2025-09-25,L01AA09,Bendamustine
Human,02509164,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 25 mg / vial powder for solution for injection,Jamp Pharma Corporation,1.0,CK,1.0,Dormant,2024-07-31,L01AA09,Bendamustine
Human,02509253,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 25 mg / vial powder for solution for injection,Auro Pharma Inc,1.0,CK,1.0,Marketed,2021-03-02,L01AA09,Bendamustine
Human,02526972,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 25 mg / vial powder for solution for injection,Hikma Canada Limited,1.0,CK,1.0,Approved,2022-05-02,L01AA09,Bendamustine
Human,02541998,Bendamustine Hydrochloride For Injection,bendamustine hydrochloride 25 mg / vial powder for solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Marketed,2025-09-08,L01AA09,Bendamustine
Human,02496887,Nat-Bendamustine,bendamustine hydrochloride 25 mg / vial powder for solution for injection,Natco Pharma (Canada) Inc,1.0,CK,1.0,Marketed,2021-02-25,L01AA09,Bendamustine
Human,02392550,Treanda,bendamustine hydrochloride 25 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2018-04-09,L01AA09,Bendamustine
Human,02527073,Esamuze,bendamustine hydrochloride 45 mg / mL solution for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Approved,2022-05-04,L01AA09,Bendamustine
Human,00004618,Myleran,busulfan 2 mg oral tablet,Aspen Pharmacare Canada Inc.,1.0,K,1.0,Marketed,2018-07-24,L01AB01,Busulfan
Human,02477343,Pms-Busulfan,busulfan 6 mg / mL solution for injection,Pharmascience Inc,1.0,K,1.0,Marketed,2019-03-29,L01AB01,Busulfan
Human,02463733,Busulfan For Injection,busulfan 60 mg / 10 mL solution for injection,Sterimax Inc,1.0,K,1.0,Marketed,2017-10-04,L01AB01,Busulfan
Human,02475006,Busulfan For Injection,busulfan 60 mg / 10 mL solution for injection,Marcan Pharmaceuticals Inc,1.0,K,1.0,Approved,2018-04-23,L01AB01,Busulfan
Human,02521296,Busulfan For Injection,busulfan 60 mg / 10 mL solution for injection,Auro Pharma Inc,1.0,K,1.0,Approved,2021-10-14,L01AB01,Busulfan
Human,02536935,Busulfan For Injection,busulfan 60 mg / 10 mL solution for injection,Eugia Pharma Inc.,1.0,K,1.0,Approved,2023-04-04,L01AB01,Busulfan
Human,02473127,Busulfan Injection,busulfan 60 mg / 10 mL solution for injection,Apotex Inc,1.0,K,1.0,Approved,2018-02-16,L01AB01,Busulfan
Human,02240602,Busulfex,busulfan 60 mg / 10 mL solution for injection,Otsuka Pharmaceutical Co Ltd,1.0,K,1.0,Cancelled post market,2020-09-01,L01AB01,Busulfan
Human,02517361,Trecondyv,treosulfan 1 g / vial powder for injection,Medexus Pharmaceuticals Inc.,1.0,CK,,Approved,2021-06-25,L01AB02,Treosulfan
Human,02517388,Trecondyv,treosulfan 5 g / vial powder for injection,Medexus Pharmaceuticals Inc.,1.0,CK,,Marketed,2021-08-31,L01AB02,Treosulfan
Human,02560585,Treosulfan For Injection,treosulfan 5 g / vial powder for injection,Marcan Pharmaceuticals Inc,1.0,CK,,Marketed,2025-11-26,L01AB02,Treosulfan
Human,02462702,Tepadina,thiotepa 100 mg / vial powder for solution for injection,Adienne Sa,1.0,K,1.0,Marketed,2017-10-31,L01AC01,Thiotepa
Human,02526425,Thiotepa For Injection Usp,thiotepa 100 mg / vial powder for solution for injection,Sterimax Inc,1.0,K,1.0,Marketed,2023-02-15,L01AC01,Thiotepa
Human,02536870,"Thiotepa For Injection, Bp",thiotepa 100 mg / vial powder for solution for injection,Hikma Canada Limited,1.0,K,1.0,Marketed,2023-06-27,L01AC01,Thiotepa
Human,00237035,Thio Tepa Inj 15Mg/Vial,thiotepa 15 mg / vial  or oral or rectal or vaginal powder for solution,Lederle Cyanamid Canada Inc.,1.0,K,1.0,Cancelled post market,1997-11-24,L01AC01,Thiotepa
Human,02462680,Tepadina,thiotepa 15 mg / vial powder for solution for injection,Adienne Sa,1.0,K,1.0,Marketed,2017-11-06,L01AC01,Thiotepa
Human,02174391,Thiotepa - (Pws 15 Mg/Vial),thiotepa 15 mg / vial powder for solution for injection,Wyeth Canada,1.0,K,1.0,Cancelled post market,2004-09-15,L01AC01,Thiotepa
Human,02526417,Thiotepa For Injection Usp,thiotepa 15 mg / vial powder for solution for injection,Sterimax Inc,1.0,K,1.0,Marketed,2023-02-15,L01AC01,Thiotepa
Human,02536862,"Thiotepa For Injection, Bp",thiotepa 15 mg / vial powder for solution for injection,Hikma Canada Limited,1.0,K,1.0,Marketed,2023-06-27,L01AC01,Thiotepa
Human,02523906,Tepadina,thiotepa 400 mg / bag powder for solution for injection,Adienne Sa,1.0,K,1.0,Marketed,2025-06-25,L01AC01,Thiotepa
Human,02555093,Bicnu,carmustine 100 mg / mL solution for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2025-04-14,L01AD01,Carmustine
Human,00297763,Bicnu,carmustine 100 mg / vial powder for solution for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2017-09-19,L01AD01,Carmustine
Human,02531879,Carmustine For Injection Usp,carmustine 100 mg / vial powder for solution for injection,Sterimax Inc,1.0,CK,1.0,Marketed,2023-05-18,L01AD01,Carmustine
Human,02238985,Gliadel Wafer,carmustine 7.7 mg intralesional wafer,Eisai Limited,1.0,CK,1.0,Cancelled post market,2015-03-02,L01AD01,Carmustine
Human,00360430,Ceenu,lomustine 10 mg oral capsule,Bristol-Myers Squibb Canada,1.0,CK,1.0,Marketed,2010-02-18,L01AD02,Lomustine
Human,00360414,Ceenu,lomustine 100 mg oral capsule,Bristol-Myers Squibb Canada,1.0,CK,1.0,Cancelled post market,2019-10-01,L01AD02,Lomustine
Human,00360422,Ceenu,lomustine 40 mg oral capsule,Bristol-Myers Squibb Canada,1.0,CK,1.0,Marketed,2009-12-14,L01AD02,Lomustine
Human,00622141,Zanosar Sterile Powder,streptozocin 1 g / vial powder for solution for injection,Paladin Pharma Inc.,1.0,K,1.0,Cancelled post market,2017-12-19,L01AD04,Streptozocin
Human,02321262,Temodal,temozolomide 100 mg / vial powder for solution for injection,Merck Canada Inc,1.0,CK,1.0,Cancelled post market,2016-02-01,L01AX03,Temozolomide
Human,02389827,Ach-Temozolomide,temozolomide 100 mg oral capsule,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2014-07-24,L01AX03,Temozolomide
Human,02413094,Apo-Temozolomide,temozolomide 100 mg oral capsule,Apotex Inc,1.0,CK,1.0,Approved,2013-09-24,L01AX03,Temozolomide
Human,02516810,Jamp Temozolomide,temozolomide 100 mg oral capsule,Jamp Pharma Corporation,1.0,CK,1.0,Marketed,2022-07-25,L01AX03,Temozolomide
Human,02443511,Taro-Temozolomide,temozolomide 100 mg oral capsule,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2015-07-23,L01AX03,Temozolomide
Human,02241095,Temodal,temozolomide 100 mg oral capsule,Merck Canada Inc,1.0,CK,1.0,Marketed,2012-03-28,L01AX03,Temozolomide
Human,02395282,Teva-Temozolomide,temozolomide 100 mg oral capsule,Teva Canada Limited,1.0,CK,1.0,Marketed,2021-10-19,L01AX03,Temozolomide
Human,02389835,Ach-Temozolomide,temozolomide 140 mg oral capsule,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2014-07-24,L01AX03,Temozolomide
Human,02413116,Apo-Temozolomide,temozolomide 140 mg oral capsule,Apotex Inc,1.0,CK,1.0,Approved,2013-09-24,L01AX03,Temozolomide
Human,02516829,Jamp Temozolomide,temozolomide 140 mg oral capsule,Jamp Pharma Corporation,1.0,CK,1.0,Marketed,2022-07-26,L01AX03,Temozolomide
Human,02443538,Taro-Temozolomide,temozolomide 140 mg oral capsule,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2015-07-23,L01AX03,Temozolomide
Human,02312794,Temodal,temozolomide 140 mg oral capsule,Merck Canada Inc,1.0,CK,1.0,Marketed,2012-03-23,L01AX03,Temozolomide
Human,02395290,Teva-Temozolomide,temozolomide 140 mg oral capsule,Teva Canada Limited,1.0,CK,1.0,Marketed,2021-10-19,L01AX03,Temozolomide
Human,02389843,Ach-Temozolomide,temozolomide 180 mg oral capsule,Accord Healthcare Inc,1.0,CK,1.0,Cancelled post market,2020-02-05,L01AX03,Temozolomide
Human,02395304,Act Temozolomide,temozolomide 180 mg oral capsule,Teva Canada Limited,1.0,CK,1.0,Cancelled pre market,2021-03-17,L01AX03,Temozolomide
Human,02413124,Apo-Temozolomide,temozolomide 180 mg oral capsule,Apotex Inc,1.0,CK,1.0,Approved,2013-09-24,L01AX03,Temozolomide
Human,02516837,Jamp Temozolomide,temozolomide 180 mg oral capsule,Jamp Pharma Corporation,1.0,CK,1.0,Approved,2021-06-10,L01AX03,Temozolomide
Human,02443546,Taro-Temozolomide,temozolomide 180 mg oral capsule,Taro Pharmaceuticals Inc,1.0,CK,1.0,Approved,2015-07-08,L01AX03,Temozolomide
Human,02312816,Temodal,temozolomide 180 mg oral capsule,Merck Canada Inc,1.0,CK,1.0,Cancelled post market,2011-07-22,L01AX03,Temozolomide
Human,02389819,Ach-Temozolomide,temozolomide 20 mg oral capsule,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2014-07-24,L01AX03,Temozolomide
Human,02413043,Apo-Temozolomide,temozolomide 20 mg oral capsule,Apotex Inc,1.0,CK,1.0,Approved,2013-09-24,L01AX03,Temozolomide
Human,02516802,Jamp Temozolomide,temozolomide 20 mg oral capsule,Jamp Pharma Corporation,1.0,CK,1.0,Marketed,2022-08-05,L01AX03,Temozolomide
Human,02443481,Taro-Temozolomide,temozolomide 20 mg oral capsule,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2015-07-23,L01AX03,Temozolomide
Human,02241094,Temodal,temozolomide 20 mg oral capsule,Merck Canada Inc,1.0,CK,1.0,Marketed,2012-03-13,L01AX03,Temozolomide
Human,02455757,Temozolomide Capsules,temozolomide 20 mg oral capsule,Mda Inc.,1.0,CK,1.0,Cancelled pre market,2021-04-23,L01AX03,Temozolomide
Human,02395274,Teva-Temozolomide,temozolomide 20 mg oral capsule,Teva Canada Limited,1.0,CK,1.0,Marketed,2021-10-19,L01AX03,Temozolomide
Human,02389851,Ach-Temozolomide,temozolomide 250 mg oral capsule,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2014-07-24,L01AX03,Temozolomide
Human,02413132,Apo-Temozolomide,temozolomide 250 mg oral capsule,Apotex Inc,1.0,CK,1.0,Approved,2013-09-24,L01AX03,Temozolomide
Human,02516845,Jamp Temozolomide,temozolomide 250 mg oral capsule,Jamp Pharma Corporation,1.0,CK,1.0,Marketed,2022-07-26,L01AX03,Temozolomide
Human,02443554,Taro-Temozolomide,temozolomide 250 mg oral capsule,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2015-07-23,L01AX03,Temozolomide
Human,02241096,Temodal,temozolomide 250 mg oral capsule,Merck Canada Inc,1.0,CK,1.0,Marketed,2012-03-21,L01AX03,Temozolomide
Human,02395312,Teva-Temozolomide,temozolomide 250 mg oral capsule,Teva Canada Limited,1.0,CK,1.0,Marketed,2021-10-19,L01AX03,Temozolomide
Human,02438119,Ach-Temozolomide,temozolomide 5 mg oral capsule,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2016-01-13,L01AX03,Temozolomide
Human,02413035,Apo-Temozolomide,temozolomide 5 mg oral capsule,Apotex Inc,1.0,CK,1.0,Approved,2013-09-24,L01AX03,Temozolomide
Human,02516799,Jamp Temozolomide,temozolomide 5 mg oral capsule,Jamp Pharma Corporation,1.0,CK,1.0,Marketed,2022-07-27,L01AX03,Temozolomide
Human,02443473,Taro-Temozolomide,temozolomide 5 mg oral capsule,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2015-07-23,L01AX03,Temozolomide
Human,02241093,Temodal,temozolomide 5 mg oral capsule,Merck Canada Inc,1.0,CK,1.0,Marketed,2012-03-15,L01AX03,Temozolomide
Human,02455749,Temozolomide Capsules,temozolomide 5 mg oral capsule,Mda Inc.,1.0,CK,1.0,Cancelled pre market,2021-04-23,L01AX03,Temozolomide
Human,02441160,Teva-Temozolomide,temozolomide 5 mg oral capsule,Teva Canada Limited,1.0,CK,1.0,Marketed,2021-10-19,L01AX03,Temozolomide
Human,02154854,Dtic-Dome -Pws Iv 200Mg/Vial,dacarbazine 10 mg / mL powder for solution for injection,Bayer Inc,1.0,CK,1.0,Cancelled post market,2005-05-31,L01AX04,Dacarbazine
Human,00521183,Dtic Dome Inj 200Mg/Vial,dacarbazine 200 mg / vial liquid for injection,Miles Canada Inc. - Pharmaceutical Division,1.0,CK,1.0,Cancelled post market,1998-09-25,L01AX04,Dacarbazine
Human,02241445,Dacarbazine For Injection Bp,dacarbazine 600 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2017-05-31,L01AX04,Dacarbazine
Human,02562839,"Methotrexate Tablets, Usp",methotrexate (methotrexate disodium) 10 mg oral tablet,Pfizer Canada Ulc,1.0,CK,1.0,Approved,2025-12-05,L01BA01,Methotrexate
Human,02509067,Ach-Methotrexate,methotrexate (methotrexate disodium) 2.5 mg oral tablet,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2021-10-21,L01BA01,Methotrexate
Human,02182963,Apo-Methotrexate,methotrexate (methotrexate disodium) 2.5 mg oral tablet,Apotex Inc,1.0,CK,1.0,Marketed,2021-07-22,L01BA01,Methotrexate
Human,02546515,Eugia-Methotrexate,methotrexate (methotrexate disodium) 2.5 mg oral tablet,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2024-03-19,L01BA01,Methotrexate
Human,02562979,Jamp Methotrexate,methotrexate (methotrexate disodium) 2.5 mg oral tablet,Jamp Pharma Corporation,1.0,CK,1.0,Approved,2025-11-28,L01BA01,Methotrexate
Human,02534916,M-Methotrexate,methotrexate (methotrexate disodium) 2.5 mg oral tablet,Mantra Pharma Inc,1.0,CK,1.0,Marketed,2024-04-24,L01BA01,Methotrexate
Human,02170698,Pms-Methotrexate,methotrexate (methotrexate disodium) 2.5 mg oral tablet,Pharmascience Inc,1.0,CK,1.0,Marketed,2018-10-04,L01BA01,Methotrexate
Human,02422174,"Methotrexate Injection, Bp",methotrexate (methotrexate sodium) 10 mg / 0.4 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-09-12,L01BA01,Methotrexate
Human,00614335,Methotrexate Dbl Inj 10Mg/Ml,methotrexate (methotrexate sodium) 10 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,1997-08-14,L01BA01,Methotrexate
Human,02182947,Methotrexate Injection Usp,methotrexate (methotrexate sodium) 10 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2017-06-06,L01BA01,Methotrexate
Human,02320037,Metoject,methotrexate (methotrexate sodium) 10 mg / mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Cancelled post market,2020-04-23,L01BA01,Methotrexate
Human,02422182,"Methotrexate Injection, Bp",methotrexate (methotrexate sodium) 15 mg / 0.6 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-09-12,L01BA01,Methotrexate
Human,02320045,Metoject,methotrexate (methotrexate sodium) 15 mg / 1.5 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Cancelled post market,2019-07-17,L01BA01,Methotrexate
Human,00614327,Methotrexate Dbl Inj 2.5Mg/Ml,methotrexate (methotrexate sodium) 2.5 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,1998-08-13,L01BA01,Methotrexate
Human,02283697,Methotrexate,methotrexate (methotrexate sodium) 2.5 mg oral tablet,Apotex Inc,1.0,CK,1.0,Approved,2019-03-21,L01BA01,Methotrexate
Human,02244798,Ratio-Methotrexate Sodium,methotrexate (methotrexate sodium) 2.5 mg oral tablet,Teva Canada Limited,1.0,CK,1.0,Cancelled post market,2018-05-07,L01BA01,Methotrexate
Human,02422190,"Methotrexate Injection, Bp",methotrexate (methotrexate sodium) 20 mg / 0.8 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-09-12,L01BA01,Methotrexate
Human,02304767,Metoject,methotrexate (methotrexate sodium) 20 mg / 2 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Cancelled post market,2017-05-19,L01BA01,Methotrexate
Human,00410195,Methotrexate Sodium Inj 20Mg,methotrexate (methotrexate sodium) 20 mg / vial powder for solution for injection,Lederle Cyanamid Canada Inc.,1.0,CK,1.0,Cancelled post market,1997-08-14,L01BA01,Methotrexate
Human,02170655,Methotrexate-Pws Im Iv Iar Int Ivr 20Mg/Vial,methotrexate (methotrexate sodium) 20 mg / vial powder for solution for injection,Wyeth-Ayerst Canada Inc.,1.0,CK,1.0,Cancelled post market,2001-05-22,L01BA01,Methotrexate
Human,02320053,Metoject,methotrexate (methotrexate sodium) 25 mg / 2.5 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Cancelled post market,2017-05-19,L01BA01,Methotrexate
Human,00614343,Methotrexate Dbl Inj 25Mg/Ml,methotrexate (methotrexate sodium) 25 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,1998-08-13,L01BA01,Methotrexate
Human,02084481,Methotrexate Sod Inj 25Mg/Ml Usp,methotrexate (methotrexate sodium) 25 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,1998-08-13,L01BA01,Methotrexate
Human,00321397,Methotrexate Sodium Inj 25.0Mg/Ml,methotrexate (methotrexate sodium) 25 mg / mL liquid for injection,Lederle Cyanamid Canada Inc.,1.0,CK,1.0,Cancelled post market,1997-08-14,L01BA01,Methotrexate
Human,01911457,Methotrexate Sodium Inj 25Mg/Ml Usp,methotrexate (methotrexate sodium) 25 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,1999-08-10,L01BA01,Methotrexate
Human,02170663,Methotrexate-Liq Im Iv Iar Int Ivr 25Mg/Ml,methotrexate (methotrexate sodium) 25 mg / mL liquid for injection,Wyeth-Ayerst Canada Inc.,1.0,CK,1.0,Cancelled post market,2001-09-19,L01BA01,Methotrexate
Human,02419173,Jamp-Methotrexate,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Jamp Pharma Corporation,1.0,CK,1.0,Cancelled post market,2022-11-14,L01BA01,Methotrexate
Human,02327236,Methotrexate Injection Bp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2019-08-26,L01BA01,Methotrexate
Human,02333023,Methotrexate Injection Bp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Uman Pharma Inc,1.0,CK,1.0,Approved,2009-09-16,L01BA01,Methotrexate
Human,02464365,Methotrexate Injection Bp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2020-10-22,L01BA01,Methotrexate
Human,02474735,Methotrexate Injection Bp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2019-04-23,L01BA01,Methotrexate
Human,02474891,Methotrexate Injection Bp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2019-04-23,L01BA01,Methotrexate
Human,02182777,Methotrexate Injection Usp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2018-08-23,L01BA01,Methotrexate
Human,02182955,Methotrexate Injection Usp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2017-06-06,L01BA01,Methotrexate
Human,02182971,Methotrexate Injection Usp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2018-04-23,L01BA01,Methotrexate
Human,02398427,Methotrexate Injection Usp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled post market,2023-07-28,L01BA01,Methotrexate
Human,02422204,"Methotrexate Injection, Bp",methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-09-12,L01BA01,Methotrexate
Human,02417626,"Methotrexate Injection, Usp",methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Strides Pharma Canada Inc,1.0,CK,1.0,Dormant,2024-10-04,L01BA01,Methotrexate
Human,02377624,Methotrexate Pf/Sa Injection,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled pre market,2018-08-01,L01BA01,Methotrexate
Human,02099705,Methotrexate Sodium Injection,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2017-08-31,L01BA01,Methotrexate
Human,02161168,Methotrexate Sodium Injection Usp,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2006-08-02,L01BA01,Methotrexate
Human,02422166,"Methotrexate Injection, Bp",methotrexate (methotrexate sodium) 7.5 mg / 0.3 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-09-12,L01BA01,Methotrexate
Human,02320029,Metoject,methotrexate (methotrexate sodium) 7.5 mg / 0.75 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Cancelled post market,2022-06-29,L01BA01,Methotrexate
Human,02448165,Auro-Methotrexate Tablets,methotrexate 10 mg oral tablet,Auro Pharma Inc,1.0,CK,1.0,Approved,2026-01-09,L01BA01,Methotrexate
Human,02553740,Jamp Methotrexate Tablets,methotrexate 10 mg oral tablet,Jamp Pharma Corporation,1.0,CK,1.0,Marketed,2025-06-10,L01BA01,Methotrexate
Human,02182750,"Methotrexate Tablets, Usp",methotrexate 10 mg oral tablet,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2017-08-17,L01BA01,Methotrexate
Human,02561956,Pms-Methotrexate Tablets,methotrexate 10 mg oral tablet,Pharmascience Inc,1.0,CK,1.0,Marketed,2025-11-28,L01BA01,Methotrexate
Human,00014915,Methotrexate Tab 2.5Mg,methotrexate 2.5 mg oral tablet,Lederle Cyanamid Canada Inc.,1.0,CK,1.0,Cancelled post market,1997-08-14,L01BA01,Methotrexate
Human,00632619,Methotrexate Tab 2.5Mg Usp,methotrexate 2.5 mg oral tablet,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,2000-08-01,L01BA01,Methotrexate
Human,02170671,Methotrexate,methotrexate 25 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2011-05-03,L01BA01,Methotrexate
Human,00874132,Rheumatrex Tab 2.5Mg,methotrexate sodium 2.5 mg / tablet oral tablet,Lederle Cyanamid Canada Inc.,1.0,CK,1.0,Cancelled post market,2000-08-02,L01BA01,Methotrexate
Human,00519286,Methotrexate Sodium Inj 25Mg/Ml,methotrexate sodium 50 mg / vial liquid for injection,Lederle Cyanamid Canada Inc.,1.0,CK,1.0,Cancelled post market,1997-08-14,L01BA01,Methotrexate
Human,02232551,Penta-Tamoxifen Tablets,tamoxifen (tamoxifen citrate) 10 mg / tablet oral tablet,Pentapharm Ltd.,1.0,CK,1.0,Cancelled (unreturned annual),2018-04-05,L01BA01,Methotrexate
Human,02232552,Penta-Tamoxifen Tablets,tamoxifen (tamoxifen citrate) 20 mg / tablet oral tablet,Pentapharm Ltd.,1.0,CK,1.0,Cancelled (unreturned annual),2018-04-05,L01BA01,Methotrexate
Human,02229566,Tomudex,raltitrexed (raltitrexed) 2 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,,Marketed,2021-12-08,L01BA03,Raltitrexed
Human,02438674,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2017-05-24,L01BA04,Pemetrexed
Human,02454610,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg / vial powder for solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled pre market,2019-08-01,L01BA04,Pemetrexed
Human,02554534,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg / vial powder for solution for injection,Hikma Canada Limited,1.0,CK,1.0,Approved,2025-01-28,L01BA04,Pemetrexed
Human,02482967,Pemetrexed Disodium For Injection Usp,pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg / vial powder for solution for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Approved,2018-11-20,L01BA04,Pemetrexed
Human,02454637,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 1000 mg / vial powder for solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled pre market,2019-08-01,L01BA04,Pemetrexed
Human,02515423,Pemetrexed For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 25 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2022-05-10,L01BA04,Pemetrexed
Human,02438682,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2017-05-29,L01BA04,Pemetrexed
Human,02441616,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg / vial powder for solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled pre market,2022-02-28,L01BA04,Pemetrexed
Human,02454629,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg / vial powder for solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled pre market,2019-08-01,L01BA04,Pemetrexed
Human,02472619,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg / vial powder for solution for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Approved,2018-02-02,L01BA04,Pemetrexed
Human,02554542,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg / vial powder for solution for injection,Hikma Canada Limited,1.0,CK,1.0,Approved,2025-01-28,L01BA04,Pemetrexed
Human,02428768,Act Pemetrexed,pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Actavis Pharma Company,1.0,CK,1.0,Cancelled pre market,2018-07-24,L01BA04,Pemetrexed
Human,02306433,Alimta,pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Eli Lilly Canada Inc,1.0,CK,1.0,Marketed,2009-01-09,L01BA04,Pemetrexed
Human,02455498,Pemetrexed,pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Apotex Inc,1.0,CK,1.0,Approved,2016-06-03,L01BA04,Pemetrexed
Human,02411016,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled pre market,2024-09-30,L01BA04,Pemetrexed
Human,02459434,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2017-03-31,L01BA04,Pemetrexed
Human,02517639,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Auro Pharma Inc,1.0,CK,1.0,Marketed,2022-09-15,L01BA04,Pemetrexed
Human,02528746,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Marketed,2024-10-08,L01BA04,Pemetrexed
Human,02534088,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Jamp Pharma Corporation,1.0,CK,1.0,Approved,2022-12-23,L01BA04,Pemetrexed
Human,02463083,"Pemetrexed For Injection, Usp",pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Marketed,2022-06-17,L01BA04,Pemetrexed
Human,02429195,Taro-Pemetrexed,pemetrexed (pemetrexed disodium) 100 mg / vial powder for solution for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2018-10-18,L01BA04,Pemetrexed
Human,02428784,Act Pemetrexed,pemetrexed (pemetrexed disodium) 1000 mg / vial powder for solution for injection,Actavis Pharma Company,1.0,CK,1.0,Cancelled pre market,2018-07-24,L01BA04,Pemetrexed
Human,02442833,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 1000 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled pre market,2024-09-30,L01BA04,Pemetrexed
Human,02517655,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 1000 mg / vial powder for solution for injection,Auro Pharma Inc,1.0,CK,1.0,Approved,2021-07-02,L01BA04,Pemetrexed
Human,02528762,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 1000 mg / vial powder for solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2022-07-08,L01BA04,Pemetrexed
Human,02480492,Taro-Pemetrexed,pemetrexed (pemetrexed disodium) 1000 mg / vial powder for solution for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2021-05-07,L01BA04,Pemetrexed
Human,02428776,Act Pemetrexed,pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Actavis Pharma Company,1.0,CK,1.0,Cancelled pre market,2018-07-24,L01BA04,Pemetrexed
Human,02253437,Alimta,pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Eli Lilly Canada Inc,1.0,CK,1.0,Cancelled post market,2021-09-17,L01BA04,Pemetrexed
Human,02455528,Pemetrexed,pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Apotex Inc,1.0,CK,1.0,Approved,2016-06-03,L01BA04,Pemetrexed
Human,02394227,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2017-03-31,L01BA04,Pemetrexed
Human,02411024,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled pre market,2024-09-30,L01BA04,Pemetrexed
Human,02517647,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Auro Pharma Inc,1.0,CK,1.0,Marketed,2022-09-15,L01BA04,Pemetrexed
Human,02528754,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Marketed,2024-10-08,L01BA04,Pemetrexed
Human,02534096,Pemetrexed Disodium For Injection,pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Jamp Pharma Corporation,1.0,CK,1.0,Approved,2022-12-23,L01BA04,Pemetrexed
Human,02463091,"Pemetrexed For Injection, Usp",pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Marketed,2022-06-17,L01BA04,Pemetrexed
Human,02429209,Taro-Pemetrexed,pemetrexed (pemetrexed disodium) 500 mg / vial powder for solution for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2017-02-15,L01BA04,Pemetrexed
Human,02481820,Folotyn,pralatrexate 20 mg / mL solution for injection,Servier Canada Inc,1.0,CK,1.0,Marketed,2019-01-15,L01BA05,Pralatrexate%
Human,02481855,Folotyn,pralatrexate 40 mg / 2 mL solution for injection,Servier Canada Inc,1.0,CK,1.0,Approved,2018-10-26,L01BA05,Pralatrexate%
Human,02415275,Mercaptopurine Tablets Usp,mercaptopurine 50 mg oral tablet,Sterimax Inc,1.0,K,1.0,Marketed,2013-11-27,L01BB02,Mercaptopurine
Human,00004723,Purinethol,mercaptopurine 50 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2014-03-19,L01BB02,Mercaptopurine
Human,00282081,Lanvis,thioguanine 40 mg oral tablet,Aspen Pharmacare Canada Inc.,1.0,CK,1.0,Marketed,2020-07-10,L01BB03,Tioguanine
Human,02319918,Cladribine Injection,cladribine 1 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Marketed,2016-08-22,L01BB04,Cladribine
Human,02494574,Cladribine Injection,cladribine 1 mg / mL solution for injection,Generic Medical Partners Inc,1.0,CK,1.0,Marketed,2020-08-19,L01BB04,Cladribine
Human,02022117,Leustatin 1Mg/Ml,cladribine 1 mg / mL solution for injection,Janssen Inc,1.0,CK,1.0,Cancelled post market,2011-12-19,L01BB04,Cladribine
Human,01989537,Fludara,fludarabine phosphate (fludarabine phosphate sodium) 50 mg / vial powder for solution for injection,"Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc",1.0,CK,,Cancelled post market,2011-03-31,L01BB05,Fludarabine
Human,02246226,Fludara,fludarabine phosphate 10 mg oral tablet,Sanofi-Aventis Canada Inc,1.0,CK,,Marketed,2014-02-28,L01BB05,Fludarabine
Human,02416069,Fludarabine Phosphate Injection,fludarabine phosphate 25 mg / mL liquid for injection,Omega Laboratories Limited,1.0,CK,,Approved,2013-11-13,L01BB05,Fludarabine
Human,02409046,Aj-Fludarabine,fludarabine phosphate 25 mg / mL solution for injection,Agila Jamp Canada Inc,1.0,CK,,Cancelled pre market,2015-11-03,L01BB05,Fludarabine
Human,02283859,Fludarabine Phosphate For Injection,fludarabine phosphate 25 mg / mL solution for injection,Teva Canada Limited,1.0,CK,,Marketed,2014-02-08,L01BB05,Fludarabine
Human,02351722,Fludarabine Phosphate Injection,fludarabine phosphate 25 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,,Dormant,2017-08-03,L01BB05,Fludarabine
Human,02406381,Fludarabine Phosphate Injection,fludarabine phosphate 25 mg / mL solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,,Cancelled pre market,2022-02-28,L01BB05,Fludarabine
Human,02438577,"Fludarabine Phosphate Injection, Usp",fludarabine phosphate 25 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,,Marketed,2022-08-25,L01BB05,Fludarabine
Human,02351730,Fludarabine Phosphate For Injection,fludarabine phosphate 50 mg / vial powder for solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,,Cancelled pre market,2024-08-28,L01BB05,Fludarabine
Human,02293846,Fludarabine Phosphate For Injection Usp,fludarabine phosphate 50 mg / vial powder for solution for injection,Hospira Healthcare Ulc,1.0,CK,,Cancelled post market,2018-08-01,L01BB05,Fludarabine
Human,02330407,Clolar,clofarabine 1 mg / mL solution for injection,Sanofi-Aventis Canada Inc,1.0,CK,1.0,Marketed,2014-04-08,L01BB06,Clofarabine
Human,02299925,Atriance,nelarabine 5 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2022-11-30,L01BB07,Nelarabine
Human,02167883,Cytarabine - Pws 1Gn/Vial,cytarabine 1 g / vial powder for solution for injection,Novopharm Limited,1.0,CK,1.0,Cancelled post market,2015-10-26,L01BC01,Cytarabine
Human,00646296,Cytosar,cytarabine 1 g / vial powder for solution for injection,Pharmascience Inc,1.0,CK,1.0,Cancelled post market,2025-07-04,L01BC01,Cytarabine
Human,02241150,Depocyt,cytarabine 10 mg / mL intrathecal suspension,Skyepharma Inc.,1.0,CK,1.0,Cancelled post market,2017-06-29,L01BC01,Cytarabine
Human,00885797,Cytarabine Inj 100Mg/Ml,cytarabine 100 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,1998-08-13,L01BC01,Cytarabine
Human,02404397,Aj-Cytarabine,cytarabine 100 mg / mL solution for injection,Agila Jamp Canada Inc,1.0,CK,1.0,Cancelled pre market,2015-11-03,L01BC01,Cytarabine
Human,02126656,Cytarabine Injection,cytarabine 100 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2017-09-12,L01BC01,Cytarabine
Human,02515296,Cytarabine Injection,cytarabine 100 mg / mL solution for injection,Sterimax Inc,1.0,CK,1.0,Marketed,2022-04-21,L01BC01,Cytarabine
Human,02394901,Cytarabine Injection Bp,cytarabine 100 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled pre market,2019-08-01,L01BC01,Cytarabine
Human,02402203,"Cytarabine Injection, Mylan Std.",cytarabine 100 mg / mL solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled pre market,2022-02-24,L01BC01,Cytarabine
Human,02403838,Cytosar,cytarabine 100 mg / mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Approved,2017-05-17,L01BC01,Cytarabine
Human,02406772,Pms-Cytarabine,cytarabine 100 mg / mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2017-02-16,L01BC01,Cytarabine
Human,02167867,Cytarabine-Pws 100Mg/Vial,cytarabine 100 mg / vial powder for solution for injection,Novopharm Limited,1.0,CK,1.0,Cancelled post market,2018-05-07,L01BC01,Cytarabine
Human,00386715,Cytosar,cytarabine 100 mg / vial powder for solution for injection,Pharmascience Inc,1.0,CK,1.0,Cancelled post market,2025-07-04,L01BC01,Cytarabine
Human,02167891,Cytarabine - Pws 2Gm/Vial,cytarabine 2 g / vial powder for solution for injection,Novopharm Limited,1.0,CK,1.0,Cancelled post market,2015-10-26,L01BC01,Cytarabine
Human,00646318,Cytosar,cytarabine 2 g / vial powder for solution for injection,Pharmascience Inc,1.0,CK,1.0,Cancelled post market,2025-07-04,L01BC01,Cytarabine
Human,02403811,Cytosar,cytarabine 20 mg / mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Approved,2017-05-17,L01BC01,Cytarabine
Human,02406764,Pms-Cytarabine,cytarabine 20 mg / mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Dormant,2024-07-31,L01BC01,Cytarabine
Human,02167875,Cytarabine - Pws 500Mg/Vial,cytarabine 500 mg / vial powder for solution for injection,Novopharm Limited,1.0,CK,1.0,Cancelled post market,2015-10-26,L01BC01,Cytarabine
Human,00194727,Cytosar,cytarabine 500 mg / vial powder for solution for injection,Pharmascience Inc,1.0,CK,1.0,Cancelled post market,2025-07-04,L01BC01,Cytarabine
Human,02485346,Tolak,fluorouracil (fluorouracil sodium) 4 % / w/w cutaneous cream,Hill Dermaceuticals Inc,1.0,CK,,Marketed,2019-06-25,L01BC02,Fluorouracil
Human,02473763,Fluorouracil Injection,fluorouracil 0.5 g / 10 mL solution for injection,Biolyse Pharma Corporation,1.0,CK,,Marketed,2021-12-02,L01BC02,Fluorouracil
Human,01982311,Fluoroplex Cream 1%,fluorouracil 1 % cutaneous cream,Allergan Herbert Skin Care Division Of Allergan Inc.,1.0,CK,,Cancelled post market,2011-08-04,L01BC02,Fluorouracil
Human,02476746,Fluorouracil Injection,fluorouracil 1000 mg / 20 mL solution for injection,Generic Medical Partners Inc,1.0,CK,,Approved,2018-05-31,L01BC02,Fluorouracil
Human,02476711,Fluorouracil Injection,fluorouracil 250 mg / 5 mL solution for injection,Generic Medical Partners Inc,1.0,CK,,Approved,2018-05-31,L01BC02,Fluorouracil
Human,00330582,Efudex,fluorouracil 5 % / w/w cutaneous cream,"Bausch Health, Canada Inc.",1.0,CK,,Marketed,2021-06-10,L01BC02,Fluorouracil
Human,02473771,Fluorouracil Injection,fluorouracil 5 g / 100 mL solution for injection,Biolyse Pharma Corporation,1.0,CK,,Marketed,2019-06-06,L01BC02,Fluorouracil
Human,00891754,Fluorouracil Inj 50Mg/Ml,fluorouracil 50 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,,Cancelled post market,1996-09-10,L01BC02,Fluorouracil
Human,02063921,Adrucil,fluorouracil 50 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,,Cancelled post market,2004-04-08,L01BC02,Fluorouracil
Human,00012882,Fluorouracil Injection,fluorouracil 50 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,,Marketed,2009-03-06,L01BC02,Fluorouracil
Human,02182742,Fluorouracil Injection Usp,fluorouracil 50 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,,Cancelled post market,2020-11-27,L01BC02,Fluorouracil
Human,02413450,Fluorouracil Injection Usp,fluorouracil 50 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,,Marketed,2017-06-15,L01BC02,Fluorouracil
Human,00428493,Adrucil Inj 50Mg/Ml,fluorouracil 500 mg / 10 mL liquid for injection,Adria Laboratories Of Canada Ltd.,1.0,CK,,Cancelled post market,1996-09-10,L01BC02,Fluorouracil
Human,02476738,Fluorouracil Injection,fluorouracil 500 mg / 10 mL solution for injection,Generic Medical Partners Inc,1.0,CK,,Approved,2018-05-31,L01BC02,Fluorouracil
Human,02476754,Fluorouracil Injection,fluorouracil 5000 mg / 100 mL solution for injection,Generic Medical Partners Inc,1.0,CK,,Approved,2018-05-31,L01BC02,Fluorouracil
Human,02437163,"Gemcitabine For Injection, Usp",gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Cancelled pre market,2022-07-13,L01BC05,Gemcitabine
Human,02436205,Act Gemcitabine,gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Actavis Pharma Company,1.0,CK,1.0,Cancelled pre market,2020-04-27,L01BC05,Gemcitabine
Human,02409062,Aj-Gemcitabine,gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Agila Jamp Canada Inc,1.0,CK,1.0,Cancelled pre market,2015-11-03,L01BC05,Gemcitabine
Human,02305534,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled post market,2018-04-30,L01BC05,Gemcitabine
Human,02324210,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Cancelled post market,2025-10-28,L01BC05,Gemcitabine
Human,02402866,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,"Telip, Llc, A Subsidiary Of Teligent, Inc.",1.0,CK,1.0,Cancelled pre market,2022-01-12,L01BC05,Gemcitabine
Human,02412098,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Approved,2015-05-19,L01BC05,Gemcitabine
Human,02409933,Gemcitabine For Injection Usp,gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Generic Medical Partners Inc,1.0,CK,1.0,Approved,2013-07-24,L01BC05,Gemcitabine
Human,02298783,"Gemcitabine For Injection, Usp",gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Hospira Healthcare Ulc,1.0,CK,1.0,Cancelled post market,2014-08-01,L01BC05,Gemcitabine
Human,02407302,"Gemcitabine For Injection, Usp",gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled post market,2017-05-08,L01BC05,Gemcitabine
Human,02302101,Gemcitabine Hydrochloride For Injection,gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled post market,2019-08-01,L01BC05,Gemcitabine
Human,02373181,Gemcitabine Sun For Injection,gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Cancelled post market,2024-12-19,L01BC05,Gemcitabine
Human,02230309,Gemzar (1Gm/Vial),gemcitabine (gemcitabine hydrochloride) 1 g / vial powder for solution for injection,Eli Lilly Canada Inc,1.0,CK,1.0,Cancelled post market,2015-11-01,L01BC05,Gemcitabine
Human,02423510,Gemcitabine For Injection Concentrate,gemcitabine (gemcitabine hydrochloride) 100 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Cancelled post market,2017-08-07,L01BC05,Gemcitabine
Human,02437171,"Gemcitabine For Injection, Usp",gemcitabine (gemcitabine hydrochloride) 2 g / vial powder for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Cancelled pre market,2022-07-13,L01BC05,Gemcitabine
Human,02409070,Aj-Gemcitabine,gemcitabine (gemcitabine hydrochloride) 2 g / vial powder for solution for injection,Agila Jamp Canada Inc,1.0,CK,1.0,Cancelled pre market,2015-11-03,L01BC05,Gemcitabine
Human,02370034,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 2 g / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Cancelled post market,2025-10-28,L01BC05,Gemcitabine
Human,02412101,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 2 g / vial powder for solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Approved,2015-05-19,L01BC05,Gemcitabine
Human,02318741,"Gemcitabine For Injection, Usp",gemcitabine (gemcitabine hydrochloride) 2 g / vial powder for solution for injection,Hospira Healthcare Ulc,1.0,CK,1.0,Cancelled post market,2018-08-01,L01BC05,Gemcitabine
Human,02407310,"Gemcitabine For Injection, Usp",gemcitabine (gemcitabine hydrochloride) 2 g / vial powder for solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled post market,2017-05-08,L01BC05,Gemcitabine
Human,02437155,"Gemcitabine For Injection, Usp",gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Cancelled pre market,2022-07-13,L01BC05,Gemcitabine
Human,02436191,Act Gemcitabine,gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Actavis Pharma Company,1.0,CK,1.0,Cancelled pre market,2020-04-27,L01BC05,Gemcitabine
Human,02409054,Aj-Gemcitabine,gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Agila Jamp Canada Inc,1.0,CK,1.0,Cancelled pre market,2015-11-03,L01BC05,Gemcitabine
Human,02305526,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled post market,2018-04-30,L01BC05,Gemcitabine
Human,02324202,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Cancelled post market,2020-01-17,L01BC05,Gemcitabine
Human,02402858,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,"Telip, Llc, A Subsidiary Of Teligent, Inc.",1.0,CK,1.0,Cancelled pre market,2022-01-12,L01BC05,Gemcitabine
Human,02412071,Gemcitabine For Injection,gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Approved,2015-05-19,L01BC05,Gemcitabine
Human,02409925,Gemcitabine For Injection Usp,gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Generic Medical Partners Inc,1.0,CK,1.0,Approved,2013-07-24,L01BC05,Gemcitabine
Human,02298775,"Gemcitabine For Injection, Usp",gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Hospira Healthcare Ulc,1.0,CK,1.0,Cancelled post market,2018-08-01,L01BC05,Gemcitabine
Human,02407299,"Gemcitabine For Injection, Usp",gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled pre market,2017-05-08,L01BC05,Gemcitabine
Human,02302098,Gemcitabine Hydrochloride For Injection,gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled post market,2019-08-01,L01BC05,Gemcitabine
Human,02373173,Gemcitabine Sun For Injection,gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Cancelled post market,2024-12-19,L01BC05,Gemcitabine
Human,02230308,Gemzar (200Mg/Vial),gemcitabine (gemcitabine hydrochloride) 200 mg / vial powder for solution for injection,Eli Lilly Canada Inc,1.0,CK,1.0,Cancelled post market,2015-03-11,L01BC05,Gemcitabine
Human,02433117,Act Gemcitabine,gemcitabine (gemcitabine hydrochloride) 38 mg / mL solution for injection,Actavis Pharma Company,1.0,CK,1.0,Cancelled post market,2019-08-13,L01BC05,Gemcitabine
Human,02402831,Gemcitabine Injection,gemcitabine (gemcitabine hydrochloride) 38 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2017-08-31,L01BC05,Gemcitabine
Human,02455382,Gemcitabine Injection,gemcitabine (gemcitabine hydrochloride) 38 mg / mL solution for injection,Apotex Inc,1.0,CK,1.0,Approved,2016-05-31,L01BC05,Gemcitabine
Human,02555468,Gemcitabine Injection,gemcitabine (gemcitabine hydrochloride) 38 mg / mL solution for injection,Juno Pharmaceuticals Corp.,1.0,CK,1.0,Approved,2025-03-11,L01BC05,Gemcitabine
Human,02412292,Gemcitabine Injection,gemcitabine (gemcitabine hydrochloride) 40 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2013-09-24,L01BC05,Gemcitabine
Human,02426757,Ach-Capecitabine,capecitabine 150 mg oral tablet,Accord Healthcare Inc,1.0,K,1.0,Marketed,2014-09-19,L01BC06,Capecitabine
Human,02434504,Apo-Capecitabine,capecitabine 150 mg oral tablet,Apotex Inc,1.0,K,1.0,Approved,2016-02-12,L01BC06,Capecitabine
Human,02514982,Capecitabine,capecitabine 150 mg oral tablet,Sanis Health Inc,1.0,K,1.0,Marketed,2021-10-22,L01BC06,Capecitabine
Human,02519879,Capecitabine,capecitabine 150 mg oral tablet,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2022-06-15,L01BC06,Capecitabine
Human,02528126,Capecitabine,capecitabine 150 mg oral tablet,Sivem Pharmaceuticals Ulc,1.0,K,1.0,Approved,2022-06-20,L01BC06,Capecitabine
Human,02508001,Mint-Capecitabine,capecitabine 150 mg oral tablet,Mint Pharmaceuticals Inc,1.0,K,1.0,Approved,2020-11-17,L01BC06,Capecitabine
Human,02421917,Sandoz Capecitabine,capecitabine 150 mg oral tablet,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2014-07-23,L01BC06,Capecitabine
Human,02457490,Taro-Capecitabine,capecitabine 150 mg oral tablet,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2017-08-31,L01BC06,Capecitabine
Human,02400022,Teva-Capecitabine,capecitabine 150 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Cancelled post market,2022-03-16,L01BC06,Capecitabine
Human,02238453,Xeloda,capecitabine 150 mg oral tablet,Cheplapharm Arzneimittel Gmbh,1.0,K,1.0,Cancelled post market,2022-12-07,L01BC06,Capecitabine
Human,02426765,Ach-Capecitabine,capecitabine 500 mg oral tablet,Accord Healthcare Inc,1.0,K,1.0,Marketed,2014-09-19,L01BC06,Capecitabine
Human,02434512,Apo-Capecitabine,capecitabine 500 mg oral tablet,Apotex Inc,1.0,K,1.0,Approved,2016-02-12,L01BC06,Capecitabine
Human,02514990,Capecitabine,capecitabine 500 mg oral tablet,Sanis Health Inc,1.0,K,1.0,Marketed,2021-10-22,L01BC06,Capecitabine
Human,02519887,Capecitabine,capecitabine 500 mg oral tablet,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2022-06-16,L01BC06,Capecitabine
Human,02528150,Capecitabine,capecitabine 500 mg oral tablet,Sivem Pharmaceuticals Ulc,1.0,K,1.0,Approved,2022-06-20,L01BC06,Capecitabine
Human,02508028,Mint-Capecitabine,capecitabine 500 mg oral tablet,Mint Pharmaceuticals Inc,1.0,K,1.0,Marketed,2021-10-05,L01BC06,Capecitabine
Human,02421925,Sandoz Capecitabine,capecitabine 500 mg oral tablet,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2014-07-23,L01BC06,Capecitabine
Human,02457504,Taro-Capecitabine,capecitabine 500 mg oral tablet,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2017-08-31,L01BC06,Capecitabine
Human,02400030,Teva-Capecitabine,capecitabine 500 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Cancelled post market,2022-03-16,L01BC06,Capecitabine
Human,02238454,Xeloda,capecitabine 500 mg oral tablet,Cheplapharm Arzneimittel Gmbh,1.0,K,1.0,Cancelled post market,2022-12-07,L01BC06,Capecitabine
Human,02462826,Azacitidine For Injection,azacitidine 100 mg / vial powder for suspension for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Marketed,2017-10-25,L01BC07,Azacitidine
Human,02501791,Azacitidine For Injection,azacitidine 100 mg / vial powder for suspension for injection,Jamp Pharma Corporation,1.0,CK,1.0,Dormant,2025-07-31,L01BC07,Azacitidine
Human,02505177,Azacitidine For Injection,azacitidine 100 mg / vial powder for suspension for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Marketed,2024-10-15,L01BC07,Azacitidine
Human,02507668,Azacitidine For Injection,azacitidine 100 mg / vial powder for suspension for injection,Hikma Canada Limited,1.0,CK,1.0,Marketed,2022-02-24,L01BC07,Azacitidine
Human,02529599,Azacitidine For Injection,azacitidine 100 mg / vial powder for suspension for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2023-04-17,L01BC07,Azacitidine
Human,02534029,Azacitidine For Injection,azacitidine 100 mg / vial powder for suspension for injection,Sterimax Inc,1.0,CK,1.0,Approved,2022-12-23,L01BC07,Azacitidine
Human,02480220,Nat-Azacitidine,azacitidine 100 mg / vial powder for suspension for injection,Natco Pharma (Canada) Inc,1.0,CK,1.0,Cancelled pre market,2023-05-11,L01BC07,Azacitidine
Human,02532085,Pms-Azacitidine For Injection,azacitidine 100 mg / vial powder for suspension for injection,Pharmascience Inc,1.0,CK,1.0,Approved,2022-10-26,L01BC07,Azacitidine
Human,02463199,Reddy-Azacitidine,azacitidine 100 mg / vial powder for suspension for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Cancelled post market,2023-06-27,L01BC07,Azacitidine
Human,02336707,Vidaza,azacitidine 100 mg / vial powder for suspension for injection,Bristol-Myers Squibb Canada,1.0,CK,1.0,Marketed,2025-02-07,L01BC07,Azacitidine
Human,02534037,Azacitidine For Injection,azacitidine 150 mg / vial powder for suspension for injection,Sterimax Inc,1.0,CK,1.0,Approved,2022-12-23,L01BC07,Azacitidine
Human,02558815,Azacitidine For Injection,azacitidine 150 mg / vial powder for suspension for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Approved,2025-06-30,L01BC07,Azacitidine
Human,02510197,Onureg,azacitidine 200 mg oral tablet,Bristol-Myers Squibb Canada,1.0,CK,1.0,Marketed,2025-01-31,L01BC07,Azacitidine
Human,02510200,Onureg,azacitidine 300 mg oral tablet,Bristol-Myers Squibb Canada,1.0,CK,1.0,Marketed,2025-01-31,L01BC07,Azacitidine
Human,02490366,Dacogen,decitabine 50 mg / vial powder for injection,Otsuka Pharmaceutical Co Ltd,1.0,K,1.0,Approved,2019-07-11,L01BC08,Decitabine
Human,02484811,Demylocan,decitabine 50 mg / vial powder for injection,Pendopharm Division Of Pharmascience Inc,1.0,K,1.0,Marketed,2021-03-24,L01BC08,Decitabine
Human,02428946,Actikerall,fluorouracil 0.5 % / w/w + salicylic acid 10 % / w/w topical solution,Cipher Pharmaceuticals Inc,1.0,CK,,Marketed,2016-02-19,L01BC52,"Fluorouracil, combinations"
Human,02501600,Inqovi,cedazuridine 100 mg + decitabine 35 mg oral tablet,"Taiho Pharma Canada, Inc.",1.0,K,1.0,Marketed,2025-06-04,L01BC58,"Decitabine, combinations"
Human,02472104,Lonsurf,tipiracil (tipiracil hydrochloride) 6.14 mg + trifluridine 15 mg oral tablet,"Taiho Pharma Canada, Inc.",1.0,CK,1.0,Marketed,2018-03-22,L01BC59,"Trifluridine, combinations"
Human,02472112,Lonsurf,tipiracil (tipiracil hydrochloride) 8.19 mg + trifluridine 20 mg oral tablet,"Taiho Pharma Canada, Inc.",1.0,CK,1.0,Marketed,2018-03-22,L01BC59,"Trifluridine, combinations"
Human,01977784,Vinblastine Sulfate Inj 1Mg/Ml,vinblastine sulfate 1 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,1998-08-13,L01CA01,Vinblastine
Human,02183056,Vinblastine Sulfate Injection,vinblastine sulfate 1 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2018-07-31,L01CA01,Vinblastine
Human,02406675,Vinblastine Sulfate Injection,vinblastine sulfate 1 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled pre market,2019-08-01,L01CA01,Vinblastine
Human,02401460,Vinblastine Sulphate Injection,vinblastine sulfate 1 mg / mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2013-02-08,L01CA01,Vinblastine
Human,00015431,Velbe 1Mg/Ml,vinblastine sulfate 10 mg / 10 mL powder for solution for injection,Eli Lilly Canada Inc,1.0,CK,1.0,Cancelled post market,2000-10-02,L01CA01,Vinblastine
Human,00611182,Oncovin Solution 1Mg/Ml,vincristine sulfate 1 mg / mL liquid for injection,Eli Lilly Canada Inc,1.0,K,1.0,Cancelled post market,1998-08-04,L01CA02,Vincristine
Human,00726575,Vincristine Sulfate Inj 1Mg/Ml Usp,vincristine sulfate 1 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,K,1.0,Cancelled post market,1999-08-10,L01CA02,Vincristine
Human,02143305,Vincristine Sulfate Injection,vincristine sulfate 1 mg / mL solution for injection,Teva Canada Limited,1.0,K,1.0,Marketed,2014-04-12,L01CA02,Vincristine
Human,02324148,Vincristine Sulfate Injection,vincristine sulfate 1 mg / mL solution for injection,Accord Healthcare Inc,1.0,K,1.0,Cancelled pre market,2017-08-07,L01CA02,Vincristine
Human,02183013,Vincristine Sulfate Injection Usp,vincristine sulfate 1 mg / mL solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2018-04-17,L01CA02,Vincristine
Human,02333198,Vincristine Sulfate Injection Usp,vincristine sulfate 1 mg / mL solution for injection,Uman Pharma Inc,1.0,K,1.0,Cancelled pre market,2021-03-12,L01CA02,Vincristine
Human,00690317,Vincristine Sulfate Inj 5Mg/Vial Usp,vincristine sulfate 5 mg / vial powder for solution for injection,David Bull Laboratories (Pty) Ltd.,1.0,K,1.0,Cancelled post market,1996-09-10,L01CA02,Vincristine
Human,02396416,Aj-Vinorelbine,vinorelbine (vinorelbine tartrate) 10 mg / mL solution for injection,Agila Jamp Canada Inc,1.0,K,1.0,Cancelled pre market,2015-11-03,L01CA04,Vinorelbine
Human,02091283,Navelbine,vinorelbine (vinorelbine tartrate) 10 mg / mL solution for injection,Pierre Fabre Pharma Canada Inc,1.0,K,1.0,Cancelled post market,2012-10-01,L01CA04,Vinorelbine
Human,02265990,Vinorelbine Injection,vinorelbine (vinorelbine tartrate) 10 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,K,1.0,Cancelled post market,2021-07-20,L01CA04,Vinorelbine
Human,02392445,"Vinorelbine Injection, Usp",vinorelbine (vinorelbine tartrate) 10 mg / mL solution for injection,Mylan Pharmaceuticals Ulc,1.0,K,1.0,Cancelled pre market,2022-02-28,L01CA04,Vinorelbine
Human,02431130,"Vinorelbine Injection, Usp",vinorelbine (vinorelbine tartrate) 10 mg / mL solution for injection,Generic Medical Partners Inc,1.0,K,1.0,Marketed,2017-08-01,L01CA04,Vinorelbine
Human,02511347,"Vinorelbine Injection, Usp",vinorelbine (vinorelbine tartrate) 10 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,K,1.0,Marketed,2021-06-25,L01CA04,Vinorelbine
Human,02257777,Vinorelbine Tartrate For Injection,vinorelbine (vinorelbine tartrate) 10 mg / mL solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2021-04-06,L01CA04,Vinorelbine
Human,02271214,Vinorelbine Tartrate For Injection,vinorelbine (vinorelbine tartrate) 10 mg / mL solution for injection,Teva Canada Limited,1.0,K,1.0,Marketed,2014-04-02,L01CA04,Vinorelbine
Human,02327643,Vinorelbine Tartrate Injection Usp,vinorelbine (vinorelbine tartrate) 10 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled pre market,2018-08-01,L01CA04,Vinorelbine
Human,02237872,Dom-Etoposide,etoposide 20 mg / mL liquid for injection,Dominion Pharmacal,1.0,K,1.0,Cancelled pre market,2017-08-03,L01CB01,Etoposide
Human,02237428,Eposin,etoposide 20 mg / mL liquid for injection,Pharmachemie B.V.,1.0,K,1.0,Cancelled pre market,2017-08-01,L01CB01,Etoposide
Human,02237873,Etoposide,etoposide 20 mg / mL liquid for injection,Pharmel Inc,1.0,K,1.0,Cancelled pre market,2017-09-12,L01CB01,Etoposide
Human,02227509,Etoposide - Liq Iv 20Mg/Ml,etoposide 20 mg / mL liquid for injection,Bdh Inc.,1.0,K,1.0,Cancelled post market,1998-07-01,L01CB01,Etoposide
Human,02239961,Etoposide Injection,etoposide 20 mg / mL liquid for injection,Fresenius Kabi Canada Ltd,1.0,K,1.0,Dormant,2017-08-03,L01CB01,Etoposide
Human,02237871,Pms-Etoposide,etoposide 20 mg / mL liquid for injection,Pharmascience Inc,1.0,K,1.0,Cancelled pre market,2017-08-03,L01CB01,Etoposide
Human,00523410,Vepesid Inj 20Mg/Ml,etoposide 20 mg / mL liquid for injection,Bristol Labs Division Of Bristol-Myers Squibb,1.0,K,1.0,Cancelled post market,2007-10-30,L01CB01,Etoposide
Human,02080036,Etoposide Injection,etoposide 20 mg / mL solution for injection,Teva Canada Limited,1.0,K,1.0,Marketed,2014-04-12,L01CB01,Etoposide
Human,02552671,Etoposide Injection,etoposide 20 mg / mL solution for injection,Hikma Canada Limited,1.0,K,1.0,Marketed,2025-06-20,L01CB01,Etoposide
Human,02380935,Etoposide Injection Usp,etoposide 20 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled post market,2023-07-28,L01CB01,Etoposide
Human,02241182,"Etoposide Injection, Usp",etoposide 20 mg / mL solution for injection,Hospira Healthcare Ulc,1.0,K,1.0,Cancelled post market,2019-01-17,L01CB01,Etoposide
Human,02422530,"Etoposide Injection, Usp",etoposide 20 mg / mL solution for injection,Strides Pharma Canada Inc,1.0,K,1.0,Dormant,2020-08-12,L01CB01,Etoposide
Human,00616192,Vepesid,etoposide 50 mg oral capsule,Cheplapharm Arzneimittel Gmbh,1.0,K,1.0,Marketed,2020-01-02,L01CB01,Etoposide
Human,00588989,Vumon,teniposide 10 mg / mL liquid for injection,Bristol-Myers Squibb Canada,1.0,CK,1.0,Cancelled post market,2018-05-31,L01CB02,Teniposide
Human,02281066,Abraxane For Injectable Suspension,paclitaxel 100 mg / vial powder for suspension for injection,Bristol-Myers Squibb Canada,1.0,CK,1.0,Marketed,2025-01-24,L01CD01,Paclitaxel
Human,02496097,"Paclitaxel Powder For Injectable Suspension Nanoparticle, Albumin-Bound Paclitaxel",paclitaxel 100 mg / vial powder for suspension for injection,Panacea Biotec Pharma Limited,1.0,CK,1.0,Marketed,2023-10-27,L01CD01,Paclitaxel
Human,02241314,Paclitaxel,paclitaxel 6 mg / mL liquid for injection,Ivax Pharmaceuticals Incorporated,1.0,CK,1.0,Cancelled pre market,2015-10-16,L01CD01,Paclitaxel
Human,02231605,Paclitaxel Injection,paclitaxel 6 mg / mL liquid for injection,Immunex Corporation,1.0,CK,1.0,Cancelled post market,2005-12-06,L01CD01,Paclitaxel
Human,02241443,Paclitaxel Injection,paclitaxel 6 mg / mL liquid for injection,Draxis Health Inc.,1.0,CK,1.0,Cancelled (unreturned annual),2018-03-28,L01CD01,Paclitaxel
Human,02241957,Paxene,paclitaxel 6 mg / mL liquid for injection,Baker Norton Pharmaceuticals Inc.,1.0,CK,1.0,Cancelled (unreturned annual),2018-03-28,L01CD01,Paclitaxel
Human,02243392,Teva-Paclitaxel For Injection,paclitaxel 6 mg / mL liquid for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled pre market,2015-10-16,L01CD01,Paclitaxel
Human,02409712,Aj-Paclitaxel,paclitaxel 6 mg / mL solution for injection,Agila Jamp Canada Inc,1.0,CK,1.0,Cancelled pre market,2015-11-03,L01CD01,Paclitaxel
Human,02248844,Apo-Paclitaxel Injectable,paclitaxel 6 mg / mL solution for injection,Apotex Inc,1.0,CK,1.0,Dormant,2017-08-04,L01CD01,Paclitaxel
Human,02244372,Paclitaxel For Injection,paclitaxel 6 mg / mL solution for injection,Biolyse Pharma Corporation,1.0,CK,1.0,Marketed,2003-06-16,L01CD01,Paclitaxel
Human,02285363,Paclitaxel For Injection,paclitaxel 6 mg / mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Approved,2013-08-29,L01CD01,Paclitaxel
Human,02296624,Paclitaxel For Injection,paclitaxel 6 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2021-04-06,L01CD01,Paclitaxel
Human,02320010,Paclitaxel For Injection Usp,paclitaxel 6 mg / mL solution for injection,Sterimax Inc,1.0,CK,1.0,Dormant,2017-08-03,L01CD01,Paclitaxel
Human,02529424,Paclitaxel Injection,paclitaxel 6 mg / mL solution for injection,Auro Pharma Inc,1.0,CK,1.0,Approved,2022-07-22,L01CD01,Paclitaxel
Human,02536056,Paclitaxel Injection,paclitaxel 6 mg / mL solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2023-03-10,L01CD01,Paclitaxel
Human,02320150,Paclitaxel Injection Usp,paclitaxel 6 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2015-03-31,L01CD01,Paclitaxel
Human,02391465,Paclitaxel Injection Usp,paclitaxel 6 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2014-07-02,L01CD01,Paclitaxel
Human,02408074,"Paclitaxel Injection, Usp",paclitaxel 6 mg / mL solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled pre market,2022-02-24,L01CD01,Paclitaxel
Human,02016796,Taxol,paclitaxel 6 mg / mL solution for injection,Bristol-Myers Squibb Canada,1.0,CK,1.0,Cancelled post market,2012-07-20,L01CD01,Paclitaxel
Human,02439336,Docetaxel Injection,docetaxel 10 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2016-06-02,L01CD02,Docetaxel
Human,02361957,Docetaxel Injection Usp,docetaxel 10 mg / mL solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2017-06-16,L01CD02,Docetaxel
Human,02465655,Taro-Docetaxel,docetaxel 160 mg / 8 mL solution for injection,Taro Pharmaceuticals Inc,1.0,K,1.0,Cancelled pre market,2022-07-11,L01CD02,Docetaxel
Human,02436361,Pms-Docetaxel,docetaxel 20 mg / 0.5 mL kit (solution) for injection,Pharmascience Inc,1.0,K,1.0,Cancelled pre market,2023-03-15,L01CD02,Docetaxel
Human,02444410,Act Docetaxel 40 Mg/Ml,docetaxel 20 mg / 0.5 mL solution for injection,Actavis Pharma Company,1.0,K,1.0,Cancelled pre market,2020-07-24,L01CD02,Docetaxel
Human,02177099,Taxotere,docetaxel 20 mg / 0.5 mL solution for injection,Sanofi-Aventis Canada Inc,1.0,K,1.0,Cancelled post market,2018-04-30,L01CD02,Docetaxel
Human,02412225,Docetaxel Injection,docetaxel 20 mg / 0.72 mL solution for injection,Teva Canada Limited,1.0,K,1.0,Cancelled post market,2018-05-17,L01CD02,Docetaxel
Human,02437031,Docetaxel Injection,docetaxel 20 mg / mL solution for injection,Accord Healthcare Inc,1.0,K,1.0,Dormant,2025-10-29,L01CD02,Docetaxel
Human,02458020,Docetaxel Injection,docetaxel 20 mg / mL solution for injection,Biolyse Pharma Corporation,1.0,K,1.0,Marketed,2017-10-17,L01CD02,Docetaxel
Human,02465531,Taro-Docetaxel,docetaxel 20 mg / mL solution for injection,Taro Pharmaceuticals Inc,1.0,K,1.0,Cancelled pre market,2022-07-11,L01CD02,Docetaxel
Human,02436388,Pms-Docetaxel,docetaxel 80 mg / 2 mL kit (solution) for injection,Pharmascience Inc,1.0,K,1.0,Cancelled pre market,2023-03-15,L01CD02,Docetaxel
Human,02441845,Act Docetaxel 40 Mg/Ml,docetaxel 80 mg / 2 mL solution for injection,Actavis Pharma Company,1.0,K,1.0,Cancelled pre market,2020-07-24,L01CD02,Docetaxel
Human,02177080,Taxotere,docetaxel 80 mg / 2 mL solution for injection,Sanofi-Aventis Canada Inc,1.0,K,1.0,Cancelled post market,2020-07-31,L01CD02,Docetaxel
Human,02412233,Docetaxel Injection,docetaxel 80 mg / 2.88 mL solution for injection,Teva Canada Limited,1.0,K,1.0,Cancelled post market,2018-05-17,L01CD02,Docetaxel
Human,02465647,Taro-Docetaxel,docetaxel 80 mg / 4 mL solution for injection,Taro Pharmaceuticals Inc,1.0,K,1.0,Cancelled pre market,2022-07-11,L01CD02,Docetaxel
Human,02503581,Cabazitaxel For Injection,cabazitaxel 40 mg / mL kit (solution) for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Approved,2020-08-13,L01CD04,Cabazitaxel
Human,02495635,Cabazitaxel For Injection,cabazitaxel 40 mg / mL solution for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Marketed,2020-06-01,L01CD04,Cabazitaxel
Human,02369524,Jevtana,cabazitaxel 40 mg / mL solution for injection,Sanofi-Aventis Canada Inc,1.0,CK,1.0,Cancelled post market,2023-12-13,L01CD04,Cabazitaxel
Human,02487497,Cabazitaxel For Injection,cabazitaxel 45 mg / 4.5 mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2019-12-18,L01CD04,Cabazitaxel
Human,02553783,Cabazitaxel For Injection,cabazitaxel 45 mg / 4.5 mL solution for injection,Formative Pharma Inc.,1.0,CK,1.0,Marketed,2025-04-10,L01CD04,Cabazitaxel
Human,02487500,Cabazitaxel For Injection,cabazitaxel 60 mg / 6 mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2019-12-18,L01CD04,Cabazitaxel
Human,02553791,Cabazitaxel For Injection,cabazitaxel 60 mg / 6 mL solution for injection,Formative Pharma Inc.,1.0,CK,1.0,Marketed,2025-04-10,L01CD04,Cabazitaxel
Human,02379422,Topotecan Hydrochloride For Injection,topotecan (topotecan hydrochloride) 1 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2017-05-18,L01CE01,Topotecan
Human,02396378,Topotecan Hydrochloride For Injection,topotecan (topotecan hydrochloride) 1 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2013-11-21,L01CE01,Topotecan
Human,02390981,Topotecan Injection,topotecan (topotecan hydrochloride) 1 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2014-02-05,L01CE01,Topotecan
Human,02409232,Topotecan Injection,topotecan (topotecan hydrochloride) 1 mg / mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled post market,2021-07-30,L01CE01,Topotecan
Human,02406438,Pms-Topotecan,topotecan (topotecan hydrochloride) 1 mg / vial powder for solution for injection,Pharmascience Inc,1.0,CK,1.0,Approved,2013-05-23,L01CE01,Topotecan
Human,02441063,Teva-Topotecan,topotecan (topotecan hydrochloride) 1 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Approved,2020-10-09,L01CE01,Topotecan
Human,02231116,Hycamtin,topotecan (topotecan hydrochloride) 4 mg / vial powder for solution for injection,Novartis Pharmaceuticals Canada Inc,1.0,CK,1.0,Cancelled post market,2019-03-18,L01CE01,Topotecan
Human,02392798,Mylan-Topotecan Hydrochloride For Injection,topotecan (topotecan hydrochloride) 4 mg / vial powder for solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled pre market,2018-06-15,L01CE01,Topotecan
Human,02406446,Pms-Topotecan,topotecan (topotecan hydrochloride) 4 mg / vial powder for solution for injection,Pharmascience Inc,1.0,CK,1.0,Cancelled post market,2025-07-04,L01CE01,Topotecan
Human,02441071,Teva-Topotecan,topotecan (topotecan hydrochloride) 4 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2020-10-09,L01CE01,Topotecan
Human,02333880,Topotecan For Injection,topotecan (topotecan hydrochloride) 4 mg / vial powder for solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled post market,2019-08-01,L01CE01,Topotecan
Human,02346656,Topotecan For Injection,topotecan (topotecan hydrochloride) 4 mg / vial powder for solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Cancelled post market,2021-07-20,L01CE01,Topotecan
Human,02344009,Topotecan Hydrochloride For Injection,topotecan (topotecan hydrochloride) 4 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Approved,2018-04-06,L01CE01,Topotecan
Human,02396564,Topotecan Hydrochloride For Injection,topotecan (topotecan hydrochloride) 4 mg / vial powder for solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled post market,2016-07-06,L01CE01,Topotecan
Human,02467135,Onivyde,irinotecan (irinotecan sucrose octasulfate) 4.3 mg / mL suspension for injection,Ipsen Biopharmaceuticals Canada Inc,1.0,CK,1.0,Marketed,2024-07-18,L01CE02,Irinotecan
Human,02412187,Irinotecan Hydrochloride Injection,irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 20 mg / mL solution for injection,"Telip, Llc, A Subsidiary Of Teligent, Inc.",1.0,CK,1.0,Cancelled post market,2022-01-19,L01CE02,Irinotecan
Human,02357585,Irinotecan Hydrochloride Injection Usp,irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 20 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2019-01-15,L01CE02,Irinotecan
Human,02452421,"Irinotecan Hydrochloride Injection, Usp",irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 20 mg / mL solution for injection,Generic Medical Partners Inc,1.0,CK,1.0,Marketed,2024-05-22,L01CE02,Irinotecan
Human,02345080,Irinotecan Hydrochloride Trihydrate For Injection,irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 20 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Dormant,2017-08-03,L01CE02,Irinotecan
Human,02501279,Irinotecan Hydrochloride Injection,irinotecan hydrochloride 100 mg / 5 mL solution for injection,Auro Pharma Inc,1.0,CK,1.0,Marketed,2022-05-19,L01CE02,Irinotecan
Human,02528800,Irinotecan Hydrochloride Injection,irinotecan hydrochloride 100 mg / 5 mL solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Marketed,2024-08-12,L01CE02,Irinotecan
Human,02231622,Camptosar,irinotecan hydrochloride 20 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2022-06-02,L01CE02,Irinotecan
Human,02410419,Irinotecan,irinotecan hydrochloride 20 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2022-06-03,L01CE02,Irinotecan
Human,02312409,Irinotecan For Injection,irinotecan hydrochloride 20 mg / mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2014-04-30,L01CE02,Irinotecan
Human,02258218,Irinotecan Hydrochloride Injection Usp,irinotecan hydrochloride 20 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2018-03-13,L01CE02,Irinotecan
Human,02305143,Irinotecan Hydrochloride Trihydrate Injection,irinotecan hydrochloride 20 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled post market,2019-08-01,L01CE02,Irinotecan
Human,02501287,Irinotecan Hydrochloride Injection,irinotecan hydrochloride 300 mg / 15 mL solution for injection,Auro Pharma Inc,1.0,CK,1.0,Approved,2020-07-07,L01CE02,Irinotecan
Human,02528797,Irinotecan Hydrochloride Injection,irinotecan hydrochloride 300 mg / 15 mL solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2022-07-11,L01CE02,Irinotecan
Human,02501260,Irinotecan Hydrochloride Injection,irinotecan hydrochloride 40 mg / 2 mL solution for injection,Auro Pharma Inc,1.0,CK,1.0,Approved,2020-07-07,L01CE02,Irinotecan
Human,02528770,Irinotecan Hydrochloride Injection,irinotecan hydrochloride 40 mg / 2 mL solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2022-07-08,L01CE02,Irinotecan
Human,02501295,Irinotecan Hydrochloride Injection,irinotecan hydrochloride 500 mg / 25 mL solution for injection,Auro Pharma Inc,1.0,CK,1.0,Marketed,2022-05-19,L01CE02,Irinotecan
Human,02528789,Irinotecan Hydrochloride Injection,irinotecan hydrochloride 500 mg / 25 mL solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Marketed,2024-02-28,L01CE02,Irinotecan
Human,02523531,Nat-Trabectedin,trabectedin 1 mg / vial powder for solution for injection,Natco Pharma (Canada) Inc,1.0,CK,1.0,Approved,2025-10-28,L01CX01,Trabectedin
Human,02351528,Yondelis,trabectedin 1 mg / vial powder for solution for injection,Valeo Pharma Inc,1.0,CK,1.0,Marketed,2020-08-24,L01CX01,Trabectedin
Human,00213071,Cosmegen,dactinomycin 0.5 mg / vial powder for solution for injection,Recordati Rare Diseases Canada Inc,1.0,CK,1.0,Marketed,2019-12-01,L01DA01,Dactinomycin
Human,02065657,Adriamycin Rdf,doxorubicin hydrochloride 10 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2006-08-02,L01DB01,Doxorubicin
Human,00357391,Adriamycin Rdf Inj 10Mg/Vial,doxorubicin hydrochloride 10 mg / vial powder for solution for injection,Carlo Erba Farmitalia Spa,1.0,K,1.0,Cancelled post market,1996-09-10,L01DB01,Doxorubicin
Human,02093057,Doxorubicin Hcl For Inj. U.S.P. 10Mg/Vial,doxorubicin hydrochloride 10 mg / vial powder for solution for injection,David Bull Laboratories (Pty) Ltd.,1.0,K,1.0,Cancelled post market,1998-08-13,L01DB01,Doxorubicin
Human,02194457,Doxorubicin Hydrochloride For Injection Usp,doxorubicin hydrochloride 10 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Cancelled pre market,2024-05-09,L01DB01,Doxorubicin
Human,02069563,Adriamycin Rdf,doxorubicin hydrochloride 150 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2006-08-02,L01DB01,Doxorubicin
Human,00768766,Adriamycin Rdf Inj 150Mg/Vial,doxorubicin hydrochloride 150 mg / vial powder for solution for injection,Adria Laboratories Of Canada Ltd.,1.0,K,1.0,Cancelled post market,1996-09-10,L01DB01,Doxorubicin
Human,02093081,Doxorubicin Hcl For Inj. U.S.P. 150Mg/Vial,doxorubicin hydrochloride 150 mg / vial powder for solution for injection,David Bull Laboratories (Pty) Ltd.,1.0,K,1.0,Cancelled post market,1997-08-14,L01DB01,Doxorubicin
Human,02194473,Doxorubicin Hydrochloride For Injection Usp,doxorubicin hydrochloride 150 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2018-06-08,L01DB01,Doxorubicin
Human,02245015,Myocet,doxorubicin hydrochloride 2 mg / mL liposomes for injection,Sopherion Therapeutics Llc,1.0,K,1.0,Dormant,2018-09-07,L01DB01,Doxorubicin
Human,02071002,Adriamycin Pfs,doxorubicin hydrochloride 2 mg / mL solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Dormant,2017-08-02,L01DB01,Doxorubicin
Human,02410397,Doxorubicin,doxorubicin hydrochloride 2 mg / mL solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2014-05-21,L01DB01,Doxorubicin
Human,02230108,Doxorubicin Hydrochloride Injection,doxorubicin hydrochloride 2 mg / mL solution for injection,Novopharm Limited,1.0,K,1.0,Cancelled post market,2018-05-02,L01DB01,Doxorubicin
Human,02375710,Doxorubicin Hydrochloride Injection,doxorubicin hydrochloride 2 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled post market,2021-04-21,L01DB01,Doxorubicin
Human,02400626,Doxorubicin Hydrochloride Injection,doxorubicin hydrochloride 2 mg / mL solution for injection,Omega Laboratories Limited,1.0,K,1.0,Approved,2013-01-30,L01DB01,Doxorubicin
Human,02409275,Doxorubicin Hydrochloride Injection,doxorubicin hydrochloride 2 mg / mL solution for injection,Teva Canada Limited,1.0,K,1.0,Marketed,2014-02-27,L01DB01,Doxorubicin
Human,02413973,"Doxorubicin Hydrochloride Injection, Usp",doxorubicin hydrochloride 2 mg / mL solution for injection,Strides Pharma Canada Inc,1.0,K,1.0,Dormant,2021-06-01,L01DB01,Doxorubicin
Human,02381982,"Doxorubicin Injection, Bp",doxorubicin hydrochloride 2 mg / mL solution for injection,Accord Healthcare Inc,1.0,K,1.0,Marketed,2019-05-27,L01DB01,Doxorubicin
Human,02238389,Caelyx,doxorubicin hydrochloride 2 mg / mL suspension for injection,Baxter Corporation,1.0,K,1.0,Marketed,2022-03-04,L01DB01,Doxorubicin
Human,02544857,Pegylated Liposomal Doxorubicin Hydrochloride For Injection,doxorubicin hydrochloride 2 mg / mL suspension for injection,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Approved,2024-02-07,L01DB01,Doxorubicin
Human,02493020,Taro-Doxorubicin Liposomal,doxorubicin hydrochloride 2 mg / mL suspension for injection,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2020-05-19,L01DB01,Doxorubicin
Human,02069555,Adriamycin Rdf,doxorubicin hydrochloride 50 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2006-08-02,L01DB01,Doxorubicin
Human,00353078,Adriamycin Rdf Inj 50Mg/Vial,doxorubicin hydrochloride 50 mg / vial powder for solution for injection,Carlo Erba Farmitalia Spa,1.0,K,1.0,Cancelled post market,1996-09-10,L01DB01,Doxorubicin
Human,02093073,Doxorubicin Hcl For Inj. U.S.P. 50Mg/Vial,doxorubicin hydrochloride 50 mg / vial powder for solution for injection,David Bull Laboratories (Pty) Ltd.,1.0,K,1.0,Cancelled post market,1997-08-14,L01DB01,Doxorubicin
Human,02194465,Doxorubicin Hydrochloride For Injection Usp,doxorubicin hydrochloride 50 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2018-06-08,L01DB01,Doxorubicin
Human,02467240,Doxorubicin Hydrochloride For Injection Usp,doxorubicin hydrochloride 50 mg / vial powder for solution for injection,Panda Pharmaceuticals Inc.,1.0,K,1.0,Approved,2017-08-16,L01DB01,Doxorubicin
Human,02539209,Daunorubicin Hydrochloride Injection,daunorubicin (daunorubicin hydrochloride) 20 mg / 4 mL solution for injection,Hikma Canada Limited,1.0,CK,1.0,Marketed,2024-01-31,L01DB02,Daunorubicin
Human,02501473,Daunorubicin Injectable Solution,daunorubicin (daunorubicin hydrochloride) 20 mg / 4 mL solution for injection,Generic Medical Partners Inc,1.0,CK,1.0,Approved,2020-07-03,L01DB02,Daunorubicin
Human,01926683,Cerubidine,daunorubicin (daunorubicin hydrochloride) 20 mg / vial powder for solution for injection,Searchlight Pharma Inc,1.0,CK,1.0,Marketed,2022-10-14,L01DB02,Daunorubicin
Human,02231420,Daunorubicin Hydrochloride For Injection,daunorubicin (daunorubicin hydrochloride) 20 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled post market,2018-04-30,L01DB02,Daunorubicin
Human,02501481,Daunorubicin Injectable Solution,daunorubicin (daunorubicin hydrochloride) 50 mg / 10 mL solution for injection,Generic Medical Partners Inc,1.0,CK,1.0,Approved,2020-07-03,L01DB02,Daunorubicin
Human,02218046,"Daunoxome Liposomal - Iv 2Mg/Ml, 50Mg/Vial",daunorubicin 2 mg / mL suspension for injection,Gilead Sciences Inc,1.0,CK,1.0,Cancelled post market,2001-09-21,L01DB02,Daunorubicin
Human,02065746,Pharmorubicin Rdf,epirubicin hydrochloride 10 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2006-08-02,L01DB03,Epirubicin
Human,02324091,Epirubicin For Injection,epirubicin hydrochloride 2 mg / mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2013-11-22,L01DB03,Epirubicin
Human,02264927,Epirubicin Hydrochloride Injection,epirubicin hydrochloride 2 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2017-09-04,L01DB03,Epirubicin
Human,02303892,Epirubicin Hydrochloride Injection,epirubicin hydrochloride 2 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Cancelled post market,2012-10-03,L01DB03,Epirubicin
Human,02312093,Epirubicin Hydrochloride Injection,epirubicin hydrochloride 2 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Dormant,2015-06-19,L01DB03,Epirubicin
Human,02322242,Epirubicin Hydrochloride Injection,epirubicin hydrochloride 2 mg / mL solution for injection,Uman Pharma Inc,1.0,CK,1.0,Approved,2009-02-04,L01DB03,Epirubicin
Human,02323001,Epirubicin Hydrochloride Injection,epirubicin hydrochloride 2 mg / mL solution for injection,Pharmaceutical Partners Of Canada Inc,1.0,CK,1.0,Cancelled pre market,2017-08-17,L01DB03,Epirubicin
Human,02387379,Epirubicin Hydrochloride Injection,epirubicin hydrochloride 2 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled pre market,2019-08-01,L01DB03,Epirubicin
Human,02409372,Epirubicin Hydrochloride Injection,epirubicin hydrochloride 2 mg / mL solution for injection,Omega Laboratories Limited,1.0,CK,1.0,Approved,2013-07-23,L01DB03,Epirubicin
Human,02413221,Epirubicin Hydrochloride Injection,epirubicin hydrochloride 2 mg / mL solution for injection,Strides Pharma Canada Inc,1.0,CK,1.0,Approved,2020-05-19,L01DB03,Epirubicin
Human,02065703,Pharmorubicin Pfs,epirubicin hydrochloride 2 mg / mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Cancelled post market,2025-07-04,L01DB03,Epirubicin
Human,02410400,Pms-Epirubicin,epirubicin hydrochloride 2 mg / mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Cancelled post market,2025-07-04,L01DB03,Epirubicin
Human,02301067,Epirubicin Hydrochloride For Injection,epirubicin hydrochloride 50 mg / vial powder for solution for injection,Hospira Healthcare Ulc,1.0,CK,1.0,Cancelled post market,2019-01-18,L01DB03,Epirubicin
Human,02069512,Pharmorubicin Rdf,epirubicin hydrochloride 50 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2006-08-02,L01DB03,Epirubicin
Human,00640069,Pharmorubicin Rdf Inj 50Mg/Vial,epirubicin hydrochloride 50 mg / vial powder for solution for injection,Adria Laboratories Of Canada Ltd.,1.0,CK,1.0,Cancelled post market,1996-09-10,L01DB03,Epirubicin
Human,02411679,Aj-Idarubicin,idarubicin hydrochloride 1 mg / mL solution for injection,Agila Jamp Canada Inc,1.0,CK,1.0,Cancelled pre market,2015-11-03,L01DB06,Idarubicin
Human,02282496,Idamycin Pfs,idarubicin hydrochloride 1 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Dormant,2017-08-02,L01DB06,Idarubicin
Human,02410028,Idarubicin,idarubicin hydrochloride 1 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2014-11-04,L01DB06,Idarubicin
Human,02337584,Idarubicin Hydrochloride Injection,idarubicin hydrochloride 1 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Cancelled post market,2021-10-07,L01DB06,Idarubicin
Human,02410354,Idarubicin Hydrochloride Injection,idarubicin hydrochloride 1 mg / mL solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled pre market,2022-02-28,L01DB06,Idarubicin
Human,02068095,Idamycin Powder -10Mg/Vial,idarubicin hydrochloride 10 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2014-03-21,L01DB06,Idarubicin
Human,01905066,Idamycin Pws 10Mg/Vial,idarubicin hydrochloride 10 mg / vial powder for solution for injection,Adria Laboratories Of Canada Ltd.,1.0,CK,1.0,Cancelled post market,1996-09-10,L01DB06,Idarubicin
Human,02166119,Idamycin - Cap 10Mg,idarubicin hydrochloride 10 mg oral capsule,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2006-08-02,L01DB06,Idarubicin
Human,02166127,Idamycin - Cap 25Mg,idarubicin hydrochloride 25 mg oral capsule,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2006-08-02,L01DB06,Idarubicin
Human,02065630,Idamycin Powder -5Mg/Vial,idarubicin hydrochloride 5 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2014-03-21,L01DB06,Idarubicin
Human,01905074,Idamycin Pws 5Mg/Vial,idarubicin hydrochloride 5 mg / vial powder for solution for injection,Adria Laboratories Of Canada Ltd.,1.0,CK,1.0,Cancelled post market,1996-09-10,L01DB06,Idarubicin
Human,02166100,Idamycin - Cap 5Mg,idarubicin hydrochloride 5 mg oral capsule,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2006-08-02,L01DB06,Idarubicin
Human,02173468,Novantrone,mitoxantrone (mitoxantrone hydrochloride) 2 mg / mL liquid for injection,Wyeth Canada,1.0,K,1.0,Cancelled post market,2005-08-10,L01DB07,Mitoxantrone
Human,00614289,Novantrone Inj 2Mg/Ml,mitoxantrone (mitoxantrone hydrochloride) 2 mg / mL liquid for injection,Lederle Cyanamid Canada Inc.,1.0,K,1.0,Cancelled post market,1997-08-14,L01DB07,Mitoxantrone
Human,02267535,Mitoxantrone Injection,mitoxantrone (mitoxantrone hydrochloride) 2 mg / mL solution for injection,Teva Canada Limited,1.0,K,1.0,Cancelled post market,2018-07-09,L01DB07,Mitoxantrone
Human,02286300,Mitoxantrone Injection,mitoxantrone (mitoxantrone hydrochloride) 2 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,K,1.0,Marketed,2015-12-30,L01DB07,Mitoxantrone
Human,02244614,Mitoxantrone Injection Usp,mitoxantrone (mitoxantrone hydrochloride) 2 mg / mL solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2019-03-26,L01DB07,Mitoxantrone
Human,02242466,Valtaxin,valrubicin 40 mg / mL intravesical solution,Endo Pharmaceuticals Solutions Inc,1.0,CK,1.0,Cancelled post market,2017-08-01,L01DB09,Valrubicin
Human,02265982,Bleomycin For Injection,bleomycin (bleomycin sulfate) 15 units / vial powder for solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Marketed,2016-08-25,L01DC01,Bleomycin
Human,02131692,Bleomycin For Injection Usp,bleomycin (bleomycin sulfate) 15 units / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2017-08-08,L01DC01,Bleomycin
Human,02367351,Bleomycin For Injection Usp,bleomycin (bleomycin sulfate) 15 units / vial powder for solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled pre market,2019-08-01,L01DC01,Bleomycin
Human,00258482,Blenoxane Pws 15Unit,bleomycin sulfate 15 units / ampoule powder for solution for injection,Bristol Labs Division Of Bristol-Myers Squibb,1.0,CK,1.0,Cancelled post market,2011-10-19,L01DC01,Bleomycin
Human,00381799,Mutamycin Inj 5Mg/Vial,mitomycin 0.5 mg / mL powder for solution for injection,Bristol-Myers Squibb Canada,1.0,CK,1.0,Cancelled post market,2006-05-29,L01DC03,Mitomycin
Human,02230451,Mitomycin For Injection,mitomycin 20 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2012-09-27,L01DC03,Mitomycin
Human,02557762,Mitomycin For Injection,mitomycin 20 mg / vial powder for solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2025-05-22,L01DC03,Mitomycin
Human,02230729,Mitomycin For Injection Usp,mitomycin 20 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2020-02-28,L01DC03,Mitomycin
Human,02464691,Mitomycin For Injection Usp,mitomycin 20 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2018-04-30,L01DC03,Mitomycin
Human,02531941,"Mitomycin For Injection, Usp",mitomycin 20 mg / vial powder for solution for injection,Hikma Canada Limited,1.0,CK,1.0,Marketed,2023-02-27,L01DC03,Mitomycin
Human,00587710,Mutamycin Inj 20Mg/Vial,mitomycin 20 mg / vial powder for solution for injection,Bristol-Myers Squibb Canada,1.0,CK,1.0,Cancelled post market,2006-05-29,L01DC03,Mitomycin
Human,02230450,Mitomycin For Injection,mitomycin 5 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled post market,2017-02-10,L01DC03,Mitomycin
Human,02237745,Mitomycin For Injection Usp,mitomycin 5 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2020-02-28,L01DC03,Mitomycin
Human,02244725,Gleevec,imatinib (imatinib mesylate) 100 mg oral capsule,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Cancelled post market,2008-09-24,L01EA01,Imatinib
Human,02490986,Ach-Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Accord Healthcare Inc,1.0,K,1.0,Marketed,2020-11-24,L01EA01,Imatinib
Human,02355337,Apo-Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2013-04-19,L01EA01,Imatinib
Human,02253275,Gleevec,imatinib (imatinib mesylate) 100 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2005-04-05,L01EA01,Imatinib
Human,02504596,Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Sanis Health Inc,1.0,K,1.0,Marketed,2021-04-07,L01EA01,Imatinib
Human,02521202,Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Sivem Pharmaceuticals Ulc,1.0,K,1.0,Marketed,2024-04-29,L01EA01,Imatinib
Human,02495066,Jamp Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Jamp Pharma Corporation,1.0,K,1.0,Dormant,2025-07-31,L01EA01,Imatinib
Human,02492334,Mint-Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Mint Pharmaceuticals Inc,1.0,K,1.0,Marketed,2020-06-19,L01EA01,Imatinib
Human,02424495,Mylan-Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Mylan Pharmaceuticals Ulc,1.0,K,1.0,Cancelled pre market,2018-10-02,L01EA01,Imatinib
Human,02397285,Nat-Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2017-08-11,L01EA01,Imatinib
Human,02431114,Pms-Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Dormant,2020-07-24,L01EA01,Imatinib
Human,02515547,Sandoz Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled pre market,2023-10-25,L01EA01,Imatinib
Human,02428318,Taro-Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Sun Pharma Canada Inc,1.0,K,1.0,Approved,2023-04-24,L01EA01,Imatinib
Human,02399806,Teva-Imatinib,imatinib (imatinib mesylate) 100 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2013-04-02,L01EA01,Imatinib
Human,02490994,Ach-Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Accord Healthcare Inc,1.0,K,1.0,Marketed,2020-11-24,L01EA01,Imatinib
Human,02355345,Apo-Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2013-04-19,L01EA01,Imatinib
Human,02253283,Gleevec,imatinib (imatinib mesylate) 400 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2004-10-25,L01EA01,Imatinib
Human,02504618,Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Sanis Health Inc,1.0,K,1.0,Marketed,2021-04-07,L01EA01,Imatinib
Human,02521210,Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Sivem Pharmaceuticals Ulc,1.0,K,1.0,Marketed,2024-04-29,L01EA01,Imatinib
Human,02495074,Jamp Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Jamp Pharma Corporation,1.0,K,1.0,Dormant,2025-07-31,L01EA01,Imatinib
Human,02492342,Mint-Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Mint Pharmaceuticals Inc,1.0,K,1.0,Marketed,2020-06-19,L01EA01,Imatinib
Human,02424509,Mylan-Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Mylan Pharmaceuticals Ulc,1.0,K,1.0,Cancelled pre market,2018-10-02,L01EA01,Imatinib
Human,02397293,Nat-Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2017-08-11,L01EA01,Imatinib
Human,02431122,Pms-Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Dormant,2018-05-16,L01EA01,Imatinib
Human,02515555,Sandoz Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled pre market,2023-10-25,L01EA01,Imatinib
Human,02428326,Taro-Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Sun Pharma Canada Inc,1.0,K,1.0,Approved,2023-04-24,L01EA01,Imatinib
Human,02399814,Teva-Imatinib,imatinib (imatinib mesylate) 400 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2013-05-22,L01EA01,Imatinib
Human,02514788,Reddy-Dasatinib,dasatinib (dasatinib (s)-propylene glycol) 100 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-16,L01EA02,Dasatinib
Human,02514796,Reddy-Dasatinib,dasatinib (dasatinib (s)-propylene glycol) 140 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-16,L01EA02,Dasatinib
Human,02514737,Reddy-Dasatinib,dasatinib (dasatinib (s)-propylene glycol) 20 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-16,L01EA02,Dasatinib
Human,02514745,Reddy-Dasatinib,dasatinib (dasatinib (s)-propylene glycol) 50 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-16,L01EA02,Dasatinib
Human,02514753,Reddy-Dasatinib,dasatinib (dasatinib (s)-propylene glycol) 70 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-16,L01EA02,Dasatinib
Human,02514761,Reddy-Dasatinib,dasatinib (dasatinib (s)-propylene glycol) 80 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-16,L01EA02,Dasatinib
Human,02562502,Apo-Dasatinib Tablets,dasatinib (dasatinib monohydrate) 100 mg oral tablet,Apotex Inc,1.0,K,1.0,Approved,2025-10-31,L01EA02,Dasatinib
Human,02320193,Sprycel,dasatinib (dasatinib monohydrate) 100 mg oral tablet,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2009-05-04,L01EA02,Dasatinib
Human,02478358,Teva-Dasatinib,dasatinib (dasatinib monohydrate) 100 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2021-05-05,L01EA02,Dasatinib
Human,02360829,Sprycel,dasatinib (dasatinib monohydrate) 140 mg oral tablet,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2011-03-29,L01EA02,Dasatinib
Human,02562464,Apo-Dasatinib Tablets,dasatinib (dasatinib monohydrate) 20 mg oral tablet,Apotex Inc,1.0,K,1.0,Approved,2025-10-31,L01EA02,Dasatinib
Human,02293129,Sprycel,dasatinib (dasatinib monohydrate) 20 mg oral tablet,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2007-04-13,L01EA02,Dasatinib
Human,02478307,Teva-Dasatinib,dasatinib (dasatinib monohydrate) 20 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2021-05-05,L01EA02,Dasatinib
Human,02562472,Apo-Dasatinib Tablets,dasatinib (dasatinib monohydrate) 50 mg oral tablet,Apotex Inc,1.0,K,1.0,Approved,2025-10-31,L01EA02,Dasatinib
Human,02293137,Sprycel,dasatinib (dasatinib monohydrate) 50 mg oral tablet,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2007-04-13,L01EA02,Dasatinib
Human,02478315,Teva-Dasatinib,dasatinib (dasatinib monohydrate) 50 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2021-05-05,L01EA02,Dasatinib
Human,02562480,Apo-Dasatinib Tablets,dasatinib (dasatinib monohydrate) 70 mg oral tablet,Apotex Inc,1.0,K,1.0,Approved,2025-10-31,L01EA02,Dasatinib
Human,02293145,Sprycel,dasatinib (dasatinib monohydrate) 70 mg oral tablet,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2007-04-13,L01EA02,Dasatinib
Human,02478323,Teva-Dasatinib,dasatinib (dasatinib monohydrate) 70 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2021-05-05,L01EA02,Dasatinib
Human,02562499,Apo-Dasatinib Tablets,dasatinib (dasatinib monohydrate) 80 mg oral tablet,Apotex Inc,1.0,K,1.0,Approved,2025-10-31,L01EA02,Dasatinib
Human,02360810,Sprycel,dasatinib (dasatinib monohydrate) 80 mg oral tablet,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2011-09-02,L01EA02,Dasatinib
Human,02478331,Teva-Dasatinib,dasatinib (dasatinib monohydrate) 80 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2021-05-05,L01EA02,Dasatinib
Human,02470721,Apo-Dasatinib,dasatinib 100 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2020-01-06,L01EA02,Dasatinib
Human,02499339,Taro-Dasatinib,dasatinib 100 mg oral tablet,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2021-03-04,L01EA02,Dasatinib
Human,02499347,Taro-Dasatinib,dasatinib 140 mg oral tablet,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2021-03-04,L01EA02,Dasatinib
Human,02470705,Apo-Dasatinib,dasatinib 20 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2020-01-06,L01EA02,Dasatinib
Human,02499282,Taro-Dasatinib,dasatinib 20 mg oral tablet,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2021-03-04,L01EA02,Dasatinib
Human,02470713,Apo-Dasatinib,dasatinib 50 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2020-01-06,L01EA02,Dasatinib
Human,02499304,Taro-Dasatinib,dasatinib 50 mg oral tablet,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2021-03-04,L01EA02,Dasatinib
Human,02481499,Apo-Dasatinib,dasatinib 70 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2020-01-06,L01EA02,Dasatinib
Human,02499312,Taro-Dasatinib,dasatinib 70 mg oral tablet,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2021-03-04,L01EA02,Dasatinib
Human,02481502,Apo-Dasatinib,dasatinib 80 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,2020-01-06,L01EA02,Dasatinib
Human,02499320,Taro-Dasatinib,dasatinib 80 mg oral tablet,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2021-03-04,L01EA02,Dasatinib
Human,02550881,Apo-Nilotinib,nilotinib (nilotinib hydrochloride monohydrate) 150 mg oral capsule,Apotex Inc,2.0,R,2.0,Marketed,2025-02-13,L01EA03,Nilotinib
Human,02556634,Reddy-Nilotinib,nilotinib (nilotinib hydrochloride monohydrate) 150 mg oral capsule,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Marketed,2025-04-24,L01EA03,Nilotinib
Human,02368250,Tasigna,nilotinib (nilotinib hydrochloride monohydrate) 150 mg oral capsule,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Marketed,2011-07-15,L01EA03,Nilotinib
Human,02550903,Apo-Nilotinib,nilotinib (nilotinib hydrochloride monohydrate) 200 mg oral capsule,Apotex Inc,2.0,R,2.0,Marketed,2025-02-13,L01EA03,Nilotinib
Human,02556642,Reddy-Nilotinib,nilotinib (nilotinib hydrochloride monohydrate) 200 mg oral capsule,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Marketed,2025-04-24,L01EA03,Nilotinib
Human,02315874,Tasigna,nilotinib (nilotinib hydrochloride monohydrate) 200 mg oral capsule,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Marketed,2008-09-30,L01EA03,Nilotinib
Human,02556626,Reddy-Nilotinib,nilotinib (nilotinib hydrochloride monohydrate) 50 mg oral capsule,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Approved,2025-04-01,L01EA03,Nilotinib
Human,02481715,Tasigna,nilotinib (nilotinib hydrochloride monohydrate) 50 mg oral capsule,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Cancelled post market,2023-10-04,L01EA03,Nilotinib
Human,02560038,Reddy-Bosutinib,bosutinib (bosutinib dihydrate) 100 mg oral tablet,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Marketed,2025-09-08,L01EA04,Bosutinib
Human,02560011,Reddy-Bosutinib,bosutinib (bosutinib dihydrate) 400 mg oral tablet,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Approved,2025-08-11,L01EA04,Bosutinib
Human,02560046,Reddy-Bosutinib,bosutinib (bosutinib dihydrate) 500 mg oral tablet,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Marketed,2025-09-08,L01EA04,Bosutinib
Human,02419149,Bosulif,bosutinib (bosutinib monohydrate) 100 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2014-04-24,L01EA04,Bosutinib
Human,02483793,Bosulif,bosutinib (bosutinib monohydrate) 400 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2025-03-31,L01EA04,Bosutinib
Human,02419157,Bosulif,bosutinib (bosutinib monohydrate) 500 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2014-03-24,L01EA04,Bosutinib
Human,02437333,Iclusig,ponatinib (ponatinib hydrochloride) 15 mg oral tablet,"Takeda Pharmaceuticals U.S.A., Inc.",2.0,P,2.0,Marketed,2023-06-29,L01EA05,Ponatinib
Human,02437341,Iclusig,ponatinib (ponatinib hydrochloride) 45 mg oral tablet,"Takeda Pharmaceuticals U.S.A., Inc.",2.0,P,2.0,Dormant,2022-08-08,L01EA05,Ponatinib
Human,02528320,Scemblix,asciminib (asciminib hydrochloride) 20 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,,Marketed,2022-09-01,L01EA06,Asciminib
Human,02528339,Scemblix,asciminib (asciminib hydrochloride) 40 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,,Marketed,2022-09-01,L01EA06,Asciminib
Human,02468050,Apo-Gefitinib,gefitinib 250 mg oral tablet,Apotex Inc,2.0,P,,Marketed,2017-10-18,L01EB01,Gefitinib
Human,02533685,Auro-Gefitinib,gefitinib 250 mg oral tablet,Auro Pharma Inc,2.0,P,,Approved,2022-12-16,L01EB01,Gefitinib
Human,02547546,Eugia-Gefitinib,gefitinib 250 mg oral tablet,Eugia Pharma Inc.,2.0,P,,Approved,2024-05-08,L01EB01,Gefitinib
Human,02248676,Iressa,gefitinib 250 mg oral tablet,Astrazeneca Canada Inc,2.0,P,,Marketed,2003-12-17,L01EB01,Gefitinib
Human,02500663,Jamp Gefitinib,gefitinib 250 mg oral tablet,Jamp Pharma Corporation,2.0,P,,Marketed,2020-12-23,L01EB01,Gefitinib
Human,02491796,Nat-Gefitinib,gefitinib 250 mg oral tablet,Natco Pharma (Canada) Inc,2.0,P,,Marketed,2019-11-13,L01EB01,Gefitinib
Human,02487748,Sandoz Gefitinib,gefitinib 250 mg oral tablet,Sandoz Canada Incorporated,2.0,P,,Marketed,2019-06-26,L01EB01,Gefitinib
Human,02461870,Apo-Erlotinib,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2017-08-22,L01EB02,Erlotinib
Human,02483920,Nat-Erlotinib,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,Natco Pharma (Canada) Inc,2.0,R,2.0,Marketed,2019-05-08,L01EB02,Erlotinib
Human,02454386,Pms-Erlotinib,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Dormant,2025-07-31,L01EB02,Erlotinib
Human,02269015,Tarceva,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,Hoffmann-La Roche Limited,2.0,R,2.0,Cancelled post market,2024-10-01,L01EB02,Erlotinib
Human,02377705,Teva-Erlotinib,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2014-12-08,L01EB02,Erlotinib
Human,02461889,Apo-Erlotinib,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2017-08-22,L01EB02,Erlotinib
Human,02483939,Nat-Erlotinib,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,Natco Pharma (Canada) Inc,2.0,R,2.0,Marketed,2019-05-08,L01EB02,Erlotinib
Human,02454394,Pms-Erlotinib,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2016-07-28,L01EB02,Erlotinib
Human,02269023,Tarceva,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,Hoffmann-La Roche Limited,2.0,R,2.0,Cancelled post market,2024-10-01,L01EB02,Erlotinib
Human,02377713,Teva-Erlotinib,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2014-12-08,L01EB02,Erlotinib
Human,02461862,Apo-Erlotinib,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2017-08-22,L01EB02,Erlotinib
Human,02483912,Nat-Erlotinib,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,Natco Pharma (Canada) Inc,2.0,R,2.0,Marketed,2019-05-08,L01EB02,Erlotinib
Human,02269007,Tarceva,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,Hoffmann-La Roche Limited,2.0,R,2.0,Cancelled post market,2024-10-01,L01EB02,Erlotinib
Human,02377691,Teva-Erlotinib,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2014-12-08,L01EB02,Erlotinib
Human,02415666,Giotrif,afatinib (afatinib dimaleate) 20 mg oral tablet,Boehringer Ingelheim (Canada) Ltd Ltee,2.0,P,2.0,Marketed,2014-01-17,L01EB03,Afatinib
Human,02517019,Mar-Afatinib,afatinib (afatinib dimaleate) 20 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,P,2.0,Marketed,2025-01-31,L01EB03,Afatinib
Human,02512777,Sandoz Afatinib,afatinib (afatinib dimaleate) 20 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2024-10-28,L01EB03,Afatinib
Human,02514591,Teva-Afatinib,afatinib (afatinib dimaleate) 20 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Cancelled pre market,2025-04-09,L01EB03,Afatinib
Human,02415674,Giotrif,afatinib (afatinib dimaleate) 30 mg oral tablet,Boehringer Ingelheim (Canada) Ltd Ltee,2.0,P,2.0,Marketed,2014-01-17,L01EB03,Afatinib
Human,02517027,Mar-Afatinib,afatinib (afatinib dimaleate) 30 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,P,2.0,Marketed,2025-01-31,L01EB03,Afatinib
Human,02512785,Sandoz Afatinib,afatinib (afatinib dimaleate) 30 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2024-10-28,L01EB03,Afatinib
Human,02514605,Teva-Afatinib,afatinib (afatinib dimaleate) 30 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Cancelled pre market,2025-04-09,L01EB03,Afatinib
Human,02415682,Giotrif,afatinib (afatinib dimaleate) 40 mg oral tablet,Boehringer Ingelheim (Canada) Ltd Ltee,2.0,P,2.0,Marketed,2014-01-17,L01EB03,Afatinib
Human,02517035,Mar-Afatinib,afatinib (afatinib dimaleate) 40 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,P,2.0,Marketed,2025-01-31,L01EB03,Afatinib
Human,02512793,Sandoz Afatinib,afatinib (afatinib dimaleate) 40 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2024-10-28,L01EB03,Afatinib
Human,02514613,Teva-Afatinib,afatinib (afatinib dimaleate) 40 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Cancelled pre market,2025-04-09,L01EB03,Afatinib
Human,02486024,Vizimpro,dacomitinib (dacomitinib monohydrate) 15 mg oral tablet,Pfizer Canada Ulc,1.0,R,,Cancelled post market,2021-11-24,L01EB07,Dacomitinib
Human,02486032,Vizimpro,dacomitinib (dacomitinib monohydrate) 30 mg oral tablet,Pfizer Canada Ulc,1.0,R,,Cancelled post market,2021-11-24,L01EB07,Dacomitinib
Human,02486040,Vizimpro,dacomitinib (dacomitinib monohydrate) 45 mg oral tablet,Pfizer Canada Ulc,1.0,R,,Cancelled post market,2022-06-09,L01EB07,Dacomitinib
Human,02380242,Zelboraf,vemurafenib 240 mg oral tablet,Hoffmann-La Roche Limited,2.0,R,2.0,Marketed,2012-03-05,L01EC01,Vemurafenib
Human,02540053,Tafinlar,dabrafenib (dabrafenib mesylate) 10 mg oral tablet for suspension,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2023-11-30,L01EC02,Dabrafenib
Human,02409607,Tafinlar,dabrafenib (dabrafenib mesylate) 50 mg oral capsule,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2016-09-27,L01EC02,Dabrafenib
Human,02409615,Tafinlar,dabrafenib (dabrafenib mesylate) 75 mg oral capsule,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2016-05-04,L01EC02,Dabrafenib
Human,02384256,Xalkori,crizotinib 200 mg oral capsule,Pfizer Canada Ulc,2.0,p,2.0,Marketed,2012-05-10,L01ED01,Crizotinib
Human,02384264,Xalkori,crizotinib 250 mg oral capsule,Pfizer Canada Ulc,2.0,p,2.0,Marketed,2012-05-10,L01ED01,Crizotinib
Human,02436779,Zykadia,ceritinib 150 mg oral capsule,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Marketed,2015-04-29,L01ED02,Ceritinib
Human,02479222,Alunbrig,brigatinib 180 mg oral tablet,Takeda Canada Inc,2.0,R,,Marketed,2018-08-31,L01ED04,Brigatinib
Human,02479230,Alunbrig,brigatinib 180 mg with brigatinib 90 mg oral kit (tablet),Takeda Canada Inc,2.0,R,,Marketed,2018-08-31,L01ED04,Brigatinib
Human,02479206,Alunbrig,brigatinib 30 mg oral tablet,Takeda Canada Inc,2.0,R,,Marketed,2018-08-31,L01ED04,Brigatinib
Human,02479214,Alunbrig,brigatinib 90 mg oral tablet,Takeda Canada Inc,2.0,R,,Marketed,2018-08-31,L01ED04,Brigatinib
Human,02485974,Lorbrena,lorlatinib 100 mg oral tablet,Pfizer Canada Ulc,1.0,R,,Marketed,2019-04-22,L01ED05,Lorlatinib
Human,02485966,Lorbrena,lorlatinib 25 mg oral tablet,Pfizer Canada Ulc,1.0,R,,Marketed,2019-04-22,L01ED05,Lorlatinib
Human,02409623,Mekinist,trametinib 0.5 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2016-07-04,L01EE01,Trametinib
Human,02409631,Mekinist,trametinib 1 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled pre market,2017-05-15,L01EE01,Trametinib
Human,02409658,Mekinist,trametinib 2 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2015-07-31,L01EE01,Trametinib
Human,02539993,Mekinist,trametinib 4.7 mg oral powder for solution,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2023-11-30,L01EE01,Trametinib
Human,02452340,Cotellic,cobimetinib (cobimetinib fumarate) 20 mg oral tablet,Hoffmann-La Roche Limited,2.0,R,2.0,Marketed,2016-04-06,L01EE02,Cobimetinib
Human,02513080,Mektovi,binimetinib 15 mg oral tablet,Pfizer Canada Ulc,1.0,,,Marketed,2021-07-05,L01EE03,Binimetinib
Human,02530139,Koselugo,selumetinib (selumetinib sulfate) 10 mg oral capsule,Alexion Pharma Gmbh,2.0,R,,Marketed,2024-04-26,L01EE04,Selumetinib
Human,02530147,Koselugo,selumetinib (selumetinib sulfate) 25 mg oral capsule,Alexion Pharma Gmbh,2.0,R,,Marketed,2024-10-02,L01EE04,Selumetinib
Human,02473569,Kisqali,ribociclib (ribociclib succinate) 200 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,,Marketed,2018-04-27,L01EF02,Ribociclib
Human,02487101,Verzenio,abemaciclib 100 mg oral tablet,Eli Lilly Canada Inc,2.0,R,,Marketed,2019-07-03,L01EF03,Abemaciclib
Human,02487128,Verzenio,abemaciclib 150 mg oral tablet,Eli Lilly Canada Inc,2.0,R,,Marketed,2019-07-03,L01EF03,Abemaciclib
Human,02487136,Verzenio,abemaciclib 200 mg oral tablet,Eli Lilly Canada Inc,2.0,R,,Marketed,2019-07-03,L01EF03,Abemaciclib
Human,02487098,Verzenio,abemaciclib 50 mg oral tablet,Eli Lilly Canada Inc,2.0,R,,Marketed,2019-07-03,L01EF03,Abemaciclib
Human,02441810,Gd-Temsirolimus,temsirolimus 25 mg / mL solution for injection,Genmed A Division Of Pfizer Canada Ulc,1.0,K,1.0,Cancelled pre market,2022-12-22,L01EG01,Temsirolimus
Human,02304104,Torisel,temsirolimus 25 mg / mL solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2011-07-11,L01EG01,Temsirolimus
Human,02326442,Tykerb,lapatinib (lapatinib ditosylate) 250 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,,,Marketed,2016-04-19,L01EH01,Lapatinib
Human,02490536,Nerlynx,neratinib (neratinib maleate) 40 mg oral tablet,Knight Therapeutics Inc.,,p,,Marketed,2019-12-20,L01EH02,Neratinib
Human,02499835,Tukysa,tucatinib 150 mg oral tablet,Pfizer Canada Ulc,2.0,R,,Marketed,2025-11-24,L01EH03,Tucatinib
Human,02499827,Tukysa,tucatinib 50 mg oral tablet,Pfizer Canada Ulc,2.0,R,,Marketed,2025-11-24,L01EH03,Tucatinib
Human,02502445,Inrebic,fedratinib (fedratinib hydrochloride) 100 mg oral capsule,Bristol-Myers Squibb Canada,2.0,R,,Marketed,2025-02-03,L01EJ02,Fedratinib
Human,02552965,Ojjaara,momelotinib (momelotinib dihydrochloride) 100 mg oral tablet,Glaxosmithkline Inc,2.0,R,,Marketed,2025-01-21,L01EJ04,Momelotinib
Human,02552973,Ojjaara,momelotinib (momelotinib dihydrochloride) 150 mg oral tablet,Glaxosmithkline Inc,2.0,R,,Marketed,2025-01-21,L01EJ04,Momelotinib
Human,02552981,Ojjaara,momelotinib (momelotinib dihydrochloride) 200 mg oral tablet,Glaxosmithkline Inc,2.0,R,,Marketed,2025-01-21,L01EJ04,Momelotinib
Human,02389630,Inlyta,axitinib 1 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2012-08-17,L01EK01,Axitinib
Human,02422883,Inlyta,axitinib 3 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Cancelled pre market,2025-03-31,L01EK01,Axitinib
Human,02389649,Inlyta,axitinib 5 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2012-08-17,L01EK01,Axitinib
Human,02422891,Inlyta,axitinib 7 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Cancelled pre market,2025-03-31,L01EK01,Axitinib
Human,02551454,Fruzaqla,fruquintinib 1 mg oral capsule,Takeda Canada Inc,2.0,R,,Marketed,2024-10-30,L01EK04,Fruquintinib
Human,02551462,Fruzaqla,fruquintinib 5 mg oral capsule,Takeda Canada Inc,2.0,R,,Marketed,2024-10-30,L01EK04,Fruquintinib
Human,02535696,Calquence,acalabrutinib (acalabrutinib maleate) 100 mg oral tablet,Astrazeneca Canada Inc,1.0,,,Marketed,2023-05-01,L01EL02,Acalabrutinib
Human,02491788,Calquence,acalabrutinib 100 mg oral capsule,Astrazeneca Canada Inc,1.0,,,Dormant,2025-07-25,L01EL02,Acalabrutinib
Human,02554267,Brukinsa,zanubrutinib 160 mg oral tablet,Beone Medicines I Gmbh,1.0,K,,Marketed,2025-11-24,L01EL03,Zanubrutinib
Human,02512963,Brukinsa,zanubrutinib 80 mg oral capsule,Beone Medicines I Gmbh,1.0,K,,Marketed,2025-11-24,L01EL03,Zanubrutinib
Human,02562014,Jaypirca,pirtobrutinib 100 mg oral tablet,Eli Lilly Canada Inc,1.0,,,Marketed,2025-11-28,L01EL05,Pirtobrutinib
Human,02562006,Jaypirca,pirtobrutinib 50 mg oral tablet,Eli Lilly Canada Inc,1.0,,,Marketed,2025-11-28,L01EL05,Pirtobrutinib
Human,02497069,Piqray,alpelisib 150 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,,Marketed,2020-06-29,L01EM03,Alpelisib
Human,02497077,Piqray,alpelisib 200 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,,Marketed,2020-06-29,L01EM03,Alpelisib
Human,02497085,Piqray,alpelisib 200 mg with alpelisib 50 mg oral kit (tablet),Novartis Pharmaceuticals Canada Inc,2.0,R,,Marketed,2020-06-29,L01EM03,Alpelisib
Human,02497042,Piqray,alpelisib 50 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,,Approved,2020-03-11,L01EM03,Alpelisib
Human,02493217,Balversa,erdafitinib 3 mg oral tablet,Janssen Inc,,P,,Marketed,2019-12-09,L01EN01,Erdafitinib
Human,02493225,Balversa,erdafitinib 4 mg oral tablet,Janssen Inc,,P,,Marketed,2019-12-09,L01EN01,Erdafitinib
Human,02493241,Balversa,erdafitinib 4 mg oral tablet,Janssen Inc,,P,,Approved,2019-10-25,L01EN01,Erdafitinib
Human,02493233,Balversa,erdafitinib 5 mg oral tablet,Janssen Inc,,P,,Marketed,2019-12-09,L01EN01,Erdafitinib
Human,02519968,Pemazyre,pemigatinib 13.5 mg oral tablet,Incyte Corporation,2.0,P,,Marketed,2021-11-26,L01EN02,Pemigatinib
Human,02519933,Pemazyre,pemigatinib 4.5 mg oral tablet,Incyte Corporation,2.0,P,,Marketed,2022-01-06,L01EN02,Pemigatinib
Human,02519941,Pemazyre,pemigatinib 9 mg oral tablet,Incyte Corporation,2.0,P,,Marketed,2021-11-30,L01EN02,Pemigatinib
Human,02520656,Truseltiq,infigratinib (infigratinib phosphate) 100 mg / dose oral capsule,"Qed Therapeutics, Inc.",,P,,Cancelled pre market,2023-01-23,L01EN03,Infigratinib
Human,02520664,Truseltiq,infigratinib (infigratinib phosphate) 125 mg / dose oral capsule,"Qed Therapeutics, Inc.",,P,,Cancelled pre market,2023-01-23,L01EN03,Infigratinib
Human,02520621,Truseltiq,infigratinib (infigratinib phosphate) 50 mg / dose oral capsule,"Qed Therapeutics, Inc.",,P,,Cancelled pre market,2023-01-23,L01EN03,Infigratinib
Human,02520648,Truseltiq,infigratinib (infigratinib phosphate) 75 mg / dose oral capsule,"Qed Therapeutics, Inc.",,P,,Cancelled pre market,2023-01-23,L01EN03,Infigratinib
Human,02532190,Auro-Sunitinib,sunitinib (sunitinib malate) 12.5 mg oral capsule,Auro Pharma Inc,2.0,P,2.0,Marketed,2023-09-18,L01EX01,Sunitinib
Human,02548038,Eugia-Sunitinib,sunitinib (sunitinib malate) 12.5 mg oral capsule,Eugia Pharma Inc.,2.0,P,2.0,Approved,2024-05-27,L01EX01,Sunitinib
Human,02552892,Nat-Sunitinib,sunitinib (sunitinib malate) 12.5 mg oral capsule,Natco Pharma (Canada) Inc,2.0,P,2.0,Marketed,2025-09-30,L01EX01,Sunitinib
Human,02280795,Sutent,sunitinib (sunitinib malate) 12.5 mg oral capsule,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2006-06-22,L01EX01,Sunitinib
Human,02524058,Taro-Sunitinib,sunitinib (sunitinib malate) 12.5 mg oral capsule,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2023-01-17,L01EX01,Sunitinib
Human,02526204,Teva-Sunitinib,sunitinib (sunitinib malate) 12.5 mg oral capsule,Teva Canada Limited,2.0,P,2.0,Marketed,2023-09-11,L01EX01,Sunitinib
Human,02532204,Auro-Sunitinib,sunitinib (sunitinib malate) 25 mg oral capsule,Auro Pharma Inc,2.0,P,2.0,Marketed,2023-07-21,L01EX01,Sunitinib
Human,02548046,Eugia-Sunitinib,sunitinib (sunitinib malate) 25 mg oral capsule,Eugia Pharma Inc.,2.0,P,2.0,Approved,2024-05-27,L01EX01,Sunitinib
Human,02552906,Nat-Sunitinib,sunitinib (sunitinib malate) 25 mg oral capsule,Natco Pharma (Canada) Inc,2.0,P,2.0,Marketed,2025-09-30,L01EX01,Sunitinib
Human,02280809,Sutent,sunitinib (sunitinib malate) 25 mg oral capsule,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2006-06-22,L01EX01,Sunitinib
Human,02524066,Taro-Sunitinib,sunitinib (sunitinib malate) 25 mg oral capsule,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2022-09-20,L01EX01,Sunitinib
Human,02526212,Teva-Sunitinib,sunitinib (sunitinib malate) 25 mg oral capsule,Teva Canada Limited,2.0,P,2.0,Marketed,2023-09-11,L01EX01,Sunitinib
Human,02532212,Auro-Sunitinib,sunitinib (sunitinib malate) 37.5 mg oral capsule,Auro Pharma Inc,2.0,P,2.0,Approved,2022-11-18,L01EX01,Sunitinib
Human,02548054,Eugia-Sunitinib,sunitinib (sunitinib malate) 37.5 mg oral capsule,Eugia Pharma Inc.,2.0,P,2.0,Approved,2024-05-27,L01EX01,Sunitinib
Human,02328607,Sutent,sunitinib (sunitinib malate) 37.5 mg oral capsule,Pfizer Canada Ulc,2.0,P,2.0,Cancelled pre market,2025-03-31,L01EX01,Sunitinib
Human,02524074,Taro-Sunitinib,sunitinib (sunitinib malate) 37.5 mg oral capsule,Taro Pharmaceuticals Inc,2.0,P,2.0,Approved,2022-01-07,L01EX01,Sunitinib
Human,02532220,Auro-Sunitinib,sunitinib (sunitinib malate) 50 mg oral capsule,Auro Pharma Inc,2.0,P,2.0,Marketed,2023-07-21,L01EX01,Sunitinib
Human,02548062,Eugia-Sunitinib,sunitinib (sunitinib malate) 50 mg oral capsule,Eugia Pharma Inc.,2.0,P,2.0,Approved,2024-05-27,L01EX01,Sunitinib
Human,02539284,Nat-Sunitinib,sunitinib (sunitinib malate) 50 mg oral capsule,Natco Pharma (Canada) Inc,2.0,P,2.0,Marketed,2025-09-30,L01EX01,Sunitinib
Human,02280817,Sutent,sunitinib (sunitinib malate) 50 mg oral capsule,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2006-06-22,L01EX01,Sunitinib
Human,02524082,Taro-Sunitinib,sunitinib (sunitinib malate) 50 mg oral capsule,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2022-09-20,L01EX01,Sunitinib
Human,02526220,Teva-Sunitinib,sunitinib (sunitinib malate) 50 mg oral capsule,Teva Canada Limited,2.0,P,2.0,Marketed,2023-09-11,L01EX01,Sunitinib
Human,02532840,Sandoz Sunitinib,sunitinib 12.5 mg oral capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2023-05-24,L01EX01,Sunitinib
Human,02532867,Sandoz Sunitinib,sunitinib 25 mg oral capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2023-05-24,L01EX01,Sunitinib
Human,02532875,Sandoz Sunitinib,sunitinib 37.5 mg oral capsule,Sandoz Canada Incorporated,2.0,P,2.0,Approved,2022-11-18,L01EX01,Sunitinib
Human,02532883,Sandoz Sunitinib,sunitinib 50 mg oral capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2023-05-24,L01EX01,Sunitinib
Human,02490641,Apo-Sorafenib,sorafenib (sorafenib tosylate) 200 mg oral tablet,Apotex Inc,2.0,R,2.0,Approved,2022-11-28,L01EX02,Sorafenib
Human,02284227,Nexavar,sorafenib (sorafenib tosylate) 200 mg oral tablet,Bayer Inc,2.0,R,2.0,Marketed,2006-07-31,L01EX02,Sorafenib
Human,02552957,Auro-Pazopanib,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2026-01-02,L01EX03,Pazopanib
Human,02525666,Pms-Pazopanib,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2022-08-31,L01EX03,Pazopanib
Human,02521180,Sandoz Pazopanib,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled pre market,2023-10-26,L01EX03,Pazopanib
Human,02352303,Votrient,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Marketed,2016-09-07,L01EX03,Pazopanib
Human,02352311,Votrient,pazopanib (pazopanib hydrochloride) 400 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Cancelled pre market,2020-07-08,L01EX03,Pazopanib
Human,02378582,Caprelsa,vandetanib 100 mg oral tablet,Sanofi-Aventis Canada Inc,1.0,K,1.0,Marketed,2025-11-27,L01EX04,Vandetanib
Human,02378590,Caprelsa,vandetanib 300 mg oral tablet,Sanofi-Aventis Canada Inc,1.0,K,1.0,Marketed,2024-04-05,L01EX04,Vandetanib
Human,02403390,Stivarga,regorafenib 40 mg oral tablet,Bayer Inc,2.0,R,2.0,Marketed,2013-04-02,L01EX05,Regorafenib
Human,02480824,Cabometyx,cabozantinib (cabozantinib malate) 20 mg oral tablet,Ipsen Biopharmaceuticals Canada Inc,2.0,R,2.0,Marketed,2018-10-10,L01EX07,Cabozantinib
Human,02480832,Cabometyx,cabozantinib (cabozantinib malate) 40 mg oral tablet,Ipsen Biopharmaceuticals Canada Inc,2.0,R,2.0,Marketed,2018-10-10,L01EX07,Cabozantinib
Human,02480840,Cabometyx,cabozantinib (cabozantinib malate) 60 mg oral tablet,Ipsen Biopharmaceuticals Canada Inc,2.0,R,2.0,Marketed,2018-10-10,L01EX07,Cabozantinib
Human,02450321,Lenvima,lenvatinib (lenvatinib mesylate) 10 mg / dose oral capsule,Eisai Limited,2.0,R,2.0,Marketed,2016-03-31,L01EX08,Lenvatinib
Human,02484129,Lenvima,lenvatinib (lenvatinib mesylate) 12 mg / dose oral capsule,Eisai Limited,2.0,R,2.0,Marketed,2019-10-21,L01EX08,Lenvatinib
Human,02450313,Lenvima,lenvatinib (lenvatinib mesylate) 14 mg / dose oral capsule,Eisai Limited,2.0,R,2.0,Marketed,2016-03-31,L01EX08,Lenvatinib
Human,02468239,Lenvima,lenvatinib (lenvatinib mesylate) 18 mg / dose oral capsule,Eisai Limited,2.0,R,2.0,Marketed,2018-05-08,L01EX08,Lenvatinib
Human,02450305,Lenvima,lenvatinib (lenvatinib mesylate) 20 mg / dose oral capsule,Eisai Limited,2.0,R,2.0,Marketed,2016-03-31,L01EX08,Lenvatinib
Human,02450291,Lenvima,lenvatinib (lenvatinib mesylate) 24 mg / dose oral capsule,Eisai Limited,2.0,R,2.0,Marketed,2016-03-31,L01EX08,Lenvatinib
Human,02484056,Lenvima,lenvatinib (lenvatinib mesylate) 4 mg / dose oral capsule,Eisai Limited,2.0,R,2.0,Marketed,2019-10-21,L01EX08,Lenvatinib
Human,02468220,Lenvima,lenvatinib (lenvatinib mesylate) 8 mg / dose oral capsule,Eisai Limited,2.0,R,2.0,Marketed,2018-05-08,L01EX08,Lenvatinib
Human,02466236,Rydapt,midostaurin 25 mg oral capsule,Novartis Pharmaceuticals Canada Inc,1.0,P,,Marketed,2017-09-08,L01EX10,Midostaurin
Human,02490323,Vitrakvi,larotrectinib (larotrectinib sulfate) 100 mg oral capsule,Bayer Inc,2.0,R,,Marketed,2020-11-13,L01EX12,Larotrectinib
Human,02490331,Vitrakvi,larotrectinib (larotrectinib sulfate) 20 mg / mL oral solution,Bayer Inc,2.0,R,,Marketed,2019-09-04,L01EX12,Larotrectinib
Human,02490315,Vitrakvi,larotrectinib (larotrectinib sulfate) 25 mg oral capsule,Bayer Inc,2.0,R,,Marketed,2020-11-13,L01EX12,Larotrectinib
Human,02495058,Xospata,gilteritinib (gilteritinib fumarate) 40 mg oral tablet,Astellas Pharma Canada Inc,1.0,P,,Marketed,2020-02-03,L01EX13,Gilteritinib
Human,02495007,Rozlytrek,entrectinib 100 mg oral capsule,Hoffmann-La Roche Limited,1.0,P,,Marketed,2020-03-10,L01EX14,Entrectinib
Human,02495015,Rozlytrek,entrectinib 200 mg oral capsule,Hoffmann-La Roche Limited,1.0,P,,Marketed,2020-03-04,L01EX14,Entrectinib
Human,02527391,Tabrecta,capmatinib (capmatinib hydrochloride) 150 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,,Marketed,2022-09-16,L01EX17,Capmatinib
Human,02527405,Tabrecta,capmatinib (capmatinib hydrochloride) 200 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,,Marketed,2022-09-16,L01EX17,Capmatinib
Human,02551780,Ayvakyt,avapritinib 100 mg oral tablet,Blueprint Medicines Corporation,2.0,R,,Marketed,2024-12-02,L01EX18,Avapritinib
Human,02551799,Ayvakyt,avapritinib 200 mg oral tablet,Blueprint Medicines Corporation,2.0,R,,Marketed,2024-12-02,L01EX18,Avapritinib
Human,02551764,Ayvakyt,avapritinib 25 mg oral tablet,Blueprint Medicines Corporation,2.0,R,,Marketed,2024-12-02,L01EX18,Avapritinib
Human,02551772,Ayvakyt,avapritinib 50 mg oral tablet,Blueprint Medicines Corporation,2.0,R,,Marketed,2024-12-02,L01EX18,Avapritinib
Human,02500833,Qinlock,ripretinib 50 mg oral tablet,Deciphera Pharmaceuticals. Llc,1.0,R,,Marketed,2020-12-10,L01EX19,Ripretinib
Human,02516322,Tepmetko,tepotinib (tepotinib hydrochloride) 225 mg oral tablet,"Emd Serono, A Division Of Emd Inc., Canada",2.0,R,,Marketed,2021-10-07,L01EX21,Tepotinib
Human,02516918,Retevmo,selpercatinib 40 mg oral capsule,Eli Lilly Canada Inc,1.0,R,,Marketed,2025-11-06,L01EX22,Selpercatinib
Human,02516926,Retevmo,selpercatinib 80 mg oral capsule,Eli Lilly Canada Inc,1.0,R,,Marketed,2025-11-06,L01EX22,Selpercatinib
Human,02517590,Gavreto,pralsetinib 100 mg oral capsule,Hoffmann-La Roche Limited,2.0,P,,Cancelled post market,2025-02-26,L01EX23,Pralsetinib
Human,02544733,Truqap,capivasertib 160 mg oral tablet,Astrazeneca Canada Inc,1.0,P,,Marketed,2024-04-16,L01EX27,Capivasertib
Human,02544741,Truqap,capivasertib 200 mg oral tablet,Astrazeneca Canada Inc,1.0,P,,Marketed,2024-04-01,L01EX27,Capivasertib
Human,02557452,Augtyro,repotrectinib 160 mg oral capsule,Bristol-Myers Squibb Canada,,P,,Cancelled pre market,2025-10-17,L01EX28,Repotrectinib
Human,02557444,Augtyro,repotrectinib 40 mg oral capsule,Bristol-Myers Squibb Canada,,P,,Cancelled pre market,2025-10-17,L01EX28,Repotrectinib
Human,02473909,Besponsa,inotuzumab ozogamicin 0.9 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2018-05-03,L01FB01,Inotuzumab ozogamicin
Human,02498235,Sarclisa,isatuximab 100 mg / 5 mL solution for injection,Sanofi-Aventis Canada Inc,1.0,,,Marketed,2020-07-03,L01FC02,Isatuximab
Human,02498243,Sarclisa,isatuximab 500 mg / 25 mL solution for injection,Sanofi-Aventis Canada Inc,1.0,,,Marketed,2020-07-03,L01FC02,Isatuximab
Human,02550970,Adheroza,trastuzumab 150 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Approved,2024-08-20,L01FD01,Trastuzumab
Human,02506211,Herzuma,trastuzumab 150 mg / vial powder for solution for injection,Celltrion Inc.,1.0,CK,1.0,Marketed,2024-10-03,L01FD01,Trastuzumab
Human,02518244,Kanjinti,trastuzumab 150 mg / vial powder for solution for injection,Amgen Canada Inc,1.0,CK,1.0,Marketed,2021-10-07,L01FD01,Trastuzumab
Human,02474425,Ogivri,trastuzumab 150 mg / vial powder for solution for injection,Biosimilar Collaborations Ireland Limited,1.0,CK,1.0,Marketed,2023-12-18,L01FD01,Trastuzumab
Human,02524317,Ontruzant,trastuzumab 150 mg / vial powder for solution for injection,"Samsung Bioepis Co., Ltd",1.0,CK,1.0,Marketed,2022-07-20,L01FD01,Trastuzumab
Human,02483475,Trazimera,trastuzumab 150 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2019-10-22,L01FD01,Trastuzumab
Human,02496690,Kanjinti,trastuzumab 420 mg / vial kit (powder for solution) for injection,Amgen Canada Inc,1.0,CK,1.0,Marketed,2020-04-16,L01FD01,Trastuzumab
Human,02550989,Adheroza,trastuzumab 420 mg / vial powder for solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Approved,2024-08-20,L01FD01,Trastuzumab
Human,02474433,Ogivri,trastuzumab 440 mg / vial + water 20 mL / vial powder for solution for injection,Biosimilar Collaborations Ireland Limited,1.0,CK,1.0,Marketed,2024-02-15,L01FD01,Trastuzumab
Human,02480794,Herzuma,trastuzumab 440 mg / vial kit (powder for solution) for injection,Celltrion Inc.,1.0,CK,1.0,Marketed,2025-11-28,L01FD01,Trastuzumab
Human,02240692,Herceptin,trastuzumab 440 mg / vial powder for solution for injection,Hoffmann-La Roche Limited,1.0,CK,1.0,Marketed,1999-08-23,L01FD01,Trastuzumab
Human,02524325,Ontruzant,trastuzumab 440 mg / vial powder for solution for injection,"Samsung Bioepis Co., Ltd",1.0,CK,1.0,Marketed,2022-07-20,L01FD01,Trastuzumab
Human,02483467,Trazimera,trastuzumab 440 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2019-10-22,L01FD01,Trastuzumab
Human,02480697,Herceptin Sc,trastuzumab 600 mg / 5 mL solution for injection,Hoffmann-La Roche Limited,1.0,CK,1.0,Marketed,2018-10-12,L01FD01,Trastuzumab
Human,02412365,Kadcyla,trastuzumab emtansine 100 mg / vial powder for solution for injection,Hoffmann-La Roche Limited,1.0,CK,1.0,Marketed,2013-10-09,L01FD03,Trastuzumab emtansine
Human,02473224,Kadcyla,trastuzumab emtansine 160 mg / vial powder for solution for injection,Hoffmann-La Roche Limited,1.0,CK,1.0,Marketed,2018-10-24,L01FD03,Trastuzumab emtansine
Human,02514400,Enhertu,trastuzumab deruxtecan 100 mg / vial powder for solution for injection,Astrazeneca Canada Inc,1.0,CK,1.0,Marketed,2021-07-09,L01FD04,Trastuzumab deruxtecan
Human,02446626,Opdivo,nivolumab 10 mg / mL solution for injection,Bristol-Myers Squibb Canada,2.0,,,Marketed,2015-10-23,L01FF01,Nivolumab
Human,02446634,Opdivo,nivolumab 10 mg / mL solution for injection,Bristol-Myers Squibb Canada,2.0,,,Marketed,2015-10-23,L01FF01,Nivolumab
Human,02557320,Opdivo Sc,nivolumab 120 mg / mL solution for injection,Bristol-Myers Squibb Canada,2.0,,,Marketed,2025-12-30,L01FF01,Nivolumab
Human,02468816,Imfinzi,durvalumab 50 mg / mL solution for injection,Astrazeneca Canada Inc,2.0,,,Marketed,2017-11-20,L01FF03,Durvalumab
Human,02469723,Bavencio,avelumab 20 mg / mL solution for injection,"Emd Serono, A Division Of Emd Inc., Canada",2.0,,,Marketed,2017-12-18,L01FF04,Avelumab
Human,02462990,Tecentriq,atezolizumab 1200 mg / 20 mL solution for injection,Hoffmann-La Roche Limited,2.0,,,Marketed,2017-05-02,L01FF05,Atezolizumab
Human,02546310,Tecentriq Sc,atezolizumab 125 mg / mL solution for injection,Hoffmann-La Roche Limited,2.0,,,Marketed,2024-05-16,L01FF05,Atezolizumab
Human,02492393,Tecentriq,atezolizumab 840 mg / 14 mL solution for injection,Hoffmann-La Roche Limited,2.0,,,Marketed,2019-10-16,L01FF05,Atezolizumab
Human,02487152,Libtayo,cemiplimab 250 mg / 5 mL solution for injection,Sanofi-Aventis Canada Inc,2.0,,,Cancelled post market,2023-12-08,L01FF06,Cemiplimab
Human,02487144,Libtayo,cemiplimab 350 mg / 7 mL solution for injection,Regeneron Canada Company,2.0,,,Marketed,2025-04-07,L01FF06,Cemiplimab
Human,02523434,Jemperli,dostarlimab 50 mg / mL solution for injection,Glaxosmithkline Inc,2.0,,,Marketed,2022-02-22,L01FF07,Dostarlimab
Human,02564009,Tevimbra,tislelizumab 100 mg / 10 mL solution for injection,Beone Medicines I Gmbh,2.0,,,Approved,2025-12-18,L01FF09,Tislelizumab
Human,02555239,Zynyz,retifanlimab 25 mg / mL solution for injection,Incyte Corporation,2.0,,,Marketed,2025-08-14,L01FF10,Retifanlimab
Human,02494388,Mylotarg,gemtuzumab ozogamicin 4.5 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2020-03-11,L01FX02,Gemtuzumab ozogamicin
Human,02401347,Adcetris,brentuximab vedotin 50 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2025-10-09,L01FX05,Brentuximab vedotin
Human,02450283,Blincyto,blinatumomab 38.5 mcg / vial powder for solution for injection,Amgen Canada Inc,2.0,P,2.0,Marketed,2016-03-17,L01FX07,Blinatumomab
Human,02527715,Poteligeo,mogamulizumab 4 mg / mL solution for injection,"Kyowa Kirin, Inc.",1.0,,,Marketed,2024-03-27,L01FX09,Mogamulizumab
Human,02518627,Minjuvi,tafasitamab 200 mg / vial powder for solution for injection,Incyte Corporation,1.0,,,Marketed,2021-12-06,L01FX12,Tafasitamab
Human,02521903,Padcev,enfortumab vedotin 20 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2025-09-19,L01FX13,Enfortumab vedotin
Human,02521911,Padcev,enfortumab vedotin 30 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2025-09-19,L01FX13,Enfortumab vedotin
Human,02499614,Polivy,polatuzumab vedotin 140 mg / vial powder for solution for injection,Hoffmann-La Roche Limited,1.0,CK,1.0,Marketed,2020-11-25,L01FX14,Polatuzumab vedotin
Human,02515431,Polivy,polatuzumab vedotin 30 mg / vial powder for solution for injection,Hoffmann-La Roche Limited,1.0,CK,1.0,Marketed,2021-10-26,L01FX14,Polatuzumab vedotin
Human,02559625,Blenrep,belantamab mafodotin 100 mg / vial powder for solution for injection,Glaxosmithkline Inc,1.0,CK,1.0,Marketed,2025-08-11,L01FX15,Belantamab mafodotin
Human,02559617,Blenrep,belantamab mafodotin 70 mg / vial powder for solution for injection,Glaxosmithkline Inc,1.0,CK,1.0,Marketed,2025-08-11,L01FX15,Belantamab mafodotin
Human,02520788,Trodelvy,sacituzumab govitecan 180 mg / vial powder for solution for injection,Gilead Sciences Canada Inc,1.0,CK,1.0,Marketed,2021-11-22,L01FX17,Sacituzumab govitecan
Human,02526182,Rybrevant,amivantamab 350 mg / 7 mL solution for injection,Janssen Inc,2.0,,,Marketed,2022-04-26,L01FX18,Amivantamab
Human,02541009,Imjudo,tremelimumab 20 mg / mL solution for injection,Astrazeneca Canada Inc,2.0,,,Marketed,2023-10-23,L01FX20,Tremelimumab
Human,02556138,Zynlonta,loncastuximab tesirine 10 mg / vial powder for solution for injection,Swedish Orphan Biovitrum Ab (Publ),,K,1.0,Approved,2025-03-07,L01FX22,Loncastuximab tesirine
Human,02539764,Tecvayli,teclistamab 153 mg / 1.7 mL solution for injection,Janssen Inc,2.0,,,Marketed,2023-10-20,L01FX24,Teclistamab
Human,02539756,Tecvayli,teclistamab 30 mg / 3 mL solution for injection,Janssen Inc,2.0,,,Marketed,2023-10-20,L01FX24,Teclistamab
Human,02560771,Elahere,mirvetuximab soravtansine 100 mg / 20 mL solution for injection,Abbvie Corporation,1.0,K,1.0,Marketed,2026-01-09,L01FX26,Mirvetuximab soravtansine
Human,02542293,Epkinly,epcoritamab 5 mg / mL solution for injection,Abbvie Corporation,2.0,,,Marketed,2023-12-18,L01FX27,Epcoritamab
Human,02542307,Epkinly,epcoritamab 60 mg / mL solution for injection,Abbvie Corporation,2.0,,,Marketed,2023-12-18,L01FX27,Epcoritamab
Human,02536560,Columvi,glofitamab 10 mg / 10 mL solution for injection,Hoffmann-La Roche Limited,2.0,,,Marketed,2023-07-05,L01FX28,Glofitamab
Human,02536552,Columvi,glofitamab 2.5 mg / 2.5 mL solution for injection,Hoffmann-La Roche Limited,2.0,,,Marketed,2023-07-05,L01FX28,Glofitamab
Human,02547392,Talvey,talquetamab 2 mg / mL solution for injection,Janssen Inc,2.0,,,Marketed,2025-03-04,L01FX29,Talquetamab
Human,02547406,Talvey,talquetamab 40 mg / mL solution for injection,Janssen Inc,2.0,,,Marketed,2025-03-04,L01FX29,Talquetamab
Human,02543559,Elrexfio,elranatamab 44 mg / 1.1 mL solution for injection,Pfizer Canada Ulc,2.0,,,Marketed,2024-01-23,L01FX32,Elranatamab
Human,02543567,Elrexfio,elranatamab 76 mg / 1.9 mL solution for injection,Pfizer Canada Ulc,2.0,,,Marketed,2024-01-23,L01FX32,Elranatamab
Human,02551551,Imdelltra,tarlatamab 1 mg / vial powder for solution for injection,Amgen Canada Inc,2.0,,,Marketed,2024-11-28,L01FX33,Tarlatamab
Human,02551578,Imdelltra,tarlatamab 10 mg / vial powder for solution for injection,Amgen Canada Inc,2.0,,,Marketed,2024-11-28,L01FX33,Tarlatamab
Human,02405024,Perjeta-Herceptin,pertuzumab 420 mg / 14 mL with trastuzumab 440 mg / vial kit (powder for solution and solution) for injection,Hoffmann-La Roche Limited,1.0,CK,1.0,Marketed,2013-05-09,L01FY01,Pertuzumab and trastuzumab
Human,02512920,Phesgo,pertuzumab 60 mg / mL + trastuzumab 60 mg / mL solution for injection,Hoffmann-La Roche Limited,1.0,CK,1.0,Marketed,2021-04-09,L01FY01,Pertuzumab and trastuzumab
Human,02512912,Phesgo,pertuzumab 80 mg / mL + trastuzumab 40 mg / mL solution for injection,Hoffmann-La Roche Limited,1.0,CK,1.0,Marketed,2021-04-08,L01FY01,Pertuzumab and trastuzumab
Human,02541416,Opdualag,nivolumab 240 mg / 20 mL + relatlimab 80 mg / 20 mL solution for injection,Bristol-Myers Squibb Canada,2.0,,,Marketed,2024-02-12,L01FY02,Nivolumab and relatlimab
Human,00644293,Cisplatin Inj 0.5Mg/Ml,cisplatin 0.5 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,1996-09-10,L01XA01,Cisplatin
Human,00692743,Cisplatin Inj 1Mg/Ml,cisplatin 1 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,CK,1.0,Cancelled post market,1998-08-13,L01XA01,Cisplatin
Human,00788740,Platinol Aq Inj 1Mg/Ml,cisplatin 1 mg / mL liquid for injection,Bristol Labs Division Of Bristol-Myers Squibb,1.0,CK,1.0,Cancelled post market,2001-07-30,L01XA01,Cisplatin
Human,02393832,Cisplatin Injection,cisplatin 1 mg / mL solution for injection,Strides Pharma Canada Inc,1.0,CK,1.0,Approved,2020-07-28,L01XA01,Cisplatin
Human,02403188,Cisplatin Injection,cisplatin 1 mg / mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2013-08-29,L01XA01,Cisplatin
Human,02409186,Cisplatin Injection,cisplatin 1 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Approved,2015-05-19,L01XA01,Cisplatin
Human,02422034,Cisplatin Injection,cisplatin 1 mg / mL solution for injection,Omega Laboratories Limited,1.0,CK,1.0,Approved,2014-03-06,L01XA01,Cisplatin
Human,02126613,Cisplatin Injection Bp,cisplatin 1 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2017-11-29,L01XA01,Cisplatin
Human,02366711,Cisplatin Injection Bp,cisplatin 1 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled post market,2022-07-25,L01XA01,Cisplatin
Human,02536285,Cisplatin Injection Bp,cisplatin 1 mg / mL solution for injection,Hikma Canada Limited,1.0,CK,1.0,Marketed,2024-02-23,L01XA01,Cisplatin
Human,02355183,"Cisplatin Injection, Bp",cisplatin 1 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2012-04-10,L01XA01,Cisplatin
Human,02396890,"Cisplatin Injection, Mylan Std.",cisplatin 1 mg / mL solution for injection,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled post market,2016-07-06,L01XA01,Cisplatin
Human,02409194,Pms-Cisplatin,cisplatin 1 mg / mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Cancelled pre market,2017-08-03,L01XA01,Cisplatin
Human,01990438,Carboplatin Injection Liq 10Mg/Ml,carboplatin 10 mg / mL liquid for injection,David Bull Laboratories (Pty) Ltd.,1.0,K,1.0,Cancelled post market,1998-08-13,L01XA02,Carboplatin
Human,00788759,Paraplatin-Aq Inj 10Mg/Ml,carboplatin 10 mg / mL liquid for injection,Bristol-Myers Squibb Canada,1.0,K,1.0,Cancelled post market,2007-07-30,L01XA02,Carboplatin
Human,02125439,Carboplatin Injection,carboplatin 10 mg / mL solution for injection,Teva Canada Limited,1.0,K,1.0,Marketed,2013-11-08,L01XA02,Carboplatin
Human,02366053,Carboplatin Injection,carboplatin 10 mg / mL solution for injection,Omega Laboratories Limited,1.0,K,1.0,Dormant,2020-07-28,L01XA02,Carboplatin
Human,02528916,Carboplatin Injection,carboplatin 10 mg / mL solution for injection,Auro Pharma Inc,1.0,K,1.0,Approved,2022-07-12,L01XA02,Carboplatin
Human,02535289,Carboplatin Injection,carboplatin 10 mg / mL solution for injection,Eugia Pharma Inc.,1.0,K,1.0,Approved,2023-02-09,L01XA02,Carboplatin
Human,02126680,Carboplatin Injection Bp,carboplatin 10 mg / mL solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2017-11-11,L01XA02,Carboplatin
Human,02320371,Carboplatin Injection Bp,carboplatin 10 mg / mL solution for injection,Accord Healthcare Inc,1.0,K,1.0,Marketed,2015-03-11,L01XA02,Carboplatin
Human,02420228,"Carboplatin Injection, Bp",carboplatin 10 mg / mL solution for injection,Strides Pharma Canada Inc,1.0,K,1.0,Approved,2020-05-20,L01XA02,Carboplatin
Human,00680060,Paraplatin Inj 150Mg/Vial,carboplatin 150 mg / vial powder for solution for injection,Bristol Labs Division Of Bristol-Myers Squibb,1.0,K,1.0,Cancelled post market,1996-09-09,L01XA02,Carboplatin
Human,02430533,Act Oxaliplatin,oxaliplatin 100 mg / vial powder for solution for injection,Actavis Pharma Company,1.0,CK,1.0,Cancelled pre market,2018-07-24,L01XA03,Oxaliplatin
Human,02296276,Eloxatin,oxaliplatin 100 mg / vial powder for solution for injection,Sanofi-Aventis Canada Inc,1.0,CK,1.0,Cancelled post market,2016-08-04,L01XA03,Oxaliplatin
Human,02413841,Oxaliplatin For Injection,oxaliplatin 100 mg / vial powder for solution for injection,Hospira Healthcare Ulc,1.0,CK,1.0,Cancelled pre market,2018-10-25,L01XA03,Oxaliplatin
Human,02432617,Act Oxaliplatin,oxaliplatin 5 mg / mL solution for injection,Actavis Pharma Company,1.0,CK,1.0,Cancelled post market,2018-07-09,L01XA03,Oxaliplatin
Human,02296284,Eloxatin,oxaliplatin 5 mg / mL solution for injection,Sanofi-Aventis Canada Inc,1.0,CK,1.0,Cancelled post market,2018-11-09,L01XA03,Oxaliplatin
Human,02444763,Oxaliplatin,oxaliplatin 5 mg / mL solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2019-01-16,L01XA03,Oxaliplatin
Human,02431688,Oxaliplatin Injection,oxaliplatin 5 mg / mL solution for injection,Hospira Healthcare Ulc,1.0,CK,1.0,Cancelled pre market,2018-10-26,L01XA03,Oxaliplatin
Human,02435071,Oxaliplatin Injection,oxaliplatin 5 mg / mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2015-12-16,L01XA03,Oxaliplatin
Human,02436167,Oxaliplatin Injection,oxaliplatin 5 mg / mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Cancelled post market,2025-10-28,L01XA03,Oxaliplatin
Human,02436957,Oxaliplatin Injection,oxaliplatin 5 mg / mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2015-12-17,L01XA03,Oxaliplatin
Human,02454084,Oxaliplatin Injection,oxaliplatin 5 mg / mL solution for injection,Generic Medical Partners Inc,1.0,CK,1.0,Approved,2016-04-25,L01XA03,Oxaliplatin
Human,02532131,Oxaliplatin Injection,oxaliplatin 5 mg / mL solution for injection,Auro Pharma Inc,1.0,CK,1.0,Approved,2022-10-21,L01XA03,Oxaliplatin
Human,02536757,Oxaliplatin Injection,oxaliplatin 5 mg / mL solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2023-03-30,L01XA03,Oxaliplatin
Human,02433206,Oxaliplatin Injection Usp,oxaliplatin 5 mg / mL solution for injection,Strides Pharma Canada Inc,1.0,CK,1.0,Approved,2020-08-12,L01XA03,Oxaliplatin
Human,02457423,"Oxaliplatin Injection, Usp",oxaliplatin 5 mg / mL solution for injection,Fresenius Kabi Canada Ltd,1.0,CK,1.0,Marketed,2022-03-31,L01XA03,Oxaliplatin
Human,02458403,"Oxaliplatin Injection, Usp",oxaliplatin 5 mg / mL solution for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Marketed,2022-07-13,L01XA03,Oxaliplatin
Human,02437074,Pms-Oxaliplatin,oxaliplatin 5 mg / mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Cancelled post market,2025-07-04,L01XA03,Oxaliplatin
Human,02449692,Taro-Oxaliplatin,oxaliplatin 5 mg / mL solution for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Cancelled post market,2024-09-18,L01XA03,Oxaliplatin
Human,02446227,Teva-Oxaliplatin Injection,oxaliplatin 5 mg / mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled pre market,2021-07-29,L01XA03,Oxaliplatin
Human,02430525,Act Oxaliplatin,oxaliplatin 50 mg / vial powder for solution for injection,Actavis Pharma Company,1.0,CK,1.0,Cancelled pre market,2018-07-24,L01XA03,Oxaliplatin
Human,02296268,Eloxatin,oxaliplatin 50 mg / vial powder for solution for injection,Sanofi-Aventis Canada Inc,1.0,CK,1.0,Cancelled post market,2016-08-03,L01XA03,Oxaliplatin
Human,02413833,Oxaliplatin For Injection,oxaliplatin 50 mg / vial powder for solution for injection,Hospira Healthcare Ulc,1.0,CK,1.0,Cancelled pre market,2018-10-25,L01XA03,Oxaliplatin
Human,00012750,Matulane,procarbazine (procarbazine hydrochloride) 50 mg oral capsule,"Leadiant Biosciences, Inc",1.0,CK,1.0,Marketed,2018-05-09,L01XB01,Procarbazine
Human,02020033,Photofrin,porfimer sodium 15 mg / vial powder for solution for injection,Concordia Laboratories Inc,,CK,,Cancelled post market,2014-11-21,L01XD01,Porfimer sodium
Human,02019876,Photofrin,porfimer sodium 75 mg / vial powder for solution for injection,Concordia Laboratories Inc,,CK,,Cancelled post market,2019-07-18,L01XD01,Porfimer sodium
Human,02520036,Jamp Tretinoin,tretinoin 10 mg oral capsule,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2022-08-29,L01XF01,Tretinoin
Human,02145839,Vesanoid,tretinoin 10 mg oral capsule,Cheplapharm Arzneimittel Gmbh,2.0,R,2.0,Marketed,2013-10-21,L01XF01,Tretinoin
Human,02480255,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 1 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Approved,2019-09-26,L01XG01,Bortezomib
Human,02494922,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 1 mg / vial powder for solution for injection,Juno Pharmaceuticals Corp.,1.0,CK,1.0,Approved,2020-07-03,L01XG01,Bortezomib
Human,02521814,Taro-Bortezomib,bortezomib (bortezomib mannitol boronic ester) 1 mg / vial powder for solution for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Approved,2021-11-01,L01XG01,Bortezomib
Human,02550075,Bortezomib Injection,bortezomib (bortezomib mannitol boronic ester) 2.5 mg / mL solution for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Marketed,2025-07-21,L01XG01,Bortezomib
Human,02467003,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 2.5 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Marketed,2020-06-23,L01XG01,Bortezomib
Human,02494930,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 2.5 mg / vial powder for solution for injection,Juno Pharmaceuticals Corp.,1.0,CK,1.0,Dormant,2024-07-19,L01XG01,Bortezomib
Human,02511932,Taro-Bortezomib,bortezomib (bortezomib mannitol boronic ester) 2.5 mg / vial powder for solution for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2022-07-18,L01XG01,Bortezomib
Human,02480263,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Approved,2019-09-26,L01XG01,Bortezomib
Human,02438399,Act Bortezomib,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2020-12-30,L01XG01,Bortezomib
Human,02456176,Bortezomib,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Apotex Inc,1.0,CK,1.0,Marketed,2019-03-25,L01XG01,Bortezomib
Human,02423405,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Teva Canada Limited,1.0,CK,1.0,Marketed,2015-05-20,L01XG01,Bortezomib
Human,02452456,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Dr Reddy'S Laboratories Ltd,1.0,CK,1.0,Marketed,2017-03-21,L01XG01,Bortezomib
Human,02453487,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled pre market,2021-04-21,L01XG01,Bortezomib
Human,02467011,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,CK,1.0,Approved,2017-08-09,L01XG01,Bortezomib
Human,02485257,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Juno Pharmaceuticals Corp.,1.0,CK,1.0,Marketed,2023-03-28,L01XG01,Bortezomib
Human,02493306,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2020-05-19,L01XG01,Bortezomib
Human,02497433,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Auro Pharma Inc,1.0,CK,1.0,Approved,2020-08-13,L01XG01,Bortezomib
Human,02536773,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2023-03-30,L01XG01,Bortezomib
Human,02541777,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Generic Medical Partners Inc,1.0,CK,1.0,Approved,2023-10-06,L01XG01,Bortezomib
Human,02547287,Bortezomib For Injection,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Hikma Canada Limited,1.0,CK,1.0,Approved,2024-05-01,L01XG01,Bortezomib
Human,02503352,Bortezomib For Injection Sdz,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2022-01-31,L01XG01,Bortezomib
Human,02466708,Pms-Bortezomib,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2018-06-05,L01XG01,Bortezomib
Human,02499061,Taro-Bortezomib,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Taro Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2021-04-12,L01XG01,Bortezomib
Human,02262452,Velcade,bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial powder for solution for injection,Janssen Inc,1.0,CK,1.0,Marketed,2005-02-01,L01XG01,Bortezomib
Human,02459930,Kyprolis,carfilzomib 10 mg / vial powder for solution for injection,Amgen Canada Inc,2.0,R,,Marketed,2017-02-13,L01XG02,Carfilzomib
Human,02459949,Kyprolis,carfilzomib 30 mg / vial powder for solution for injection,Amgen Canada Inc,2.0,R,,Marketed,2017-02-06,L01XG02,Carfilzomib
Human,02451034,Kyprolis,carfilzomib 60 mg / vial powder for solution for injection,Amgen Canada Inc,2.0,R,,Marketed,2016-02-11,L01XG02,Carfilzomib
Human,02456796,Ninlaro,ixazomib (ixazomib citrate) 2.3 mg oral capsule,Takeda Canada Inc,1.0,CK,1.0,Marketed,2016-09-21,L01XG03,Ixazomib
Human,02456818,Ninlaro,ixazomib (ixazomib citrate) 3 mg oral capsule,Takeda Canada Inc,1.0,CK,1.0,Marketed,2016-09-21,L01XG03,Ixazomib
Human,02456826,Ninlaro,ixazomib (ixazomib citrate) 4 mg oral capsule,Takeda Canada Inc,1.0,CK,1.0,Marketed,2016-09-21,L01XG03,Ixazomib
Human,02327619,Zolinza,vorinostat 100 mg oral capsule,Merck Canada Inc,1.0,CK,1.0,Marketed,2009-06-29,L01XH01,Vorinostat
Human,02414295,Istodax,romidepsin 10 mg / vial kit (powder for solution) for injection,Bristol-Myers Squibb Canada,1.0,CK,1.0,Marketed,2025-11-04,L01XH02,Romidepsin
Human,02409267,Erivedge,vismodegib 150 mg oral capsule,Hoffmann-La Roche Limited,2.0,R,2.0,Marketed,2013-08-09,L01XJ01,Vismodegib
Human,02500337,Odomzo,sonidegib (sonidegib phosphate) 200 mg oral capsule,Sun Pharmaceutical Industries Limited,2.0,R,2.0,Marketed,2022-01-04,L01XJ02,Sonidegib
Human,02498480,Daurismo,glasdegib (glasdegib maleate) 100 mg oral tablet,Pfizer Canada Ulc,,P,,Marketed,2020-08-10,L01XJ03,Glasdegib
Human,02498472,Daurismo,glasdegib (glasdegib maleate) 25 mg oral tablet,Pfizer Canada Ulc,,P,,Marketed,2020-08-10,L01XJ03,Glasdegib
Human,02475200,Lynparza,olaparib 100 mg oral tablet,Astrazeneca Canada Inc,2.0,P,2.0,Marketed,2018-05-23,L01XK01,Olaparib
Human,02475219,Lynparza,olaparib 150 mg oral tablet,Astrazeneca Canada Inc,2.0,P,2.0,Marketed,2018-05-23,L01XK01,Olaparib
Human,02454408,Lynparza,olaparib 50 mg oral capsule,Astrazeneca Canada Inc,2.0,P,2.0,Cancelled post market,2021-01-11,L01XK01,Olaparib
Human,02489783,Zejula,niraparib (niraparib tosylate) 100 mg oral capsule,Glaxosmithkline Inc,1.0,CK,,Dormant,2024-10-26,L01XK02,Niraparib
Human,02530031,Zejula,niraparib (niraparib tosylate) 100 mg oral tablet,Glaxosmithkline Inc,1.0,CK,,Marketed,2023-09-13,L01XK02,Niraparib
Human,02555050,Talzenna,talazoparib (talazoparib tosylate) 0.1 mg oral capsule,Pfizer Canada Ulc,1.0,CK,,Marketed,2025-05-16,L01XK04,Talazoparib
Human,02492032,Talzenna,talazoparib (talazoparib tosylate) 0.25 mg oral capsule,Pfizer Canada Ulc,1.0,CK,,Marketed,2025-05-16,L01XK04,Talazoparib
Human,02555069,Talzenna,talazoparib (talazoparib tosylate) 0.35 mg oral capsule,Pfizer Canada Ulc,1.0,CK,,Approved,2025-01-30,L01XK04,Talazoparib
Human,02555077,Talzenna,talazoparib (talazoparib tosylate) 0.5 mg oral capsule,Pfizer Canada Ulc,1.0,CK,,Approved,2025-01-30,L01XK04,Talazoparib
Human,02492040,Talzenna,talazoparib (talazoparib tosylate) 1 mg oral capsule,Pfizer Canada Ulc,1.0,CK,,Approved,2019-09-06,L01XK04,Talazoparib
Human,02538563,Akeega,abiraterone acetate 500 mg + niraparib (niraparib tosylate) 100 mg oral tablet,Janssen Inc,1.0,CK,2.0,Marketed,2023-08-14,L01XK52,Niraparib and abiraterone
Human,02538555,Akeega,abiraterone acetate 500 mg + niraparib (niraparib tosylate) 50 mg oral tablet,Janssen Inc,1.0,CK,2.0,Marketed,2023-08-14,L01XK52,Niraparib and abiraterone
Human,02485435,Idhifa,enasidenib (enasidenib mesylate) 100 mg oral tablet,Celgene Inc,,P,,Cancelled post market,2023-06-30,L01XM01,Enasidenib
Human,02485427,Idhifa,enasidenib (enasidenib mesylate) 50 mg oral tablet,Celgene Inc,,P,,Cancelled post market,2023-06-30,L01XM01,Enasidenib
Human,02549980,Tibsovo,ivosidenib 250 mg oral immediate release tablet,Servier Canada Inc,2.0,R,,Marketed,2024-10-28,L01XM02,Ivosidenib
Human,02551225,Voranigo,vorasidenib 10 mg oral tablet,Servier Canada Inc,2.0,,,Marketed,2024-10-21,L01XM04,Vorasidenib
Human,02551233,Voranigo,vorasidenib 40 mg oral tablet,Servier Canada Inc,2.0,,,Marketed,2024-10-21,L01XM04,Vorasidenib
Human,00582212,Amsa Pd,amsacrine 50 mg / mL liquid for injection,Searchlight Pharma Inc,1.0,CK,1.0,Cancelled post market,2024-07-18,L01XX01,Amsacrine
Human,02126230,Hexalen,altretamine 50 mg oral capsule,Eisai Inc,1.0,CK,1.0,Cancelled post market,2013-09-09,L01XX03,Altretamine
Human,02247937,Apo-Hydroxyurea,hydroxyurea 500 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2017-12-12,L01XX05,Hydroxycarbamide
Human,02552582,Eugia-Hydroxyurea,hydroxyurea 500 mg oral capsule,Eugia Pharma Inc.,1.0,K,1.0,Approved,2024-10-22,L01XX05,Hydroxycarbamide
Human,00465283,Hydrea,hydroxyurea 500 mg oral capsule,Cheplapharm Arzneimittel Gmbh,1.0,K,1.0,Marketed,2022-11-18,L01XX05,Hydroxycarbamide
Human,02343096,Hydroxyurea,hydroxyurea 500 mg oral capsule,Sanis Health Inc,1.0,K,1.0,Cancelled post market,2017-07-31,L01XX05,Hydroxycarbamide
Human,02242920,Mylan-Hydroxyurea,hydroxyurea 500 mg oral capsule,Mylan Pharmaceuticals Ulc,1.0,K,1.0,Marketed,2010-01-29,L01XX05,Hydroxycarbamide
Human,02530260,Riva-Hydroxyurea,hydroxyurea 500 mg oral capsule,Laboratoire Riva Inc.,1.0,K,1.0,Marketed,2023-05-01,L01XX05,Hydroxycarbamide
Human,02011247,Nipent Pws 10Mg/Vial,pentostatin 10 mg / vial powder for solution for injection,"Parke-Davis Division, Warner-Lambert Canada Inc.",1.0,CK,1.0,Cancelled post market,1997-08-25,L01XX08,Pentostatin
Human,02063794,Emcyt,estramustine phosphate sodium 140 mg oral capsule,Pfizer Canada Ulc,1.0,CK,1.0,Cancelled post market,2020-04-30,L01XX11,Estramustine
Human,01990934,Emcyt Cap 140Mg,estramustine phosphate sodium 140 mg oral capsule,Kabi Pharmacia Canada Inc.,1.0,CK,1.0,Cancelled post market,1996-09-10,L01XX11,Estramustine
Human,00463221,Lysodren,mitotane 500 mg oral tablet,Esteve Pharmaceuticals S.A.,1.0,CK,1.0,Marketed,2025-06-26,L01XX23,Mitotane
Human,02492768,Arsenic Trioxide For Injection,arsenic trioxide 1 mg / mL solution for injection,Sterimax Inc,1.0,CK,1.0,Marketed,2019-12-20,L01XX27,Arsenic trioxide
Human,02554364,Arsenic Trioxide For Injection,arsenic trioxide 1 mg / mL solution for injection,Marcan Pharmaceuticals Inc,1.0,CK,1.0,Marketed,2025-05-27,L01XX27,Arsenic trioxide
Human,02513420,Arsenic Trioxide For Injection,arsenic trioxide 10 mg / 10 mL solution for injection,Sandoz Canada Incorporated,1.0,CK,1.0,Marketed,2022-03-11,L01XX27,Arsenic trioxide
Human,02487357,Arsenic Trioxide Solution For Injection,arsenic trioxide 10 mg / 10 mL solution for injection,Phebra Pty Ltd,1.0,CK,1.0,Marketed,2020-01-31,L01XX27,Arsenic trioxide
Human,02484358,Teva-Arsenic Trioxide For Injection,arsenic trioxide 10 mg / 10 mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled pre market,2021-07-29,L01XX27,Arsenic trioxide
Human,02407833,Trisenox,arsenic trioxide 10 mg / 10 mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled post market,2022-12-16,L01XX27,Arsenic trioxide
Human,02484366,Teva-Arsenic Trioxide For Injection,arsenic trioxide 12 mg / 6 mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled pre market,2021-07-29,L01XX27,Arsenic trioxide
Human,02480387,Trisenox,arsenic trioxide 12 mg / 6 mL solution for injection,Teva Canada Limited,1.0,CK,1.0,Cancelled post market,2023-04-18,L01XX27,Arsenic trioxide
Human,02540517,Arsenic Trioxide For Injection,arsenic trioxide 2 mg / mL solution for injection,Auro Pharma Inc,1.0,CK,1.0,Approved,2023-08-17,L01XX27,Arsenic trioxide
Human,02541971,Arsenic Trioxide For Injection,arsenic trioxide 2 mg / mL solution for injection,Eugia Pharma Inc.,1.0,CK,1.0,Approved,2023-10-06,L01XX27,Arsenic trioxide
Human,02545950,Eribulin Mesylate Injection,eribulin mesylate 0.5 mg / mL solution for injection,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2025-07-11,L01XX41,Eribulin
Human,02560399,Eribulin Mesylate Injection,eribulin mesylate 0.5 mg / mL solution for injection,Baxter Corporation,1.0,K,1.0,Approved,2025-10-10,L01XX41,Eribulin
Human,02564467,Eribulin Mesylate Injection,eribulin mesylate 0.5 mg / mL solution for injection,Marcan Pharmaceuticals Inc,1.0,K,1.0,Approved,2026-01-09,L01XX41,Eribulin
Human,02377438,Halaven,eribulin mesylate 0.5 mg / mL solution for injection,Eisai Limited,1.0,K,1.0,Marketed,2012-03-19,L01XX41,Eribulin
Human,02539136,Nat-Eribulin,eribulin mesylate 0.5 mg / mL solution for injection,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2024-01-08,L01XX41,Eribulin
Human,02421070,Zaltrap,aflibercept 100 mg / 4 mL solution for injection,Sanofi-Aventis Canada Inc,2.0,R,,Cancelled post market,2020-07-13,L01XX44,Aflibercept
Human,02421089,Zaltrap,aflibercept 200 mg / 8 mL solution for injection,Sanofi-Aventis Canada Inc,2.0,R,,Cancelled post market,2020-07-13,L01XX44,Aflibercept
Human,02458039,Venclexta,venetoclax 10 mg oral tablet,Abbvie Corporation,1.0,CK,,Marketed,2016-10-31,L01XX52,Venetoclax
Human,02458063,Venclexta,venetoclax 10 mg with venetoclax 100 mg with venetoclax 50 mg oral kit (tablet),Abbvie Corporation,1.0,CK,,Marketed,2016-10-31,L01XX52,Venetoclax
Human,02458055,Venclexta,venetoclax 100 mg oral tablet,Abbvie Corporation,1.0,CK,,Marketed,2016-10-31,L01XX52,Venetoclax
Human,02458047,Venclexta,venetoclax 50 mg oral tablet,Abbvie Corporation,1.0,CK,,Marketed,2016-10-31,L01XX52,Venetoclax
Human,02527677,Xpovio,selinexor 20 mg oral tablet,Forus Therapeutics Inc.,2.0,P,,Marketed,2022-07-07,L01XX66,Selinexor
Human,02520834,Zepzelca,lurbinectedin 4 mg / vial powder for injection,Jazz Pharmaceuticals Ireland Limited,1.0,K,1.0,Marketed,2021-12-06,L01XX69,Lurbinectedin
Human,02520095,Lumakras,sotorasib 120 mg oral tablet,Amgen Canada Inc,,P,,Marketed,2021-10-22,L01XX73,Sotorasib
Human,02552655,Lumakras,sotorasib 240 mg oral tablet,Amgen Canada Inc,,P,,Marketed,2025-10-14,L01XX73,Sotorasib
Human,02528908,Welireg,belzutifan 40 mg oral tablet,Merck Canada Inc,1.0,R,,Marketed,2022-09-01,L01XX74,Belzutifan
Human,02527588,Kimmtrak,tebentafusp 100 mcg / 0.5 mL solution for injection,Immunocore Ireland Limited,2.0,,,Marketed,2022-08-23,L01XX75,Tebentafusp
Human,02515490,Vyxeos,cytarabine 100 mg + daunorubicin 44 mg powder for injection,Jazz Pharmaceuticals Ireland Limited,1.0,CK,1.0,Marketed,2021-07-06,L01XY01,Cytarabine and daunorubicin
Human,02091488,Stilbestrol Tablets 0.1 Mg,diethylstilbestrol 0.105 mg oral tablet,Wellspring Pharmaceutical Canada Corp,1.0,K,1.0,Cancelled post market,2009-02-23,L02AA01,Diethylstilbestrol
Human,01904426,Stilbestrol 0.5Mg Tablet,diethylstilbestrol 0.5 mg / tablet oral tablet,Glaxo Canada Inc,1.0,K,1.0,Cancelled post market,1998-07-30,L02AA01,Diethylstilbestrol
Human,02100304,Stilbestrol Tablets 0.5 Mg,diethylstilbestrol 0.51 mg oral tablet,Wellspring Pharmaceutical Canada Corp,1.0,K,1.0,Cancelled post market,2009-02-23,L02AA01,Diethylstilbestrol
Human,01904434,Stilbestrol 1.0Mg Tablet,diethylstilbestrol 1 mg / tablet oral tablet,Glaxo Canada Inc,1.0,K,1.0,Cancelled post market,1996-09-10,L02AA01,Diethylstilbestrol
Human,02091461,Stilbestrol Tablets 1.0 Mg,diethylstilbestrol 1 mg oral tablet,Wellspring Pharmaceutical Canada Corp,1.0,K,1.0,Cancelled post market,2009-02-23,L02AA01,Diethylstilbestrol
Human,00013781,Honvol Tablets 100Mg,diethylstilbestrol diphosphate sodium 100 mg / tablet oral tablet,Carter-Horner Corp.,1.0,K,1.0,Cancelled post market,2001-05-22,L02AA01,Diethylstilbestrol
Human,00013587,Honvol Ampoules 250Mg,diethylstilbestrol diphosphate sodium 250 mg / 5 mL liquid for injection,Carter-Horner Corp.,1.0,K,1.0,Cancelled post market,2000-11-17,L02AA01,Diethylstilbestrol
Human,02405512,Apo-Megestrol,megestrol acetate 160 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2021-06-24,L02AB01,Megestrol
Human,02176106,Linmegestrol - Tab 160Mg,megestrol acetate 160 mg oral tablet,Linson Pharma Co.,2.0,P,2.0,Cancelled post market,2006-05-29,L02AB01,Megestrol
Human,00731323,Megace,megestrol acetate 160 mg oral tablet,Bristol-Myers Squibb Canada,2.0,P,2.0,Cancelled post market,2009-03-09,L02AB01,Megestrol
Human,02185423,Megestrol,megestrol acetate 160 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2020-12-16,L02AB01,Megestrol
Human,02195925,Megestrol,megestrol acetate 160 mg oral tablet,Aa Pharma Inc,2.0,P,2.0,Marketed,2021-09-23,L02AB01,Megestrol
Human,02223112,Megestrol-160 - Tab 160 Mg,megestrol acetate 160 mg oral tablet,Pro Doc Limitee,2.0,P,2.0,Cancelled post market,2010-07-13,L02AB01,Megestrol
Human,02168979,Megace Os,megestrol acetate 40 mg / mL oral suspension,Bristol-Myers Squibb Canada,2.0,P,2.0,Cancelled post market,2017-10-20,L02AB01,Megestrol
Human,02405504,Apo-Megestrol,megestrol acetate 40 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2021-06-24,L02AB01,Megestrol
Human,02176092,Linmegestrol - Tab 40Mg,megestrol acetate 40 mg oral tablet,Linson Pharma Co.,2.0,P,2.0,Cancelled post market,2004-08-05,L02AB01,Megestrol
Human,00386391,Megace,megestrol acetate 40 mg oral tablet,Bristol-Myers Squibb Canada,2.0,P,2.0,Cancelled post market,2006-05-29,L02AB01,Megestrol
Human,02185415,Megestrol,megestrol acetate 40 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2020-12-16,L02AB01,Megestrol
Human,02195917,Megestrol,megestrol acetate 40 mg oral tablet,Aa Pharma Inc,2.0,P,2.0,Marketed,2021-09-23,L02AB01,Megestrol
Human,02223104,Megestrol-40 - Tab 40Mg,megestrol acetate 40 mg oral tablet,Pro Doc Limitee,2.0,P,2.0,Cancelled post market,2010-07-13,L02AB01,Megestrol
Human,00680028,Suprefact Inj 1Mg/Ml,buserelin (buserelin acetate) 1 mg / mL liquid for injection,Hoechst Canada Inc.,2.0,R,,Cancelled post market,1998-08-25,L02AE01,Buserelin
Human,01989669,Suprefact Liq 1Mg/Ml,buserelin (buserelin acetate) 1 mg / mL nasal liquid,Hoechst Roussel Canada Inc.,2.0,R,,Cancelled post market,2000-07-28,L02AE01,Buserelin
Human,02225166,Suprefact,buserelin (buserelin acetate) 1 mg / mL solution for injection,Cheplapharm Arzneimittel Gmbh,2.0,R,,Marketed,2020-06-05,L02AE01,Buserelin
Human,02225158,Suprefact,buserelin (buserelin acetate) 100 mcg / actuation nasal solution,Cheplapharm Arzneimittel Gmbh,2.0,R,,Cancelled post market,2022-04-29,L02AE01,Buserelin
Human,02228955,Suprefact Depot 2 Months,buserelin (buserelin acetate) 6.3 mg implant for injection,Cheplapharm Arzneimittel Gmbh,2.0,R,,Dormant,2025-11-01,L02AE01,Buserelin
Human,02240749,Suprefact Depot 3 Months,buserelin (buserelin acetate) 9.45 mg implant for injection,Cheplapharm Arzneimittel Gmbh,2.0,R,,Dormant,2024-10-13,L02AE01,Buserelin
Human,00680036,Suprefact Intranasal Solution 1Mg/Ml,buserelin acetate 1 mg / mL nasal spray,Hoechst Canada Inc.,2.0,R,,Cancelled post market,1996-08-29,L02AE01,Buserelin
Human,02522446,Camcevi,leuprolide (leuprolide mesylate) 42 mg / syrup prolonged-release emulsion for injection,Accord Healthcare Inc,2.0,R,2.0,Approved,2021-11-16,L02AE02,Leuprorelin
Human,02239834,Lupron Depot,leuprolide acetate 11.25 mg / syrup sustained-release powder for suspension for injection,Abbvie Corporation,2.0,R,2.0,Marketed,2013-11-04,L02AE02,Leuprorelin
Human,02148722,Lupron Depot,leuprolide acetate 11.25 mg / vial sustained-release powder for suspension for injection,Abbvie Corporation,2.0,R,2.0,Cancelled pre market,2016-06-22,L02AE02,Leuprorelin
Human,02148730,Lupron Depot,leuprolide acetate 15 mg / vial sustained-release powder for suspension for injection,Abbvie Corporation,2.0,R,2.0,Cancelled pre market,2016-06-22,L02AE02,Leuprorelin
Human,02248240,Eligard,leuprolide acetate 22.5 mg / syrup sustained-release powder for suspension for injection,Tolmar International Ltd.,2.0,R,2.0,Marketed,2022-03-25,L02AE02,Leuprorelin
Human,02230248,Lupron Depot,leuprolide acetate 22.5 mg / syrup sustained-release powder for suspension for injection,Abbvie Corporation,2.0,R,2.0,Marketed,2013-12-09,L02AE02,Leuprorelin
Human,02462699,Zeulide Depot,leuprolide acetate 22.5 mg / vial kit (sustained-release powder for suspension) for injection,Verity Pharmaceuticals Inc.,2.0,R,2.0,Marketed,2019-10-08,L02AE02,Leuprorelin
Human,00884502,Lupron Depot,leuprolide acetate 3.75 mg / syrup sustained-release powder for suspension for injection,Abbvie Corporation,2.0,R,2.0,Marketed,2013-12-01,L02AE02,Leuprorelin
Human,02429977,Zeulide Depot,leuprolide acetate 3.75 mg / vial kit (sustained-release powder for suspension) for injection,Verity Pharmaceuticals Inc.,2.0,R,2.0,Marketed,2019-10-08,L02AE02,Leuprorelin
Human,02248999,Eligard,leuprolide acetate 30 mg / syrup sustained-release powder for suspension for injection,Tolmar International Ltd.,2.0,R,2.0,Marketed,2022-04-08,L02AE02,Leuprorelin
Human,02239833,Lupron Depot,leuprolide acetate 30 mg / syrup sustained-release powder for suspension for injection,Abbvie Corporation,2.0,R,2.0,Marketed,2013-12-17,L02AE02,Leuprorelin
Human,02268892,Eligard,leuprolide acetate 45 mg / syrup sustained-release powder for suspension for injection,Tolmar International Ltd.,2.0,R,2.0,Marketed,2022-04-22,L02AE02,Leuprorelin
Human,02562855,Lupron Depot,leuprolide acetate 45 mg / syrup sustained-release powder for suspension for injection,Abbvie Corporation,2.0,R,2.0,Approved,2025-11-13,L02AE02,Leuprorelin
Human,02240264,Leuprolide Acetate Injection,leuprolide acetate 5 mg / mL liquid for injection,Novopharm Limited,2.0,R,2.0,Cancelled pre market,2015-10-16,L02AE02,Leuprorelin
Human,00727695,Lupron,leuprolide acetate 5 mg / mL solution for injection,Abbvie Corporation,2.0,R,2.0,Cancelled post market,2022-09-14,L02AE02,Leuprorelin
Human,02248239,Eligard,leuprolide acetate 7.5 mg / syrup sustained-release powder for suspension for injection,Tolmar International Ltd.,2.0,R,2.0,Marketed,2022-05-30,L02AE02,Leuprorelin
Human,00836273,Lupron Depot,leuprolide acetate 7.5 mg / syrup sustained-release powder for suspension for injection,Abbvie Corporation,2.0,R,2.0,Marketed,2013-12-11,L02AE02,Leuprorelin
Human,02225905,Zoladex La,goserelin (goserelin acetate) 10.8 mg implant for injection,Tersera Therapeutics Llc,2.0,R,2.0,Marketed,2018-02-28,L02AE03,Goserelin
Human,02049325,Zoladex,goserelin (goserelin acetate) 3.6 mg implant for injection,Tersera Therapeutics Llc,2.0,R,2.0,Marketed,2018-02-28,L02AE03,Goserelin
Human,02243856,Trelstar,triptorelin (triptorelin pamoate) 11.25 mg / vial sustained-release powder for suspension for injection,Knight Therapeutics Inc.,2.0,R,2.0,Marketed,2020-09-14,L02AE04,Triptorelin
Human,02412322,Trelstar,triptorelin (triptorelin pamoate) 22.5 mg / vial sustained-release powder for suspension for injection,Knight Therapeutics Inc.,2.0,R,2.0,Marketed,2020-10-14,L02AE04,Triptorelin
Human,02240000,Trelstar,triptorelin (triptorelin pamoate) 3.75 mg / vial sustained-release powder for suspension for injection,Knight Therapeutics Inc.,2.0,R,2.0,Marketed,2020-09-08,L02AE04,Triptorelin
Human,02389282,Decapeptyl,triptorelin acetate 0.1 mg / mL solution for injection,Ferring Inc,2.0,R,2.0,Marketed,2012-08-09,L02AE04,Triptorelin
Human,02278383,Vantas,histrelin acetate 50 mg kit (implant) for injection,Paladin Pharma Inc.,2.0,R,2.0,Cancelled post market,2017-04-07,L02AE05,Histrelin
Human,02237598,Dom-Tamoxifen,tamoxifen (tamoxifen citrate) 10 mg / tablet oral tablet,Dominion Pharmacal,1.0,K,1.0,Cancelled post market,2016-10-25,L02BA01,Tamoxifen
Human,00812404,Apo-Tamox Tab 10Mg,tamoxifen (tamoxifen citrate) 10 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,1989-12-31,L02BA01,Tamoxifen
Human,02088428,Mylan-Tamoxifen,tamoxifen (tamoxifen citrate) 10 mg oral tablet,Mylan Pharmaceuticals Ulc,1.0,K,1.0,Cancelled post market,2017-01-09,L02BA01,Tamoxifen
Human,02048477,Nolvadex Tab 10Mg,tamoxifen (tamoxifen citrate) 10 mg oral tablet,Astrazeneca Canada Inc,1.0,K,1.0,Cancelled post market,2003-04-01,L02BA01,Tamoxifen
Human,02237459,Pms-Tamoxifen,tamoxifen (tamoxifen citrate) 10 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Cancelled post market,2016-10-28,L02BA01,Tamoxifen
Human,01926624,Tamofen 10,tamoxifen (tamoxifen citrate) 10 mg oral tablet,Sanofi-Aventis Canada Inc,1.0,K,1.0,Cancelled post market,2011-01-11,L02BA01,Tamoxifen
Human,02063778,Tamone - (10 Mg),tamoxifen (tamoxifen citrate) 10 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2007-10-02,L02BA01,Tamoxifen
Human,02237596,Tamoxifen,tamoxifen (tamoxifen citrate) 10 mg oral tablet,Pharmel Inc,1.0,K,1.0,Cancelled post market,2016-10-25,L02BA01,Tamoxifen
Human,02296721,Tamoxifene - 10,tamoxifen (tamoxifen citrate) 10 mg oral tablet,Pro Doc Limitee,1.0,K,1.0,Cancelled post market,2011-07-27,L02BA01,Tamoxifen
Human,00851965,Teva-Tamoxifen,tamoxifen (tamoxifen citrate) 10 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2011-06-01,L02BA01,Tamoxifen
Human,02237599,Dom-Tamoxifen,tamoxifen (tamoxifen citrate) 20 mg / tablet oral tablet,Dominion Pharmacal,1.0,K,1.0,Cancelled pre market,2016-10-25,L02BA01,Tamoxifen
Human,00812390,Apo-Tamox Tab 20Mg,tamoxifen (tamoxifen citrate) 20 mg oral tablet,Apotex Inc,1.0,K,1.0,Marketed,1989-12-31,L02BA01,Tamoxifen
Human,02089858,Mylan-Tamoxifen,tamoxifen (tamoxifen citrate) 20 mg oral tablet,Mylan Pharmaceuticals Ulc,1.0,K,1.0,Cancelled post market,2017-01-09,L02BA01,Tamoxifen
Human,02048485,Nolvadex-D Tab 20Mg,tamoxifen (tamoxifen citrate) 20 mg oral tablet,Astrazeneca Canada Inc,1.0,K,1.0,Cancelled post market,2023-03-22,L02BA01,Tamoxifen
Human,02237460,Pms-Tamoxifen,tamoxifen (tamoxifen citrate) 20 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Cancelled post market,2016-10-28,L02BA01,Tamoxifen
Human,01926632,Tamofen 20,tamoxifen (tamoxifen citrate) 20 mg oral tablet,Sanofi-Aventis Canada Inc,1.0,K,1.0,Cancelled post market,2011-01-14,L02BA01,Tamoxifen
Human,02063751,Tamone - (20 Mg),tamoxifen (tamoxifen citrate) 20 mg oral tablet,Pfizer Canada Ulc,1.0,K,1.0,Cancelled post market,2007-10-02,L02BA01,Tamoxifen
Human,02237597,Tamoxifen,tamoxifen (tamoxifen citrate) 20 mg oral tablet,Pharmel Inc,1.0,K,1.0,Cancelled post market,2016-10-25,L02BA01,Tamoxifen
Human,02296748,Tamoxifene - 20,tamoxifen (tamoxifen citrate) 20 mg oral tablet,Pro Doc Limitee,1.0,K,1.0,Cancelled post market,2011-07-27,L02BA01,Tamoxifen
Human,00851973,Teva-Tamoxifen,tamoxifen (tamoxifen citrate) 20 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2011-06-01,L02BA01,Tamoxifen
Human,00810444,Tamone Tab 10Mg,tamoxifen citrate 10 mg / tablet oral tablet,Adria Laboratories Of Canada Ltd.,1.0,K,1.0,Cancelled post market,1996-09-10,L02BA01,Tamoxifen
Human,01951939,Tamoplex Tab 10Mg,tamoxifen citrate 10 mg / tablet oral tablet,Dupont Merck Pharma Inc.,1.0,K,1.0,Cancelled post market,1996-09-09,L02BA01,Tamoxifen
Human,00810452,Tamone Tab 20Mg,tamoxifen citrate 20 mg / tablet oral tablet,Adria Laboratories Of Canada Ltd.,1.0,K,1.0,Cancelled post market,1996-09-10,L02BA01,Tamoxifen
Human,01951947,Tamoplex Tab 20Mg,tamoxifen citrate 20 mg / tablet oral tablet,Dupont Merck Pharma Inc.,1.0,K,1.0,Cancelled post market,1996-09-09,L02BA01,Tamoxifen
Human,02558971,Fulvestrant Injection,fulvestrant 250 mg / 5 mL solution for injection,Sterimax Inc,2.0,R,2.0,Marketed,2025-09-30,L02BA03,Fulvestrant
Human,02463075,Act Fulvestrant,fulvestrant 50 mg / mL solution for injection,Actavis Pharma Company,2.0,R,2.0,Cancelled pre market,2020-04-23,L02BA03,Fulvestrant
Human,02486350,Apo-Fulvestrant,fulvestrant 50 mg / mL solution for injection,Apotex Inc,2.0,R,2.0,Approved,2019-03-05,L02BA03,Fulvestrant
Human,02248624,Faslodex,fulvestrant 50 mg / mL solution for injection,Astrazeneca Canada Inc,2.0,R,2.0,Marketed,2004-06-14,L02BA03,Fulvestrant
Human,02530635,Fulvestrant Injectable,fulvestrant 50 mg / mL solution for injection,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2024-09-12,L02BA03,Fulvestrant
Human,02468549,Fulvestrant Injection,fulvestrant 50 mg / mL solution for injection,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2025-03-31,L02BA03,Fulvestrant
Human,02483610,Fulvestrant Injection,fulvestrant 50 mg / mL solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2019-02-01,L02BA03,Fulvestrant
Human,02486792,Fulvestrant Injection,fulvestrant 50 mg / mL solution for injection,Accord Healthcare Inc,2.0,R,2.0,Cancelled post market,2024-11-01,L02BA03,Fulvestrant
Human,02533111,Fulvestrant Injection,fulvestrant 50 mg / mL solution for injection,Auro Pharma Inc,2.0,R,2.0,Approved,2022-12-06,L02BA03,Fulvestrant
Human,02536293,Fulvestrant Injection,fulvestrant 50 mg / mL solution for injection,Formative Pharma Inc.,2.0,R,2.0,Marketed,2023-12-18,L02BA03,Fulvestrant
Human,02536668,Fulvestrant Injection,fulvestrant 50 mg / mL solution for injection,Eugia Pharma Inc.,2.0,R,2.0,Approved,2023-03-28,L02BA03,Fulvestrant
Human,02460130,Teva-Fulvestrant Injection,fulvestrant 50 mg / mL solution for injection,Teva Canada Limited,2.0,R,2.0,Marketed,2019-01-15,L02BA03,Fulvestrant
Human,02230524,Dom-Flutamide,flutamide 250 mg / tablet oral tablet,Dominion Pharmacal,2.0,P,,Cancelled pre market,2025-03-26,L02BB01,Flutamide
Human,02239388,Flutamide-250,flutamide 250 mg / tablet oral tablet,Pro Doc Limitee,2.0,P,,Cancelled post market,2009-07-23,L02BB01,Flutamide
Human,02239082,Nu-Flutamide Tablets,flutamide 250 mg / tablet oral tablet,Nu-Pharm Inc,2.0,P,,Cancelled (unreturned annual),2018-03-28,L02BB01,Flutamide
Human,02233019,Penta-Flutamide,flutamide 250 mg / tablet oral tablet,Pentapharm Ltd.,2.0,P,,Cancelled (unreturned annual),2018-04-05,L02BB01,Flutamide
Human,00637726,Euflex,flutamide 250 mg oral tablet,Merck Canada Inc,2.0,P,,Cancelled post market,2015-06-01,L02BB01,Flutamide
Human,02059673,Flutamide,flutamide 250 mg oral tablet,Schering-Plough Canada Inc,2.0,P,,Cancelled post market,2014-07-31,L02BB01,Flutamide
Human,02230875,Flutamide,flutamide 250 mg oral tablet,Pharmascience Inc,2.0,P,,Cancelled post market,2016-10-28,L02BB01,Flutamide
Human,02238560,Flutamide,flutamide 250 mg oral tablet,Aa Pharma Inc,2.0,P,,Marketed,2020-05-25,L02BB01,Flutamide
Human,02239045,Flutamide,flutamide 250 mg oral tablet,Pharmel Inc,2.0,P,,Cancelled post market,2016-10-25,L02BB01,Flutamide
Human,02230104,Pms-Flutamide,flutamide 250 mg oral tablet,Pharmascience Inc,2.0,P,,Cancelled post market,2025-07-04,L02BB01,Flutamide
Human,02230089,Teva-Flutamide,flutamide 250 mg oral tablet,Teva Canada Limited,2.0,P,,Cancelled post market,2018-04-30,L02BB01,Flutamide
Human,02400731,Accel-Bicalutamide Tablets Usp,bicalutamide 50 mg oral tablet,Accel Pharma Inc,2.0,p,2.0,Cancelled pre market,2017-05-19,L02BB03,Bicalutamide
Human,02325985,Ach-Bicalutamide,bicalutamide 50 mg oral tablet,Accord Healthcare Inc,2.0,p,2.0,Marketed,2014-08-23,L02BB03,Bicalutamide
Human,02274337,Act Bicalutamide,bicalutamide 50 mg oral tablet,Actavis Pharma Company,2.0,p,2.0,Cancelled post market,2018-07-11,L02BB03,Bicalutamide
Human,02374412,Ag-Bicalutamide,bicalutamide 50 mg oral tablet,Angita Pharma Inc.,2.0,p,2.0,Approved,2011-10-25,L02BB03,Bicalutamide
Human,02296063,Apo-Bicalutamide,bicalutamide 50 mg oral tablet,Apotex Inc,2.0,p,2.0,Dormant,2023-05-14,L02BB03,Bicalutamide
Human,02360993,Ava-Bicalutamide,bicalutamide 50 mg oral tablet,Avanstra Inc,2.0,p,2.0,Cancelled post market,2014-08-21,L02BB03,Bicalutamide
Human,02325233,Bicalutamide,bicalutamide 50 mg oral tablet,Sorres Pharma Inc,2.0,p,2.0,Cancelled post market,2014-06-20,L02BB03,Bicalutamide
Human,02382423,Bicalutamide,bicalutamide 50 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,p,2.0,Cancelled post market,2020-01-22,L02BB03,Bicalutamide
Human,02519178,Bicalutamide,bicalutamide 50 mg oral tablet,Sanis Health Inc,2.0,p,2.0,Marketed,2022-04-28,L02BB03,Bicalutamide
Human,02360098,Bicalutamide Tablets,bicalutamide 50 mg oral tablet,Fresenius Kabi Canada Ltd,2.0,p,2.0,Cancelled pre market,2023-03-10,L02BB03,Bicalutamide
Human,02184478,Casodex,bicalutamide 50 mg oral tablet,Astrazeneca Canada Inc,2.0,p,2.0,Cancelled post market,2025-03-07,L02BB03,Bicalutamide
Human,02281139,Dom-Bicalutamide,bicalutamide 50 mg oral tablet,Dominion Pharmacal,2.0,p,2.0,Cancelled post market,2025-05-09,L02BB03,Bicalutamide
Human,02357216,Jamp-Bicalutamide,bicalutamide 50 mg oral tablet,Jamp Pharma Corporation,2.0,p,2.0,Marketed,2016-02-01,L02BB03,Bicalutamide
Human,02407531,Med-Bicalutamide,bicalutamide 50 mg oral tablet,Generic Medical Partners Inc,2.0,p,2.0,Approved,2013-06-04,L02BB03,Bicalutamide
Human,02302403,Mylan-Bicalutamide,bicalutamide 50 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,p,2.0,Cancelled post market,2017-01-09,L02BB03,Bicalutamide
Human,02358557,Ntp-Bicalutamide,bicalutamide 50 mg oral tablet,Teva Canada Limited,2.0,p,2.0,Cancelled pre market,2015-08-06,L02BB03,Bicalutamide
Human,02336545,Nu-Bicalutamide,bicalutamide 50 mg oral tablet,Nu-Pharm Inc,2.0,p,2.0,Cancelled (unreturned annual),2018-03-28,L02BB03,Bicalutamide
Human,02281163,Phl-Bicalutamide,bicalutamide 50 mg oral tablet,Pharmel Inc,2.0,p,2.0,Cancelled post market,2006-07-21,L02BB03,Bicalutamide
Human,02275589,Pms-Bicalutamide,bicalutamide 50 mg oral tablet,Pharmascience Inc,2.0,p,2.0,Marketed,2006-02-08,L02BB03,Bicalutamide
Human,02311038,Pro-Bicalutamide - 50,bicalutamide 50 mg oral tablet,Pro Doc Limitee,2.0,p,2.0,Marketed,2008-07-09,L02BB03,Bicalutamide
Human,02371324,Ran-Bicalutamide,bicalutamide 50 mg oral tablet,Ranbaxy Pharmaceuticals Canada Inc.,2.0,p,2.0,Cancelled post market,2022-08-23,L02BB03,Bicalutamide
Human,02277700,Ratio-Bicalutamide,bicalutamide 50 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,p,2.0,Cancelled post market,2014-09-19,L02BB03,Bicalutamide
Human,02276089,Sandoz Bicalutamide,bicalutamide 50 mg oral tablet,Sandoz Canada Incorporated,2.0,p,2.0,Cancelled post market,2019-08-01,L02BB03,Bicalutamide
Human,02270226,Teva-Bicalutamide,bicalutamide 50 mg oral tablet,Teva Canada Limited,2.0,p,2.0,Marketed,2015-05-06,L02BB03,Bicalutamide
Human,02428709,Van-Bicalutamide,bicalutamide 50 mg oral tablet,Vanc Pharmaceuticals Inc,2.0,p,2.0,Cancelled post market,2019-08-07,L02BB03,Bicalutamide
Human,02407329,Xtandi,enzalutamide 40 mg oral capsule,Astellas Pharma Canada Inc,2.0,R,2.0,Marketed,2013-06-07,L02BB04,Enzalutamide
Human,02540185,Erleada,apalutamide 240 mg oral tablet,Janssen Inc,2.0,P,,Marketed,2023-11-01,L02BB05,Apalutamide
Human,02478374,Erleada,apalutamide 60 mg oral tablet,Janssen Inc,2.0,P,,Marketed,2018-07-27,L02BB05,Apalutamide
Human,02496348,Nubeqa,darolutamide 300 mg oral tablet,Bayer Inc,1.0,p,,Marketed,2020-03-24,L02BB06,Darolutamide
Human,02397692,Accel-Anastrozole Tablets,anastrozole 1 mg oral tablet,Accel Pharma Inc,2.0,R,2.0,Cancelled pre market,2017-05-09,L02BG03,Anastrozole
Human,02351218,Ach-Anastrozole,anastrozole 1 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Marketed,2014-10-23,L02BG03,Anastrozole
Human,02534118,Ag-Anastrozole,anastrozole 1 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Marketed,2023-07-27,L02BG03,Anastrozole
Human,02553686,Ag-Anastrozole Tablets,anastrozole 1 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Marketed,2025-07-22,L02BG03,Anastrozole
Human,02442736,Anastrozole,anastrozole 1 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Marketed,2015-07-22,L02BG03,Anastrozole
Human,02529904,Anastrozole,anastrozole 1 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2025-05-29,L02BG03,Anastrozole
Human,02374420,Apo-Anastrozole,anastrozole 1 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2012-10-25,L02BG03,Anastrozole
Human,02224135,Arimidex,anastrozole 1 mg oral tablet,Astrazeneca Canada Inc,2.0,R,2.0,Marketed,2002-01-25,L02BG03,Anastrozole
Human,02404990,Auro-Anastrozole,anastrozole 1 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Cancelled post market,2015-06-02,L02BG03,Anastrozole
Human,02392488,Bio-Anastrozole,anastrozole 1 mg oral tablet,Biomed Pharma,2.0,R,2.0,Marketed,2013-01-15,L02BG03,Anastrozole
Human,02458799,Ccp-Anastrozole,anastrozole 1 mg oral tablet,Cellchem Pharmaceuticals Inc.,2.0,R,2.0,Cancelled post market,2023-08-03,L02BG03,Anastrozole
Human,02459191,Dom-Anastrozole,anastrozole 1 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Approved,2016-12-01,L02BG03,Anastrozole
Human,02326094,Ipg-Anastrozole,anastrozole 1 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Approved,2016-03-21,L02BG03,Anastrozole
Human,02540584,Jamp Anastrozole Tablets,anastrozole 1 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2025-09-29,L02BG03,Anastrozole
Human,02339080,Jamp-Anastrozole,anastrozole 1 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2012-10-25,L02BG03,Anastrozole
Human,02379562,Mar-Anastrozole,anastrozole 1 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Marketed,2012-10-25,L02BG03,Anastrozole
Human,02379104,Med-Anastrozole,anastrozole 1 mg oral tablet,Generic Medical Partners Inc,2.0,R,2.0,Dormant,2018-03-23,L02BG03,Anastrozole
Human,02393573,Mint-Anastrozole,anastrozole 1 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2013-11-26,L02BG03,Anastrozole
Human,02361418,Mylan-Anastrozole,anastrozole 1 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-09,L02BG03,Anastrozole
Human,02417855,Nat-Anastrozole,anastrozole 1 mg oral tablet,Natco Pharma (Canada) Inc,2.0,R,2.0,Marketed,2015-02-03,L02BG03,Anastrozole
Human,02565358,Nra-Anastrozole,anastrozole 1 mg oral tablet,Nora Pharma Inc,2.0,R,2.0,Approved,2026-01-30,L02BG03,Anastrozole
Human,02320738,Pms-Anastrozole,anastrozole 1 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2012-10-25,L02BG03,Anastrozole
Human,02395649,Pro-Anastrozole,anastrozole 1 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2025-10-30,L02BG03,Anastrozole
Human,02328690,Ran-Anastrozole,anastrozole 1 mg oral tablet,Ranbaxy Pharmaceuticals Canada Inc.,2.0,R,2.0,Cancelled post market,2024-01-22,L02BG03,Anastrozole
Human,02392259,Riva-Anastrozole,anastrozole 1 mg oral tablet,Laboratoire Riva Inc.,2.0,R,2.0,Marketed,2025-12-29,L02BG03,Anastrozole
Human,02338467,Sandoz Anastrozole,anastrozole 1 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2012-07-26,L02BG03,Anastrozole
Human,02365650,Taro-Anastrozole,anastrozole 1 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2012-10-25,L02BG03,Anastrozole
Human,02313049,Teva-Anastrozole,anastrozole 1 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2018-06-11,L02BG03,Anastrozole
Human,02394898,Teva-Anastrozole,anastrozole 1 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2020-01-21,L02BG03,Anastrozole
Human,02427818,Van-Anastrozole,anastrozole 1 mg oral tablet,Vanc Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2019-08-07,L02BG03,Anastrozole
Human,02326035,Zinda-Anastrozole,anastrozole 1 mg oral tablet,Stason Pharmaceuticals Inc,2.0,R,2.0,Dormant,2017-09-21,L02BG03,Anastrozole
Human,02406330,Accel-Letrozole Tablets Usp,letrozole 2.5 mg / tablet oral tablet,Accel Pharma Inc,2.0,R,2.0,Cancelled pre market,2017-05-19,L02BG04,Letrozole
Human,02338459,Ach-Letrozole,letrozole 2.5 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Marketed,2014-05-03,L02BG04,Letrozole
Human,02374439,Ag-Letrozole,letrozole 2.5 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Marketed,2022-05-16,L02BG04,Letrozole
Human,02543419,Ag-Letrozole Tablets,letrozole 2.5 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Marketed,2024-08-20,L02BG04,Letrozole
Human,02358514,Apo-Letrozole,letrozole 2.5 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2020-11-24,L02BG04,Letrozole
Human,02404400,Auro-Letrozole,letrozole 2.5 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Cancelled post market,2015-04-24,L02BG04,Letrozole
Human,02392496,Bio-Letrozole,letrozole 2.5 mg oral tablet,Biomed Pharma,2.0,R,2.0,Marketed,2024-11-20,L02BG04,Letrozole
Human,02459884,Ccp-Letrozole,letrozole 2.5 mg oral tablet,Cellchem Pharmaceuticals Inc.,2.0,R,2.0,Cancelled post market,2023-08-03,L02BG04,Letrozole
Human,02352052,Co Letrozole,letrozole 2.5 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled pre market,2017-09-01,L02BG04,Letrozole
Human,02316374,Dom-Letrozole,letrozole 2.5 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled pre market,2025-05-30,L02BG04,Letrozole
Human,02231384,Femara,letrozole 2.5 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Marketed,1997-09-02,L02BG04,Letrozole
Human,02370794,Ipg-Letrozole,letrozole 2.5 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Approved,2016-06-24,L02BG04,Letrozole
Human,02541912,Jamp Letrozole Tablets,letrozole 2.5 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2024-08-20,L02BG04,Letrozole
Human,02373009,Jamp-Letrozole,letrozole 2.5 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2022-05-16,L02BG04,Letrozole
Human,02347997,Letrozole,letrozole 2.5 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2013-12-10,L02BG04,Letrozole
Human,02348896,Letrozole,letrozole 2.5 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-25,L02BG04,Letrozole
Human,02348969,Letrozole,letrozole 2.5 mg oral tablet,Actavis Pharma Company,2.0,R,2.0,Cancelled post market,2018-06-18,L02BG04,Letrozole
Human,02402025,Letrozole,letrozole 2.5 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2013-02-14,L02BG04,Letrozole
Human,02504472,Letrozole,letrozole 2.5 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Dormant,2025-08-29,L02BG04,Letrozole
Human,02524244,Letrozole,letrozole 2.5 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2022-07-18,L02BG04,Letrozole
Human,02375273,Letrozole Sun,letrozole 2.5 mg oral tablet,Taro Pharmaceuticals Inc,2.0,R,2.0,Cancelled pre market,2022-07-11,L02BG04,Letrozole
Human,02381958,Letrozole Tablets,letrozole 2.5 mg oral tablet,Fresenius Kabi Canada Ltd,2.0,R,2.0,Cancelled pre market,2023-03-10,L02BG04,Letrozole
Human,02549972,M-Letrozole,letrozole 2.5 mg oral tablet,Mantra Pharma Inc,2.0,R,2.0,Marketed,2025-04-25,L02BG04,Letrozole
Human,02373424,Mar-Letrozole,letrozole 2.5 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Marketed,2022-02-09,L02BG04,Letrozole
Human,02322315,Med-Letrozole,letrozole 2.5 mg oral tablet,Generic Medical Partners Inc,2.0,R,2.0,Dormant,2018-05-25,L02BG04,Letrozole
Human,02508109,Mint-Letrozole,letrozole 2.5 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2021-07-20,L02BG04,Letrozole
Human,02372169,Myl-Letrozole,letrozole 2.5 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2016-06-28,L02BG04,Letrozole
Human,02322544,Mylan-Letrozole,letrozole 2.5 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2016-11-02,L02BG04,Letrozole
Human,02421585,Nat-Letrozole,letrozole 2.5 mg oral tablet,Natco Pharma (Canada) Inc,2.0,R,2.0,Marketed,2015-02-03,L02BG04,Letrozole
Human,02520486,Nra-Letrozole,letrozole 2.5 mg oral tablet,Nora Pharma Inc,2.0,R,2.0,Marketed,2022-03-25,L02BG04,Letrozole
Human,02316366,Phl-Letrozole,letrozole 2.5 mg oral tablet,Pharmel Inc,2.0,R,2.0,Cancelled pre market,2017-09-13,L02BG04,Letrozole
Human,02309114,Pms-Letrozole,letrozole 2.5 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2010-04-28,L02BG04,Letrozole
Human,02504286,Priva-Letrozole,letrozole 2.5 mg oral tablet,Pharmapar Inc,2.0,R,2.0,Cancelled pre market,2022-07-29,L02BG04,Letrozole
Human,02398656,Riva-Letrozole,letrozole 2.5 mg oral tablet,Laboratoire Riva Inc.,2.0,R,2.0,Marketed,2024-07-03,L02BG04,Letrozole
Human,02344815,Sandoz Letrozole,letrozole 2.5 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2010-04-27,L02BG04,Letrozole
Human,02431335,Stason-Letrozole,letrozole 2.5 mg oral tablet,Vpi Pharmaceuticals Inc,2.0,R,2.0,Cancelled pre market,2018-06-27,L02BG04,Letrozole
Human,02372282,Taro-Letrozole,letrozole 2.5 mg oral tablet,Sun Pharma Canada Inc,2.0,R,2.0,Cancelled post market,2022-11-22,L02BG04,Letrozole
Human,02343657,Teva-Letrozole,letrozole 2.5 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2013-07-08,L02BG04,Letrozole
Human,02428156,Van-Letrozole,letrozole 2.5 mg oral tablet,Vanc Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2019-08-07,L02BG04,Letrozole
Human,02378213,Zinda-Letrozole,letrozole 2.5 mg oral tablet,Stason Pharmaceuticals Inc,2.0,R,2.0,Dormant,2018-07-17,L02BG04,Letrozole
Human,02390183,Act Exemestane,exemestane 25 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2020-01-31,L02BG06,Exemestane
Human,02419726,Apo-Exemestane,exemestane 25 mg oral tablet,Apotex Inc,2.0,R,2.0,Dormant,2017-08-04,L02BG06,Exemestane
Human,02242705,Aromasin,exemestane 25 mg oral tablet,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2004-11-16,L02BG06,Exemestane
Human,02359693,Gd-Exemestane,exemestane 25 mg oral tablet,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2020-10-29,L02BG06,Exemestane
Human,02407841,Med-Exemestane,exemestane 25 mg oral tablet,Generic Medical Partners Inc,2.0,R,2.0,Marketed,2013-12-02,L02BG06,Exemestane
Human,02405075,Mylan-Exemestane,exemestane 25 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2016-11-02,L02BG06,Exemestane
Human,02408473,Teva-Exemestane,exemestane 25 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2025-01-17,L02BG06,Exemestane
Human,02337037,Firmagon,degarelix (degarelix acetate) 120 mg / vial powder for solution for injection,Ferring Inc,2.0,R,2.0,Marketed,2009-11-24,L02BX02,Degarelix
Human,02337029,Firmagon,degarelix (degarelix acetate) 80 mg / vial powder for solution for injection,Ferring Inc,2.0,R,2.0,Marketed,2009-11-24,L02BX02,Degarelix
Human,02521652,Sandoz Abiraterone,abiraterone acetate 1000 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Approved,2021-10-22,L02BX03,Abiraterone
Human,02525372,Abiraterone,abiraterone acetate 250 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Approved,2022-02-17,L02BX03,Abiraterone
Human,02473917,Apo-Abiraterone,abiraterone acetate 250 mg oral tablet,Apotex Inc,2.0,R,2.0,Approved,2021-01-11,L02BX03,Abiraterone
Human,02491397,Apo-Abiraterone Film Coated Tablets,abiraterone acetate 250 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2021-01-25,L02BX03,Abiraterone
Human,02502305,Jamp Abiraterone,abiraterone acetate 250 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2021-02-22,L02BX03,Abiraterone
Human,02503980,Mar-Abiraterone,abiraterone acetate 250 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Marketed,2021-02-03,L02BX03,Abiraterone
Human,02494132,Nat-Abiraterone,abiraterone acetate 250 mg oral tablet,Natco Pharma (Canada) Inc,2.0,R,2.0,Marketed,2021-01-18,L02BX03,Abiraterone
Human,02492601,Pms-Abiraterone,abiraterone acetate 250 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2021-01-11,L02BX03,Abiraterone
Human,02540452,Prz-Abiraterone,abiraterone acetate 250 mg oral tablet,Pharmaris Canada Inc,2.0,R,2.0,Marketed,2025-10-01,L02BX03,Abiraterone
Human,02477114,Reddy-Abiraterone,abiraterone acetate 250 mg oral tablet,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Marketed,2021-03-26,L02BX03,Abiraterone
Human,02486393,Sandoz Abiraterone,abiraterone acetate 250 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2021-01-18,L02BX03,Abiraterone
Human,02473356,Teva-Abiraterone,abiraterone acetate 250 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled pre market,2026-01-08,L02BX03,Abiraterone
Human,02371065,Zytiga,abiraterone acetate 250 mg oral tablet,Janssen Inc,2.0,R,2.0,Marketed,2011-07-28,L02BX03,Abiraterone
Human,02525380,Abiraterone,abiraterone acetate 500 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Dormant,2025-07-31,L02BX03,Abiraterone
Human,02496100,Apo-Abiraterone Acetate Film Coated Tablets,abiraterone acetate 500 mg oral tablet,Apotex Inc,2.0,R,2.0,Approved,2021-05-19,L02BX03,Abiraterone
Human,02491400,Apo-Abiraterone Film Coated Tablets,abiraterone acetate 500 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2021-01-25,L02BX03,Abiraterone
Human,02529629,Jamp Abiraterone,abiraterone acetate 500 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2023-01-30,L02BX03,Abiraterone
Human,02503999,Mar-Abiraterone,abiraterone acetate 500 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Marketed,2021-02-03,L02BX03,Abiraterone
Human,02501503,Pms-Abiraterone,abiraterone acetate 500 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2021-01-11,L02BX03,Abiraterone
Human,02540460,Prz-Abiraterone,abiraterone acetate 500 mg oral tablet,Pharmaris Canada Inc,2.0,R,2.0,Marketed,2025-10-01,L02BX03,Abiraterone
Human,02533251,Reddy-Abiraterone,abiraterone acetate 500 mg oral tablet,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Marketed,2023-04-28,L02BX03,Abiraterone
Human,02521644,Sandoz Abiraterone,abiraterone acetate 500 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2022-03-28,L02BX03,Abiraterone
Human,02487446,Teva-Abiraterone,abiraterone acetate 500 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled pre market,2026-01-13,L02BX03,Abiraterone
Human,02457113,Zytiga,abiraterone acetate 500 mg oral tablet,Janssen Inc,2.0,R,2.0,Marketed,2016-09-22,L02BX03,Abiraterone
Human,02542137,Orgovyx,relugolix 120 mg oral tablet,Knight Therapeutics Inc.,2.0,R,,Marketed,2025-11-05,L02BX04,Relugolix
Human,02371456,Victrelis Triple,boceprevir 200 mg / capsule + peginterferon alfa-2b 100 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2017-01-10,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02371464,Victrelis Triple,boceprevir 200 mg / capsule + peginterferon alfa-2b 120 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2016-09-02,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02371472,Victrelis Triple,boceprevir 200 mg / capsule + peginterferon alfa-2b 150 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2016-09-02,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02371448,Victrelis Triple,boceprevir 200 mg / capsule + peginterferon alfa-2b 80 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2017-01-10,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02241159,Rebetron Solution (Albumin (Human) Free) (18 Miu Multi-Dose Pen / 200Mg Capsules),interferon alfa-2b 15000000 units / mL with ribavirin 200 mg / capsule kit (capsule and liquid) for injection,Schering-Plough Canada Inc,2.0,R,2.0,Cancelled post market,2004-10-27,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02239730,Rebetron Ready To Use Solution (Albumin(Human)Free) (6000000 Iu/Ml And 200Mg Capsules),interferon alfa-2b 6000000 units / mL with ribavirin 200 mg / capsule kit (capsule and liquid) for injection,Schering-Plough Canada Inc,2.0,R,2.0,Cancelled post market,2004-10-27,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02246028,Pegetron,peginterferon alfa-2b 100 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2013-01-23,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02254603,Pegetron,peginterferon alfa-2b 100 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2017-10-05,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02246029,Pegetron,peginterferon alfa-2b 120 mcg / 0.5 mL + ribavirin 200 mg / capsule capsule or powder for solution for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2013-01-23,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02254638,Pegetron,peginterferon alfa-2b 120 mcg / 0.5 mL + ribavirin 200 mg / capsule capsule or powder for solution for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2017-10-05,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02246030,Pegetron,peginterferon alfa-2b 150 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2017-04-04,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02254646,Pegetron,peginterferon alfa-2b 150 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2017-10-05,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02246026,Pegetron,peginterferon alfa-2b 50 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2017-04-04,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02246027,Pegetron,peginterferon alfa-2b 80 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2013-01-23,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02254581,Pegetron,peginterferon alfa-2b 80 mcg / 0.5 mL + ribavirin 200 mg / capsule powder for solution or capsule for injection,Merck Canada Inc,2.0,R,2.0,Cancelled post market,2017-10-05,L03AB60,"Peginterferon alfa-2b, combinations"
Human,02253429,Pegasys Rbv,peginterferon alfa-2a 180 mcg / 0.5 mL + ribavirin 200 mg / tablet tablet or solution for injection,Hoffmann-La Roche Limited,2.0,R,2.0,Cancelled post market,2018-07-10,L03AB61,"Peginterferon alfa-2a, combinations"
Human,02253410,Pegasys Rbv,peginterferon alfa-2a 180 mcg / mL + ribavirin 200 mg / tablet tablet or solution for injection,Hoffmann-La Roche Limited,2.0,R,2.0,Cancelled post market,2018-07-10,L03AB61,"Peginterferon alfa-2a, combinations"
Human,02153513,Oncotice,bacillus calmette-guerin (bcg) strain tice 800000000 units / vial intravesical powder for solution,Merck Canada Inc,1.0,KH,,Marketed,2013-05-21,L03AX03,Bcg vaccine
Human,02194376,Immucyst,bacillus calmette-guerin (bcg) substrain connaught 81 mg / vial intravesical powder for suspension,Sanofi Vaccines Canada Ltd.,1.0,KH,,Cancelled post market,2018-01-31,L03AX03,Bcg vaccine
Human,02130947,Pacis,bacillus calmette-guerin (bcg) substrain montreal 120 mg / vial intravesicular powder for solution,Id Biomedical Corporation Of Quebec,1.0,KH,,Cancelled post market,2005-12-02,L03AX03,Bcg vaccine
Human,00884308,Bcg Therapeutic,bacillus calmette-guerin bcg 27 mg / vial irrigation powder for solution,Connaught Laboratories Ltd.,1.0,KH,,Cancelled post market,1999-12-03,L03AX03,Bcg vaccine
Human,02508613,Verity-Bcg,bacillus calmette-guérin (bcg) - strain russian bcg-i 40 mg / vial intravesical powder for suspension,Verity Pharmaceuticals Inc.,1.0,KH,,Marketed,2021-08-30,L03AX03,Bcg vaccine
Human,02377225,Mozobil,plerixafor 20 mg / mL solution for injection,Sanofi-Aventis Canada Inc,2.0,R,2.0,Cancelled post market,2025-10-31,L03AX16,Plerixafor
Human,02490846,Plerixafor Injection,plerixafor 20 mg / mL solution for injection,Fresenius Kabi Canada Ltd,2.0,R,2.0,Approved,2022-08-02,L03AX16,Plerixafor
Human,02529815,Plerixafor Injection,plerixafor 20 mg / mL solution for injection,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2023-08-31,L03AX16,Plerixafor
Human,02539454,Plerixafor Injection,plerixafor 20 mg / mL solution for injection,Eugia Pharma Inc.,2.0,R,2.0,Marketed,2024-01-05,L03AX16,Plerixafor
Human,02240347,Cellcept I.V.,mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg / vial powder for solution for injection,Hoffmann-La Roche Limited,2.0,P,2.0,Marketed,1999-12-20,L04AA06,Mycophenolic acid
Human,02479974,Mycophenolate Mofetil For Injection Usp,mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg / vial powder for solution for injection,Sterimax Inc,2.0,P,2.0,Dormant,2024-12-19,L04AA06,Mycophenolic acid
Human,02444836,"Mycophenolate Mofetil For Injection, Usp",mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg / vial powder for solution for injection,Accord Healthcare Inc,2.0,P,2.0,Marketed,2019-04-23,L04AA06,Mycophenolic acid
Human,02532735,Ach-Mycophenolate,mycophenolate mofetil 200 mg / mL oral powder for suspension,Accord Healthcare Inc,2.0,P,2.0,Approved,2022-11-16,L04AA06,Mycophenolic acid
Human,02242145,Cellcept,mycophenolate mofetil 200 mg / mL oral powder for suspension,Hoffmann-La Roche Limited,2.0,P,2.0,Marketed,2002-08-27,L04AA06,Mycophenolic acid
Human,02522233,Mar-Mycophenolate Mofetil,mycophenolate mofetil 200 mg / mL oral powder for suspension,Marcan Pharmaceuticals Inc,2.0,P,2.0,Marketed,2022-02-03,L04AA06,Mycophenolic acid
Human,02401053,Accel-Mycophenolate Mofetil Capsules,mycophenolate mofetil 250 mg oral capsule,Accel Pharma Inc,2.0,P,2.0,Cancelled pre market,2017-05-19,L04AA06,Mycophenolic acid
Human,02383780,Ach-Mycophenolate,mycophenolate mofetil 250 mg oral capsule,Accord Healthcare Inc,2.0,P,2.0,Marketed,2014-05-08,L04AA06,Mycophenolic acid
Human,02352559,Apo-Mycophenolate,mycophenolate mofetil 250 mg oral capsule,Apotex Inc,2.0,P,2.0,Dormant,2025-06-29,L04AA06,Mycophenolic acid
Human,02513714,Apo-Mycophenolate Mofetil,mycophenolate mofetil 250 mg oral capsule,Apotex Inc,2.0,P,2.0,Approved,2021-03-19,L04AA06,Mycophenolic acid
Human,02192748,Cellcept,mycophenolate mofetil 250 mg oral capsule,Hoffmann-La Roche Limited,2.0,P,2.0,Marketed,1995-12-31,L04AA06,Mycophenolic acid
Human,02386399,Jamp-Mycophenolate Capsules,mycophenolate mofetil 250 mg oral capsule,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2025-10-07,L04AA06,Mycophenolic acid
Human,02457369,Mycophenolate Mofetil,mycophenolate mofetil 250 mg oral capsule,Sanis Health Inc,2.0,P,2.0,Marketed,2016-09-29,L04AA06,Mycophenolic acid
Human,02371154,Mylan-Mycophenolate,mycophenolate mofetil 250 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,P,2.0,Cancelled post market,2017-01-09,L04AA06,Mycophenolic acid
Human,02320630,Sandoz Mycophenolate Mofetil,mycophenolate mofetil 250 mg oral capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2012-02-03,L04AA06,Mycophenolic acid
Human,02364883,Teva-Mycophenolate,mycophenolate mofetil 250 mg oral capsule,Teva Canada Limited,2.0,P,2.0,Marketed,2017-08-08,L04AA06,Mycophenolic acid
Human,02433680,Van-Mycophenolate,mycophenolate mofetil 250 mg oral capsule,Vanc Pharmaceuticals Inc,2.0,P,2.0,Cancelled post market,2019-08-07,L04AA06,Mycophenolic acid
Human,02400723,Accel-Mycophenolate Mofetil Tablets,mycophenolate mofetil 500 mg oral tablet,Accel Pharma Inc,2.0,P,2.0,Cancelled pre market,2017-05-19,L04AA06,Mycophenolic acid
Human,02378574,Ach-Mycophenolate,mycophenolate mofetil 500 mg oral tablet,Accord Healthcare Inc,2.0,P,2.0,Marketed,2023-03-28,L04AA06,Mycophenolic acid
Human,02497182,Ag-Mycophenolate,mycophenolate mofetil 500 mg oral tablet,Angita Pharma Inc.,2.0,P,2.0,Approved,2020-03-16,L04AA06,Mycophenolic acid
Human,02352567,Apo-Mycophenolate,mycophenolate mofetil 500 mg oral tablet,Apotex Inc,2.0,P,2.0,Dormant,2025-04-18,L04AA06,Mycophenolic acid
Human,02513722,Apo-Mycophenolate Mofetil,mycophenolate mofetil 500 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2021-03-19,L04AA06,Mycophenolic acid
Human,02237484,Cellcept,mycophenolate mofetil 500 mg oral tablet,Hoffmann-La Roche Limited,2.0,P,2.0,Marketed,1998-11-11,L04AA06,Mycophenolic acid
Human,02379996,Co Mycophenolate,mycophenolate mofetil 500 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,P,2.0,Cancelled post market,2018-05-07,L04AA06,Mycophenolic acid
Human,02380382,Jamp-Mycophenolate,mycophenolate mofetil 500 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Dormant,2025-07-31,L04AA06,Mycophenolic acid
Human,02457377,Mycophenolate Mofetil,mycophenolate mofetil 500 mg oral tablet,Sanis Health Inc,2.0,P,2.0,Marketed,2016-09-29,L04AA06,Mycophenolic acid
Human,02370549,Mylan-Mycophenolate,mycophenolate mofetil 500 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,2.0,Cancelled post market,2017-01-09,L04AA06,Mycophenolic acid
Human,02313855,Sandoz Mycophenolate Mofetil,mycophenolate mofetil 500 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2012-02-03,L04AA06,Mycophenolic acid
Human,02389754,Taro-Mycophenolate,mycophenolate mofetil 500 mg oral tablet,Sun Pharma Canada Inc,2.0,P,2.0,Approved,2021-10-22,L04AA06,Mycophenolic acid
Human,02348675,Teva-Mycophenolate,mycophenolate mofetil 500 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2017-08-08,L04AA06,Mycophenolic acid
Human,02432625,Van-Mycophenolate,mycophenolate mofetil 500 mg oral tablet,Vanc Pharmaceuticals Inc,2.0,P,2.0,Cancelled post market,2019-08-07,L04AA06,Mycophenolic acid
Human,02264560,Myfortic,mycophenolic acid (mycophenolate sodium) 180 mg oral delayed-release tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2026-01-08,L04AA06,Mycophenolic acid
Human,02372738,Apo-Mycophenolic Acid,mycophenolic acid (mycophenolate sodium) 180 mg oral gastro-resistant tablet,Apotex Inc,2.0,P,2.0,Marketed,2014-07-02,L04AA06,Mycophenolic acid
Human,02518538,Jamp Mycophenolic Acid,mycophenolic acid (mycophenolate sodium) 180 mg oral gastro-resistant tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2025-03-13,L04AA06,Mycophenolic acid
Human,02511673,Mar-Mycophenolic Acid,mycophenolic acid (mycophenolate sodium) 180 mg oral gastro-resistant tablet,Marcan Pharmaceuticals Inc,2.0,P,2.0,Marketed,2021-04-07,L04AA06,Mycophenolic acid
Human,02465809,Sandoz Mycophenolic Acid,mycophenolic acid (mycophenolate sodium) 180 mg oral gastro-resistant tablet,Sandoz Canada Incorporated,2.0,P,2.0,Cancelled pre market,2019-08-01,L04AA06,Mycophenolic acid
Human,02264579,Myfortic,mycophenolic acid (mycophenolate sodium) 360 mg oral delayed-release tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2026-01-08,L04AA06,Mycophenolic acid
Human,02372746,Apo-Mycophenolic Acid,mycophenolic acid (mycophenolate sodium) 360 mg oral gastro-resistant tablet,Apotex Inc,2.0,P,2.0,Marketed,2014-07-02,L04AA06,Mycophenolic acid
Human,02518511,Jamp Mycophenolic Acid,mycophenolic acid (mycophenolate sodium) 360 mg oral gastro-resistant tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2025-03-13,L04AA06,Mycophenolic acid
Human,02511681,Mar-Mycophenolic Acid,mycophenolic acid (mycophenolate sodium) 360 mg oral gastro-resistant tablet,Marcan Pharmaceuticals Inc,2.0,P,2.0,Marketed,2021-04-07,L04AA06,Mycophenolic acid
Human,02465817,Sandoz Mycophenolic Acid,mycophenolic acid (mycophenolate sodium) 360 mg oral gastro-resistant tablet,Sandoz Canada Incorporated,2.0,P,2.0,Cancelled pre market,2019-08-01,L04AA06,Mycophenolic acid
Human,02259052,Amevive,alefacept 15 mg / 0.5 mL powder for solution for injection,Astellas Pharma Canada Inc,2.0,P,2.0,Cancelled post market,2012-12-01,L04AA15,Alefacept
Human,02553295,Apo-Cladribine,cladribine 10 mg oral tablet,Apotex Inc,1.0,CK,1.0,Marketed,2025-12-22,L04AA40,Cladribine
Human,02470179,Mavenclad,cladribine 10 mg oral tablet,"Emd Serono, A Division Of Emd Inc., Canada",1.0,CK,1.0,Marketed,2017-11-30,L04AA40,Cladribine
Human,02526115,Rezurock,belumosudil (belumosudil mesylate) 200 mg oral tablet,Sanofi-Aventis Canada Inc,2.0,R,,Marketed,2023-03-08,L04AA48,Belumosudil
Human,02519283,Skyrizi,risankizumab 150 mg / 1 mL solution for injection,Abbvie Corporation,2.0,,,Marketed,2022-06-01,L04AC18,Rizankizumab
Human,02519291,Skyrizi,risankizumab 150 mg / 1 mL solution for injection,Abbvie Corporation,2.0,,,Marketed,2022-06-01,L04AC18,Rizankizumab
Human,02552507,Skyrizi,risankizumab 180 mg / 1.2 mL solution for injection,Abbvie Corporation,2.0,,,Marketed,2025-02-14,L04AC18,Rizankizumab
Human,02532093,Skyrizi,risankizumab 360 mg / 2.4 mL solution for injection,Abbvie Corporation,2.0,,,Marketed,2023-03-14,L04AC18,Rizankizumab
Human,02532107,Skyrizi,risankizumab 60 mg / mL solution for injection,Abbvie Corporation,2.0,,,Marketed,2022-12-01,L04AC18,Rizankizumab
Human,02487454,Skyrizi,risankizumab 75 mg / 0.83 mL solution for injection,Abbvie Corporation,2.0,,,Cancelled post market,2025-01-28,L04AC18,Rizankizumab
Human,02546922,Skyrizi,risankizumab 90 mg / 1 mL solution for injection,Abbvie Corporation,2.0,,,Approved,2024-04-05,L04AC18,Rizankizumab
Human,02237671,Neoral,cyclosporine 10 mg oral capsule,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,1998-10-02,L04AD01,Ciclosporin
Human,00593249,Sandimmune Oral Sol 100Mg/Ml,cyclosporine 100 mg / mL oral liquid,Sandoz Canada Inc,1.0,K,1.0,Cancelled post market,1997-04-15,L04AD01,Ciclosporin
Human,02244324,Apo-Cyclosporine Oral Solution,cyclosporine 100 mg / mL oral solution,Apotex Inc,1.0,K,1.0,Cancelled post market,2018-01-11,L04AD01,Ciclosporin
Human,02150697,Neoral,cyclosporine 100 mg / mL oral solution,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2014-07-12,L04AD01,Ciclosporin
Human,02495813,Cyclosporine,cyclosporine 100 mg oral capsule,"Edenbridge Pharmaceuticals, Llc",1.0,K,1.0,Dormant,2025-03-07,L04AD01,Ciclosporin
Human,02150670,Neoral,cyclosporine 100 mg oral capsule,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2014-07-12,L04AD01,Ciclosporin
Human,00755605,Sandimmune Soft Gelatin Cap 100Mg,cyclosporine 100 mg oral capsule,Sandoz Canada Inc,1.0,K,1.0,Cancelled post market,1997-04-15,L04AD01,Ciclosporin
Human,02242821,Sandoz Cyclosporine,cyclosporine 100 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2006-02-18,L04AD01,Ciclosporin
Human,02334763,Cyclosporine,cyclosporine 25 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled pre market,2018-08-01,L04AD01,Ciclosporin
Human,02495805,Cyclosporine,cyclosporine 25 mg oral capsule,"Edenbridge Pharmaceuticals, Llc",1.0,K,1.0,Dormant,2025-03-07,L04AD01,Ciclosporin
Human,02150689,Neoral,cyclosporine 25 mg oral capsule,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2014-07-12,L04AD01,Ciclosporin
Human,00755591,Sandimmune Soft Gelatine Cap 25Mg,cyclosporine 25 mg oral capsule,Sandoz Canada Inc,1.0,K,1.0,Cancelled post market,1997-04-15,L04AD01,Ciclosporin
Human,02247073,Sandoz Cyclosporine,cyclosporine 25 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2006-02-18,L04AD01,Ciclosporin
Human,00593257,Sandimmune I.V.,cyclosporine 50 mg / mL solution for injection,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,1998-07-30,L04AD01,Ciclosporin
Human,02495821,Cyclosporine,cyclosporine 50 mg oral capsule,"Edenbridge Pharmaceuticals, Llc",1.0,K,1.0,Dormant,2025-03-07,L04AD01,Ciclosporin
Human,02150662,Neoral,cyclosporine 50 mg oral capsule,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2014-07-12,L04AD01,Ciclosporin
Human,01907182,Sandimmune Cap 50Mg,cyclosporine 50 mg oral capsule,Sandoz Canada Inc,1.0,K,1.0,Cancelled post market,1996-11-14,L04AD01,Ciclosporin
Human,02247074,Sandoz Cyclosporine,cyclosporine 50 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2006-10-18,L04AD01,Ciclosporin
Human,02416816,Sandoz Tacrolimus,tacrolimus (tacrolimus monohydrate) 0.5 mg oral immediate release capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2014-06-11,L04AD02,Tacrolimus
Human,02456095,Ach-Tacrolimus,tacrolimus (tacrolimus monohydrate) 1 mg oral immediate release capsule,Accord Healthcare Inc,2.0,P,2.0,Marketed,2023-09-15,L04AD02,Tacrolimus
Human,02459477,Apo-Tacrolimus,tacrolimus (tacrolimus monohydrate) 1 mg oral immediate release capsule,Apotex Inc,2.0,P,2.0,Approved,2017-04-11,L04AD02,Tacrolimus
Human,02460246,Jamp-Tacrolimus,tacrolimus (tacrolimus monohydrate) 1 mg oral immediate release capsule,Jamp Pharma Corporation,2.0,P,2.0,Cancelled pre market,2022-09-08,L04AD02,Tacrolimus
Human,02416824,Sandoz Tacrolimus,tacrolimus (tacrolimus monohydrate) 1 mg oral immediate release capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2013-11-25,L04AD02,Tacrolimus
Human,02456109,Ach-Tacrolimus,tacrolimus (tacrolimus monohydrate) 5 mg oral immediate release capsule,Accord Healthcare Inc,2.0,P,2.0,Marketed,2023-09-15,L04AD02,Tacrolimus
Human,02459485,Apo-Tacrolimus,tacrolimus (tacrolimus monohydrate) 5 mg oral immediate release capsule,Apotex Inc,2.0,P,2.0,Approved,2017-04-11,L04AD02,Tacrolimus
Human,02460254,Jamp-Tacrolimus,tacrolimus (tacrolimus monohydrate) 5 mg oral immediate release capsule,Jamp Pharma Corporation,2.0,P,2.0,Cancelled pre market,2022-09-08,L04AD02,Tacrolimus
Human,02416832,Sandoz Tacrolimus,tacrolimus (tacrolimus monohydrate) 5 mg oral immediate release capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2013-11-25,L04AD02,Tacrolimus
Human,02243144,Prograf,tacrolimus 0.5 mg oral capsule,Astellas Pharma Canada Inc,2.0,P,2.0,Marketed,2005-11-07,L04AD02,Tacrolimus
Human,02454068,Ach-Tacrolimus,tacrolimus 0.5 mg oral immediate release capsule,Accord Healthcare Inc,2.0,P,2.0,Marketed,2023-09-21,L04AD02,Tacrolimus
Human,02459213,Apo-Tacrolimus,tacrolimus 0.5 mg oral immediate release capsule,Apotex Inc,2.0,P,2.0,Approved,2017-04-11,L04AD02,Tacrolimus
Human,02460238,Jamp-Tacrolimus,tacrolimus 0.5 mg oral immediate release capsule,Jamp Pharma Corporation,2.0,P,2.0,Cancelled pre market,2022-09-08,L04AD02,Tacrolimus
Human,02296462,Advagraf,tacrolimus 0.5 mg oral prolonged-release capsule,Astellas Pharma Canada Inc,2.0,P,2.0,Marketed,2008-04-09,L04AD02,Tacrolimus
Human,02528592,Sandoz Tacrolimus Xr,tacrolimus 0.5 mg oral prolonged-release capsule,Sandoz Canada Incorporated,2.0,P,2.0,Approved,2022-07-06,L04AD02,Tacrolimus
Human,02485877,Envarsus Pa,tacrolimus 0.75 mg oral prolonged-release tablet,Endo Operations Ltd.,2.0,P,2.0,Marketed,2019-04-17,L04AD02,Tacrolimus
Human,02175991,Prograf,tacrolimus 1 mg oral capsule,Astellas Pharma Canada Inc,2.0,P,2.0,Marketed,2006-04-03,L04AD02,Tacrolimus
Human,02474506,Apo-Tacrolimus Capsules,tacrolimus 1 mg oral immediate release capsule,Apotex Inc,2.0,P,2.0,Approved,2023-12-20,L04AD02,Tacrolimus
Human,02296470,Advagraf,tacrolimus 1 mg oral prolonged-release capsule,Astellas Pharma Canada Inc,2.0,P,2.0,Marketed,2008-04-09,L04AD02,Tacrolimus
Human,02528606,Sandoz Tacrolimus Xr,tacrolimus 1 mg oral prolonged-release capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2025-11-25,L04AD02,Tacrolimus
Human,02485885,Envarsus Pa,tacrolimus 1 mg oral prolonged-release tablet,Endo Operations Ltd.,2.0,P,2.0,Marketed,2019-04-17,L04AD02,Tacrolimus
Human,02528614,Sandoz Tacrolimus Xr,tacrolimus 2 mg oral prolonged-release capsule,Sandoz Canada Incorporated,2.0,P,2.0,Approved,2022-07-06,L04AD02,Tacrolimus
Human,02331667,Advagraf,tacrolimus 3 mg oral prolonged-release capsule,Astellas Pharma Canada Inc,2.0,P,2.0,Marketed,2010-04-05,L04AD02,Tacrolimus
Human,02528622,Sandoz Tacrolimus Xr,tacrolimus 3 mg oral prolonged-release capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2025-11-25,L04AD02,Tacrolimus
Human,02485893,Envarsus Pa,tacrolimus 4 mg oral prolonged-release tablet,Endo Operations Ltd.,2.0,P,2.0,Marketed,2019-04-17,L04AD02,Tacrolimus
Human,02176009,Prograf,tacrolimus 5 mg / mL solution for injection,Astellas Pharma Canada Inc,2.0,P,2.0,Marketed,2005-09-15,L04AD02,Tacrolimus
Human,02175983,Prograf,tacrolimus 5 mg oral capsule,Astellas Pharma Canada Inc,2.0,P,2.0,Marketed,2006-04-03,L04AD02,Tacrolimus
Human,02474514,Apo-Tacrolimus Capsules,tacrolimus 5 mg oral immediate release capsule,Apotex Inc,2.0,P,2.0,Approved,2023-12-20,L04AD02,Tacrolimus
Human,02453428,Taro-Tacrolimus,tacrolimus 5 mg oral immediate release capsule,Sun Pharma Canada Inc,2.0,P,2.0,Cancelled pre market,2023-02-06,L04AD02,Tacrolimus
Human,02296489,Advagraf,tacrolimus 5 mg oral prolonged-release capsule,Astellas Pharma Canada Inc,2.0,P,2.0,Marketed,2008-04-09,L04AD02,Tacrolimus
Human,02528630,Sandoz Tacrolimus Xr,tacrolimus 5 mg oral prolonged-release capsule,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2025-11-25,L04AD02,Tacrolimus
Human,02482533,Gilenya,fingolimod (fingolimod hydrochloride) 0.25 mg oral capsule,Novartis Pharmaceuticals Canada Inc,2.0,P,,Marketed,2019-01-03,L04AE01,Fingolimod
Human,02475669,Ach-Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Accord Healthcare Inc,2.0,P,,Marketed,2019-12-11,L04AE01,Fingolimod
Human,02469936,Apo-Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Apotex Inc,2.0,P,,Dormant,2025-06-12,L04AE01,Fingolimod
Human,02500914,Asn-Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Ascend Laboratories Ltd,2.0,P,,Approved,2020-06-23,L04AE01,Fingolimod
Human,02365480,Gilenya,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Novartis Pharmaceuticals Canada Inc,2.0,P,,Marketed,2011-03-28,L04AE01,Fingolimod
Human,02487772,Jamp Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Jamp Pharma Corporation,2.0,P,,Marketed,2019-10-31,L04AE01,Fingolimod
Human,02474743,Mar-Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Marcan Pharmaceuticals Inc,2.0,P,,Dormant,2022-07-06,L04AE01,Fingolimod
Human,02469715,Mylan-Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,P,,Marketed,2019-09-25,L04AE01,Fingolimod
Human,02469782,Pms-Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Pharmascience Inc,2.0,P,,Marketed,2019-08-30,L04AE01,Fingolimod
Human,02482606,Sandoz Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Sandoz Canada Incorporated,2.0,P,,Marketed,2019-10-31,L04AE01,Fingolimod
Human,02469618,Taro-Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Taro Pharmaceuticals Inc,2.0,P,,Marketed,2019-10-24,L04AE01,Fingolimod
Human,02469561,Teva-Fingolimod,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,Teva Canada Limited,2.0,P,,Cancelled post market,2025-10-27,L04AE01,Fingolimod
Human,02496429,Mayzent,siponimod 0.25 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,R,,Marketed,2020-04-24,L04AE03,Siponimod
Human,02543370,Mayzent,siponimod 1 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,R,,Approved,2023-11-21,L04AE03,Siponimod
Human,02496437,Mayzent,siponimod 2 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,R,,Marketed,2020-04-24,L04AE03,Siponimod
Human,02515474,Ponvory,ponesimod 10 mg + ponesimod 2 mg + ponesimod 3 mg + ponesimod 4 mg + ponesimod 5 mg + ponesimod 6 mg + ponesimod 7 mg + ponesimod 8 mg + ponesimod 9 mg oral tablet,Vanda Pharmaceuticals Inc.,,P,,Dormant,2025-08-27,L04AE04,Ponesimod
Human,02515482,Ponvory,ponesimod 20 mg oral tablet,Vanda Pharmaceuticals Inc.,,P,,Marketed,2025-08-25,L04AE04,Ponesimod
Human,02538261,Apo-Tofacitinib,tofacitinib (tofacitinib citrate) 10 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2023-05-19,L04AF01,Tofacitinib
Human,02530015,Auro-Tofacitinib,tofacitinib (tofacitinib citrate) 10 mg oral tablet,Auro Pharma Inc,2.0,P,2.0,Marketed,2022-11-28,L04AF01,Tofacitinib
Human,02551705,Sandoz Tofacitinib,tofacitinib (tofacitinib citrate) 10 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2025-08-27,L04AF01,Tofacitinib
Human,02511312,Taro-Tofacitinib,tofacitinib (tofacitinib citrate) 10 mg oral tablet,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2022-11-28,L04AF01,Tofacitinib
Human,02544326,Teva-Tofacitinib,tofacitinib (tofacitinib citrate) 10 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Approved,2024-01-03,L04AF01,Tofacitinib
Human,02480786,Xeljanz,tofacitinib (tofacitinib citrate) 10 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2019-01-30,L04AF01,Tofacitinib
Human,02553988,Taro-Tofacitinib Xr,tofacitinib (tofacitinib citrate) 11 mg oral prolonged-release tablet,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2025-03-03,L04AF01,Tofacitinib
Human,02470608,Xeljanz Xr,tofacitinib (tofacitinib citrate) 11 mg oral prolonged-release tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2018-03-29,L04AF01,Tofacitinib
Human,02538253,Apo-Tofacitinib,tofacitinib (tofacitinib citrate) 5 mg oral tablet,Apotex Inc,2.0,P,2.0,Approved,2023-05-19,L04AF01,Tofacitinib
Human,02530007,Auro-Tofacitinib,tofacitinib (tofacitinib citrate) 5 mg oral tablet,Auro Pharma Inc,2.0,P,2.0,Marketed,2022-11-28,L04AF01,Tofacitinib
Human,02522896,Jamp Tofacitinib,tofacitinib (tofacitinib citrate) 5 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2023-10-20,L04AF01,Tofacitinib
Human,02522799,Pms-Tofacitinib,tofacitinib (tofacitinib citrate) 5 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Marketed,2022-11-25,L04AF01,Tofacitinib
Human,02551691,Sandoz Tofacitinib,tofacitinib (tofacitinib citrate) 5 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2025-08-27,L04AF01,Tofacitinib
Human,02511304,Taro-Tofacitinib,tofacitinib (tofacitinib citrate) 5 mg oral tablet,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2022-11-28,L04AF01,Tofacitinib
Human,02544318,Teva-Tofacitinib,tofacitinib (tofacitinib citrate) 5 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Approved,2024-01-03,L04AF01,Tofacitinib
Human,02423898,Xeljanz,tofacitinib (tofacitinib citrate) 5 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2014-06-03,L04AF01,Tofacitinib
Human,02480018,Olumiant,baricitinib 2 mg oral tablet,Eli Lilly Canada Inc,1.0,P,,Marketed,2018-09-27,L04AF02,Baricitinib
Human,02544768,Olumiant,baricitinib 4 mg oral tablet,Eli Lilly Canada Inc,1.0,P,,Marketed,2024-04-09,L04AF02,Baricitinib
Human,02495155,Rinvoq,upadacitinib 15 mg oral prolonged-release tablet,Abbvie Corporation,1.0,P,,Marketed,2020-01-16,L04AF03,Upadacitinib
Human,02520893,Rinvoq,upadacitinib 30 mg oral prolonged-release tablet,Abbvie Corporation,1.0,P,,Marketed,2021-10-28,L04AF03,Upadacitinib
Human,02539721,Rinvoq,upadacitinib 45 mg oral prolonged-release tablet,Abbvie Corporation,1.0,P,,Marketed,2023-09-07,L04AF03,Upadacitinib
Human,02543532,Litfulo,ritlecitinib (ritlecitinib tosylate) 50 mg oral capsule,Pfizer Canada Ulc,,P,,Marketed,2024-02-13,L04AF08,Ritlecitinib
Human,02467224,Ocrevus,ocrelizumab 30 mg / mL solution for injection,Hoffmann-La Roche Limited,1.0,,,Marketed,2017-09-21,L04AG08,Ocrelizumab
Human,02543931,Uplizna,inebilizumab 10 mg / mL solution for injection,Amgen Canada Inc,,R,,Marketed,2025-03-31,L04AG10,Inebilizumab
Human,02373386,Gd-Sirolimus,sirolimus 1 mg / mL oral solution,Genmed A Division Of Pfizer Canada Ulc,2.0,P,2.0,Approved,2011-10-04,L04AH01,Sirolimus
Human,02243237,Rapamune,sirolimus 1 mg / mL oral solution,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2013-06-10,L04AH01,Sirolimus
Human,02373394,Gd-Sirolimus,sirolimus 1 mg oral tablet,Genmed A Division Of Pfizer Canada Ulc,2.0,P,2.0,Approved,2011-10-04,L04AH01,Sirolimus
Human,02247111,Rapamune,sirolimus 1 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Marketed,2012-02-28,L04AH01,Sirolimus
Human,02373408,Gd-Sirolimus,sirolimus 2 mg oral tablet,Genmed A Division Of Pfizer Canada Ulc,2.0,P,2.0,Cancelled pre market,2025-03-26,L04AH01,Sirolimus
Human,02270617,Rapamune,sirolimus 2 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Cancelled pre market,2024-08-09,L04AH01,Sirolimus
Human,02373416,Gd-Sirolimus,sirolimus 5 mg oral tablet,Genmed A Division Of Pfizer Canada Ulc,2.0,P,2.0,Cancelled pre market,2025-03-26,L04AH01,Sirolimus
Human,02270684,Rapamune,sirolimus 5 mg oral tablet,Pfizer Canada Ulc,2.0,P,2.0,Cancelled pre market,2024-08-09,L04AH01,Sirolimus
Human,02375907,Certican,everolimus 0.25 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Approved,2011-11-14,L04AH02,Everolimus
Human,02375915,Certican,everolimus 0.5 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Approved,2011-11-14,L04AH02,Everolimus
Human,02375923,Certican,everolimus 0.75 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Approved,2011-11-14,L04AH02,Everolimus
Human,02339528,Afinitor,everolimus 10 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2010-01-19,L04AH02,Everolimus
Human,02530120,Nat-Everolimus,everolimus 10 mg oral tablet,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2023-04-05,L04AH02,Everolimus
Human,02504693,Pms-Everolimus,everolimus 10 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Marketed,2021-09-08,L04AH02,Everolimus
Human,02532433,Reddy-Everolimus,everolimus 10 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2024-08-27,L04AH02,Everolimus
Human,02492946,Sandoz Everolimus,everolimus 10 mg oral tablet,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2020-09-17,L04AH02,Everolimus
Human,02463253,Teva-Everolimus,everolimus 10 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2019-12-06,L04AH02,Everolimus
Human,02425645,Afinitor Disperz,everolimus 2 mg oral tablet for suspension,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2014-11-28,L04AH02,Everolimus
Human,02369257,Afinitor,everolimus 2.5 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2011-08-05,L04AH02,Everolimus
Human,02530090,Nat-Everolimus,everolimus 2.5 mg oral tablet,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2023-04-05,L04AH02,Everolimus
Human,02504677,Pms-Everolimus,everolimus 2.5 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Marketed,2021-09-08,L04AH02,Everolimus
Human,02532409,Reddy-Everolimus,everolimus 2.5 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2024-08-27,L04AH02,Everolimus
Human,02492911,Sandoz Everolimus,everolimus 2.5 mg oral tablet,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2020-09-17,L04AH02,Everolimus
Human,02463229,Teva-Everolimus,everolimus 2.5 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2019-12-06,L04AH02,Everolimus
Human,02425653,Afinitor Disperz,everolimus 3 mg oral tablet for suspension,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2014-11-28,L04AH02,Everolimus
Human,02339501,Afinitor,everolimus 5 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2010-03-15,L04AH02,Everolimus
Human,02530104,Nat-Everolimus,everolimus 5 mg oral tablet,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2023-04-05,L04AH02,Everolimus
Human,02504685,Pms-Everolimus,everolimus 5 mg oral tablet,Pharmascience Inc,1.0,K,1.0,Marketed,2021-09-08,L04AH02,Everolimus
Human,02532417,Reddy-Everolimus,everolimus 5 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2024-08-27,L04AH02,Everolimus
Human,02492938,Sandoz Everolimus,everolimus 5 mg oral tablet,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2020-09-17,L04AH02,Everolimus
Human,02463237,Teva-Everolimus,everolimus 5 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Marketed,2019-12-06,L04AH02,Everolimus
Human,02425661,Afinitor Disperz,everolimus 5 mg oral tablet for suspension,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Marketed,2014-11-28,L04AH02,Everolimus
Human,02450267,Afinitor,everolimus 7.5 mg oral tablet,Novartis Pharmaceuticals Canada Inc,1.0,K,1.0,Cancelled post market,2018-07-09,L04AH02,Everolimus
Human,02530112,Nat-Everolimus,everolimus 7.5 mg oral tablet,Natco Pharma (Canada) Inc,1.0,K,1.0,Approved,2022-08-29,L04AH02,Everolimus
Human,02532425,Reddy-Everolimus,everolimus 7.5 mg oral tablet,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Approved,2022-11-01,L04AH02,Everolimus
Human,02463245,Teva-Everolimus,everolimus 7.5 mg oral tablet,Teva Canada Limited,1.0,K,1.0,Cancelled pre market,2025-06-26,L04AH02,Everolimus
Human,02491559,Ultomiris,ravulizumab 10 mg / mL solution for injection,Alexion Pharma Gmbh,,R,,Cancelled post market,2025-08-26,L04AJ02,Ravulizumab
Human,02533456,Ultomiris,ravulizumab 1100 mg / 11 mL solution for injection,Alexion Pharma Gmbh,,R,,Marketed,2023-04-19,L04AJ02,Ravulizumab
Human,02533448,Ultomiris,ravulizumab 300 mg / 3 mL solution for injection,Alexion Pharma Gmbh,,R,,Marketed,2023-04-19,L04AJ02,Ravulizumab
Human,02533294,Empaveli,pegcetacoplan 1080 mg / 20 mL solution for injection,Swedish Orphan Biovitrum Ab (Publ),,p,,Marketed,2023-02-15,L04AJ03,Pegcetacoplan
Human,02526662,Tavneos,avacopan 10 mg oral capsule,Vifor Fresenius Medical Care Renal Pharma Ltd,2.0,R,,Marketed,2022-11-04,L04AJ05,Avacopan
Human,02554313,Fabhalta,iptacopan (iptacopan hydrochloride) 200 mg oral capsule,Novartis Pharmaceuticals Canada Inc,2.0,,,Marketed,2025-03-28,L04AJ08,Iptacopan
Human,02478862,Accel-Leflunomide,leflunomide 10 mg oral tablet,Accel Pharma Inc,2.0,P,,Marketed,2019-09-19,L04AK01,Leflunomide
Human,02256495,Apo-Leflunomide,leflunomide 10 mg oral tablet,Apotex Inc,2.0,P,,Marketed,2004-09-14,L04AK01,Leflunomide
Human,02241888,Arava,leflunomide 10 mg oral tablet,Sanofi-Aventis Canada Inc,2.0,P,,Marketed,2008-11-03,L04AK01,Leflunomide
Human,02309343,Dom-Leflunomide,leflunomide 10 mg oral tablet,Dominion Pharmacal,2.0,P,,Approved,2008-04-29,L04AK01,Leflunomide
Human,02351668,Leflunomide,leflunomide 10 mg oral tablet,Sanis Health Inc,2.0,P,,Marketed,2014-07-12,L04AK01,Leflunomide
Human,02543575,Leflunomide,leflunomide 10 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,P,,Marketed,2024-06-03,L04AK01,Leflunomide
Human,02551918,Mar-Leflunomide,leflunomide 10 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,P,,Marketed,2024-12-04,L04AK01,Leflunomide
Human,02319225,Mylan-Leflunomide,leflunomide 10 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,,Cancelled post market,2017-01-09,L04AK01,Leflunomide
Human,02346346,Ntp-Leflunomide,leflunomide 10 mg oral tablet,Teva Canada Limited,2.0,P,,Cancelled pre market,2015-08-06,L04AK01,Leflunomide
Human,02336138,Nu-Leflunomide,leflunomide 10 mg oral tablet,Nu-Pharm Inc,2.0,P,,Cancelled (unreturned annual),2018-03-28,L04AK01,Leflunomide
Human,02465868,Odan-Leflunomide,leflunomide 10 mg oral tablet,Odan Laboratories Ltd,2.0,P,,Approved,2017-07-05,L04AK01,Leflunomide
Human,02309327,Phl-Leflunomide,leflunomide 10 mg oral tablet,Pharmel Inc,2.0,P,,Cancelled post market,2008-10-31,L04AK01,Leflunomide
Human,02288265,Pms-Leflunomide,leflunomide 10 mg oral tablet,Pharmascience Inc,2.0,P,,Dormant,2018-08-02,L04AK01,Leflunomide
Human,02415828,Pro-Leflunomide,leflunomide 10 mg oral tablet,Pro Doc Limitee,2.0,P,,Marketed,2025-11-27,L04AK01,Leflunomide
Human,02283964,Sandoz Leflunomide,leflunomide 10 mg oral tablet,Sandoz Canada Incorporated,2.0,P,,Marketed,2006-08-15,L04AK01,Leflunomide
Human,02261251,Teva-Leflunomide,leflunomide 10 mg oral tablet,Teva Canada Limited,2.0,P,,Marketed,2014-02-14,L04AK01,Leflunomide
Human,02241890,Arava,leflunomide 100 mg oral tablet,Sanofi-Aventis Canada Inc,2.0,P,,Cancelled post market,2023-07-14,L04AK01,Leflunomide
Human,02478870,Accel-Leflunomide,leflunomide 20 mg oral tablet,Accel Pharma Inc,2.0,P,,Marketed,2019-09-19,L04AK01,Leflunomide
Human,02256509,Apo-Leflunomide,leflunomide 20 mg oral tablet,Apotex Inc,2.0,P,,Marketed,2004-09-14,L04AK01,Leflunomide
Human,02241889,Arava,leflunomide 20 mg oral tablet,Sanofi-Aventis Canada Inc,2.0,P,,Marketed,2008-10-10,L04AK01,Leflunomide
Human,02309351,Dom-Leflunomide,leflunomide 20 mg oral tablet,Dominion Pharmacal,2.0,P,,Approved,2008-04-29,L04AK01,Leflunomide
Human,02351676,Leflunomide,leflunomide 20 mg oral tablet,Sanis Health Inc,2.0,P,,Marketed,2014-07-12,L04AK01,Leflunomide
Human,02543583,Leflunomide,leflunomide 20 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,P,,Marketed,2024-06-03,L04AK01,Leflunomide
Human,02551926,Mar-Leflunomide,leflunomide 20 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,P,,Marketed,2024-12-04,L04AK01,Leflunomide
Human,02319233,Mylan-Leflunomide,leflunomide 20 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,P,,Cancelled post market,2017-01-09,L04AK01,Leflunomide
Human,02346354,Ntp-Leflunomide,leflunomide 20 mg oral tablet,Teva Canada Limited,2.0,P,,Cancelled pre market,2015-08-06,L04AK01,Leflunomide
Human,02336146,Nu-Leflunomide,leflunomide 20 mg oral tablet,Nu-Pharm Inc,2.0,P,,Cancelled (unreturned annual),2018-03-28,L04AK01,Leflunomide
Human,02465876,Odan-Leflunomide,leflunomide 20 mg oral tablet,Odan Laboratories Ltd,2.0,P,,Approved,2017-07-05,L04AK01,Leflunomide
Human,02309335,Phl-Leflunomide,leflunomide 20 mg oral tablet,Pharmel Inc,2.0,P,,Cancelled post market,2008-10-31,L04AK01,Leflunomide
Human,02288273,Pms-Leflunomide,leflunomide 20 mg oral tablet,Pharmascience Inc,2.0,P,,Dormant,2018-08-02,L04AK01,Leflunomide
Human,02415836,Pro-Leflunomide,leflunomide 20 mg oral tablet,Pro Doc Limitee,2.0,P,,Marketed,2025-11-27,L04AK01,Leflunomide
Human,02283972,Sandoz Leflunomide,leflunomide 20 mg oral tablet,Sandoz Canada Incorporated,2.0,P,,Marketed,2006-08-15,L04AK01,Leflunomide
Human,02261278,Teva-Leflunomide,leflunomide 20 mg oral tablet,Teva Canada Limited,2.0,P,,Marketed,2014-02-14,L04AK01,Leflunomide
Human,02502933,Ach-Teriflunomide,teriflunomide 14 mg oral tablet,Accord Healthcare Inc,2.0,P,2.0,Cancelled post market,2024-11-01,L04AK02,Teriflunomide
Human,02500639,Apo-Teriflunomide,teriflunomide 14 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2022-05-16,L04AK02,Teriflunomide
Human,02416328,Aubagio,teriflunomide 14 mg oral tablet,Sanofi-Aventis Canada Inc,2.0,P,2.0,Cancelled post market,2024-11-19,L04AK02,Teriflunomide
Human,02500515,Auro-Teriflunomide,teriflunomide 14 mg oral tablet,Auro Pharma Inc,2.0,P,2.0,Approved,2022-05-16,L04AK02,Teriflunomide
Human,02504170,Jamp Teriflunomide,teriflunomide 14 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2022-05-16,L04AK02,Teriflunomide
Human,02523833,M-Teriflunomide,teriflunomide 14 mg oral tablet,Mantra Pharma Inc,2.0,P,2.0,Marketed,2022-05-16,L04AK02,Teriflunomide
Human,02500469,Mar-Teriflunomide,teriflunomide 14 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,P,2.0,Marketed,2022-05-18,L04AK02,Teriflunomide
Human,02500310,Nat-Teriflunomide,teriflunomide 14 mg oral tablet,Natco Pharma (Canada) Inc,2.0,P,2.0,Marketed,2022-05-16,L04AK02,Teriflunomide
Human,02500434,Pms-Teriflunomide,teriflunomide 14 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Marketed,2022-05-16,L04AK02,Teriflunomide
Human,02505843,Sandoz Teriflunomide,teriflunomide 14 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2022-05-16,L04AK02,Teriflunomide
Human,02501090,Teva-Teriflunomide,teriflunomide 14 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2022-05-16,L04AK02,Teriflunomide
Human,02231575,Azathioprine Sodium For Injection,azathioprine (azathioprine sodium) 100 mg / vial powder for solution for injection,Novopharm Limited,1.0,CK,1.0,Cancelled pre market,2015-10-16,L04AX01,Azathioprine
Human,00337854,Imuran Inj 100Mg,azathioprine (azathioprine sodium) 100 mg / vial powder for solution for injection,Glaxo Wellcome Inc.,1.0,CK,1.0,Cancelled post market,2000-10-25,L04AX01,Azathioprine
Human,02244895,Imuran,azathioprine (azathioprine sodium) 50 mg / vial powder for solution for injection,Aspen Pharmacare Canada Inc.,1.0,CK,1.0,Dormant,2022-07-26,L04AX01,Azathioprine
Human,02235352,Azathioprine,azathioprine 50 mg / tablet oral tablet,Bdh Inc.,1.0,CK,1.0,Cancelled post market,2000-08-03,L04AX01,Azathioprine
Human,02242907,Apo-Azathioprine,azathioprine 50 mg oral tablet,Apotex Inc,1.0,CK,1.0,Marketed,2000-10-17,L04AX01,Azathioprine
Human,02343002,Azathioprine,azathioprine 50 mg oral tablet,Sanis Health Inc,1.0,CK,1.0,Cancelled post market,2017-07-31,L04AX01,Azathioprine
Human,02243371,Azathioprine-50,azathioprine 50 mg oral tablet,Pro Doc Limitee,1.0,CK,1.0,Cancelled post market,2023-07-10,L04AX01,Azathioprine
Human,00004596,Imuran,azathioprine 50 mg oral tablet,Aspen Pharmacare Canada Inc.,1.0,CK,1.0,Marketed,2018-01-18,L04AX01,Azathioprine
Human,02231491,Mylan-Azathioprine,azathioprine 50 mg oral tablet,Mylan Pharmaceuticals Ulc,1.0,CK,1.0,Cancelled post market,2017-11-14,L04AX01,Azathioprine
Human,02358573,Ntp-Azathioprine,azathioprine 50 mg oral tablet,Teva Canada Limited,1.0,CK,1.0,Cancelled pre market,2015-08-06,L04AX01,Azathioprine
Human,02248843,Nu-Azathioprine,azathioprine 50 mg oral tablet,Nu-Pharm Inc,1.0,CK,1.0,Cancelled (unreturned annual),2018-03-28,L04AX01,Azathioprine
Human,02236799,Ratio-Azathioprine,azathioprine 50 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,1.0,CK,1.0,Cancelled post market,2006-08-04,L04AX01,Azathioprine
Human,02242148,Riva-Azathioprine 50 Mg,azathioprine 50 mg oral tablet,Laboratoire Riva Inc.,1.0,CK,1.0,Cancelled post market,2003-07-28,L04AX01,Azathioprine
Human,02236819,Teva-Azathioprine,azathioprine 50 mg oral tablet,Teva Canada Limited,1.0,CK,1.0,Marketed,2010-04-23,L04AX01,Azathioprine
Human,02355205,Thalomid,thalidomide 100 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2024-08-26,L04AX02,Thalidomide
Human,02355213,Thalomid,thalidomide 150 mg oral capsule,Celgene Inc,1.0,K,1.0,Cancelled pre market,2024-04-15,L04AX02,Thalidomide
Human,02355221,Thalomid,thalidomide 200 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Cancelled post market,2024-03-28,L04AX02,Thalidomide
Human,02355191,Thalomid,thalidomide 50 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2024-06-12,L04AX02,Thalidomide
Human,02524023,Auro-Methotrexate,methotrexate (methotrexate disodium) 2.5 mg oral tablet,Auro Pharma Inc,1.0,CK,1.0,Marketed,2023-02-02,L04AX03,Methotrexate
Human,02530775,Methofill Self-Dose Injector,methotrexate (methotrexate sodium) 10 mg / 0.2 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2025-07-02,L04AX03,Methotrexate
Human,02491281,Methotrexate Subcutaneous,methotrexate (methotrexate sodium) 10 mg / 0.2 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2025-10-20,L04AX03,Methotrexate
Human,02454831,Metoject Subcutaneous,methotrexate (methotrexate sodium) 10 mg / 0.2 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Marketed,2019-09-16,L04AX03,Methotrexate
Human,02539608,Pms-Methotrexate Injection,methotrexate (methotrexate sodium) 10 mg / 0.2 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-03-14,L04AX03,Methotrexate
Human,02546558,Nordimet,methotrexate (methotrexate sodium) 10 mg / 0.4 mL solution for injection,Nordic Group B.V.,1.0,CK,1.0,Marketed,2024-08-01,L04AX03,Methotrexate
Human,02530783,Methofill Self-Dose Injector,methotrexate (methotrexate sodium) 12.5 mg / 0.25 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2025-07-02,L04AX03,Methotrexate
Human,02491303,Methotrexate Subcutaneous,methotrexate (methotrexate sodium) 12.5 mg / 0.25 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2025-10-20,L04AX03,Methotrexate
Human,02454750,Metoject Subcutaneous,methotrexate (methotrexate sodium) 12.5 mg / 0.25 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Marketed,2019-09-16,L04AX03,Methotrexate
Human,02539616,Pms-Methotrexate Injection,methotrexate (methotrexate sodium) 12.5 mg / 0.25 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-03-14,L04AX03,Methotrexate
Human,02546566,Nordimet,methotrexate (methotrexate sodium) 12.5 mg / 0.5 mL solution for injection,Nordic Group B.V.,1.0,CK,1.0,Approved,2024-03-26,L04AX03,Methotrexate
Human,02530791,Methofill Self-Dose Injector,methotrexate (methotrexate sodium) 15 mg / 0.3 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2025-07-02,L04AX03,Methotrexate
Human,02491311,Methotrexate Subcutaneous,methotrexate (methotrexate sodium) 15 mg / 0.3 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2020-06-02,L04AX03,Methotrexate
Human,02454858,Metoject Subcutaneous,methotrexate (methotrexate sodium) 15 mg / 0.3 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Marketed,2018-11-30,L04AX03,Methotrexate
Human,02539624,Pms-Methotrexate Injection,methotrexate (methotrexate sodium) 15 mg / 0.3 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-03-14,L04AX03,Methotrexate
Human,02546574,Nordimet,methotrexate (methotrexate sodium) 15 mg / 0.6 mL solution for injection,Nordic Group B.V.,1.0,CK,1.0,Marketed,2024-08-01,L04AX03,Methotrexate
Human,02530805,Methofill Self-Dose Injector,methotrexate (methotrexate sodium) 17.5 mg / 0.35 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2025-07-02,L04AX03,Methotrexate
Human,02491338,Methotrexate Subcutaneous,methotrexate (methotrexate sodium) 17.5 mg / 0.35 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2020-02-28,L04AX03,Methotrexate
Human,02454769,Metoject Subcutaneous,methotrexate (methotrexate sodium) 17.5 mg / 0.35 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Marketed,2016-12-02,L04AX03,Methotrexate
Human,02539632,Pms-Methotrexate Injection,methotrexate (methotrexate sodium) 17.5 mg / 0.35 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-03-14,L04AX03,Methotrexate
Human,02546582,Nordimet,methotrexate (methotrexate sodium) 17.5 mg / 0.7 mL solution for injection,Nordic Group B.V.,1.0,CK,1.0,Approved,2024-03-26,L04AX03,Methotrexate
Human,02171767,Rheumatrex-Tab 2.5Mg,methotrexate (methotrexate sodium) 2.5 mg oral tablet,Wyeth-Ayerst Canada Inc.,1.0,CK,1.0,Cancelled post market,2000-08-02,L04AX03,Methotrexate
Human,02530813,Methofill Self-Dose Injector,methotrexate (methotrexate sodium) 20 mg / 0.4 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2025-07-02,L04AX03,Methotrexate
Human,02491346,Methotrexate Subcutaneous,methotrexate (methotrexate sodium) 20 mg / 0.4 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2020-02-28,L04AX03,Methotrexate
Human,02454866,Metoject Subcutaneous,methotrexate (methotrexate sodium) 20 mg / 0.4 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Marketed,2016-12-02,L04AX03,Methotrexate
Human,02539640,Pms-Methotrexate Injection,methotrexate (methotrexate sodium) 20 mg / 0.4 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-03-14,L04AX03,Methotrexate
Human,02546590,Nordimet,methotrexate (methotrexate sodium) 20 mg / 0.8 mL solution for injection,Nordic Group B.V.,1.0,CK,1.0,Marketed,2024-08-01,L04AX03,Methotrexate
Human,02530848,Methofill Self-Dose Injector,methotrexate (methotrexate sodium) 22.5 mg / 0.45 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2025-07-02,L04AX03,Methotrexate
Human,02491354,Methotrexate Subcutaneous,methotrexate (methotrexate sodium) 22.5 mg / 0.45 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2020-02-28,L04AX03,Methotrexate
Human,02454777,Metoject Subcutaneous,methotrexate (methotrexate sodium) 22.5 mg / 0.45 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Marketed,2016-12-02,L04AX03,Methotrexate
Human,02539659,Pms-Methotrexate Injection,methotrexate (methotrexate sodium) 22.5 mg / 0.45 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-03-14,L04AX03,Methotrexate
Human,02546604,Nordimet,methotrexate (methotrexate sodium) 22.5 mg / 0.9 mL solution for injection,Nordic Group B.V.,1.0,CK,1.0,Approved,2024-03-26,L04AX03,Methotrexate
Human,02530856,Methofill Self-Dose Injector,methotrexate (methotrexate sodium) 25 mg / 0.5 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2025-07-02,L04AX03,Methotrexate
Human,02491362,Methotrexate Subcutaneous,methotrexate (methotrexate sodium) 25 mg / 0.5 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Marketed,2020-02-28,L04AX03,Methotrexate
Human,02454874,Metoject Subcutaneous,methotrexate (methotrexate sodium) 25 mg / 0.5 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Marketed,2016-12-02,L04AX03,Methotrexate
Human,02539667,Pms-Methotrexate Injection,methotrexate (methotrexate sodium) 25 mg / 0.5 mL solution for injection,Pharmascience Inc,1.0,CK,1.0,Marketed,2024-03-14,L04AX03,Methotrexate
Human,02546612,Nordimet,methotrexate (methotrexate sodium) 25 mg / mL solution for injection,Nordic Group B.V.,1.0,CK,1.0,Marketed,2024-08-01,L04AX03,Methotrexate
Human,02530767,Methofill Self-Dose Injector,methotrexate (methotrexate sodium) 7.5 mg / 0.15 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Approved,2022-09-15,L04AX03,Methotrexate
Human,02491273,Methotrexate Subcutaneous,methotrexate (methotrexate sodium) 7.5 mg / 0.15 mL solution for injection,Accord Healthcare Inc,1.0,CK,1.0,Approved,2019-08-07,L04AX03,Methotrexate
Human,02454823,Metoject Subcutaneous,methotrexate (methotrexate sodium) 7.5 mg / 0.15 mL solution for injection,Medexus Pharmaceuticals Inc.,1.0,CK,1.0,Approved,2016-05-17,L04AX03,Methotrexate
Human,02546531,Nordimet,methotrexate (methotrexate sodium) 7.5 mg / 0.3 mL solution for injection,Nordic Group B.V.,1.0,CK,1.0,Marketed,2024-08-01,L04AX03,Methotrexate
Human,02530880,Teva-Lenalidomide,lenalidomide (lenalidomide hydrochloride monohydrate) 10 mg oral capsule,Teva Canada Limited,1.0,K,1.0,Cancelled pre market,2023-05-24,L04AX04,Lenalidomide
Human,02530899,Teva-Lenalidomide,lenalidomide (lenalidomide hydrochloride monohydrate) 15 mg oral capsule,Teva Canada Limited,1.0,K,1.0,Cancelled pre market,2023-05-24,L04AX04,Lenalidomide
Human,02530864,Teva-Lenalidomide,lenalidomide (lenalidomide hydrochloride monohydrate) 2.5 mg oral capsule,Teva Canada Limited,1.0,K,1.0,Cancelled pre market,2023-05-24,L04AX04,Lenalidomide
Human,02530902,Teva-Lenalidomide,lenalidomide (lenalidomide hydrochloride monohydrate) 20 mg oral capsule,Teva Canada Limited,1.0,K,1.0,Cancelled pre market,2023-05-24,L04AX04,Lenalidomide
Human,02530910,Teva-Lenalidomide,lenalidomide (lenalidomide hydrochloride monohydrate) 25 mg oral capsule,Teva Canada Limited,1.0,K,1.0,Cancelled pre market,2023-05-24,L04AX04,Lenalidomide
Human,02530872,Teva-Lenalidomide,lenalidomide (lenalidomide hydrochloride monohydrate) 5 mg oral capsule,Teva Canada Limited,1.0,K,1.0,Cancelled pre market,2023-05-24,L04AX04,Lenalidomide
Human,02507943,Apo-Lenalidomide,lenalidomide 10 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02543826,Eugia-Lenalidomide,lenalidomide 10 mg oral capsule,Eugia Pharma Inc.,1.0,K,1.0,Approved,2024-09-04,L04AX04,Lenalidomide
Human,02506157,Jamp Lenalidomide,lenalidomide 10 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2022-02-02,L04AX04,Lenalidomide
Human,02493950,Lenalidomide,lenalidomide 10 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2022-11-16,L04AX04,Lenalidomide
Human,02493861,Nat-Lenalidomide,lenalidomide 10 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02483025,Reddy-Lenalidomide,lenalidomide 10 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02304902,Revlimid,lenalidomide 10 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2025-01-31,L04AX04,Lenalidomide
Human,02518589,Sandoz Lenalidomide,lenalidomide 10 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2021-09-07,L04AX04,Lenalidomide
Human,02507889,Taro-Lenalidomide,lenalidomide 10 mg oral capsule,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2022-06-13,L04AX04,Lenalidomide
Human,02507951,Apo-Lenalidomide,lenalidomide 15 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02543796,Eugia-Lenalidomide,lenalidomide 15 mg oral capsule,Eugia Pharma Inc.,1.0,K,1.0,Approved,2024-09-04,L04AX04,Lenalidomide
Human,02506165,Jamp Lenalidomide,lenalidomide 15 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2022-02-02,L04AX04,Lenalidomide
Human,02493969,Lenalidomide,lenalidomide 15 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2022-11-16,L04AX04,Lenalidomide
Human,02493888,Nat-Lenalidomide,lenalidomide 15 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02483033,Reddy-Lenalidomide,lenalidomide 15 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02317699,Revlimid,lenalidomide 15 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2025-02-03,L04AX04,Lenalidomide
Human,02518597,Sandoz Lenalidomide,lenalidomide 15 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2021-09-07,L04AX04,Lenalidomide
Human,02507897,Taro-Lenalidomide,lenalidomide 15 mg oral capsule,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2022-06-13,L04AX04,Lenalidomide
Human,02507927,Apo-Lenalidomide,lenalidomide 2.5 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02543753,Eugia-Lenalidomide,lenalidomide 2.5 mg oral capsule,Eugia Pharma Inc.,1.0,K,1.0,Approved,2024-09-04,L04AX04,Lenalidomide
Human,02506130,Jamp Lenalidomide,lenalidomide 2.5 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2022-02-02,L04AX04,Lenalidomide
Human,02493926,Lenalidomide,lenalidomide 2.5 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2022-11-16,L04AX04,Lenalidomide
Human,02493837,Nat-Lenalidomide,lenalidomide 2.5 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02484714,Reddy-Lenalidomide,lenalidomide 2.5 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02459418,Revlimid,lenalidomide 2.5 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2024-11-22,L04AX04,Lenalidomide
Human,02518562,Sandoz Lenalidomide,lenalidomide 2.5 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2021-09-07,L04AX04,Lenalidomide
Human,02507862,Taro-Lenalidomide,lenalidomide 2.5 mg oral capsule,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2022-06-13,L04AX04,Lenalidomide
Human,02507978,Apo-Lenalidomide,lenalidomide 20 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02543788,Eugia-Lenalidomide,lenalidomide 20 mg oral capsule,Eugia Pharma Inc.,1.0,K,1.0,Approved,2024-09-04,L04AX04,Lenalidomide
Human,02506173,Jamp Lenalidomide,lenalidomide 20 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2022-02-02,L04AX04,Lenalidomide
Human,02493977,Lenalidomide,lenalidomide 20 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2022-11-16,L04AX04,Lenalidomide
Human,02493896,Nat-Lenalidomide,lenalidomide 20 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02483041,Reddy-Lenalidomide,lenalidomide 20 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02440601,Revlimid,lenalidomide 20 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2025-02-05,L04AX04,Lenalidomide
Human,02518600,Sandoz Lenalidomide,lenalidomide 20 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2021-09-07,L04AX04,Lenalidomide
Human,02507900,Taro-Lenalidomide,lenalidomide 20 mg oral capsule,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2022-06-13,L04AX04,Lenalidomide
Human,02507986,Apo-Lenalidomide,lenalidomide 25 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02543818,Eugia-Lenalidomide,lenalidomide 25 mg oral capsule,Eugia Pharma Inc.,1.0,K,1.0,Approved,2024-09-04,L04AX04,Lenalidomide
Human,02506181,Jamp Lenalidomide,lenalidomide 25 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2022-02-02,L04AX04,Lenalidomide
Human,02493985,Lenalidomide,lenalidomide 25 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2022-11-16,L04AX04,Lenalidomide
Human,02493918,Nat-Lenalidomide,lenalidomide 25 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02483068,Reddy-Lenalidomide,lenalidomide 25 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02317710,Revlimid,lenalidomide 25 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2025-01-31,L04AX04,Lenalidomide
Human,02518619,Sandoz Lenalidomide,lenalidomide 25 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2021-09-07,L04AX04,Lenalidomide
Human,02507919,Taro-Lenalidomide,lenalidomide 25 mg oral capsule,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2022-06-13,L04AX04,Lenalidomide
Human,02507935,Apo-Lenalidomide,lenalidomide 5 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02543761,Eugia-Lenalidomide,lenalidomide 5 mg oral capsule,Eugia Pharma Inc.,1.0,K,1.0,Approved,2024-09-04,L04AX04,Lenalidomide
Human,02506149,Jamp Lenalidomide,lenalidomide 5 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2022-02-02,L04AX04,Lenalidomide
Human,02493934,Lenalidomide,lenalidomide 5 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2022-11-16,L04AX04,Lenalidomide
Human,02493845,Nat-Lenalidomide,lenalidomide 5 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02483017,Reddy-Lenalidomide,lenalidomide 5 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2021-09-01,L04AX04,Lenalidomide
Human,02304899,Revlimid,lenalidomide 5 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2025-01-31,L04AX04,Lenalidomide
Human,02518570,Sandoz Lenalidomide,lenalidomide 5 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2021-09-07,L04AX04,Lenalidomide
Human,02507870,Taro-Lenalidomide,lenalidomide 5 mg oral capsule,Taro Pharmaceuticals Inc,1.0,K,1.0,Marketed,2022-06-13,L04AX04,Lenalidomide
Human,02493942,Lenalidomide,lenalidomide 7.5 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2022-11-16,L04AX04,Lenalidomide
Human,02493853,Nat-Lenalidomide,lenalidomide 7.5 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Approved,2021-09-01,L04AX04,Lenalidomide
Human,02520427,Apo-Pomalidomide,pomalidomide 1 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02538059,Jamp Pomalidomide,pomalidomide 1 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2023-08-01,L04AX06,Pomalidomide
Human,02506394,Nat-Pomalidomide,pomalidomide 1 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02517051,Pomalidomide,pomalidomide 1 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2024-09-09,L04AX06,Pomalidomide
Human,02419580,Pomalyst,pomalidomide 1 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2024-11-11,L04AX06,Pomalidomide
Human,02504073,Reddy-Pomalidomide,pomalidomide 1 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2023-03-15,L04AX06,Pomalidomide
Human,02523973,Sandoz Pomalidomide,pomalidomide 1 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02520435,Apo-Pomalidomide,pomalidomide 2 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02538075,Jamp Pomalidomide,pomalidomide 2 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2023-08-01,L04AX06,Pomalidomide
Human,02506408,Nat-Pomalidomide,pomalidomide 2 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02517078,Pomalidomide,pomalidomide 2 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2024-09-09,L04AX06,Pomalidomide
Human,02419599,Pomalyst,pomalidomide 2 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2025-01-31,L04AX06,Pomalidomide
Human,02504081,Reddy-Pomalidomide,pomalidomide 2 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2023-03-15,L04AX06,Pomalidomide
Human,02523981,Sandoz Pomalidomide,pomalidomide 2 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02520443,Apo-Pomalidomide,pomalidomide 3 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02538083,Jamp Pomalidomide,pomalidomide 3 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2023-08-01,L04AX06,Pomalidomide
Human,02506416,Nat-Pomalidomide,pomalidomide 3 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02517086,Pomalidomide,pomalidomide 3 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2024-09-09,L04AX06,Pomalidomide
Human,02419602,Pomalyst,pomalidomide 3 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2025-02-03,L04AX06,Pomalidomide
Human,02504103,Reddy-Pomalidomide,pomalidomide 3 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2023-03-15,L04AX06,Pomalidomide
Human,02524007,Sandoz Pomalidomide,pomalidomide 3 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02520451,Apo-Pomalidomide,pomalidomide 4 mg oral capsule,Apotex Inc,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02538091,Jamp Pomalidomide,pomalidomide 4 mg oral capsule,Jamp Pharma Corporation,1.0,K,1.0,Marketed,2023-08-01,L04AX06,Pomalidomide
Human,02506424,Nat-Pomalidomide,pomalidomide 4 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02517094,Pomalidomide,pomalidomide 4 mg oral capsule,Natco Pharma (Canada) Inc,1.0,K,1.0,Cancelled pre market,2024-09-09,L04AX06,Pomalidomide
Human,02419610,Pomalyst,pomalidomide 4 mg oral capsule,Bristol-Myers Squibb Canada,1.0,K,1.0,Marketed,2025-01-31,L04AX06,Pomalidomide
Human,02504111,Reddy-Pomalidomide,pomalidomide 4 mg oral capsule,Dr Reddy'S Laboratories Ltd,1.0,K,1.0,Marketed,2023-03-15,L04AX06,Pomalidomide
Human,02524015,Sandoz Pomalidomide,pomalidomide 4 mg oral capsule,Sandoz Canada Incorporated,1.0,K,1.0,Marketed,2023-02-28,L04AX06,Pomalidomide
Human,02519380,Myinfla,colchicine 0.5 mg oral prolonged-release tablet,Pendopharm Division Of Pharmascience Inc,2.0,R,2.0,Marketed,2021-09-13,M01,Antiinflammatory and antirheumatic products
Human,02520141,Pms-Colchicine Er,colchicine 0.5 mg oral prolonged-release tablet,Pharmascience Inc,2.0,R,2.0,Approved,2021-09-10,M01,Antiinflammatory and antirheumatic products
Human,01917056,Arthrotec 50,diclofenac sodium 50 mg + misoprostol 200 mcg oral delayed-release tablet,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2005-11-21,M01AB55,"Diclofenac, combinations"
Human,02341689,Gd-Diclofenac/Misoprostol 50,diclofenac sodium 50 mg + misoprostol 200 mcg oral delayed-release tablet,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Marketed,2014-07-22,M01AB55,"Diclofenac, combinations"
Human,02413469,Pms-Diclofenac-Misoprostol,diclofenac sodium 50 mg + misoprostol 200 mcg oral delayed-release tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2018-12-11,M01AB55,"Diclofenac, combinations"
Human,02397145,Act Diclo-Miso,diclofenac sodium 50 mg + misoprostol 200 mcg oral gastro-resistant tablet,Actavis Pharma Company,2.0,R,2.0,Cancelled post market,2019-08-08,M01AB55,"Diclofenac, combinations"
Human,02405474,Diclofenac Misoprostol,diclofenac sodium 50 mg + misoprostol 200 mcg oral gastro-resistant tablet,Abri Pharmaceuticals Inc,2.0,R,2.0,Cancelled pre market,2017-09-12,M01AB55,"Diclofenac, combinations"
Human,02400596,Sandoz Diclofenac Misoprostol,diclofenac sodium 50 mg + misoprostol 200 mcg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled pre market,2021-04-21,M01AB55,"Diclofenac, combinations"
Human,02229837,Arthrotec 75,diclofenac sodium 75 mg + misoprostol 200 mcg oral delayed-release tablet,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2006-01-12,M01AB55,"Diclofenac, combinations"
Human,02341697,Gd-Diclofenac/Misoprostol 75,diclofenac sodium 75 mg + misoprostol 200 mcg oral delayed-release tablet,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Marketed,2014-07-22,M01AB55,"Diclofenac, combinations"
Human,02413477,Pms-Diclofenac-Misoprostol,diclofenac sodium 75 mg + misoprostol 200 mcg oral delayed-release tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2018-12-11,M01AB55,"Diclofenac, combinations"
Human,02397153,Act Diclo-Miso,diclofenac sodium 75 mg + misoprostol 200 mcg oral gastro-resistant tablet,Actavis Pharma Company,2.0,R,2.0,Cancelled post market,2019-08-08,M01AB55,"Diclofenac, combinations"
Human,02405482,Diclofenac Misoprostol,diclofenac sodium 75 mg + misoprostol 200 mcg oral gastro-resistant tablet,Abri Pharmaceuticals Inc,2.0,R,2.0,Cancelled pre market,2017-09-12,M01AB55,"Diclofenac, combinations"
Human,02400618,Sandoz Diclofenac Misoprostol,diclofenac sodium 75 mg + misoprostol 200 mcg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled pre market,2021-04-21,M01AB55,"Diclofenac, combinations"
Human,00000396,Colchicine Tab 0.6Mg,colchicine 0.6 mg oral tablet,"Abbott Laboratories, Limited",2.0,R,2.0,Cancelled post market,2007-07-31,M04AC01,Colchicine
Human,00094382,Colchicine Tab 0.6Mg,colchicine 0.6 mg oral tablet,D.C. Labs Limited,2.0,R,2.0,Cancelled post market,2003-07-11,M04AC01,Colchicine
Human,00572349,Colchicine Tab 0.6Mg,colchicine 0.6 mg oral tablet,Odan Laboratories Ltd,2.0,R,2.0,Marketed,1982-12-31,M04AC01,Colchicine
Human,02456559,Euro-Colchicine,colchicine 0.6 mg oral tablet,Euro-Pharm International Canada Inc,2.0,R,2.0,Marketed,2019-10-10,M04AC01,Colchicine
Human,02373823,Jamp-Colchicine,colchicine 0.6 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2011-10-07,M04AC01,Colchicine
Human,02402181,Pms-Colchicine,colchicine 0.6 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2013-02-27,M04AC01,Colchicine
Human,00287873,Sandoz Colchicine,colchicine 0.6 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2025-08-14,M04AC01,Colchicine
Human,00206032,Colchicine,colchicine 1 mg oral tablet,Euro-Pharm International Canada Inc,2.0,R,2.0,Cancelled post market,2012-06-14,M04AC01,Colchicine
Human,00621374,Colchicine Tab 1Mg,colchicine 1 mg oral tablet,Odan Laboratories Ltd,2.0,R,2.0,Cancelled post market,2013-03-06,M04AC01,Colchicine
Human,02373831,Jamp-Colchicine,colchicine 1 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Cancelled post market,2013-04-03,M04AC01,Colchicine
Human,02248418,Pms-Pamidronate,pamidronate disodium 15 mg / vial powder for solution for injection,Pharmascience Inc,2.0,R,2.0,Approved,2004-01-27,M05BA03,Pamidronic acid
Human,01974491,Aredia Liq Inj 3Mg/Ml,pamidronate disodium 3 mg / mL liquid for injection,"Geigy Pharmaceuticals, Ciba-Geigy Canada Ltd.",2.0,R,2.0,Cancelled post market,1996-09-09,M05BA03,Pamidronic acid
Human,02244550,Pamidronate Disodium For Injection,pamidronate disodium 3 mg / mL solution for injection,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2018-02-21,M05BA03,Pamidronic acid
Human,02246597,Pamidronate Disodium For Injection,pamidronate disodium 3 mg / mL solution for injection,Fresenius Kabi Canada Ltd,2.0,R,2.0,Marketed,2015-07-07,M05BA03,Pamidronic acid
Human,02264951,Pamidronate Disodium For Injection,pamidronate disodium 3 mg / mL solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,M05BA03,Pamidronic acid
Human,02249669,Pamidronate Disodium Omega 3 Mg/Ml,pamidronate disodium 3 mg / mL solution for injection,Omega Laboratories Limited,2.0,R,2.0,Dormant,2017-08-04,M05BA03,Pamidronic acid
Human,02059762,Aredia 30Mg,pamidronate disodium 30 mg / vial powder for solution for injection,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Cancelled post market,2016-02-23,M05BA03,Pamidronic acid
Human,02266784,Pamidronate Disodium For Injection,pamidronate disodium 30 mg / vial powder for solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled pre market,2017-05-26,M05BA03,Pamidronic acid
Human,02245998,Pms-Pamidronate,pamidronate disodium 30 mg / vial powder for solution for injection,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2025-07-04,M05BA03,Pamidronic acid
Human,02244551,Pamidronate Disodium For Injection,pamidronate disodium 6 mg / mL solution for injection,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2018-03-21,M05BA03,Pamidronic acid
Human,02246598,Pamidronate Disodium For Injection,pamidronate disodium 6 mg / mL solution for injection,Fresenius Kabi Canada Ltd,2.0,R,2.0,Marketed,2015-07-07,M05BA03,Pamidronic acid
Human,02264978,Pamidronate Disodium For Injection,pamidronate disodium 6 mg / mL solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,M05BA03,Pamidronic acid
Human,02560305,Pamidronate Disodium For Injection,pamidronate disodium 6 mg / mL solution for injection,Jamp Pharma Corporation,2.0,R,2.0,Approved,2025-09-24,M05BA03,Pamidronic acid
Human,02249677,Pamidronate Disodium Omega 6 Mg/Ml,pamidronate disodium 6 mg / mL solution for injection,Omega Laboratories Limited,2.0,R,2.0,Marketed,2006-05-24,M05BA03,Pamidronic acid
Human,02059770,Aredia,pamidronate disodium 60 mg / vial powder for solution for injection,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Cancelled post market,2001-07-30,M05BA03,Pamidronic acid
Human,02248194,Pms-Pamidronate,pamidronate disodium 60 mg / vial powder for solution for injection,Pharmascience Inc,2.0,R,2.0,Approved,2003-12-09,M05BA03,Pamidronic acid
Human,02244552,Pamidronate Disodium For Injection,pamidronate disodium 9 mg / mL solution for injection,Pfizer Canada Ulc,2.0,R,2.0,Marketed,2018-07-25,M05BA03,Pamidronic acid
Human,02246599,Pamidronate Disodium For Injection,pamidronate disodium 9 mg / mL solution for injection,Fresenius Kabi Canada Ltd,2.0,R,2.0,Marketed,2015-07-09,M05BA03,Pamidronic acid
Human,02264986,Pamidronate Disodium For Injection,pamidronate disodium 9 mg / mL solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,M05BA03,Pamidronic acid
Human,02560313,Pamidronate Disodium For Injection,pamidronate disodium 9 mg / mL solution for injection,Jamp Pharma Corporation,2.0,R,2.0,Approved,2025-09-24,M05BA03,Pamidronic acid
Human,02249685,Pamidronate Disodium Omega 9 Mg/Ml,pamidronate disodium 9 mg / mL solution for injection,Omega Laboratories Limited,2.0,R,2.0,Marketed,2005-07-27,M05BA03,Pamidronic acid
Human,02382032,Val-Pamidronate Disodium,pamidronate disodium 9 mg / mL solution for injection,Valeo Pharma Inc,2.0,R,2.0,Cancelled post market,2015-07-17,M05BA03,Pamidronic acid
Human,02059789,Aredia 90Mg,pamidronate disodium 90 mg / vial powder for solution for injection,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Cancelled post market,2016-02-23,M05BA03,Pamidronic acid
Human,02266792,Pamidronate Disodium For Injection,pamidronate disodium 90 mg / vial powder for solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled pre market,2017-05-26,M05BA03,Pamidronic acid
Human,02245999,Pms-Pamidronate,pamidronate disodium 90 mg / vial powder for solution for injection,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2025-07-04,M05BA03,Pamidronic acid
Human,02426412,Val-Zoledronic Acid,zoledronic acid (zoledronic acid hemipentahydrate) 4 mg / 5 mL solution for injection,"Bausch Health, Canada Inc.",2.0,R,2.0,Approved,2021-09-16,M05BA08,Zoledronic acid
Human,02408325,Act Zoledronic Acid Concentrate,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Actavis Pharma Company,2.0,R,2.0,Cancelled pre market,2017-09-01,M05BA08,Zoledronic acid
Human,02482525,Jamp-Zoledronic Acid,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2020-01-20,M05BA08,Zoledronic acid
Human,02403056,Pms-Zoledronic Acid,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2025-07-04,M05BA08,Zoledronic acid
Human,02415186,Taro-Zoledronic Acid Concentrate,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Taro Pharmaceuticals Inc,2.0,R,2.0,Marketed,2014-02-26,M05BA08,Zoledronic acid
Human,02401606,Zoledronic Acid - Z,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2014-01-15,M05BA08,Zoledronic acid
Human,02304007,Zoledronic Acid Concentrate,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Apotex Inc,2.0,R,2.0,Approved,2015-07-20,M05BA08,Zoledronic acid
Human,02424894,Zoledronic Acid Concentrate For Injection,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Generic Medical Partners Inc,2.0,R,2.0,Approved,2014-05-08,M05BA08,Zoledronic acid
Human,02407639,Zoledronic Acid For Injection,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2020-05-15,M05BA08,Zoledronic acid
Human,02421550,Zoledronic Acid For Injection,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2021-04-08,M05BA08,Zoledronic acid
Human,02434458,Zoledronic Acid For Injection,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Fresenius Kabi Canada Ltd,2.0,R,2.0,Marketed,2016-02-10,M05BA08,Zoledronic acid
Human,02444739,Zoledronic Acid For Injection,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Juno Pharmaceuticals Corp.,2.0,R,2.0,Dormant,2023-07-31,M05BA08,Zoledronic acid
Human,02472805,Zoledronic Acid For Injection,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Marcan Pharmaceuticals Inc,2.0,R,2.0,Marketed,2019-01-29,M05BA08,Zoledronic acid
Human,02413701,Zoledronic Acid For Injection Concentrate,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Omega Laboratories Limited,2.0,R,2.0,Dormant,2017-08-04,M05BA08,Zoledronic acid
Human,02420961,Zoledronic Acid For Injection Concentrate,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Strides Pharma Canada Inc,2.0,R,2.0,Approved,2020-08-12,M05BA08,Zoledronic acid
Human,02422425,Zoledronic Acid For Injection Concentrate,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Marketed,2014-05-28,M05BA08,Zoledronic acid
Human,02248296,Zometa Concentrate,zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 mL solution for injection,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Marketed,2004-10-14,M05BA08,Zoledronic acid
Human,02242725,Zometa Lyophilized Powder,zoledronic acid (zoledronic acid monohydrate) 4 mg / vial powder for solution for injection,Novartis Pharmaceuticals Canada Inc,2.0,R,2.0,Cancelled post market,2008-10-31,M05BA08,Zoledronic acid
Human,02269198,Aclasta,zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 mL solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Marketed,2022-12-13,M05BA08,Zoledronic acid
Human,02408449,Act Zoledronic Acid,zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 mL solution for injection,Actavis Pharma Company,2.0,R,2.0,Cancelled pre market,2020-04-08,M05BA08,Zoledronic acid
Human,02415100,Taro-Zoledronic Acid,zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 mL solution for injection,Taro Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2025-03-04,M05BA08,Zoledronic acid
Human,02421720,Zoledronic Acid - A,zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 mL solution for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled pre market,2019-08-01,M05BA08,Zoledronic acid
Human,02408082,Zoledronic Acid Injection,zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 mL solution for injection,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2019-08-08,M05BA08,Zoledronic acid
Human,02422433,Zoledronic Acid Injection,zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 mL solution for injection,Dr Reddy'S Laboratories Ltd,2.0,R,2.0,Marketed,2014-05-28,M05BA08,Zoledronic acid
Human,02479311,Zoledronic Acid Injection,zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 mL solution for injection,Marcan Pharmaceuticals Inc,2.0,R,2.0,Approved,2018-07-25,M05BA08,Zoledronic acid
Human,02564696,Zoledronic Acid Injection,zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 mL solution for injection,Juno Pharma Canada Inc.,2.0,R,2.0,Approved,2026-01-19,M05BA08,Zoledronic acid
Human,02420449,Zoledronic Acid Injection A,zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 mL solution for injection,Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2022-06-01,M05BA08,Zoledronic acid
Human,02509695,Zolgensma,onasemnogene abeparvovec 20000000000000 VG / mL solution for injection,Novartis Pharmaceuticals Canada Inc,1.0,KH,,Marketed,2021-02-04,M09AX09,Onasemnogene abeparvovec
Human,02514931,Evrysdi,risdiplam 0.75 mg / mL oral powder for solution,Hoffmann-La Roche Limited,1.0,K,,Marketed,2021-05-19,M09AX10,Risdiplam
Human,02560747,Evrysdi,risdiplam 5 mg oral tablet,Hoffmann-La Roche Limited,1.0,K,,Marketed,2025-11-27,M09AX10,Risdiplam
Human,02524627,Sohonos,palovarotene 1 mg oral capsule,Ipsen Biopharmaceuticals Canada Inc,,R,,Marketed,2022-06-20,M09AX11,Palovarotene
Human,02524635,Sohonos,palovarotene 1.5 mg oral capsule,Ipsen Biopharmaceuticals Canada Inc,,R,,Marketed,2022-06-20,M09AX11,Palovarotene
Human,02524678,Sohonos,palovarotene 10 mg oral capsule,Ipsen Biopharmaceuticals Canada Inc,,R,,Marketed,2022-06-20,M09AX11,Palovarotene
Human,02524643,Sohonos,palovarotene 2.5 mg oral capsule,Ipsen Biopharmaceuticals Canada Inc,,R,,Marketed,2022-06-20,M09AX11,Palovarotene
Human,02524651,Sohonos,palovarotene 5 mg oral capsule,Ipsen Biopharmaceuticals Canada Inc,,R,,Marketed,2022-06-20,M09AX11,Palovarotene
Human,02228947,Migranal Nasal Spray 4Mg/Ml,dihydroergotamine mesylate 0.5 mg / actuation nasal liquid,Sterimax Inc,2.0,R,2.0,Marketed,2004-11-01,N02CA01,Dihydroergotamine
Human,00027243,"Dihydroergotamine (Dhe), 1Mg/Ml",dihydroergotamine mesylate 1 mg / mL liquid for injection,Sterimax Inc,2.0,R,2.0,Marketed,2004-07-30,N02CA01,Dihydroergotamine
Human,02241163,Dihydroergotamine Mesylate Injection Usp,dihydroergotamine mesylate 1 mg / mL liquid for injection,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2017-08-01,N02CA01,Dihydroergotamine
Human,02242457,Pms-Dihydroergotamine,dihydroergotamine mesylate 1 mg / mL liquid for injection,Pharmascience Inc,2.0,R,2.0,Cancelled pre market,2017-08-03,N02CA01,Dihydroergotamine
Human,02242411,Pms-Dihydroergotamine,dihydroergotamine mesylate 4 mg / mL nasal liquid,Pharmascience Inc,2.0,R,2.0,Cancelled pre market,2017-08-03,N02CA01,Dihydroergotamine
Human,02532581,Ubrelvy,ubrogepant 100 mg oral tablet,Abbvie Corporation,2.0,,,Marketed,2023-04-04,N02CD04,Ubrogepant
Human,02532530,Ubrelvy,ubrogepant 50 mg oral tablet,Abbvie Corporation,2.0,,,Marketed,2023-05-11,N02CD04,Ubrogepant
Human,02543605,Nurtec Odt,rimegepant (rimegepant sulfate) 75 mg orally disintegrating tablet,Pfizer Canada Ulc,2.0,,,Marketed,2024-03-25,N02CD06,Rimegepant
Human,00023450,Dilantin-125 Suspension,phenytoin 125 mg / 5 mL oral suspension,Bgp Pharma Ulc,2.0,P,2.0,Cancelled post market,2025-12-09,N03AB02,Phenytoin
Human,02250896,Taro-Phenytoin,phenytoin 125 mg / 5 mL oral suspension,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2005-05-03,N03AB02,Phenytoin
Human,00023442,Dilantin-30 Suspension,phenytoin 30 mg / 5 mL oral suspension,Bgp Pharma Ulc,2.0,P,2.0,Cancelled post market,2025-12-09,N03AB02,Phenytoin
Human,00023698,Dilantin Infatabs,phenytoin 50 mg chewable tablet,Bgp Pharma Ulc,2.0,P,2.0,Marketed,2023-08-02,N03AB02,Phenytoin
Human,00022780,Dilantin,phenytoin sodium 100 mg oral capsule,Bgp Pharma Ulc,2.0,P,2.0,Marketed,2023-06-07,N03AB02,Phenytoin
Human,00037435,Novo-Phenytoin Cap 100Mg,phenytoin sodium 100 mg oral capsule,Novopharm Limited,2.0,P,2.0,Cancelled post market,2018-11-06,N03AB02,Phenytoin
Human,02460912,Phenytoin Sodium,phenytoin sodium 100 mg oral capsule,Aa Pharma Inc,2.0,P,2.0,Marketed,2021-07-13,N03AB02,Phenytoin
Human,02468255,Taro-Phenytoin,phenytoin sodium 100 mg oral capsule,Taro Pharmaceuticals Inc,2.0,P,2.0,Cancelled pre market,2022-06-27,N03AB02,Phenytoin
Human,00245453,Dilantin Inj 50Mg/Ml,phenytoin sodium 250 mg / 5 mL liquid for injection,"Parke-Davis Division, Warner-Lambert Canada Inc.",2.0,P,2.0,Cancelled post market,1996-09-10,N03AB02,Phenytoin
Human,00022772,Dilantin,phenytoin sodium 30 mg oral capsule,Bgp Pharma Ulc,2.0,P,2.0,Marketed,2023-06-07,N03AB02,Phenytoin
Human,00780626,Phenytoin Sodium Injection Usp,phenytoin sodium 50 mg / mL liquid for injection,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2005-10-01,N03AB02,Phenytoin
Human,00498335,Phenytoin Sodium Injection Usp,phenytoin sodium 50 mg / mL solution for injection,Omega Laboratories Limited,2.0,P,2.0,Marketed,2021-07-13,N03AB02,Phenytoin
Human,02431378,Phenytoin Sodium Injection Usp,phenytoin sodium 50 mg / mL solution for injection,Hikma Canada Limited,2.0,P,2.0,Marketed,2024-02-16,N03AB02,Phenytoin
Human,00497304,Phenytoin Soidum Injection Usp,phenytoin sodium 50 mg / mL solution for injection,Pfizer Canada Ulc,2.0,P,2.0,Cancelled post market,2020-02-21,N03AB02,Phenytoin
Human,02230988,Cerebyx,fosphenytoin sodium 75 mg / mL solution for injection,Searchlight Pharma Inc,2.0,P,2.0,Marketed,2022-10-07,N03AB05,Fosphenytoin
Human,00275131,Dilantin W Phenobarbital 15Mg,phenobarbital 15 mg / capsule + phenytoin sodium 100 mg / capsule oral capsule,"Parke-Davis Division, Warner-Lambert Canada Inc.",2.0,P,2.0,Cancelled post market,1999-04-08,N03AB52,"Phenytoin, combinations"
Human,00439770,Dilantin W Phenobarbital 30Mg Cap,phenobarbital 30 mg / capsule + phenytoin sodium 100 mg / capsule oral capsule,"Parke-Davis Division, Warner-Lambert Canada Inc.",2.0,P,2.0,Cancelled post market,1997-08-25,N03AB52,"Phenytoin, combinations"
Human,02442027,Clonazepam,clonazepam 0.25 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-07-12,N03AE01,Clonazepam
Human,02236947,Phl-Clonazepam - 0.25Mg,clonazepam 0.25 mg oral tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2009-10-30,N03AE01,Clonazepam
Human,02179660,Pms-Clonazepam,clonazepam 0.25 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,1995-12-31,N03AE01,Clonazepam
Human,02365243,Accel-Clonazepam,clonazepam 0.5 mg oral tablet,Accel Pharma Inc,2.0,R,2.0,Cancelled pre market,2017-05-19,N03AE01,Clonazepam
Human,02177889,Apo-Clonazepam,clonazepam 0.5 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2021-06-11,N03AE01,Clonazepam
Human,02230366,Clonapam,clonazepam 0.5 mg oral tablet,"Bausch Health, Canada Inc.",2.0,R,2.0,Dormant,2021-03-10,N03AE01,Clonazepam
Human,02173344,Clonazepam,clonazepam 0.5 mg oral tablet,Apotex Inc,2.0,R,2.0,Approved,2020-12-15,N03AE01,Clonazepam
Human,02442035,Clonazepam,clonazepam 0.5 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-09-25,N03AE01,Clonazepam
Human,02220598,Clonazepam-0.5 - Tab 0.5Mg,clonazepam 0.5 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2010-07-13,N03AE01,Clonazepam
Human,02344629,Clonazepam-R,clonazepam 0.5 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-25,N03AE01,Clonazepam
Human,02270641,Co Clonazepam,clonazepam 0.5 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled post market,2018-05-18,N03AE01,Clonazepam
Human,02130998,Dom-Clonazepam - Tab 0.5Mg,clonazepam 0.5 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2019-02-20,N03AE01,Clonazepam
Human,02224100,Dom-Clonazepam-R - Tab 0.5Mg,clonazepam 0.5 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2019-02-25,N03AE01,Clonazepam
Human,02230950,Mylan-Clonazepam,clonazepam 0.5 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-12-12,N03AE01,Clonazepam
Human,02145227,Phl-Clonazepam - Tab 0.5Mg,clonazepam 0.5 mg oral tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2003-04-08,N03AE01,Clonazepam
Human,02236948,Phl-Clonazepam-R,clonazepam 0.5 mg oral tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2004-12-02,N03AE01,Clonazepam
Human,02048701,Pms-Clonazepam,clonazepam 0.5 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Dormant,2025-07-31,N03AE01,Clonazepam
Human,02207818,Pms-Clonazepam-R,clonazepam 0.5 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,1996-12-31,N03AE01,Clonazepam
Human,02311593,Pro-Clonazepam,clonazepam 0.5 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2014-07-26,N03AE01,Clonazepam
Human,02103656,Ratio-Clonazepam,clonazepam 0.5 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2015-10-26,N03AE01,Clonazepam
Human,02242077,Riva-Clonazepam,clonazepam 0.5 mg oral tablet,Laboratoire Riva Inc.,2.0,R,2.0,Dormant,2025-07-22,N03AE01,Clonazepam
Human,00382825,Rivotril,clonazepam 0.5 mg oral tablet,Cheplapharm Arzneimittel Gmbh,2.0,R,2.0,Marketed,2023-01-31,N03AE01,Clonazepam
Human,02233960,Sandoz Clonazepam,clonazepam 0.5 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2018-08-01,N03AE01,Clonazepam
Human,02239024,Teva-Clonazepam,clonazepam 0.5 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2021-07-29,N03AE01,Clonazepam
Human,02303310,Zym-Clonazepam,clonazepam 0.5 mg oral tablet,Zymcan Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2010-02-12,N03AE01,Clonazepam
Human,02345676,Zym-Clonazepam,clonazepam 0.5 mg oral tablet,Zymcan Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2014-06-16,N03AE01,Clonazepam
Human,02365251,Accel-Clonazepam,clonazepam 1 mg oral tablet,Accel Pharma Inc,2.0,R,2.0,Cancelled pre market,2017-05-19,N03AE01,Clonazepam
Human,02230368,Clonapam,clonazepam 1 mg oral tablet,"Bausch Health, Canada Inc.",2.0,R,2.0,Dormant,2021-03-10,N03AE01,Clonazepam
Human,02344602,Clonazepam,clonazepam 1 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-25,N03AE01,Clonazepam
Human,02442043,Clonazepam,clonazepam 1 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-12-19,N03AE01,Clonazepam
Human,02270668,Co Clonazepam,clonazepam 1 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled post market,2018-05-18,N03AE01,Clonazepam
Human,02145235,Phl-Clonazepam - Tab 1Mg,clonazepam 1 mg oral tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2016-05-14,N03AE01,Clonazepam
Human,02048728,Pms-Clonazepam,clonazepam 1 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,1993-12-31,N03AE01,Clonazepam
Human,02311607,Pro-Clonazepam,clonazepam 1 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2008-07-09,N03AE01,Clonazepam
Human,02233982,Sandoz Clonazepam,clonazepam 1 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2018-08-01,N03AE01,Clonazepam
Human,02303329,Zym-Clonazepam,clonazepam 1 mg oral tablet,Zymcan Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2014-06-16,N03AE01,Clonazepam
Human,02365278,Accel-Clonazepam,clonazepam 2 mg oral tablet,Accel Pharma Inc,2.0,R,2.0,Cancelled pre market,2017-05-19,N03AE01,Clonazepam
Human,02177897,Apo-Clonazepam,clonazepam 2 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2021-06-11,N03AE01,Clonazepam
Human,02230369,Clonapam,clonazepam 2 mg oral tablet,"Bausch Health, Canada Inc.",2.0,R,2.0,Dormant,2021-03-10,N03AE01,Clonazepam
Human,02173352,Clonazepam,clonazepam 2 mg oral tablet,Apotex Inc,2.0,R,2.0,Approved,2020-12-15,N03AE01,Clonazepam
Human,02344610,Clonazepam,clonazepam 2 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-25,N03AE01,Clonazepam
Human,02442051,Clonazepam,clonazepam 2 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2018-07-11,N03AE01,Clonazepam
Human,02220601,Clonazepam-2 - Tab 2Mg,clonazepam 2 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2010-07-13,N03AE01,Clonazepam
Human,02270676,Co Clonazepam,clonazepam 2 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled post market,2018-05-18,N03AE01,Clonazepam
Human,02131013,Dom-Clonazepam - Tab 2Mg,clonazepam 2 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2019-02-20,N03AE01,Clonazepam
Human,02230951,Mylan-Clonazepam,clonazepam 2 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2018-04-10,N03AE01,Clonazepam
Human,02145243,Phl-Clonazepam - Tab 2Mg,clonazepam 2 mg oral tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2016-05-14,N03AE01,Clonazepam
Human,02048736,Pms-Clonazepam,clonazepam 2 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,1993-12-31,N03AE01,Clonazepam
Human,02311615,Pro-Clonazepam,clonazepam 2 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2008-07-09,N03AE01,Clonazepam
Human,02103737,Ratio-Clonazepam,clonazepam 2 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2015-10-26,N03AE01,Clonazepam
Human,02242078,Riva-Clonazepam,clonazepam 2 mg oral tablet,Laboratoire Riva Inc.,2.0,R,2.0,Dormant,2025-07-22,N03AE01,Clonazepam
Human,00382841,Rivotril,clonazepam 2 mg oral tablet,Cheplapharm Arzneimittel Gmbh,2.0,R,2.0,Marketed,2023-01-31,N03AE01,Clonazepam
Human,02233985,Sandoz Clonazepam,clonazepam 2 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2018-08-01,N03AE01,Clonazepam
Human,02239025,Teva-Clonazepam,clonazepam 2 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2021-07-29,N03AE01,Clonazepam
Human,02303337,Zym-Clonazepam,clonazepam 2 mg oral tablet,Zymcan Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2014-06-16,N03AE01,Clonazepam
Human,02367394,Taro-Carbamazepine,carbamazepine 100 mg / 5 mL oral suspension,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2011-10-07,N03AF01,Carbamazepine
Human,02194333,Tegretol Suspension,carbamazepine 100 mg / 5 mL oral suspension,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,1999-06-10,N03AF01,Carbamazepine
Human,02231542,Pms-Carbamazepine,carbamazepine 100 mg chewable tablet,Pharmascience Inc,2.0,P,2.0,Cancelled post market,2018-10-15,N03AF01,Carbamazepine
Human,02261855,Sandoz-Carbamazepine Chewtabs,carbamazepine 100 mg chewable tablet,Sandoz Canada Incorporated,2.0,P,2.0,Cancelled post market,2018-08-01,N03AF01,Carbamazepine
Human,02244403,Taro-Carbamazepine Chewable Tablets,carbamazepine 100 mg chewable tablet,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2002-04-19,N03AF01,Carbamazepine
Human,00369810,Tegretol Chewtabs 100 Mg,carbamazepine 100 mg chewable tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2017-09-27,N03AF01,Carbamazepine
Human,02238222,Dom-Carbamazepine Cr,carbamazepine 200 mg / sustained-release tablet oral prolonged-release tablet,Dominion Pharmacal,2.0,P,2.0,Cancelled post market,2025-05-30,N03AF01,Carbamazepine
Human,02232755,Carbamazepine 200Mg Tablets,carbamazepine 200 mg / tablet oral tablet,Laboratoires Confab Inc,2.0,P,2.0,Cancelled pre market,2021-04-09,N03AF01,Carbamazepine
Human,02231670,Dom-Carbamazepine,carbamazepine 200 mg / tablet oral tablet,Dominion Pharmacal,2.0,P,2.0,Cancelled pre market,2025-05-30,N03AF01,Carbamazepine
Human,02231540,Pms-Carbamazepine,carbamazepine 200 mg chewable tablet,Pharmascience Inc,2.0,P,2.0,Cancelled post market,2018-10-15,N03AF01,Carbamazepine
Human,02261863,Sandoz-Carbamazepine Chewtabs,carbamazepine 200 mg chewable tablet,Sandoz Canada Incorporated,2.0,P,2.0,Cancelled post market,2018-08-01,N03AF01,Carbamazepine
Human,02244404,Taro-Carbamazepine Chewable Tablets,carbamazepine 200 mg chewable tablet,Taro Pharmaceuticals Inc,2.0,P,2.0,Marketed,2002-04-19,N03AF01,Carbamazepine
Human,00665088,Tegretol Chewtabs 200 Mg,carbamazepine 200 mg chewable tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2017-09-26,N03AF01,Carbamazepine
Human,02242908,Apo-Carbamazepine Cr,carbamazepine 200 mg oral prolonged-release tablet,Apotex Inc,2.0,P,2.0,Approved,2013-11-18,N03AF01,Carbamazepine
Human,02413590,Carbamazepine Cr,carbamazepine 200 mg oral prolonged-release tablet,Pro Doc Limitee,2.0,P,2.0,Cancelled post market,2020-03-11,N03AF01,Carbamazepine
Human,02243511,Carbamazepine-Cr  -(200Mg),carbamazepine 200 mg oral prolonged-release tablet,Pro Doc Limitee,2.0,P,2.0,Cancelled post market,2009-07-23,N03AF01,Carbamazepine
Human,02241882,Mylan-Carbamazepine Cr,carbamazepine 200 mg oral prolonged-release tablet,Mylan Pharmaceuticals Ulc,2.0,P,2.0,Cancelled post market,2017-01-09,N03AF01,Carbamazepine
Human,02238640,Phl-Carbamazepine Cr,carbamazepine 200 mg oral prolonged-release tablet,Pharmel Inc,2.0,P,2.0,Cancelled post market,2009-10-26,N03AF01,Carbamazepine
Human,02280744,Pms-Carbamazepine Cr,carbamazepine 200 mg oral prolonged-release tablet,Pharmascience Inc,2.0,P,2.0,Approved,2006-06-01,N03AF01,Carbamazepine
Human,02231543,Pms-Carbamazepine-Cr,carbamazepine 200 mg oral prolonged-release tablet,Pharmascience Inc,2.0,P,2.0,Cancelled post market,2025-07-04,N03AF01,Carbamazepine
Human,02261839,Sandoz-Carbamazepine Cr,carbamazepine 200 mg oral prolonged-release tablet,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2006-02-02,N03AF01,Carbamazepine
Human,02237907,Taro-Carbamazepine Cr,carbamazepine 200 mg oral prolonged-release tablet,Taro Pharmaceuticals Inc,2.0,P,2.0,Cancelled post market,2022-02-04,N03AF01,Carbamazepine
Human,00773611,Tegretol Cr,carbamazepine 200 mg oral prolonged-release tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,1999-03-10,N03AF01,Carbamazepine
Human,00402699,Apo-Carbamazepine,carbamazepine 200 mg oral tablet,Apotex Inc,2.0,P,2.0,Dormant,2017-08-04,N03AF01,Carbamazepine
Human,02247135,Bio-Carbamazepine,carbamazepine 200 mg oral tablet,Biomed Pharma,2.0,P,2.0,Cancelled post market,2010-03-16,N03AF01,Carbamazepine
Human,00578460,Carbamazepine 200 Tab 200Mg,carbamazepine 200 mg oral tablet,Pro Doc Limitee,2.0,P,2.0,Cancelled post market,2013-07-15,N03AF01,Carbamazepine
Human,00504742,Mazepine,carbamazepine 200 mg oral tablet,Biomed Pharma,2.0,P,2.0,Dormant,2017-08-04,N03AF01,Carbamazepine
Human,02541238,Mint-Carbamazepine,carbamazepine 200 mg oral tablet,Mint Pharmaceuticals Inc,2.0,P,2.0,Marketed,2024-04-19,N03AF01,Carbamazepine
Human,02042568,Nu-Carbamazepine Tab 200Mg,carbamazepine 200 mg oral tablet,Nu-Pharm Inc,2.0,P,2.0,Cancelled post market,2012-09-04,N03AF01,Carbamazepine
Human,00667110,Pms-Carbamazepine,carbamazepine 200 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Cancelled post market,2017-09-30,N03AF01,Carbamazepine
Human,02231541,Pms-Carbamazepine,carbamazepine 200 mg oral tablet,Pharmascience Inc,2.0,P,2.0,Approved,1997-07-02,N03AF01,Carbamazepine
Human,02407515,Taro-Carbamazepine,carbamazepine 200 mg oral tablet,Taro Pharmaceuticals Inc,2.0,P,2.0,Cancelled post market,2024-09-04,N03AF01,Carbamazepine
Human,02052423,Taro-Carbamazepine Tab 200Mg,carbamazepine 200 mg oral tablet,Taro Pharmaceuticals Inc,2.0,P,2.0,Cancelled post market,2001-08-21,N03AF01,Carbamazepine
Human,00010405,Tegretol,carbamazepine 200 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,1997-12-15,N03AF01,Carbamazepine
Human,00782718,Teva-Carbamazepine,carbamazepine 200 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2010-11-26,N03AF01,Carbamazepine
Human,02238223,Dom-Carbamazepine Cr,carbamazepine 400 mg / sustained-release tablet oral prolonged-release tablet,Dominion Pharmacal,2.0,P,2.0,Cancelled post market,2025-05-30,N03AF01,Carbamazepine
Human,02242909,Apo-Carbamazepine Cr,carbamazepine 400 mg oral prolonged-release tablet,Apotex Inc,2.0,P,2.0,Approved,2013-11-18,N03AF01,Carbamazepine
Human,02413604,Carbamazepine Cr,carbamazepine 400 mg oral prolonged-release tablet,Pro Doc Limitee,2.0,P,2.0,Cancelled post market,2020-03-11,N03AF01,Carbamazepine
Human,02243512,Carbamazepine-Cr  -(400Mg),carbamazepine 400 mg oral prolonged-release tablet,Pro Doc Limitee,2.0,P,2.0,Cancelled post market,2009-07-23,N03AF01,Carbamazepine
Human,02241883,Mylan-Carbamazepine Cr,carbamazepine 400 mg oral prolonged-release tablet,Mylan Pharmaceuticals Ulc,2.0,P,2.0,Cancelled post market,2017-01-09,N03AF01,Carbamazepine
Human,02238641,Phl-Carbamazepine Cr,carbamazepine 400 mg oral prolonged-release tablet,Pharmel Inc,2.0,P,2.0,Cancelled post market,2009-10-26,N03AF01,Carbamazepine
Human,02280752,Pms-Carbamazepine Cr,carbamazepine 400 mg oral prolonged-release tablet,Pharmascience Inc,2.0,P,2.0,Approved,2006-06-01,N03AF01,Carbamazepine
Human,02231544,Pms-Carbamazepine-Cr,carbamazepine 400 mg oral prolonged-release tablet,Pharmascience Inc,2.0,P,2.0,Cancelled post market,2025-07-04,N03AF01,Carbamazepine
Human,02261847,Sandoz-Carbamazepine Cr,carbamazepine 400 mg oral prolonged-release tablet,Sandoz Canada Incorporated,2.0,P,2.0,Marketed,2006-02-02,N03AF01,Carbamazepine
Human,02237908,Taro-Carbamazepine Cr,carbamazepine 400 mg oral prolonged-release tablet,Taro Pharmaceuticals Inc,2.0,P,2.0,Cancelled post market,2022-02-04,N03AF01,Carbamazepine
Human,00755583,Tegretol Cr,carbamazepine 400 mg oral prolonged-release tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,1998-08-18,N03AF01,Carbamazepine
Human,02284294,Apo-Oxcarbazepine,oxcarbazepine 150 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2022-02-08,N03AF02,Oxcarbazepine
Human,02560593,Jamp Oxcarbazepine,oxcarbazepine 150 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Approved,2025-08-19,N03AF02,Oxcarbazepine
Human,02440717,Jamp-Oxcarbazepine,oxcarbazepine 150 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Cancelled post market,2022-09-06,N03AF02,Oxcarbazepine
Human,02312026,Novo-Oxcarbazepine,oxcarbazepine 150 mg oral tablet,Novopharm Limited,2.0,P,2.0,Cancelled pre market,2018-07-24,N03AF02,Oxcarbazepine
Human,02439743,Oxcarbazepine,oxcarbazepine 150 mg oral tablet,Jubilant Generics Limited,2.0,P,2.0,Approved,2015-04-13,N03AF02,Oxcarbazepine
Human,02466295,Sandoz Oxcarbazepine,oxcarbazepine 150 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Cancelled pre market,2019-08-01,N03AF02,Oxcarbazepine
Human,02242067,Trileptal 150 Mg,oxcarbazepine 150 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2019-10-10,N03AF02,Oxcarbazepine
Human,02284308,Apo-Oxcarbazepine,oxcarbazepine 300 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2016-06-08,N03AF02,Oxcarbazepine
Human,02560607,Jamp Oxcarbazepine,oxcarbazepine 300 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Approved,2025-08-19,N03AF02,Oxcarbazepine
Human,02440725,Jamp-Oxcarbazepine,oxcarbazepine 300 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Cancelled post market,2022-09-06,N03AF02,Oxcarbazepine
Human,02312034,Novo-Oxcarbazepine,oxcarbazepine 300 mg oral tablet,Novopharm Limited,2.0,P,2.0,Cancelled pre market,2018-07-24,N03AF02,Oxcarbazepine
Human,02439751,Oxcarbazepine,oxcarbazepine 300 mg oral tablet,Jubilant Generics Limited,2.0,P,2.0,Approved,2015-04-13,N03AF02,Oxcarbazepine
Human,02466309,Sandoz Oxcarbazepine,oxcarbazepine 300 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Cancelled pre market,2019-08-01,N03AF02,Oxcarbazepine
Human,02242068,Trileptal 300 Mg,oxcarbazepine 300 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2002-04-01,N03AF02,Oxcarbazepine
Human,02244673,Trileptal Oral Suspension,oxcarbazepine 60 mg / mL oral suspension,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2002-09-05,N03AF02,Oxcarbazepine
Human,02284316,Apo-Oxcarbazepine,oxcarbazepine 600 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2016-06-08,N03AF02,Oxcarbazepine
Human,02560615,Jamp Oxcarbazepine,oxcarbazepine 600 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Approved,2025-08-19,N03AF02,Oxcarbazepine
Human,02440733,Jamp-Oxcarbazepine,oxcarbazepine 600 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Cancelled post market,2022-09-06,N03AF02,Oxcarbazepine
Human,02312042,Novo-Oxcarbazepine,oxcarbazepine 600 mg oral tablet,Novopharm Limited,2.0,P,2.0,Cancelled pre market,2018-07-24,N03AF02,Oxcarbazepine
Human,02439778,Oxcarbazepine,oxcarbazepine 600 mg oral tablet,Jubilant Generics Limited,2.0,P,2.0,Approved,2015-04-13,N03AF02,Oxcarbazepine
Human,02466317,Sandoz Oxcarbazepine,oxcarbazepine 600 mg oral tablet,Sandoz Canada Incorporated,2.0,P,2.0,Cancelled pre market,2019-08-01,N03AF02,Oxcarbazepine
Human,02242069,Trileptal 600 Mg,oxcarbazepine 600 mg oral tablet,Novartis Pharmaceuticals Canada Inc,2.0,P,2.0,Marketed,2002-04-01,N03AF02,Oxcarbazepine
Human,02537931,Apo-Eslicarbazepine,eslicarbazepine acetate 200 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2025-05-06,N03AF04,Eslicarbazepine
Human,02426862,Aptiom,eslicarbazepine acetate 200 mg oral tablet,"Sumitomo Pharma Canada, Inc.",2.0,R,2.0,Marketed,2024-05-30,N03AF04,Eslicarbazepine
Human,02527421,Auro-Eslicarbazepine,eslicarbazepine acetate 200 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2025-05-08,N03AF04,Eslicarbazepine
Human,02537958,Apo-Eslicarbazepine,eslicarbazepine acetate 400 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2025-05-06,N03AF04,Eslicarbazepine
Human,02426870,Aptiom,eslicarbazepine acetate 400 mg oral tablet,"Sumitomo Pharma Canada, Inc.",2.0,R,2.0,Marketed,2024-04-12,N03AF04,Eslicarbazepine
Human,02527448,Auro-Eslicarbazepine,eslicarbazepine acetate 400 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2025-05-08,N03AF04,Eslicarbazepine
Human,02537966,Apo-Eslicarbazepine,eslicarbazepine acetate 600 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2025-05-06,N03AF04,Eslicarbazepine
Human,02426889,Aptiom,eslicarbazepine acetate 600 mg oral tablet,"Sumitomo Pharma Canada, Inc.",2.0,R,2.0,Marketed,2024-05-15,N03AF04,Eslicarbazepine
Human,02527456,Auro-Eslicarbazepine,eslicarbazepine acetate 600 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2025-05-08,N03AF04,Eslicarbazepine
Human,02537974,Apo-Eslicarbazepine,eslicarbazepine acetate 800 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2025-05-06,N03AF04,Eslicarbazepine
Human,02426897,Aptiom,eslicarbazepine acetate 800 mg oral tablet,"Sumitomo Pharma Canada, Inc.",2.0,R,2.0,Marketed,2024-02-07,N03AF04,Eslicarbazepine
Human,02527464,Auro-Eslicarbazepine,eslicarbazepine acetate 800 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2025-05-08,N03AF04,Eslicarbazepine
Human,02239698,Apo-Divalproex,valproic acid (divalproex sodium) 125 mg oral delayed-release tablet,Apotex Inc,2.0,R,2.0,Marketed,2021-12-21,N03AG01,Valproic acid
Human,02239517,Divalproex,valproic acid (divalproex sodium) 125 mg oral delayed-release tablet,Apotex Inc,2.0,R,2.0,Approved,2021-05-27,N03AG01,Valproic acid
Human,00596418,Epival,valproic acid (divalproex sodium) 125 mg oral delayed-release tablet,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2016-11-29,N03AG01,Valproic acid
Human,02551144,Jamp Divalproex,valproic acid (divalproex sodium) 125 mg oral delayed-release tablet,Jamp Pharma Corporation,2.0,R,2.0,Approved,2024-08-22,N03AG01,Valproic acid
Human,02265133,Myl-Divalproex,valproic acid (divalproex sodium) 125 mg oral delayed-release tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-11,N03AG01,Valproic acid
Human,02458926,Mylan-Divalproex,valproic acid (divalproex sodium) 125 mg oral delayed-release tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2017-04-21,N03AG01,Valproic acid
Human,02400499,Divalproex,valproic acid (divalproex sodium) 125 mg oral gastro-resistant tablet,Sanis Health Inc,2.0,R,2.0,Dormant,2017-08-03,N03AG01,Valproic acid
Human,02240341,Divalproex-125,valproic acid (divalproex sodium) 125 mg oral gastro-resistant tablet,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2017-05-05,N03AG01,Valproic acid
Human,02245751,Dom-Divalproex,valproic acid (divalproex sodium) 125 mg oral gastro-resistant tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-05-09,N03AG01,Valproic acid
Human,02294109,Phl-Divalproex,valproic acid (divalproex sodium) 125 mg oral gastro-resistant tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2016-10-25,N03AG01,Valproic acid
Human,02244138,Pms-Divalproex (125Mg),valproic acid (divalproex sodium) 125 mg oral gastro-resistant tablet,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2025-07-04,N03AG01,Valproic acid
Human,02239701,Teva-Divalproex,valproic acid (divalproex sodium) 125 mg oral gastro-resistant tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2020-06-10,N03AG01,Valproic acid
Human,02400502,Divalproex,valproic acid (divalproex sodium) 250 mg / enteric-coated tablet oral gastro-resistant tablet,Sanis Health Inc,2.0,R,2.0,Dormant,2017-07-31,N03AG01,Valproic acid
Human,02239699,Apo-Divalproex,valproic acid (divalproex sodium) 250 mg oral delayed-release tablet,Apotex Inc,2.0,R,2.0,Marketed,2021-12-21,N03AG01,Valproic acid
Human,02239518,Divalproex,valproic acid (divalproex sodium) 250 mg oral delayed-release tablet,Apotex Inc,2.0,R,2.0,Approved,2021-05-27,N03AG01,Valproic acid
Human,00596426,Epival,valproic acid (divalproex sodium) 250 mg oral delayed-release tablet,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2016-07-22,N03AG01,Valproic acid
Human,02551152,Jamp Divalproex,valproic acid (divalproex sodium) 250 mg oral delayed-release tablet,Jamp Pharma Corporation,2.0,R,2.0,Approved,2024-08-22,N03AG01,Valproic acid
Human,02265141,Myl-Divalproex,valproic acid (divalproex sodium) 250 mg oral delayed-release tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-11,N03AG01,Valproic acid
Human,02458934,Mylan-Divalproex,valproic acid (divalproex sodium) 250 mg oral delayed-release tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2017-05-21,N03AG01,Valproic acid
Human,02240342,Divalproex-250,valproic acid (divalproex sodium) 250 mg oral gastro-resistant tablet,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2015-10-31,N03AG01,Valproic acid
Human,02245752,Dom-Divalproex,valproic acid (divalproex sodium) 250 mg oral gastro-resistant tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-05-09,N03AG01,Valproic acid
Human,02294117,Phl-Divalproex,valproic acid (divalproex sodium) 250 mg oral gastro-resistant tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2016-10-25,N03AG01,Valproic acid
Human,02244139,Pms-Divalproex (250Mg),valproic acid (divalproex sodium) 250 mg oral gastro-resistant tablet,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2025-07-04,N03AG01,Valproic acid
Human,02239702,Teva-Divalproex,valproic acid (divalproex sodium) 250 mg oral gastro-resistant tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2020-06-10,N03AG01,Valproic acid
Human,02400510,Divalproex,valproic acid (divalproex sodium) 500 mg / enteric-coated tablet oral gastro-resistant tablet,Sanis Health Inc,2.0,R,2.0,Dormant,2017-07-31,N03AG01,Valproic acid
Human,02239700,Apo-Divalproex,valproic acid (divalproex sodium) 500 mg oral delayed-release tablet,Apotex Inc,2.0,R,2.0,Marketed,2021-12-21,N03AG01,Valproic acid
Human,02239519,Divalproex,valproic acid (divalproex sodium) 500 mg oral delayed-release tablet,Apotex Inc,2.0,R,2.0,Approved,2021-05-27,N03AG01,Valproic acid
Human,00596434,Epival,valproic acid (divalproex sodium) 500 mg oral delayed-release tablet,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2016-05-25,N03AG01,Valproic acid
Human,02551160,Jamp Divalproex,valproic acid (divalproex sodium) 500 mg oral delayed-release tablet,Jamp Pharma Corporation,2.0,R,2.0,Approved,2024-08-22,N03AG01,Valproic acid
Human,02265168,Myl-Divalproex,valproic acid (divalproex sodium) 500 mg oral delayed-release tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2017-01-11,N03AG01,Valproic acid
Human,02459019,Mylan-Divalproex,valproic acid (divalproex sodium) 500 mg oral delayed-release tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2017-04-11,N03AG01,Valproic acid
Human,02240343,Divalproex-500,valproic acid (divalproex sodium) 500 mg oral gastro-resistant tablet,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2015-11-30,N03AG01,Valproic acid
Human,02245753,Dom-Divalproex,valproic acid (divalproex sodium) 500 mg oral gastro-resistant tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-05-09,N03AG01,Valproic acid
Human,02294125,Phl-Divalproex,valproic acid (divalproex sodium) 500 mg oral gastro-resistant tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2016-10-25,N03AG01,Valproic acid
Human,02244140,Pms-Divalproex (500Mg),valproic acid (divalproex sodium) 500 mg oral gastro-resistant tablet,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2025-07-04,N03AG01,Valproic acid
Human,02239703,Teva-Divalproex,valproic acid (divalproex sodium) 500 mg oral gastro-resistant tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2020-06-10,N03AG01,Valproic acid
Human,02242736,Epival Er,valproic acid (divalproex sodium) 500 mg oral prolonged-release tablet,"Abbott Laboratories, Limited",2.0,R,2.0,Cancelled post market,2008-06-06,N03AG01,Valproic acid
Human,02238370,Apo-Valproic Acid Oral Solution,valproic acid (sodium valproate) 250 mg / 5 mL oral solution,Apotex Inc,2.0,R,2.0,Dormant,2024-10-07,N03AG01,Valproic acid
Human,00443832,Depakene,valproic acid (sodium valproate) 250 mg / 5 mL oral solution,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2016-09-15,N03AG01,Valproic acid
Human,02238817,Dom-Valproic Acid,valproic acid (sodium valproate) 250 mg / 5 mL oral solution,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-05-09,N03AG01,Valproic acid
Human,02532441,Jamp Valproic Acid Oral Solution,valproic acid (sodium valproate) 250 mg / 5 mL oral solution,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2023-10-05,N03AG01,Valproic acid
Human,02549190,Odan-Valproic Acid,valproic acid (sodium valproate) 250 mg / 5 mL oral solution,Odan Laboratories Ltd,2.0,R,2.0,Marketed,2024-11-06,N03AG01,Valproic acid
Human,02236807,Pms-Valproic Acid,valproic acid (sodium valproate) 250 mg / 5 mL oral solution,Pharmascience Inc,2.0,R,2.0,Marketed,1997-11-20,N03AG01,Valproic acid
Human,02238069,Valproic Acid Oral Solution,valproic acid (sodium valproate) 250 mg / 5 mL oral solution,Apotex Inc,2.0,R,2.0,Approved,2020-11-20,N03AG01,Valproic acid
Human,02238042,Deproic Syrup,valproic acid (sodium valproate) 250 mg / 5 mL oral syrup,Technilab Pharma Inc.,2.0,R,2.0,Cancelled post market,2006-07-28,N03AG01,Valproic acid
Human,02238210,Phl-Valproic Acid,valproic acid (sodium valproate) 250 mg / 5 mL oral syrup,Pharmel Inc,2.0,R,2.0,Cancelled post market,2012-01-28,N03AG01,Valproic acid
Human,00443840,Depakene,valproic acid (sodium valproate) 250 mg oral capsule,Bgp Pharma Ulc,2.0,R,2.0,Cancelled post market,2017-05-16,N03AG01,Valproic acid
Human,02140063,Ratio-Valproic 50Mg/Ml Syrup,valproic acid (sodium valproate) 50 mg / mL oral syrup,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2015-10-26,N03AG01,Valproic acid
Human,02238368,Epiject I.V.,valproic acid (sodium valproate) 500 mg / 5 mL liquid for injection,"Abbott Laboratories, Limited",2.0,R,2.0,Cancelled post market,2007-10-05,N03AG01,Valproic acid
Human,02238448,Ftp-Valproic Acid,valproic acid 250 mg / capsule oral capsule,Ftp-Pharmacal Inc.,2.0,R,2.0,Cancelled post market,2004-08-03,N03AG01,Valproic acid
Human,02231248,Penta-Valproic Capsules,valproic acid 250 mg / capsule oral capsule,Pentapharm Ltd.,2.0,R,2.0,Cancelled (unreturned annual),2018-04-05,N03AG01,Valproic acid
Human,02238048,Apo-Valproic Acid,valproic acid 250 mg oral capsule,Apotex Inc,2.0,R,2.0,Marketed,2021-08-13,N03AG01,Valproic acid
Human,02231030,Dom-Valproic Acid,valproic acid 250 mg oral capsule,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-05-09,N03AG01,Valproic acid
Human,02184648,Mylan-Valproic,valproic acid 250 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2016-06-28,N03AG01,Valproic acid
Human,02100630,Novo-Valproic,valproic acid 250 mg oral capsule,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2018-05-02,N03AG01,Valproic acid
Human,02260654,Phl-Valproic Acid,valproic acid 250 mg oral capsule,Pharmel Inc,2.0,R,2.0,Cancelled post market,2016-10-25,N03AG01,Valproic acid
Human,02230768,Pms-Valproic Acid,valproic acid 250 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Marketed,1997-02-27,N03AG01,Valproic acid
Human,02217414,Ratio-Valproic,valproic acid 250 mg oral capsule,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2018-05-18,N03AG01,Valproic acid
Human,02140047,Ratio-Valproic-Cap 250Mg,valproic acid 250 mg oral capsule,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2014-09-19,N03AG01,Valproic acid
Human,02239714,Sandoz Valproic,valproic acid 250 mg oral capsule,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N03AG01,Valproic acid
Human,02237830,Valproic Acid,valproic acid 250 mg oral capsule,Apotex Inc,2.0,R,2.0,Approved,2020-11-20,N03AG01,Valproic acid
Human,02238546,Valproic-250,valproic acid 250 mg oral capsule,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2012-07-23,N03AG01,Valproic acid
Human,00507989,Depakene Cap 500Mg,valproic acid 500 mg oral gastro-resistant capsule,"Abbott Laboratories, Limited",2.0,R,2.0,Cancelled post market,2007-05-11,N03AG01,Valproic acid
Human,02231031,Dom-Valproic Acid E.C.,valproic acid 500 mg oral gastro-resistant capsule,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-05-09,N03AG01,Valproic acid
Human,02218321,Novo-Valproic,valproic acid 500 mg oral gastro-resistant capsule,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2018-05-02,N03AG01,Valproic acid
Human,02260662,Phl-Valproic Acid E.C.,valproic acid 500 mg oral gastro-resistant capsule,Pharmel Inc,2.0,R,2.0,Cancelled post market,2016-10-25,N03AG01,Valproic acid
Human,02229628,Pms-Valproic Acid E.C.,valproic acid 500 mg oral gastro-resistant capsule,Pharmascience Inc,2.0,R,2.0,Marketed,1996-12-13,N03AG01,Valproic acid
Human,02231489,Ratio-Valproic,valproic acid 500 mg oral gastro-resistant capsule,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2018-05-18,N03AG01,Valproic acid
Human,02140055,Ratio-Valproic - Ecc 500Mg,valproic acid 500 mg oral gastro-resistant capsule,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2010-08-02,N03AG01,Valproic acid
Human,02239713,Sandoz Valproic,valproic acid 500 mg oral gastro-resistant capsule,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2008-08-07,N03AG01,Valproic acid
Human,02068028,Sabril Pwr 1G/Sachet,vigabatrin 1 g / pack oral powder,Aventis Pharma Inc,2.0,R,2.0,Cancelled pre market,2017-07-17,N03AG04,Vigabatrin
Human,02068001,Sabril Pwr 2G/Sachet,vigabatrin 2 g / pack oral powder,Aventis Pharma Inc,2.0,R,2.0,Cancelled pre market,2017-07-17,N03AG04,Vigabatrin
Human,02067994,Sabril Pwr 3G/Sachet,vigabatrin 3 g / pack oral powder,Aventis Pharma Inc,2.0,R,2.0,Cancelled pre market,2017-07-17,N03AG04,Vigabatrin
Human,02068036,Sabril,vigabatrin 500 mg / sachet oral powder for solution,Lundbeck Pharmaceuticals Llc,2.0,R,2.0,Marketed,2009-10-07,N03AG04,Vigabatrin
Human,02065819,Sabril,vigabatrin 500 mg oral tablet,Lundbeck Pharmaceuticals Llc,2.0,R,2.0,Marketed,2009-10-07,N03AG04,Vigabatrin
Human,02414619,Abbott-Topiramate,topiramate 100 mg oral tablet,Bgp Pharma Ulc,2.0,R,2.0,Cancelled post market,2015-12-31,N03AX11,Topiramate
Human,02435349,Accel-Topiramate,topiramate 100 mg oral tablet,Accel Pharma Inc,2.0,R,2.0,Cancelled post market,2017-01-27,N03AX11,Topiramate
Human,02395746,Ach-Topiramate,topiramate 100 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Cancelled post market,2026-01-16,N03AX11,Topiramate
Human,02475944,Ag-Topiramate,topiramate 100 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Dormant,2025-07-30,N03AX11,Topiramate
Human,02536730,Ag-Topiramate Tablets,topiramate 100 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Marketed,2024-02-28,N03AX11,Topiramate
Human,02279630,Apo-Topiramate,topiramate 100 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2006-04-21,N03AX11,Topiramate
Human,02345838,Auro-Topiramate,topiramate 100 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2020-03-31,N03AX11,Topiramate
Human,02370980,Ava-Topiramate,topiramate 100 mg oral tablet,Avanstra Inc,2.0,R,2.0,Cancelled post market,2014-08-21,N03AX11,Topiramate
Human,02271168,Dom-Topiramate,topiramate 100 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-05-09,N03AX11,Topiramate
Human,02352877,Gd-Topiramate,topiramate 100 mg oral tablet,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2014-12-10,N03AX11,Topiramate
Human,02287773,Gln-Topiramate,topiramate 100 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,R,2.0,Marketed,2021-09-28,N03AX11,Topiramate
Human,02471329,Gln-Topiramate,topiramate 100 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,R,2.0,Cancelled pre market,2018-07-17,N03AX11,Topiramate
Human,02431009,Ipg-Topiramate,topiramate 100 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Approved,2016-04-21,N03AX11,Topiramate
Human,02345269,Jamp Topiramate Tablets,topiramate 100 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2024-02-28,N03AX11,Topiramate
Human,02435616,Jamp-Topiramate,topiramate 100 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2015-02-06,N03AX11,Topiramate
Human,02432102,Mar-Topiramate,topiramate 100 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Dormant,2018-09-30,N03AX11,Topiramate
Human,02315653,Mint-Topiramate,topiramate 100 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2024-06-26,N03AX11,Topiramate
Human,02263378,Mylan-Topiramate,topiramate 100 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2010-02-04,N03AX11,Topiramate
Human,02538458,Nra-Topiramate,topiramate 100 mg oral tablet,Nora Pharma Inc,2.0,R,2.0,Marketed,2024-01-11,N03AX11,Topiramate
Human,02334348,Nu-Topiramate,topiramate 100 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,N03AX11,Topiramate
Human,02271192,Phl-Topiramate,topiramate 100 mg oral tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2005-10-11,N03AX11,Topiramate
Human,02263009,Pms-Topiramate,topiramate 100 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2005-09-14,N03AX11,Topiramate
Human,02313669,Pro-Topiramate,topiramate 100 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2008-10-27,N03AX11,Topiramate
Human,02372703,Q-Topiramate,topiramate 100 mg oral tablet,Qd Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2015-08-21,N03AX11,Topiramate
Human,02396084,Ran-Topiramate,topiramate 100 mg oral tablet,Ranbaxy Pharmaceuticals Canada Inc.,2.0,R,2.0,Cancelled post market,2020-11-03,N03AX11,Topiramate
Human,02256835,Ratio-Topiramate,topiramate 100 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2012-07-21,N03AX11,Topiramate
Human,02260069,Sandoz Topiramate,topiramate 100 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N03AX11,Topiramate
Human,02431815,Sandoz Topiramate Tablets,topiramate 100 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2023-04-11,N03AX11,Topiramate
Human,02248861,Teva-Topiramate,topiramate 100 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2011-05-07,N03AX11,Topiramate
Human,02230894,Topamax 100Mg,topiramate 100 mg oral tablet,Janssen Inc,2.0,R,2.0,Marketed,1997-03-25,N03AX11,Topiramate
Human,02344866,Topiramate,topiramate 100 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled pre market,2017-09-01,N03AX11,Topiramate
Human,02345439,Topiramate,topiramate 100 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-25,N03AX11,Topiramate
Human,02356864,Topiramate,topiramate 100 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Marketed,2010-10-06,N03AX11,Topiramate
Human,02389487,Topiramate,topiramate 100 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2018-05-04,N03AX11,Topiramate
Human,02430800,Topiramate Tablets Usp,topiramate 100 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Cancelled post market,2023-01-13,N03AX11,Topiramate
Human,02444291,Van-Topiramate,topiramate 100 mg oral tablet,Vanc Pharmaceuticals Inc,2.0,R,2.0,Cancelled pre market,2019-07-31,N03AX11,Topiramate
Human,02325144,Zym-Topiramate,topiramate 100 mg oral tablet,Zymcan Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2014-06-16,N03AX11,Topiramate
Human,02239907,Topamax,topiramate 15 mg oral capsule,Janssen Inc,2.0,R,2.0,Marketed,1999-06-11,N03AX11,Topiramate
Human,02414627,Abbott-Topiramate,topiramate 200 mg oral tablet,Bgp Pharma Ulc,2.0,R,2.0,Cancelled post market,2015-12-31,N03AX11,Topiramate
Human,02435357,Accel-Topiramate,topiramate 200 mg oral tablet,Accel Pharma Inc,2.0,R,2.0,Cancelled post market,2017-01-27,N03AX11,Topiramate
Human,02395754,Ach-Topiramate,topiramate 200 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Cancelled post market,2026-01-16,N03AX11,Topiramate
Human,02475952,Ag-Topiramate,topiramate 200 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Approved,2018-05-22,N03AX11,Topiramate
Human,02536749,Ag-Topiramate Tablets,topiramate 200 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Approved,2023-03-30,N03AX11,Topiramate
Human,02279649,Apo-Topiramate,topiramate 200 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2006-04-21,N03AX11,Topiramate
Human,02345846,Auro-Topiramate,topiramate 200 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2020-03-31,N03AX11,Topiramate
Human,02370999,Ava-Topiramate,topiramate 200 mg oral tablet,Avanstra Inc,2.0,R,2.0,Cancelled post market,2014-08-21,N03AX11,Topiramate
Human,02271176,Dom-Topiramate,topiramate 200 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-05-09,N03AX11,Topiramate
Human,02352885,Gd-Topiramate,topiramate 200 mg oral tablet,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2015-08-25,N03AX11,Topiramate
Human,02287781,Gln-Topiramate,topiramate 200 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,R,2.0,Marketed,2021-09-28,N03AX11,Topiramate
Human,02471337,Gln-Topiramate,topiramate 200 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,R,2.0,Cancelled pre market,2018-07-17,N03AX11,Topiramate
Human,02431017,Ipg-Topiramate,topiramate 200 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Approved,2016-04-21,N03AX11,Topiramate
Human,02345277,Jamp Topiramate Tablets,topiramate 200 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2023-12-14,N03AX11,Topiramate
Human,02435624,Jamp-Topiramate,topiramate 200 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Dormant,2025-07-31,N03AX11,Topiramate
Human,02432110,Mar-Topiramate,topiramate 200 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Dormant,2018-09-30,N03AX11,Topiramate
Human,02315661,Mint-Topiramate,topiramate 200 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2024-06-26,N03AX11,Topiramate
Human,02263386,Mylan-Topiramate,topiramate 200 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2009-11-06,N03AX11,Topiramate
Human,02538474,Nra-Topiramate,topiramate 200 mg oral tablet,Nora Pharma Inc,2.0,R,2.0,Marketed,2024-01-11,N03AX11,Topiramate
Human,02334356,Nu-Topiramate,topiramate 200 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,N03AX11,Topiramate
Human,02271206,Phl-Topiramate,topiramate 200 mg oral tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2005-10-11,N03AX11,Topiramate
Human,02263017,Pms-Topiramate,topiramate 200 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2005-09-14,N03AX11,Topiramate
Human,02313677,Pro-Topiramate,topiramate 200 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2008-10-27,N03AX11,Topiramate
Human,02372711,Q-Topiramate,topiramate 200 mg oral tablet,Qd Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2015-08-21,N03AX11,Topiramate
Human,02396092,Ran-Topiramate,topiramate 200 mg oral tablet,Ranbaxy Pharmaceuticals Canada Inc.,2.0,R,2.0,Cancelled post market,2020-11-03,N03AX11,Topiramate
Human,02256843,Ratio-Topiramate,topiramate 200 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2012-07-21,N03AX11,Topiramate
Human,02267837,Sandoz Topiramate,topiramate 200 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N03AX11,Topiramate
Human,02431823,Sandoz Topiramate Tablets,topiramate 200 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2023-04-11,N03AX11,Topiramate
Human,02248862,Teva-Topiramate,topiramate 200 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2011-05-07,N03AX11,Topiramate
Human,02230896,Topamax 200Mg,topiramate 200 mg oral tablet,Janssen Inc,2.0,R,2.0,Marketed,1997-03-25,N03AX11,Topiramate
Human,02344874,Topiramate,topiramate 200 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled pre market,2017-09-01,N03AX11,Topiramate
Human,02345447,Topiramate,topiramate 200 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-25,N03AX11,Topiramate
Human,02356872,Topiramate,topiramate 200 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Marketed,2010-10-06,N03AX11,Topiramate
Human,02389495,Topiramate,topiramate 200 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2015-08-06,N03AX11,Topiramate
Human,02553880,Topiramate,topiramate 200 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2025-12-29,N03AX11,Topiramate
Human,02430819,Topiramate Tablets Usp,topiramate 200 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Cancelled post market,2023-01-13,N03AX11,Topiramate
Human,02444305,Van-Topiramate,topiramate 200 mg oral tablet,Vanc Pharmaceuticals Inc,2.0,R,2.0,Cancelled pre market,2019-07-31,N03AX11,Topiramate
Human,02325152,Zym-Topiramate,topiramate 200 mg oral tablet,Zymcan Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2014-06-16,N03AX11,Topiramate
Human,02239908,Topamax,topiramate 25 mg oral capsule,Janssen Inc,2.0,R,2.0,Marketed,1999-06-11,N03AX11,Topiramate
Human,02414600,Abbott-Topiramate,topiramate 25 mg oral tablet,Bgp Pharma Ulc,2.0,R,2.0,Cancelled post market,2015-12-31,N03AX11,Topiramate
Human,02435330,Accel-Topiramate,topiramate 25 mg oral tablet,Accel Pharma Inc,2.0,R,2.0,Cancelled post market,2017-01-27,N03AX11,Topiramate
Human,02395738,Ach-Topiramate,topiramate 25 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Cancelled post market,2026-01-16,N03AX11,Topiramate
Human,02475936,Ag-Topiramate,topiramate 25 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Dormant,2025-07-30,N03AX11,Topiramate
Human,02536722,Ag-Topiramate Tablets,topiramate 25 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Marketed,2023-07-19,N03AX11,Topiramate
Human,02279614,Apo-Topiramate,topiramate 25 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2006-04-21,N03AX11,Topiramate
Human,02345803,Auro-Topiramate,topiramate 25 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2020-03-31,N03AX11,Topiramate
Human,02370972,Ava-Topiramate,topiramate 25 mg oral tablet,Avanstra Inc,2.0,R,2.0,Cancelled post market,2014-08-21,N03AX11,Topiramate
Human,02271141,Dom-Topiramate,topiramate 25 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-05-09,N03AX11,Topiramate
Human,02352850,Gd-Topiramate,topiramate 25 mg oral tablet,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Cancelled post market,2014-12-10,N03AX11,Topiramate
Human,02287765,Gln-Topiramate,topiramate 25 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,R,2.0,Marketed,2021-09-28,N03AX11,Topiramate
Human,02471310,Gln-Topiramate,topiramate 25 mg oral tablet,Glenmark Pharmaceuticals Canada Inc.,2.0,R,2.0,Cancelled pre market,2018-07-17,N03AX11,Topiramate
Human,02430991,Ipg-Topiramate,topiramate 25 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Approved,2016-04-21,N03AX11,Topiramate
Human,02345250,Jamp Topiramate Tablets,topiramate 25 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2023-03-01,N03AX11,Topiramate
Human,02435608,Jamp-Topiramate,topiramate 25 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Dormant,2025-07-31,N03AX11,Topiramate
Human,02432099,Mar-Topiramate,topiramate 25 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Dormant,2018-09-30,N03AX11,Topiramate
Human,02315645,Mint-Topiramate,topiramate 25 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2024-06-26,N03AX11,Topiramate
Human,02263351,Mylan-Topiramate,topiramate 25 mg oral tablet,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2009-10-21,N03AX11,Topiramate
Human,02538466,Nra-Topiramate,topiramate 25 mg oral tablet,Nora Pharma Inc,2.0,R,2.0,Marketed,2024-01-11,N03AX11,Topiramate
Human,02334313,Nu-Topiramate,topiramate 25 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,N03AX11,Topiramate
Human,02271184,Phl-Topiramate,topiramate 25 mg oral tablet,Pharmel Inc,2.0,R,2.0,Cancelled post market,2005-10-11,N03AX11,Topiramate
Human,02262991,Pms-Topiramate,topiramate 25 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2005-09-14,N03AX11,Topiramate
Human,02313650,Pro-Topiramate,topiramate 25 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2008-10-27,N03AX11,Topiramate
Human,02372681,Q-Topiramate,topiramate 25 mg oral tablet,Qd Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2015-08-21,N03AX11,Topiramate
Human,02396076,Ran-Topiramate,topiramate 25 mg oral tablet,Ranbaxy Pharmaceuticals Canada Inc.,2.0,R,2.0,Cancelled post market,2020-11-03,N03AX11,Topiramate
Human,02256827,Ratio-Topiramate,topiramate 25 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2012-07-21,N03AX11,Topiramate
Human,02260050,Sandoz Topiramate,topiramate 25 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N03AX11,Topiramate
Human,02431807,Sandoz Topiramate Tablets,topiramate 25 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2023-04-11,N03AX11,Topiramate
Human,02248860,Teva-Topiramate,topiramate 25 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2011-05-07,N03AX11,Topiramate
Human,02230893,Topamax 25Mg,topiramate 25 mg oral tablet,Janssen Inc,2.0,R,2.0,Marketed,1997-03-25,N03AX11,Topiramate
Human,02344858,Topiramate,topiramate 25 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled pre market,2017-09-01,N03AX11,Topiramate
Human,02345412,Topiramate,topiramate 25 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-26,N03AX11,Topiramate
Human,02356856,Topiramate,topiramate 25 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Marketed,2010-10-06,N03AX11,Topiramate
Human,02389460,Topiramate,topiramate 25 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2018-07-06,N03AX11,Topiramate
Human,02430797,Topiramate Tablets Usp,topiramate 25 mg oral tablet,Accord Healthcare Inc,2.0,R,2.0,Cancelled post market,2023-01-13,N03AX11,Topiramate
Human,02444283,Van-Topiramate,topiramate 25 mg oral tablet,Vanc Pharmaceuticals Inc,2.0,R,2.0,Cancelled pre market,2019-07-31,N03AX11,Topiramate
Human,02325136,Zym-Topiramate,topiramate 25 mg oral tablet,Zymcan Pharmaceuticals Inc,2.0,R,2.0,Cancelled post market,2014-06-16,N03AX11,Topiramate
Human,02231386,Topamax,topiramate 300 mg oral tablet,Janssen Inc,2.0,R,2.0,Cancelled pre market,2014-12-18,N03AX11,Topiramate
Human,02231387,Topamax,topiramate 400 mg oral tablet,Janssen Inc,2.0,R,2.0,Cancelled pre market,2014-12-18,N03AX11,Topiramate
Human,02548178,Ag-Topiramate Tablets,topiramate 50 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Approved,2024-05-27,N03AX11,Topiramate
Human,02279622,Apo-Topiramate,topiramate 50 mg oral tablet,Apotex Inc,2.0,R,2.0,Approved,2006-04-19,N03AX11,Topiramate
Human,02345811,Auro-Topiramate,topiramate 50 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Approved,2020-03-31,N03AX11,Topiramate
Human,02544377,Jamp Topiramate Tablets,topiramate 50 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2024-08-28,N03AX11,Topiramate
Human,02334321,Nu-Topiramate,topiramate 50 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,N03AX11,Topiramate
Human,02312085,Pms-Topiramate,topiramate 50 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2008-06-17,N03AX11,Topiramate
Human,02231385,Topamax,topiramate 50 mg oral tablet,Janssen Inc,2.0,R,2.0,Cancelled pre market,2014-12-18,N03AX11,Topiramate
Human,02389479,Topiramate,topiramate 50 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2015-08-06,N03AX11,Topiramate
Human,02516780,Topiramate,topiramate 50 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Approved,2021-09-02,N03AX11,Topiramate
Human,02398974,Diacomit,stiripentol 250 mg / sachet oral powder for suspension,Biocodex Sas,2.0,,,Marketed,2013-05-01,N03AX17,Stiripentol
Human,02398958,Diacomit,stiripentol 250 mg oral capsule,Biocodex Sas,2.0,,,Marketed,2013-05-01,N03AX17,Stiripentol
Human,02398982,Diacomit,stiripentol 500 mg / sachet oral powder for suspension,Biocodex Sas,2.0,,,Dormant,2017-08-31,N03AX17,Stiripentol
Human,02398966,Diacomit,stiripentol 500 mg oral capsule,Biocodex Sas,2.0,,,Marketed,2013-05-01,N03AX17,Stiripentol
Human,02538733,Xcopri,cenobamate 100 mg oral tablet,Knight Therapeutics Inc.,2.0,R,,Marketed,2025-12-19,N03AX25,Cenobamate
Human,02538806,Xcopri,cenobamate 100 mg with cenobamate 150 mg oral kit (tablet),Knight Therapeutics Inc.,2.0,R,,Approved,2025-12-19,N03AX25,Cenobamate
Human,02538784,Xcopri,cenobamate 100 mg with cenobamate 50 mg oral kit (tablet),Knight Therapeutics Inc.,2.0,R,,Marketed,2025-12-19,N03AX25,Cenobamate
Human,02538652,Xcopri,cenobamate 12.5 mg oral tablet,Knight Therapeutics Inc.,2.0,R,,Marketed,2025-12-19,N03AX25,Cenobamate
Human,02538776,Xcopri,cenobamate 12.5 mg with cenobamate 25 mg oral kit (tablet),Knight Therapeutics Inc.,2.0,R,,Marketed,2025-12-19,N03AX25,Cenobamate
Human,02538741,Xcopri,cenobamate 150 mg oral tablet,Knight Therapeutics Inc.,2.0,R,,Marketed,2025-12-19,N03AX25,Cenobamate
Human,02538792,Xcopri,cenobamate 150 mg with cenobamate 200 mg oral kit (tablet),Knight Therapeutics Inc.,2.0,R,,Approved,2025-12-19,N03AX25,Cenobamate
Human,02538814,Xcopri,cenobamate 150 mg with cenobamate 200 mg oral kit (tablet),Knight Therapeutics Inc.,2.0,R,,Approved,2025-12-19,N03AX25,Cenobamate
Human,02538768,Xcopri,cenobamate 200 mg oral tablet,Knight Therapeutics Inc.,2.0,R,,Marketed,2025-12-19,N03AX25,Cenobamate
Human,02538660,Xcopri,cenobamate 25 mg oral tablet,Knight Therapeutics Inc.,2.0,R,,Marketed,2025-12-19,N03AX25,Cenobamate
Human,02538725,Xcopri,cenobamate 50 mg oral tablet,Knight Therapeutics Inc.,2.0,R,,Marketed,2025-12-19,N03AX25,Cenobamate
Human,02500264,Kynmobi,apomorphine hydrochloride 10 mg / film sublingual soluble film,Sunovion Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2023-09-29,N04BC07,Apomorphine
Human,02459132,Movapo,apomorphine hydrochloride 10 mg / mL solution for injection,Paladin Pharma Inc.,2.0,P,2.0,Cancelled post market,2023-10-23,N04BC07,Apomorphine
Human,02459140,Movapo,apomorphine hydrochloride 10 mg / mL solution for injection,Paladin Pharma Inc.,2.0,P,2.0,Cancelled pre market,2023-10-23,N04BC07,Apomorphine
Human,02500272,Kynmobi,apomorphine hydrochloride 15 mg / film sublingual soluble film,Sunovion Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2023-09-29,N04BC07,Apomorphine
Human,02500280,Kynmobi,apomorphine hydrochloride 20 mg / film sublingual soluble film,Sunovion Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2023-09-29,N04BC07,Apomorphine
Human,02500299,Kynmobi,apomorphine hydrochloride 25 mg / film sublingual soluble film,Sunovion Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2023-09-29,N04BC07,Apomorphine
Human,02500302,Kynmobi,apomorphine hydrochloride 30 mg / film sublingual soluble film,Sunovion Pharmaceuticals Canada Inc,2.0,P,2.0,Cancelled post market,2023-09-29,N04BC07,Apomorphine
Human,02514532,Ag-Rasagiline,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,Angita Pharma Inc.,2.0,P,2.0,Approved,2021-04-09,N04BD02,Rasagiline
Human,02404680,Apo-Rasagiline,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2016-01-12,N04BD02,Rasagiline
Human,02489120,Asn-Rasagiline,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,Ascend Laboratories Ltd,2.0,P,2.0,Approved,2019-06-04,N04BD02,Rasagiline
Human,02284642,Azilect,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2021-06-03,N04BD02,Rasagiline
Human,02491974,Jamp Rasagiline,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2020-09-04,N04BD02,Rasagiline
Human,02533723,Mint-Rasagiline,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,Mint Pharmaceuticals Inc,2.0,P,2.0,Approved,2022-12-21,N04BD02,Rasagiline
Human,02418436,Teva-Rasagiline,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2016-05-30,N04BD02,Rasagiline
Human,02514540,Ag-Rasagiline,rasagiline (rasagiline mesylate) 1 mg oral tablet,Angita Pharma Inc.,2.0,P,2.0,Approved,2021-04-09,N04BD02,Rasagiline
Human,02404699,Apo-Rasagiline,rasagiline (rasagiline mesylate) 1 mg oral tablet,Apotex Inc,2.0,P,2.0,Marketed,2016-01-12,N04BD02,Rasagiline
Human,02489139,Asn-Rasagiline,rasagiline (rasagiline mesylate) 1 mg oral tablet,Ascend Laboratories Ltd,2.0,P,2.0,Approved,2019-06-04,N04BD02,Rasagiline
Human,02284650,Azilect,rasagiline (rasagiline mesylate) 1 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2021-06-03,N04BD02,Rasagiline
Human,02491982,Jamp Rasagiline,rasagiline (rasagiline mesylate) 1 mg oral tablet,Jamp Pharma Corporation,2.0,P,2.0,Marketed,2020-09-04,N04BD02,Rasagiline
Human,02533731,Mint-Rasagiline,rasagiline (rasagiline mesylate) 1 mg oral tablet,Mint Pharmaceuticals Inc,2.0,P,2.0,Approved,2022-12-21,N04BD02,Rasagiline
Human,02418444,Teva-Rasagiline,rasagiline (rasagiline mesylate) 1 mg oral tablet,Teva Canada Limited,2.0,P,2.0,Marketed,2016-05-30,N04BD02,Rasagiline
Human,02449544,Auro-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg oral capsule,Auro Pharma Inc,2.0,R,2.0,Marketed,2018-03-19,N05AE04,Ziprasidone
Human,02441357,Gd-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg oral capsule,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2020-10-13,N05AE04,Ziprasidone
Human,02429365,Mylan-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2023-05-31,N05AE04,Ziprasidone
Human,02478803,Pms-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Approved,2024-02-06,N05AE04,Ziprasidone
Human,02298597,Zeldox,ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg oral capsule,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2023-09-15,N05AE04,Ziprasidone
Human,02449552,Auro-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg oral capsule,Auro Pharma Inc,2.0,R,2.0,Marketed,2018-03-19,N05AE04,Ziprasidone
Human,02441365,Gd-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg oral capsule,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2020-10-13,N05AE04,Ziprasidone
Human,02429373,Mylan-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2023-05-31,N05AE04,Ziprasidone
Human,02478811,Pms-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Approved,2024-02-06,N05AE04,Ziprasidone
Human,02298600,Zeldox,ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg oral capsule,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2023-09-15,N05AE04,Ziprasidone
Human,02449560,Auro-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg oral capsule,Auro Pharma Inc,2.0,R,2.0,Marketed,2018-03-19,N05AE04,Ziprasidone
Human,02441373,Gd-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg oral capsule,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2020-10-13,N05AE04,Ziprasidone
Human,02429381,Mylan-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2023-05-31,N05AE04,Ziprasidone
Human,02478838,Pms-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Approved,2024-02-06,N05AE04,Ziprasidone
Human,02298619,Zeldox,ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg oral capsule,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2023-09-15,N05AE04,Ziprasidone
Human,02449579,Auro-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg oral capsule,Auro Pharma Inc,2.0,R,2.0,Marketed,2018-03-19,N05AE04,Ziprasidone
Human,02441381,Gd-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg oral capsule,Genmed A Division Of Pfizer Canada Ulc,2.0,R,2.0,Cancelled pre market,2020-10-13,N05AE04,Ziprasidone
Human,02429403,Mylan-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg oral capsule,Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled pre market,2023-05-31,N05AE04,Ziprasidone
Human,02478846,Pms-Ziprasidone,ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Approved,2024-02-06,N05AE04,Ziprasidone
Human,02298627,Zeldox,ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg oral capsule,Bgp Pharma Ulc,2.0,R,2.0,Marketed,2023-09-15,N05AE04,Ziprasidone
Human,00846392,Frisium Tab 10Mg,clobazam 10 mg / tablet oral tablet,Hoechst Canada Inc.,2.0,R,2.0,Cancelled post market,1996-08-29,N05BA09,Clobazam
Human,02244638,Apo-Clobazam,clobazam 10 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2001-11-28,N05BA09,Clobazam
Human,02248454,Clobazam-10,clobazam 10 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2017-05-05,N05BA09,Clobazam
Human,02247230,Dom-Clobazam,clobazam 10 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2016-10-25,N05BA09,Clobazam
Human,02221799,Frisium Tablet 10Mg,clobazam 10 mg oral tablet,Lundbeck Pharmaceuticals Llc,2.0,R,2.0,Cancelled post market,2018-08-31,N05BA09,Clobazam
Human,01989634,Frisium Tablets 10Mg,clobazam 10 mg oral tablet,Hoechst Roussel Canada Inc.,2.0,R,2.0,Cancelled post market,1999-08-11,N05BA09,Clobazam
Human,02347598,Ntp-Clobazam,clobazam 10 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled pre market,2015-08-06,N05BA09,Clobazam
Human,02244474,Pms-Clobazam,clobazam 10 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Dormant,2018-08-02,N05BA09,Clobazam
Human,02238797,Ratio-Clobazam,clobazam 10 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2010-08-02,N05BA09,Clobazam
Human,02238334,Teva-Clobazam,clobazam 10 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2017-01-10,N05BA09,Clobazam
Human,02239071,Penta-Temazepam Capsules,temazepam 15 mg / capsule oral capsule,Pentapharm Ltd.,2.0,R,2.0,Cancelled (unreturned annual),2018-04-05,N05CD07,Temazepam
Human,02225964,Apo-Temazepam,temazepam 15 mg oral capsule,Apotex Inc,2.0,R,2.0,Dormant,2021-10-21,N05CD07,Temazepam
Human,02244814,Co Temazepam Capsules 15Mg,temazepam 15 mg oral capsule,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled post market,2015-08-07,N05CD07,Temazepam
Human,02229756,Dom-Temazepam,temazepam 15 mg oral capsule,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2016-10-25,N05CD07,Temazepam
Human,02231615,Gen-Temazepam 15Mg,temazepam 15 mg oral capsule,Genpharm Ulc,2.0,R,2.0,Cancelled post market,2009-10-15,N05CD07,Temazepam
Human,02347865,Ntp-Temazepam,temazepam 15 mg oral capsule,Nt Pharma Canada Ltd,2.0,R,2.0,Cancelled pre market,2017-03-16,N05CD07,Temazepam
Human,02297957,Phl-Temazepam,temazepam 15 mg oral capsule,Pharmel Inc,2.0,R,2.0,Cancelled post market,2016-10-25,N05CD07,Temazepam
Human,02273039,Pms-Temazepam,temazepam 15 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Dormant,2017-08-03,N05CD07,Temazepam
Human,02229455,Pms-Temazepam - 15Mg,temazepam 15 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2009-10-21,N05CD07,Temazepam
Human,02243023,Ratio-Temazepam,temazepam 15 mg oral capsule,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2014-09-19,N05CD07,Temazepam
Human,00604453,Restoril,temazepam 15 mg oral capsule,Aa Pharma Inc,2.0,R,2.0,Marketed,2018-01-31,N05CD07,Temazepam
Human,02223570,Temazepam,temazepam 15 mg oral capsule,Apotex Inc,2.0,R,2.0,Approved,2020-12-08,N05CD07,Temazepam
Human,02229760,Temazepam-15,temazepam 15 mg oral capsule,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2017-05-05,N05CD07,Temazepam
Human,02230095,Teva-Temazepam,temazepam 15 mg oral capsule,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2018-05-17,N05CD07,Temazepam
Human,02239072,Penta-Temazepam Capsules,temazepam 30 mg / capsule oral capsule,Pentapharm Ltd.,2.0,R,2.0,Cancelled (unreturned annual),2018-04-05,N05CD07,Temazepam
Human,02225972,Apo-Temazepam,temazepam 30 mg oral capsule,Apotex Inc,2.0,R,2.0,Dormant,2021-10-21,N05CD07,Temazepam
Human,02244815,Co Temazepam Capsules 30Mg,temazepam 30 mg oral capsule,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled post market,2015-08-07,N05CD07,Temazepam
Human,02229758,Dom-Temazepam,temazepam 30 mg oral capsule,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2016-10-25,N05CD07,Temazepam
Human,02231616,Gen-Temazepam 30Mg,temazepam 30 mg oral capsule,Genpharm Ulc,2.0,R,2.0,Cancelled post market,2009-10-15,N05CD07,Temazepam
Human,02347873,Ntp-Temazepam,temazepam 30 mg oral capsule,Nt Pharma Canada Ltd,2.0,R,2.0,Cancelled pre market,2017-03-16,N05CD07,Temazepam
Human,02297965,Phl-Temazepam,temazepam 30 mg oral capsule,Pharmel Inc,2.0,R,2.0,Cancelled post market,2016-10-25,N05CD07,Temazepam
Human,02273047,Pms-Temazepam,temazepam 30 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Dormant,2018-08-02,N05CD07,Temazepam
Human,02229456,Pms-Temazepam - 30Mg,temazepam 30 mg oral capsule,Pharmascience Inc,2.0,R,2.0,Cancelled post market,2009-10-21,N05CD07,Temazepam
Human,02243024,Ratio-Temazepam,temazepam 30 mg oral capsule,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2014-09-19,N05CD07,Temazepam
Human,00604461,Restoril,temazepam 30 mg oral capsule,Aa Pharma Inc,2.0,R,2.0,Marketed,2018-03-06,N05CD07,Temazepam
Human,02223589,Temazepam,temazepam 30 mg oral capsule,Apotex Inc,2.0,R,2.0,Approved,2020-12-08,N05CD07,Temazepam
Human,02229761,Temazepam-30,temazepam 30 mg oral capsule,Pro Doc Limitee,2.0,R,2.0,Cancelled post market,2017-05-05,N05CD07,Temazepam
Human,02230102,Teva-Temazepam,temazepam 30 mg oral capsule,Teva Canada Limited,2.0,R,2.0,Cancelled post market,2018-05-17,N05CD07,Temazepam
Human,02507374,Dayvigo,lemborexant 10 mg oral tablet,Eisai Limited,2.0,,,Marketed,2020-11-06,N05CJ02,Lemborexant
Human,02507366,Dayvigo,lemborexant 5 mg oral tablet,Eisai Limited,2.0,,,Marketed,2020-11-06,N05CJ02,Lemborexant
Human,02464381,Dexmedetomidine Hydrochloride For Injection,dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / mL solution for injection,Auro Pharma Inc,,R,,Marketed,2019-10-10,N05CM18,Dexmedetomidine
Human,02477327,Dexmedetomidine Hydrochloride For Injection,dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / mL solution for injection,Accord Healthcare Inc,,R,,Marketed,2019-03-29,N05CM18,Dexmedetomidine
Human,02493314,Dexmedetomidine Hydrochloride For Injection,dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / mL solution for injection,Sandoz Canada Incorporated,,R,,Cancelled pre market,2023-04-04,N05CM18,Dexmedetomidine
Human,02528886,Dexmedetomidine Hydrochloride For Injection,dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / mL solution for injection,Eugia Pharma Inc.,,R,,Marketed,2024-10-07,N05CM18,Dexmedetomidine
Human,02537095,Dexmedetomidine Hydrochloride For Injection Usp,dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / mL solution for injection,Hikma Canada Limited,,R,,Approved,2023-04-05,N05CM18,Dexmedetomidine
Human,02467976,"Dexmedetomidine Hydrochloride For Injection, Usp",dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / mL solution for injection,Juno Pharmaceuticals Corp.,,R,,Marketed,2021-03-01,N05CM18,Dexmedetomidine
Human,02513978,"Dexmedetomidine Hydrochloride For Injection, Usp",dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / mL solution for injection,Baxter Corporation,,R,,Marketed,2024-06-05,N05CM18,Dexmedetomidine
Human,02539152,"Dexmedetomidine Hydrochloride For Injection, Usp",dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / mL solution for injection,Omega Laboratories Limited,,R,,Approved,2023-06-28,N05CM18,Dexmedetomidine
Human,02339366,Precedex,dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / mL solution for injection,Pfizer Canada Ulc,,R,,Cancelled post market,2025-11-13,N05CM18,Dexmedetomidine
Human,02487365,Dexmedetomidine Hydrochloride Injection,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg / 50 mL solution for injection,Juno Pharmaceuticals Corp.,,R,,Marketed,2020-09-30,N05CM18,Dexmedetomidine
Human,02539462,Dexmedetomidine Hydrochloride Injection,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg / 50 mL solution for injection,Omega Laboratories Limited,,R,,Approved,2023-07-11,N05CM18,Dexmedetomidine
Human,02536463,Dexmedetomidine Hydrochloride Injection,dexmedetomidine (dexmedetomidine hydrochloride) 4 mcg / mL solution for injection,Fresenius Kabi Canada Ltd,,R,,Approved,2023-03-22,N05CM18,Dexmedetomidine
Human,02537109,Dexmedetomidine Hydrochloride Injection,dexmedetomidine (dexmedetomidine hydrochloride) 4 mcg / mL solution for injection,Hikma Canada Limited,,R,,Marketed,2023-11-03,N05CM18,Dexmedetomidine
Human,02437147,Precedex,dexmedetomidine (dexmedetomidine hydrochloride) 4 mcg / mL solution for injection,Pfizer Canada Ulc,,R,,Marketed,2019-03-04,N05CM18,Dexmedetomidine
Human,02487373,Dexmedetomidine Hydrochloride Injection,dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg / 100 mL solution for injection,Juno Pharmaceuticals Corp.,,R,,Marketed,2020-09-30,N05CM18,Dexmedetomidine
Human,02539470,Dexmedetomidine Hydrochloride Injection,dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg / 100 mL solution for injection,Omega Laboratories Limited,,R,,Approved,2023-07-11,N05CM18,Dexmedetomidine
Human,02248447,Dom-Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 10 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-03-31,N06AB05,Paroxetine
Human,02382504,Ntp-Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 10 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled pre market,2016-03-17,N06AB05,Paroxetine
Human,02248450,Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 10 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-25,N06AB05,Paroxetine
Human,02302012,Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 10 mg oral tablet,Sorres Pharma Inc,2.0,R,2.0,Cancelled post market,2014-06-20,N06AB05,Paroxetine
Human,02248556,Teva-Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 10 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2024-02-15,N06AB05,Paroxetine
Human,02248448,Dom-Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 20 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-03-31,N06AB05,Paroxetine
Human,02382512,Ntp-Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 20 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled pre market,2016-03-17,N06AB05,Paroxetine
Human,02248451,Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 20 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-25,N06AB05,Paroxetine
Human,02302020,Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 20 mg oral tablet,Sorres Pharma Inc,2.0,R,2.0,Cancelled post market,2014-06-20,N06AB05,Paroxetine
Human,02248557,Teva-Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 20 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2024-02-15,N06AB05,Paroxetine
Human,02248449,Dom-Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 30 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled post market,2025-03-31,N06AB05,Paroxetine
Human,02382520,Ntp-Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 30 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Cancelled pre market,2016-03-17,N06AB05,Paroxetine
Human,02248452,Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 30 mg oral tablet,Meliapharm Inc,2.0,R,2.0,Cancelled post market,2014-06-25,N06AB05,Paroxetine
Human,02302039,Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 30 mg oral tablet,Sorres Pharma Inc,2.0,R,2.0,Cancelled post market,2014-06-20,N06AB05,Paroxetine
Human,02248558,Teva-Paroxetine,paroxetine (paroxetine hydrochloride acetone solvate) 30 mg oral tablet,Teva Canada Limited,2.0,R,2.0,Marketed,2024-02-15,N06AB05,Paroxetine
Human,02475537,Ag-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Dormant,2024-07-31,N06AB05,Paroxetine
Human,02383276,Auro-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2012-07-24,N06AB05,Paroxetine
Human,02444909,Bio-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Biomed Pharma,2.0,R,2.0,Marketed,2016-12-21,N06AB05,Paroxetine
Human,02410834,Ipg-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Approved,2016-01-19,N06AB05,Paroxetine
Human,02368862,Jamp-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Dormant,2025-07-31,N06AB05,Paroxetine
Human,02467402,M-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Mantra Pharma Inc,2.0,R,2.0,Marketed,2018-03-07,N06AB05,Paroxetine
Human,02411946,Mar-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Marketed,2014-06-24,N06AB05,Paroxetine
Human,02421372,Mint-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2014-03-17,N06AB05,Paroxetine
Human,02479753,Nra-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Nora Pharma Inc,2.0,R,2.0,Marketed,2018-12-10,N06AB05,Paroxetine
Human,02282844,Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Marketed,2021-09-27,N06AB05,Paroxetine
Human,02477823,Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Altamed Pharma,2.0,R,2.0,Marketed,2023-03-22,N06AB05,Paroxetine
Human,02444313,Priva-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Pharmapar Inc,2.0,R,2.0,Cancelled post market,2022-07-29,N06AB05,Paroxetine
Human,02248559,Riva-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet,Laboratoire Riva Inc.,2.0,R,2.0,Marketed,2016-04-22,N06AB05,Paroxetine
Human,02475545,Ag-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Dormant,2024-07-31,N06AB05,Paroxetine
Human,02383284,Auro-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2012-07-24,N06AB05,Paroxetine
Human,02444917,Bio-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Biomed Pharma,2.0,R,2.0,Marketed,2016-12-21,N06AB05,Paroxetine
Human,02410842,Ipg-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Approved,2016-01-19,N06AB05,Paroxetine
Human,02368870,Jamp-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2016-01-18,N06AB05,Paroxetine
Human,02467410,M-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Mantra Pharma Inc,2.0,R,2.0,Marketed,2018-03-07,N06AB05,Paroxetine
Human,02411954,Mar-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Marketed,2014-06-24,N06AB05,Paroxetine
Human,02421380,Mint-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2014-03-17,N06AB05,Paroxetine
Human,02479761,Nra-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Nora Pharma Inc,2.0,R,2.0,Marketed,2018-12-10,N06AB05,Paroxetine
Human,02282852,Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Marketed,2021-09-27,N06AB05,Paroxetine
Human,02477831,Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Altamed Pharma,2.0,R,2.0,Marketed,2023-02-22,N06AB05,Paroxetine
Human,02444321,Priva-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Pharmapar Inc,2.0,R,2.0,Cancelled post market,2022-07-29,N06AB05,Paroxetine
Human,02248560,Riva-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet,Laboratoire Riva Inc.,2.0,R,2.0,Marketed,2016-04-22,N06AB05,Paroxetine
Human,02475553,Ag-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Dormant,2024-07-31,N06AB05,Paroxetine
Human,02383292,Auro-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Auro Pharma Inc,2.0,R,2.0,Marketed,2012-07-24,N06AB05,Paroxetine
Human,02444925,Bio-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Biomed Pharma,2.0,R,2.0,Marketed,2016-12-21,N06AB05,Paroxetine
Human,02410850,Ipg-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Approved,2016-01-19,N06AB05,Paroxetine
Human,02368889,Jamp-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Dormant,2024-07-31,N06AB05,Paroxetine
Human,02467429,M-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Mantra Pharma Inc,2.0,R,2.0,Marketed,2018-07-30,N06AB05,Paroxetine
Human,02411962,Mar-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Marcan Pharmaceuticals Inc,2.0,R,2.0,Marketed,2014-06-24,N06AB05,Paroxetine
Human,02421399,Mint-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Mint Pharmaceuticals Inc,2.0,R,2.0,Marketed,2014-03-17,N06AB05,Paroxetine
Human,02479788,Nra-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Nora Pharma Inc,2.0,R,2.0,Marketed,2018-12-10,N06AB05,Paroxetine
Human,02282860,Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Sanis Health Inc,2.0,R,2.0,Marketed,2021-09-27,N06AB05,Paroxetine
Human,02477858,Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Altamed Pharma,2.0,R,2.0,Marketed,2023-03-29,N06AB05,Paroxetine
Human,02444348,Priva-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Pharmapar Inc,2.0,R,2.0,Cancelled post market,2022-07-29,N06AB05,Paroxetine
Human,02248561,Riva-Paroxetine,paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet,Laboratoire Riva Inc.,2.0,R,2.0,Marketed,2016-04-22,N06AB05,Paroxetine
Human,02262746,Act Paroxetine,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Actavis Pharma Company,2.0,R,2.0,Cancelled post market,2020-10-21,N06AB05,Paroxetine
Human,02510480,Ag-Paroxetine Tablets,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Marketed,2022-03-18,N06AB05,Paroxetine
Human,02240907,Apo-Paroxetine,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2003-10-24,N06AB05,Paroxetine
Human,02507773,Jamp Paroxetine Tablets,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2022-01-03,N06AB05,Paroxetine
Human,02248719,Nu-Paroxetine,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,N06AB05,Paroxetine
Human,02342383,Paroxetine,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled pre market,2017-09-01,N06AB05,Paroxetine
Human,02388227,Paroxetine,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2016-02-09,N06AB05,Paroxetine
Human,02027887,Paxil Tab 10Mg,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Glaxosmithkline Inc,2.0,R,2.0,Cancelled post market,2025-03-31,N06AB05,Paroxetine
Human,02247750,Pms-Paroxetine,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2018-09-05,N06AB05,Paroxetine
Human,02248913,Pro-Paroxetine,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2025-10-16,N06AB05,Paroxetine
Human,02247810,Ratio-Paroxetine,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2014-09-19,N06AB05,Paroxetine
Human,02269422,Sandoz Paroxetine,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N06AB05,Paroxetine
Human,02431777,Sandoz Paroxetine Tablets,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N06AB05,Paroxetine
Human,02248503,Paxil Cr,paroxetine (paroxetine hydrochloride) 12.5 mg oral prolonged-release tablet,Glaxosmithkline Inc,2.0,R,2.0,Marketed,2004-01-05,N06AB05,Paroxetine
Human,02262754,Act Paroxetine,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Actavis Pharma Company,2.0,R,2.0,Cancelled post market,2020-10-21,N06AB05,Paroxetine
Human,02510499,Ag-Paroxetine Tablets,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Marketed,2022-03-18,N06AB05,Paroxetine
Human,02240908,Apo-Paroxetine,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2003-10-24,N06AB05,Paroxetine
Human,02507781,Jamp Paroxetine Tablets,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2022-01-03,N06AB05,Paroxetine
Human,02248720,Nu-Paroxetine,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,N06AB05,Paroxetine
Human,02342391,Paroxetine,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled pre market,2017-09-01,N06AB05,Paroxetine
Human,02388235,Paroxetine,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2016-02-09,N06AB05,Paroxetine
Human,01940481,Paxil Tab 20Mg,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Glaxosmithkline Inc,2.0,R,2.0,Marketed,2002-09-13,N06AB05,Paroxetine
Human,02247751,Pms-Paroxetine,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2003-10-29,N06AB05,Paroxetine
Human,02248914,Pro-Paroxetine,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2025-10-16,N06AB05,Paroxetine
Human,02247811,Ratio-Paroxetine,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2014-09-19,N06AB05,Paroxetine
Human,02269430,Sandoz Paroxetine,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N06AB05,Paroxetine
Human,02431785,Sandoz Paroxetine Tablets,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N06AB05,Paroxetine
Human,02248504,Paxil Cr,paroxetine (paroxetine hydrochloride) 25 mg oral prolonged-release tablet,Glaxosmithkline Inc,2.0,R,2.0,Marketed,2004-01-05,N06AB05,Paroxetine
Human,02262762,Act Paroxetine,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Actavis Pharma Company,2.0,R,2.0,Cancelled post market,2020-10-21,N06AB05,Paroxetine
Human,02510510,Ag-Paroxetine Tablets,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Angita Pharma Inc.,2.0,R,2.0,Marketed,2022-03-18,N06AB05,Paroxetine
Human,02240909,Apo-Paroxetine,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Apotex Inc,2.0,R,2.0,Marketed,2003-10-24,N06AB05,Paroxetine
Human,02507803,Jamp Paroxetine Tablets,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Jamp Pharma Corporation,2.0,R,2.0,Marketed,2021-12-30,N06AB05,Paroxetine
Human,02248721,Nu-Paroxetine,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Nu-Pharm Inc,2.0,R,2.0,Cancelled (unreturned annual),2018-03-28,N06AB05,Paroxetine
Human,02342405,Paroxetine,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Cobalt Pharmaceuticals Company,2.0,R,2.0,Cancelled pre market,2017-09-01,N06AB05,Paroxetine
Human,02388243,Paroxetine,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Sivem Pharmaceuticals Ulc,2.0,R,2.0,Marketed,2016-02-09,N06AB05,Paroxetine
Human,01940473,Paxil Tab 30Mg,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Glaxosmithkline Inc,2.0,R,2.0,Marketed,2002-11-13,N06AB05,Paroxetine
Human,02247752,Pms-Paroxetine,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Marketed,2003-10-29,N06AB05,Paroxetine
Human,02248915,Pro-Paroxetine,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Pro Doc Limitee,2.0,R,2.0,Marketed,2025-10-16,N06AB05,Paroxetine
Human,02247812,Ratio-Paroxetine,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Ratiopharm Inc Division Of Teva Canada Limited,2.0,R,2.0,Cancelled post market,2014-09-19,N06AB05,Paroxetine
Human,02269449,Sandoz Paroxetine,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N06AB05,Paroxetine
Human,02431793,Sandoz Paroxetine Tablets,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2019-08-01,N06AB05,Paroxetine
Human,02267128,Paxil Cr,paroxetine (paroxetine hydrochloride) 37.5 mg oral prolonged-release tablet,Glaxosmithkline Inc,2.0,R,2.0,Cancelled pre market,2017-02-10,N06AB05,Paroxetine
Human,02298961,Dom-Paroxetine,paroxetine (paroxetine hydrochloride) 40 mg oral tablet,Dominion Pharmacal,2.0,R,2.0,Cancelled pre market,2025-03-31,N06AB05,Paroxetine
Human,02293749,Pms-Paroxetine,paroxetine (paroxetine hydrochloride) 40 mg oral tablet,Pharmascience Inc,2.0,R,2.0,Dormant,2018-08-02,N06AB05,Paroxetine
Human,02248012,Mylan-Paroxetine,"paroxetine (paroxetine hydrochloride, isopropyl solvate) 10 mg oral tablet",Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2018-07-12,N06AB05,Paroxetine
Human,02338793,Q-Paroxetine,"paroxetine (paroxetine hydrochloride, isopropyl solvate) 10 mg oral tablet",Qd Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2015-08-21,N06AB05,Paroxetine
Human,02248013,Mylan-Paroxetine,"paroxetine (paroxetine hydrochloride, isopropyl solvate) 20 mg oral tablet",Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2018-07-12,N06AB05,Paroxetine
Human,02338807,Q-Paroxetine,"paroxetine (paroxetine hydrochloride, isopropyl solvate) 20 mg oral tablet",Qd Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2015-08-21,N06AB05,Paroxetine
Human,02254751,Sandoz Paroxetine,"paroxetine (paroxetine hydrochloride, isopropyl solvate) 20 mg oral tablet",Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2012-02-20,N06AB05,Paroxetine
Human,02248014,Mylan-Paroxetine,"paroxetine (paroxetine hydrochloride, isopropyl solvate) 30 mg oral tablet",Mylan Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2018-07-12,N06AB05,Paroxetine
Human,02338815,Q-Paroxetine,"paroxetine (paroxetine hydrochloride, isopropyl solvate) 30 mg oral tablet",Qd Pharmaceuticals Ulc,2.0,R,2.0,Cancelled post market,2015-08-21,N06AB05,Paroxetine
Human,02254778,Sandoz Paroxetine,"paroxetine (paroxetine hydrochloride, isopropyl solvate) 30 mg oral tablet",Sandoz Canada Incorporated,2.0,R,2.0,Cancelled post market,2012-02-20,N06AB05,Paroxetine
Human,02502984,Firdapse,amifampridine (amifampridine phosphate) 10 mg oral tablet,Kye Pharmaceuticals Inc.,,p,,Marketed,2020-10-23,N07XX05,Amifampridine
Human,02503034,Ruzurgi,amifampridine 10 mg oral tablet,Medunik Canada,,p,,Marketed,2023-01-24,N07XX05,Amifampridine
Human,02517841,Vyndamax,tafamidis 61 mg oral capsule,Pfizer Canada Ulc,2.0,,,Marketed,2021-09-15,N07XX08,Tafamidis
Human,02495732,Vyndaqel,tafamidis meglumine 20 mg oral capsule,Pfizer Canada Ulc,2.0,,,Marketed,2020-04-07,N07XX08,Tafamidis
Human,02532611,Radicava,edaravone 105 mg / 5 mL oral suspension,Mitsubishi Tanabe Pharma Corporation,,R,,Marketed,2023-02-09,N07XX14,Edaravone
Human,02475472,Radicava,edaravone 30 mg / 100 mL solution for injection,Mitsubishi Tanabe Pharma Corporation,,R,,Cancelled post market,2025-04-01,N07XX14,Edaravone
Human,02527707,Albrioza,sodium phenylbutyrate 3 g / sachet + ursodoxicoltaurine 1 g / sachet oral powder for suspension,Amylyx Pharmaceuticals Inc.,,R,,Cancelled post market,2024-09-23,N07XX19,Sodium phenylbutyrate and ursodoxicoltaurine
Human,02559056,Amivas-Artesunate,artesunate 110 mg / vial powder for solution for injection,Amivas Ireland Ltd.,1.0,,,Approved,2025-07-04,P01BE03,Artesunate
Human,01926748,Pentacarinat 300 Inj Pws 300Mg/Vial,pentamidine isetionate 300 mg / vial powder for solution for injection,Aventis Pharma Inc,,RH,,Cancelled post market,2005-08-01,P01CX01,Pentamidine isethionate
Human,00886874,Pentamidine Isethionate Inj 300Mg/Vial Bp,pentamidine isetionate 300 mg / vial powder for solution for injection,David Bull Laboratories (Pty) Ltd.,,RH,,Cancelled post market,1998-08-13,P01CX01,Pentamidine isethionate
Human,02183080,Pentamidine Isetionate For Injection Bp,pentamidine isetionate 300 mg / vial powder for solution for injection,Pfizer Canada Ulc,,RH,,Marketed,2018-06-27,P01CX01,Pentamidine isethionate
Human,02517663,Pentamidine Isetionate For Injection Bp,pentamidine isetionate 300 mg / vial powder for solution for injection,Marcan Pharmaceuticals Inc,,RH,,Marketed,2021-10-14,P01CX01,Pentamidine isethionate
Human,00438677,Sopamycetin Solution Ophthalmique 0.2%,chloramphenicol 0.2 % / % ophthalmic drops,Laboratoires Charton Laboratories,1.0,K,1.0,Cancelled post market,1999-01-16,S01AA01,Chloramphenicol
Human,00763535,Sopamycetin Oph Ont 0.2%,chloramphenicol 0.2 % / % ophthalmic ointment,Laboratoires Charton Laboratories,1.0,K,1.0,Cancelled post market,1999-01-16,S01AA01,Chloramphenicol
Human,00763454,Cebenicol Oph Liq 0.4%,chloramphenicol 0.4 % / % ophthalmic liquid,Chauvin Pharma Inc.,1.0,K,1.0,Cancelled post market,1997-07-15,S01AA01,Chloramphenicol
Human,00001082,Chloroptic Dps 0.5%,chloramphenicol 0.5 % / % ophthalmic drops,Allergan Inc,1.0,K,1.0,Cancelled post market,2011-08-04,S01AA01,Chloramphenicol
Human,00861383,Pms-Chloramphenicol Ophthalmic Soln 0.5%,chloramphenicol 0.5 % / % ophthalmic drops,Pharmascience Inc,1.0,K,1.0,Cancelled post market,2016-10-28,S01AA01,Chloramphenicol
Human,00221678,Chloromycetin Oph Soln 0.5%,chloramphenicol 0.5 % / % ophthalmic liquid,"Parke-Davis Division, Warner-Lambert Canada Inc.",1.0,K,1.0,Cancelled post market,1997-08-25,S01AA01,Chloramphenicol
Human,00707457,Ophtho-Chloram Liq 0.5%,chloramphenicol 0.5 % / % ophthalmic liquid,Altimed Pharma Inc.,1.0,K,1.0,Cancelled post market,1999-09-17,S01AA01,Chloramphenicol
Human,02148374,Minims Chloramphenicol 0.5%,chloramphenicol 0.5 % / % ophthalmic or topical drops,Chauvin Pharmaceuticals Limited,1.0,K,1.0,Cancelled post market,1999-12-31,S01AA01,Chloramphenicol
Human,02023857,Chloramphenicol,chloramphenicol 0.5 % ophthalmic solution,Pharma Stulln Inc.,1.0,K,1.0,Dormant,2019-08-13,S01AA01,Chloramphenicol
Human,00622958,Odan-Chloramphenicol,chloramphenicol 0.5 mg / mL ophthalmic liquid,Odan Laboratories Ltd,1.0,K,1.0,Dormant,2017-06-22,S01AA01,Chloramphenicol
Human,00024066,Chloromycetin Oph Ont 1%,chloramphenicol 1 % / % ophthalmic ointment,"Parke-Davis Division, Warner-Lambert Canada Inc.",1.0,K,1.0,Cancelled post market,1999-04-08,S01AA01,Chloramphenicol
Human,02026260,Chloramphenicol,chloramphenicol 1 % / w/w cutaneous ointment,Steri-Med Pharma Inc.,1.0,K,1.0,Approved,2025-03-04,S01AA01,Chloramphenicol
Human,00001341,Chloroptic Oph Ont 1%,chloramphenicol 10 mg / g ophthalmic ointment,Allergan Inc,1.0,K,1.0,Cancelled post market,2011-08-04,S01AA01,Chloramphenicol
Human,00627720,Odan-Chloramphenicol,chloramphenicol 10 mg / g ophthalmic ointment,Odan Laboratories Ltd,1.0,K,1.0,Dormant,2017-06-22,S01AA01,Chloramphenicol
Human,01980564,Pentamycetin Ont 10Mg/Gm,chloramphenicol 10 mg / g ophthalmic ointment,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled post market,2019-08-01,S01AA01,Chloramphenicol
Human,02237691,Pms-Chloramphenicol Ophthalmic Ointment,chloramphenicol 10 mg / g ophthalmic ointment,Pharmascience Inc,1.0,K,1.0,Cancelled pre market,2016-10-28,S01AA01,Chloramphenicol
Human,01980556,Pentamycetin Liq 2.5Mg/Ml,chloramphenicol 2.5 mg / mL ophthalmic solution,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled post market,2019-08-01,S01AA01,Chloramphenicol
Human,02164051,Pentamycetin Ophthalmic Solution 0.5% - Liq,chloramphenicol 5 mg / mL ophthalmic solution,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled post market,2019-08-01,S01AA01,Chloramphenicol
Human,02248119,Apo-Trifluridine Ophthalmic Solution,trifluridine 1 % ophthalmic solution,Apotex Inc,1.0,CK,1.0,Approved,2003-10-31,S01AD02,Trifluridine
Human,02248529,Sandoz Trifluridine,trifluridine 1 % ophthalmic solution,Sandoz Canada Incorporated,1.0,CK,1.0,Cancelled post market,2019-08-01,S01AD02,Trifluridine
Human,00687456,Viroptic,trifluridine 1 % ophthalmic solution,Bausch & Lomb Inc,1.0,CK,1.0,Dormant,2022-12-13,S01AD02,Trifluridine
Human,02530546,Eyezirgan,ganciclovir 0.15 % / w/w ophthalmic gel,Laboratoires Thea,1.0,CK,1.0,Marketed,2023-09-26,S01AD09,Ganciclovir
Human,02233015,"Vitrasert, Intravitreal Implant",ganciclovir 4.5 mg / implant intravitreal implant,Bausch & Lomb Inc,1.0,CK,1.0,Cancelled post market,2008-07-28,S01AD09,Ganciclovir
Human,00438669,Sopamycetin/Hc Susp,chloramphenicol 0.2 % / % + hydrocortisone acetate 1 % / % ophthalmic drops,Laboratoires Charton Laboratories,1.0,K,1.0,Cancelled post market,1999-01-16,S01CA03,Hydrocortisone and antiinfectives
Human,00156175,Ophthocort Ont,chloramphenicol 10 mg / g + hydrocortisone acetate 5 mg / g + polymyxin b (polymyxin b sulfate) 5000 units / g ophthalmic ointment,"Parke-Davis Division, Warner-Lambert Canada Inc.",1.0,K,1.0,Cancelled post market,1998-04-07,S01CA03,Hydrocortisone and antiinfectives
Human,02554178,Aflivu,aflibercept 2 mg / 0.05 mL intravitreal solution,Apotex Inc,2.0,R,,Marketed,2025-07-02,S01LA05,Aflibercept
Human,02554194,Aflivu,aflibercept 2 mg / 0.05 mL intravitreal solution,Apotex Inc,2.0,R,,Marketed,2025-07-02,S01LA05,Aflibercept
Human,02562928,Ahzantive,aflibercept 2 mg / 0.05 mL intravitreal solution,Valorum Biologics Llc,2.0,R,,Approved,2025-11-19,S01LA05,Aflibercept
Human,02562510,Enzeevu,aflibercept 2 mg / 0.05 mL intravitreal solution,Sandoz Canada Incorporated,2.0,R,,Approved,2025-10-30,S01LA05,Aflibercept
Human,02562529,Enzeevu,aflibercept 2 mg / 0.05 mL intravitreal solution,Sandoz Canada Incorporated,2.0,R,,Approved,2025-10-30,S01LA05,Aflibercept
Human,02563037,Eydenzelt,aflibercept 2 mg / 0.05 mL intravitreal solution,Celltrion Inc.,2.0,R,,Approved,2025-11-24,S01LA05,Aflibercept
Human,02563045,Eydenzelt,aflibercept 2 mg / 0.05 mL intravitreal solution,Celltrion Inc.,2.0,R,,Approved,2025-11-24,S01LA05,Aflibercept
Human,02415992,Eylea,aflibercept 2 mg / 0.05 mL intravitreal solution,Bayer Inc,2.0,R,,Marketed,2013-12-23,S01LA05,Aflibercept
Human,02505355,Eylea,aflibercept 2 mg / 0.05 mL intravitreal solution,Bayer Inc,2.0,R,,Marketed,2020-11-17,S01LA05,Aflibercept
Human,02561883,Opuviz,aflibercept 2 mg / 0.05 mL intravitreal solution,"Samsung Bioepis Co., Ltd",2.0,R,,Approved,2025-10-09,S01LA05,Aflibercept
Human,02561891,Opuviz,aflibercept 2 mg / 0.05 mL intravitreal solution,"Samsung Bioepis Co., Ltd",2.0,R,,Approved,2025-10-09,S01LA05,Aflibercept
Human,02550628,Pavblu,aflibercept 2 mg / 0.05 mL intravitreal solution,Amgen Canada Inc,2.0,R,,Approved,2025-07-08,S01LA05,Aflibercept
Human,02550636,Pavblu,aflibercept 2 mg / 0.05 mL intravitreal solution,Amgen Canada Inc,2.0,R,,Marketed,2025-09-03,S01LA05,Aflibercept
Human,02535858,Yesafili,aflibercept 2 mg / 0.05 mL intravitreal solution,Biosimilar Collaborations Ireland Limited,2.0,R,,Marketed,2025-07-01,S01LA05,Aflibercept
Human,02558238,Yesafili,aflibercept 2 mg / 0.05 mL intravitreal solution,Biosimilar Collaborations Ireland Limited,2.0,R,,Marketed,2025-07-01,S01LA05,Aflibercept
Human,02545004,Eylea Hd,aflibercept 8 mg / 0.07 mL intravitreal solution,Bayer Inc,2.0,R,,Marketed,2024-09-03,S01LA05,Aflibercept
Human,02554798,Eylea Hd,aflibercept 8 mg / 0.07 mL intravitreal solution,Bayer Inc,2.0,R,,Marketed,2025-04-07,S01LA05,Aflibercept
Human,02355655,Restasis,cyclosporine 0.05 % / w/v ophthalmic emulsion,Abbvie Corporation,1.0,K,1.0,Marketed,2024-02-05,S01XA18,Ciclosporin
Human,02476835,Restasis Multidose,cyclosporine 0.05 % / w/v ophthalmic emulsion,Abbvie Corporation,1.0,K,1.0,Marketed,2023-07-19,S01XA18,Ciclosporin
Human,02462486,Teva-Cyclosporine,cyclosporine 0.05 % / w/v ophthalmic emulsion,Teva Canada Limited,1.0,K,1.0,Marketed,2017-12-04,S01XA18,Ciclosporin
Human,02512629,Cequa,cyclosporine 0.09 % / w/v ophthalmic solution,Sun Pharmaceutical Industries Limited,1.0,K,1.0,Marketed,2022-12-08,S01XA18,Ciclosporin
Human,02484137,Verkazia,cyclosporine 0.1 % / w/v ophthalmic emulsion,Apotex Inc,1.0,K,1.0,Marketed,2025-12-08,S01XA18,Ciclosporin
Human,02505851,Luxturna,voretigene neparvovec 5000000000000 VG / mL subretinal solution,Novartis Pharmaceuticals Canada Inc,1.0,KH,,Marketed,2022-03-14,S01XA27,Voretigene neparvovec
Human,00717932,Sopamycetin Soln Otique 5%,chloramphenicol 5 % / % otic drops,Laboratoires Charton Laboratories,1.0,K,1.0,Cancelled post market,1999-01-16,S02AA01,Chloramphenicol
Human,00763543,Sopamycetin/Hc Ont,chloramphenicol 0.2 % / % + hydrocortisone acetate 1 % / % ophthalmic or otic ointment,Laboratoires Charton Laboratories,1.0,K,1.0,Cancelled post market,1999-01-16,S03CA04,Hydrocortisone and antiinfectives
Human,00837350,Sopamycetin/Hc Ointment,chloramphenicol 10 mg / g + hydrocortisone acetate 10 mg / g ophthalmic or otic ointment,Laboratoires Charton Laboratories,1.0,K,1.0,Cancelled post market,1999-01-16,S03CA04,Hydrocortisone and antiinfectives
Human,01980580,Pentamycetin/Hc,chloramphenicol 10 mg / g + hydrocortisone acetate 10 mg / g ophthalmic or otic ointment,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled post market,2019-08-01,S03CA04,Hydrocortisone and antiinfectives
Human,01980572,Pentamycetin/Hc,chloramphenicol 2 mg / mL + hydrocortisone acetate 10 mg / mL ophthalmic or otic suspension,Sandoz Canada Incorporated,1.0,K,1.0,Cancelled post market,2019-08-01,S03CA04,Hydrocortisone and antiinfectives
Human,01966073,Calcium Disodium Versenate Liq 200Mg/Ml,sodium calcium edetate 200 mg / mL liquid for injection,"3M Pharmaceuticals, A Division Of 3M Canada Company",2.0,R,2.0,Cancelled post market,2006-07-24,V03AB03,Edetates
Human,02436523,Ferriprox,deferiprone 100 mg / mL oral solution,Chiesi Canada Corp.,2.0,p,2.0,Marketed,2020-03-12,V03AC02,Deferiprone
Human,02536579,Ferriprox Mr,deferiprone 1000 mg oral prolonged-release tablet,Chiesi Canada Corp.,2.0,p,2.0,Marketed,2023-06-05,V03AC02,Deferiprone
Human,02436558,Ferriprox,deferiprone 1000 mg oral tablet,Chiesi Canada Corp.,2.0,p,2.0,Marketed,2020-03-12,V03AC02,Deferiprone
Human,02553112,Taro-Deferiprone,deferiprone 1000 mg oral tablet,Taro Pharmaceuticals Inc,2.0,p,2.0,Marketed,2025-03-03,V03AC02,Deferiprone
Human,02436531,Ferriprox,deferiprone 500 mg oral tablet,Chiesi Canada Corp.,2.0,p,2.0,Marketed,2020-03-12,V03AC02,Deferiprone
Human,02544083,Dexrazoxane For Injection,dexrazoxane 250 mg / vial powder for solution for injection,Juno Pharmaceuticals Corp.,1.0,K,1.0,Marketed,2025-06-21,V03AF02,Dexrazoxane
Human,02557649,Dexrazoxane For Injection,dexrazoxane 250 mg / vial powder for solution for injection,Hikma Canada Limited,1.0,K,1.0,Approved,2025-05-23,V03AF02,Dexrazoxane
Human,02153432,Zinecard,dexrazoxane 250 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Marketed,2009-02-03,V03AF02,Dexrazoxane
Human,02544091,Dexrazoxane For Injection,dexrazoxane 500 mg / vial powder for solution for injection,Juno Pharmaceuticals Corp.,1.0,K,1.0,Approved,2023-12-28,V03AF02,Dexrazoxane
Human,02153440,Zinecard,dexrazoxane 500 mg / vial powder for solution for injection,Pfizer Canada Ulc,1.0,K,1.0,Dormant,2018-03-29,V03AF02,Dexrazoxane
Human,02218054,Ethyol - Pws Iv 500Mg/Vial,amifostine 500 mg / vial powder for solution for injection,"Medimmune Oncology, Inc.",,R,,Cancelled post market,2008-01-01,V03AF05,Amifostine
Human,02274221,Kepivance,palifermin 6.25 mg / vial powder for solution for injection,Swedish Orphan Biovitrum Ab (Publ),2.0,P,2.0,Cancelled post market,2016-01-30,V03AF08,Palifermin
Human,02126699,Relisorm 100 For Inj.-Pws Liq-Kit Sc Iv,gonadorelin (gonadorelin acetate) 100 mcg / vial + sodium chloride 0.9 % / vial powder for solution or liquid for injection,"Emd Serono, A Division Of Emd Inc., Canada",2.0,,,Cancelled post market,2019-07-04,V04CM01,Gonadorelin
Human,02126702,Relisorm 500 For Inj.-Pws Liq-Kit Iv Sc,gonadorelin (gonadorelin acetate) 500 mcg / vial + sodium chloride 0.9 % / vial liquid or powder for solution for injection,"Emd Serono, A Division Of Emd Inc., Canada",2.0,,,Cancelled post market,2019-07-04,V04CM01,Gonadorelin
Human,02041820,Factrel Pws 500Mcg/Vial,gonadorelin (gonadorelin hydrochloride) 500 mcg / vial powder for solution for injection,Wyeth-Ayerst Canada Inc.,2.0,,,Cancelled post market,1999-10-26,V04CM01,Gonadorelin
Human,00368385,Factrel Inj 0.5Mg/Vial,gonadorelin hydrochloride 0.5 mg / vial powder for solution for injection,Ayerst Laboratories,2.0,,,Cancelled post market,1996-09-10,V04CM01,Gonadorelin
Human,02042096,Factrel Pws 100Mcg/Vial,gonadorelin hydrochloride 100 mcg / vial powder for solution for injection,Wyeth-Ayerst Canada Inc.,2.0,,,Cancelled post market,1999-10-26,V04CM01,Gonadorelin
Veterinary,00828939,Ecp Sterile Solution,estradiol cypionate 1 mg / mL solution for injection,The Upjohn Company - Animal Health Division,2.0,P,2.0,Cancelled post market,2004-07-22,G03AC03,Levonorgestrel
Veterinary,00241318,Chloralean Drops,chloramphenicol 4 mg / mL ophthalmic or otic solution,Bimeda-Mtc Animal Health Inc,1.0,K,1.0,Dormant,2018-07-31,S03AA08,Chloramphenicol
